1	ORIGINAL	JJ	O	original	amod	2	SENT_1	[p1l60t81r240b118],
2	ARTICLE	NN	O	article	_	0	SENT_1	[p1l251t81r400b118],

1	The	DT	O	the	det	5	SENT_2	[p1l62t195r235b270],
2	A	NN	O	a	nn	5	SENT_2	[p1l257t193r620b271],
3	—	NN	O	—	nn	5	SENT_2	[p1l257t193r620b271],
4	444C	NN	O	444c	nn	5	SENT_2	[p1l257t193r620b271],
5	Polymorphism	NN	O	polymorphism	nsubj	13	SENT_2	[p1l650t193r1315b291],
6	in	IN	O	in	_	0	SENT_2	[p1l1344t193r1430b269],
7	the	DT	O	the	det	11	SENT_2	[p1l1458t195r1596b270],
8	Leukotriene	NN	O	leukotriene	nn	11	SENT_2	[p1l61t310r612b387],
9	C4	NN	O	c4	nn	11	SENT_2	[p1l644t310r746b413],
10	Synthase	NN	O	synthase	nn	11	SENT_2	[p1l776t310r1179b408],
11	Gene	NN	O	gene	prep_in	5	SENT_2	[p1l1209t310r1441b388],
12	Is	VBZ	O	be	cop	13	SENT_2	[p1l1470t312r1548b387],
13	Associated	NNP	O	Associated	_	0	SENT_2	[p1l1571t310r2052b387],
14	With	IN	O	with	_	0	SENT_2	[p1l61t447r286b524],
15	Aspirin-Induced	NNP	O	Aspirin-Induced	nn	16	SENT_2	[p1l308t447r1055b545],
16	Urticaria	NNP	O	Urticaria	prep_with	13	SENT_2	[p1l1083t447r1499b525],

1	M	NN	O	m	_	0	SENT_3	[p1l64t600r105b648],
2	Sanchez-Borges	NNS	O	sanchez-borge	rcmod	1	SENT_3	[p1l132t597r577b664],
3	,	,	O	,	_	0	SENT_3	[p1l132t597r577b664],
4	‘	CD	NUMBER	‘	num	6	SENT_3	[p1l132t597r577b664],
5	N	NN	O	n	nn	6	SENT_3	[p1l607t600r637b648],
6	Acevedo	NNP	PERSON	Acevedo	appos	2	SENT_3	[p1l661t597r942b657],
7	,	,	O	,	_	0	SENT_3	[p1l661t597r942b657],
8	”	CD	NUMBER	”	num	9	SENT_3	[p1l661t597r942b657],
9	C	NN	O	c	appos	2	SENT_3	[p1l965t600r995b649],
10	Vergara	NNP	O	Vergara	dep	9	SENT_3	[p1l1015t597r1274b664],
11	,2	CD	NUMBER	,2	num	10	SENT_3	[p1l1015t597r1274b664],
12	'	''	O	'	_	0	SENT_3	[p1l1015t597r1274b664],
13	3	CD	NUMBER	3	num	14	SENT_3	[p1l1015t597r1274b664],
14	Sjiménez	NN	O	sjiménez	dep	2	SENT_3	[p1l1296t597r1613b661],
15	,2	NN	O	,2	dep	14	SENT_3	[p1l1296t597r1613b661],
16	'	''	O	'	_	0	SENT_3	[p1l1296t597r1613b661],
17	3	CD	NUMBER	3	num	19	SENT_3	[p1l1296t597r1613b661],
18	P	NN	O	p	nn	19	SENT_3	[p1l1638t600r1662b648],
19	Zabner-Ozie	NNP	O	Zabner-Ozie	dep	2	SENT_3	[p1l1685t597r2056b657],
20	|	CD	NUMBER	|	number	21	SENT_3	[p1l1685t597r2056b657],
21	,4	CD	NUMBER	,4	dep	19	SENT_3	[p1l1685t597r2056b657],
22	A	DT	O	a	det	25	SENT_3	[p1l59t697r96b745],
23	Monzon	NNP	O	Monzon	nn	25	SENT_3	[p1l120t694r363b754],
24	,4	CD	NUMBER	,4	num	25	SENT_3	[p1l120t694r363b754],
25	L	NN	O	l	dep	21	SENT_3	[p1l386t697r407b745],
26	Caraballo2	NN	O	caraballo2	dep	1	SENT_3	[p1l429t694r719b746],
27	'	''	O	'	_	0	SENT_3	[p1l429t694r719b746],
28	3	CD	NUMBER	3	dep	26	SENT_3	[p1l429t694r719b746],

1	‘	NN	O	‘	_	0	SENT_4	[p1l61t823r308b869],
2	Immunology	NN	O	immunology	rcmod	1	SENT_4	[p1l61t823r308b869],
3	and	CC	O	and	_	0	SENT_4	[p1l322t823r385b858],
4	Allergology	NNP	ORGANIZATION	Allergology	nn	5	SENT_4	[p1l400t823r607b869],
5	Service	NNP	ORGANIZATION	Service	rcmod	1	SENT_4	[p1l621t824r755b864],
6	,	,	O	,	_	0	SENT_4	[p1l621t824r755b864],
7	El	NNP	ORGANIZATION	El	nn	9	SENT_4	[p1l773t823r799b858],
8	Avila	NNP	ORGANIZATION	Avila	nn	9	SENT_4	[p1l814t815r901b858],
9	Clinic	NNP	ORGANIZATION	Clinic	conj_and	2	SENT_4	[p1l918t823r1015b858],
10	and	CC	O	and	_	0	SENT_4	[p1l1031t823r1093b858],
11	La	NNP	ORGANIZATION	La	nn	14	SENT_4	[p1l1112t825r1145b858],
12	Trinidad	NNP	ORGANIZATION	Trinidad	nn	14	SENT_4	[p1l1161t823r1303b858],
13	Medical	NNP	ORGANIZATION	Medical	nn	14	SENT_4	[p1l1323t823r1458b858],
14	Center	NNP	ORGANIZATION	Center	conj_and	2	SENT_4	[p1l1476t824r1598b864],
15	,	,	O	,	_	0	SENT_4	[p1l1476t824r1598b864],
16	Caracas	NNP	LOCATION	Caracas	conj_and	2	SENT_4	[p1l1615t824r1758b864],
17	,	,	O	,	_	0	SENT_4	[p1l1615t824r1758b864],
18	Venezuela	NNP	LOCATION	Venezuela	nn	19	SENT_4	[p1l1773t823r1952b858],
19	2Institute	NNP	O	2Institute	rcmod	1	SENT_4	[p1l60t886r231b922],
20	for	IN	O	for	_	0	SENT_4	[p1l246t886r298b922],
21	Immunological	NNP	ORGANIZATION	Immunological	nn	22	SENT_4	[p1l313t886r580b933],
22	Research	NNP	ORGANIZATION	Research	prep_for	19	SENT_4	[p1l599t886r763b928],
23	,	,	O	,	_	0	SENT_4	[p1l599t886r763b928],
24	University	NNP	ORGANIZATION	University	rcmod	1	SENT_4	[p1l781t887r958b933],
25	of	IN	ORGANIZATION	of	_	0	SENT_4	[p1l973t886r1011b922],
26	Cartagena	NNP	ORGANIZATION	Cartagena	prep_of	24	SENT_4	[p1l1024t888r1215b933],
27	,	,	O	,	_	0	SENT_4	[p1l1024t888r1215b933],
28	Cartagena	NNP	LOCATION	Cartagena	nn	32	SENT_4	[p1l1232t888r1423b933],
29	,	,	O	,	_	0	SENT_4	[p1l1232t888r1423b933],
30	Colombia	NNP	LOCATION	Colombia	appos	32	SENT_4	[p1l1440t886r1606b922],
31	3	CD	NUMBER	3	num	32	SENT_4	[p1l60t950r71b971],
32	Fundemeb	NNP	O	Fundemeb	conj_and	2	SENT_4	[p1l83t950r273b992],
33	,	,	O	,	_	0	SENT_4	[p1l83t950r273b992],
34	Foundation	NNP	O	Foundation	rcmod	1	SENT_4	[p1l291t950r492b986],
35	for	IN	O	for	_	0	SENT_4	[p1l508t950r560b986],
36	the	DT	O	the	det	37	SENT_4	[p1l574t950r631b986],
37	Development	NN	ORGANIZATION	development	prep_for	34	SENT_4	[p1l649t950r885b997],
38	of	IN	ORGANIZATION	of	_	0	SENT_4	[p1l900t950r938b986],
39	Medical	NNP	ORGANIZATION	Medical	nn	42	SENT_4	[p1l952t950r1088b986],
40	and	CC	ORGANIZATION	and	_	0	SENT_4	[p1l1105t950r1168b986],
41	Biological	NNP	ORGANIZATION	Biological	conj_and	39	SENT_4	[p1l1187t950r1358b997],
42	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	37	SENT_4	[p1l1375t951r1534b992],
43	,	,	O	,	_	0	SENT_4	[p1l1375t951r1534b992],
44	Colombia	NNP	LOCATION	Colombia	nn	47	SENT_4	[p1l1550t950r1716b986],
45	‘	CD	NUMBER	‘	num	47	SENT_4	[p1l59t1014r308b1061],
46	llmmunology	NNP	O	llmmunology	nn	47	SENT_4	[p1l59t1014r308b1061],
47	Service	NNP	O	Service	conj_and	2	SENT_4	[p1l322t1015r457b1056],
48	,	,	O	,	_	0	SENT_4	[p1l322t1015r457b1056],
49	Institute	NNP	ORGANIZATION	Institute	conj_and	2	SENT_4	[p1l472t1015r623b1050],
50	of	IN	ORGANIZATION	of	_	0	SENT_4	[p1l640t1014r678b1050],
51	Oncology	NNP	ORGANIZATION	Oncology	prep_of	49	SENT_4	[p1l690t1014r859b1061],
52	and	CC	ORGANIZATION	and	_	0	SENT_4	[p1l873t1014r936b1050],
53	Hematology	NNP	ORGANIZATION	Hematology	conj_and	51	SENT_4	[p1l955t1014r1177b1061],
54	,	,	O	,	_	0	SENT_4	[p1l955t1014r1177b1061],
55	Ministry	NNP	ORGANIZATION	Ministry	rcmod	1	SENT_4	[p1l1195t1015r1340b1061],
56	of	IN	ORGANIZATION	of	_	0	SENT_4	[p1l1355t1014r1393b1050],
57	Health	NNP	ORGANIZATION	Health	nn	60	SENT_4	[p1l1407t1014r1520b1050],
58	and	CC	O	and	_	0	SENT_4	[p1l1538t1014r1600b1050],
59	Social	NNP	O	Social	nn	60	SENT_4	[p1l1618t1014r1720b1050],
60	Development	NNP	O	Development	prep_of	55	SENT_4	[p1l1739t1014r1983b1061],
61	,	,	O	,	_	0	SENT_4	[p1l1739t1014r1983b1061],
62	Venezuela	NNP	LOCATION	Venezuela	dep	1	SENT_4	[p1l80t1078r259b1113],

1	I	PRP	O	I	_	0	SENT_5	[p1l108t1239r137b1268],
2	Abstract	JJ	O	abstract	advmod	1	SENT_5	[p1l149t1235r296b1269],
3	Bar/rgrouna	NN	O	bar/rgrouna	prep	1	SENT_5	[p1l109t1300r411b1340],
4	’	NN	O	’	dep	3	SENT_5	[p1l109t1300r411b1340],
5	.	.	O	.	_	0	SENT_5	[p1l109t1300r411b1340],
6	'	''	O	'	_	0	SENT_5	[p1l109t1300r411b1340],

1	Cysteinyl	NN	O	cysteinyl	nn	3	SENT_6	[p1l109t1300r411b1340],
2	leukotriene	NN	O	leukotriene	nn	3	SENT_6	[p1l424t1300r580b1331],
3	production	NN	O	production	nsubj	4	SENT_6	[p1l593t1300r743b1340],
4	seems	VBZ	O	seem	_	0	SENT_6	[p1l755t1308r842b1331],
5	to	TO	O	to	aux	7	SENT_6	[p1l852t1304r879b1331],
6	be	VB	O	be	auxpass	7	SENT_6	[p1l893t1300r924b1331],
7	dysregulated	VBN	O	dysregulate	xcomp	4	SENT_6	[p1l936t1300r1115b1340],
8	in	IN	O	in	_	0	SENT_6	[p1l1129t1301r1151b1330],
9	patients	NNS	O	patient	prep_in	7	SENT_6	[p1l1165t1301r1276b1340],
10	with	IN	O	with	_	0	SENT_6	[p1l1287t1300r1347b1331],
11	hypersensitivity	NN	O	hypersensitivity	prep_with	9	SENT_6	[p1l1361t1300r1576b1340],
12	to	TO	O	to	_	0	SENT_6	[p1l1586t1304r1613b1331],
13	aspirin	NN	O	aspirin	nn	18	SENT_6	[p1l1625t1301r1717b1340],
14	and	CC	O	and	_	0	SENT_6	[p1l1730t1300r1780b1331],
15	other	JJ	O	other	nn	18	SENT_6	[p1l1793t1300r1867b1331],
16	nonsteroidal	JJ	O	nonsteroidal	amod	18	SENT_6	[p1l1879t1300r2052b1331],
17	anti-inﬁammatory	JJ	O	anti-inﬁammatory	amod	18	SENT_6	[p1l108t1342r362b1381],
18	drugs	NNS	O	drug	prep_to	7	SENT_6	[p1l375t1341r452b1381],
19	(	VBN	O	(	partmod	18	SENT_6	[p1l465t1343r599b1378],
20	NSAIDs	NNS	MISC	nsaid	dobj	19	SENT_6	[p1l465t1343r599b1378],
21	)	CD	NUMBER	)	dep	20	SENT_6	[p1l465t1343r599b1378],
22	.	.	O	.	_	0	SENT_6	[p1l465t1343r599b1378],

1	However	RB	O	however	advmod	12	SENT_7	[p1l613t1343r740b1377],
2	,	,	O	,	_	0	SENT_7	[p1l613t1343r740b1377],
3	the	DT	O	the	det	6	SENT_7	[p1l752t1341r797b1372],
4	underlying	VBG	O	underlie	amod	6	SENT_7	[p1l812t1341r959b1381],
5	pathogenic	JJ	O	pathogenic	amod	6	SENT_7	[p1l973t1341r1129b1382],
6	mechanisms	NNS	O	mechanism	nsubjpass	12	SENT_7	[p1l1144t1341r1316b1372],
7	of	IN	O	of	_	0	SENT_7	[p1l1330t1341r1358b1372],
8	these	DT	O	these	det	9	SENT_7	[p1l1368t1341r1443b1372],
9	reactions	NNS	O	reaction	prep_of	6	SENT_7	[p1l1458t1342r1584b1372],
10	are	VBP	O	be	auxpass	12	SENT_7	[p1l1598t1350r1640b1372],
11	poorly	RB	O	poorly	advmod	12	SENT_7	[p1l1655t1341r1741b1382],
12	understood	VBN	O	understand	_	0	SENT_7	[p1l1755t1341r1922b1373],
13	.	.	O	.	_	0	SENT_7	[p1l1755t1341r1922b1373],

1	Previous	JJ	O	previous	amod	2	SENT_8	[p1l1937t1342r2053b1372],
2	studies	NNS	O	study	nsubj	4	SENT_8	[p1l108t1383r205b1414],
3	have	VBP	O	have	aux	4	SENT_8	[p1l222t1383r286b1414],
4	suggested	VBN	O	suggest	_	0	SENT_8	[p1l301t1383r443b1423],
5	a	DT	O	a	det	6	SENT_8	[p1l459t1392r473b1414],
6	role	NN	O	role	dobj	4	SENT_8	[p1l490t1383r540b1414],
7	for	IN	O	for	_	0	SENT_8	[p1l555t1383r594b1414],
8	the	DT	O	the	det	10	SENT_8	[p1l607t1383r651b1414],
9	A	NN	O	a	nn	10	SENT_8	[p1l663t1385r781b1414],
10	—	NN	O	—	prep_for	6	SENT_8	[p1l663t1385r781b1414],
11	444C	NN	O	444c	nn	12	SENT_8	[p1l663t1385r781b1414],
12	polymorphism	NN	O	polymorphism	dep	22	SENT_8	[p1l798t1383r994b1423],
13	on	IN	O	on	_	0	SENT_8	[p1l1011t1392r1043b1414],
14	the	DT	O	the	det	17	SENT_8	[p1l1059t1383r1103b1414],
15	leukotriene	NN	O	leukotriene	nn	17	SENT_8	[p1l1119t1383r1275b1414],
16	C4	NN	O	c4	nn	17	SENT_8	[p1l1291t1385r1321b1427],
17	synthase	NN	O	synthase	prep_on	12	SENT_8	[p1l1335t1383r1456b1423],
18	gene	NN	O	gene	dep	22	SENT_8	[p1l1471t1392r1539b1423],
19	(	CD	NUMBER	(	num	18	SENT_8	[p1l1554t1385r1652b1420],
20	[	CD	NUMBER	[	number	21	SENT_8	[p1l1554t1385r1652b1420],
21	7645	CD	NUMBER	7645	num	22	SENT_8	[p1l1554t1385r1652b1420],
22	)	NN	O	)	dep	26	SENT_8	[p1l1554t1385r1652b1420],
23	in	IN	O	in	_	0	SENT_8	[p1l1668t1384r1690b1414],
24	aspirin-induced	JJ	O	aspirin-induced	amod	25	SENT_8	[p1l1706t1383r1922b1423],
25	urticaria	NN	O	urticarium	prep_in	22	SENT_8	[p1l1939t1384r2052b1414],
26	(	CD	NUMBER	(	dep	6	SENT_8	[p1l108t1427r187b1462],
27	AIU	NNP	ORGANIZATION	AIU	dep	26	SENT_8	[p1l108t1427r187b1462],
28	)	CD	NUMBER	)	num	27	SENT_8	[p1l108t1427r187b1462],
29	,	,	O	,	_	0	SENT_8	[p1l108t1427r187b1462],
30	but	CC	O	but	_	0	SENT_8	[p1l200t1425r245b1456],
31	the	DT	O	the	det	32	SENT_8	[p1l256t1425r300b1456],
32	results	NNS	O	result	nsubj	34	SENT_8	[p1l313t1425r402b1456],
33	are	VBP	O	be	cop	34	SENT_8	[p1l415t1433r457b1456],
34	controversial	JJ	O	controversial	conj_but	4	SENT_8	[p1l470t1425r658b1456],
35	.	.	O	.	_	0	SENT_8	[p1l470t1425r658b1456],

1	Object/ve	NN	O	object/ve	_	0	SENT_9	[p1l111t1467r279b1507],
2	.	.	O	.	_	0	SENT_9	[p1l111t1467r279b1507],
3	'	''	O	'	_	0	SENT_9	[p1l111t1467r279b1507],

1	To	TO	O	to	aux	2	SENT_10	[p1l111t1467r279b1507],
2	evaluate	VB	O	evaluate	_	0	SENT_10	[p1l293t1467r410b1497],
3	in	IN	O	in	_	0	SENT_10	[p1l424t1468r445b1497],
4	a	DT	O	a	det	6	SENT_10	[p1l459t1475r472b1497],
5	case-control	JJ	O	case-control	amod	6	SENT_10	[p1l486t1467r657b1497],
6	study	NN	O	study	prep_in	2	SENT_10	[p1l670t1467r745b1507],
7	whether	IN	O	whether	complm	18	SENT_10	[p1l755t1467r872b1497],
8	the	DT	O	the	det	10	SENT_10	[p1l883t1467r927b1497],
9	A-444C	NN	O	a-444c	nn	10	SENT_10	[p1l936t1468r1054b1497],
10	polymorphism	NN	O	polymorphism	nsubjpass	18	SENT_10	[p1l1068t1467r1264b1507],
11	in	IN	O	in	_	0	SENT_10	[p1l1279t1468r1301b1497],
12	the	DT	O	the	det	14	SENT_10	[p1l1313t1467r1357b1497],
13	promoter	NN	O	promoter	nn	14	SENT_10	[p1l1371t1471r1500b1507],
14	region	NN	O	region	prep_in	10	SENT_10	[p1l1512t1467r1599b1507],
15	of	IN	O	of	_	0	SENT_10	[p1l1612t1466r1640b1497],
16	ITC45	NN	O	itc45	prep_of	14	SENT_10	[p1l1652t1468r1734b1497],
17	is	VBZ	O	be	auxpass	18	SENT_10	[p1l1741t1468r1759b1497],
18	associated	VBN	O	associate	ccomp	2	SENT_10	[p1l1772t1467r1918b1497],
19	with	IN	O	with	_	0	SENT_10	[p1l1931t1467r1991b1497],
20	AIU	NNP	ORGANIZATION	AIU	prep_with	18	SENT_10	[p1l2001t1468r2051b1497],
21	and	CC	O	and	_	0	SENT_10	[p1l108t1508r158b1539],
22	atopic	JJ	O	atopic	amod	23	SENT_10	[p1l172t1509r257b1548],
23	phenotypes	NNS	O	phenotype	conj_and	20	SENT_10	[p1l270t1508r431b1548],
24	in	IN	O	in	_	0	SENT_10	[p1l444t1509r466b1539],
25	a	DT	O	a	det	27	SENT_10	[p1l479t1517r493b1539],
26	Venezuelan	JJ	LOCATION	venezuelan	amod	27	SENT_10	[p1l503t1508r665b1539],
27	population	NN	O	population	prep_in	18	SENT_10	[p1l680t1508r839b1548],
28	.	.	O	.	_	0	SENT_10	[p1l680t1508r839b1548],

1	Methods	NNS	O	method	_	0	SENT_11	[p1l110t1550r238b1581],
2	.	.	O	.	_	0	SENT_11	[p1l110t1550r238b1581],

1	‘	NNP	O	‘	nsubjpass	13	SENT_12	[p1l110t1550r238b1581],
2	One	CD	NUMBER	one	num	1	SENT_12	[p1l250t1551r305b1581],
3	hundred	CD	NUMBER	hundred	number	4	SENT_12	[p1l322t1550r436b1581],
4	ten	CD	NUMBER	ten	num	5	SENT_12	[p1l453t1554r496b1581],
5	patients	NNS	O	patient	npadvmod	1	SENT_12	[p1l514t1551r625b1590],
6	with	IN	O	with	_	0	SENT_12	[p1l640t1550r700b1581],
7	AIU	NNP	ORGANIZATION	AIU	prep_with	1	SENT_12	[p1l714t1552r764b1581],
8	and	CC	O	and	_	0	SENT_12	[p1l781t1550r832b1581],
9	165	CD	NUMBER	165	num	11	SENT_12	[p1l850t1551r902b1581],
10	nonallergic	JJ	O	nonallergic	amod	11	SENT_12	[p1l920t1550r1074b1590],
11	controls	NNS	O	control	prep_with	1	SENT_12	[p1l1090t1550r1200b1581],
12	were	VBD	O	be	auxpass	13	SENT_12	[p1l1215t1558r1284b1581],
13	included	VBN	O	include	_	0	SENT_12	[p1l1301t1550r1426b1581],
14	.	.	O	.	_	0	SENT_12	[p1l1301t1550r1426b1581],

1	AIU	NNP	ORGANIZATION	AIU	nsubjpass	8	SENT_13	[p1l1438t1552r1488b1581],
2	was	VBD	O	be	auxpass	3	SENT_13	[p1l1505t1558r1560b1581],
3	diagnosed	VBN	O	diagnose	_	0	SENT_13	[p1l1576t1550r1719b1590],
4	by	IN	O	by	_	0	SENT_13	[p1l1738t1550r1768b1590],
5	clinical	JJ	O	clinical	amod	6	SENT_13	[p1l1783t1550r1876b1581],
6	history	NN	O	history	agent	3	SENT_13	[p1l1894t1550r1987b1590],
7	and	CC	O	and	_	0	SENT_13	[p1l2002t1550r2052b1581],
8	conﬁrmed	VBN	O	conﬁrmed	conj_and	3	SENT_13	[p1l108t1592r247b1623],
9	by	IN	O	by	_	0	SENT_13	[p1l264t1592r294b1632],
10	double-blind	JJ	O	double-blind	amod	12	SENT_13	[p1l308t1592r485b1623],
11	placebo	NN	O	placebo	nn	12	SENT_13	[p1l502t1592r763b1632],
12	—	NN	O	—	prep_by	8	SENT_13	[p1l502t1592r763b1632],
13	controlled	VBN	O	control	partmod	12	SENT_13	[p1l502t1592r763b1632],
14	oral	JJ	O	oral	amod	16	SENT_13	[p1l780t1592r830b1623],
15	provocation	NN	O	provocation	nn	16	SENT_13	[p1l847t1593r1011b1632],
16	tests	NNS	O	test	dobj	13	SENT_13	[p1l1026t1596r1091b1623],
17	with	IN	O	with	_	0	SENT_13	[p1l1105t1592r1165b1623],
18	NSAlDs	NNS	O	nsald	prep_with	13	SENT_13	[p1l1182t1593r1292b1623],
19	.	.	O	.	_	0	SENT_13	[p1l1182t1593r1292b1623],

1	Genotyping	NN	O	genotyping	nsubjpass	7	SENT_14	[p1l1307t1593r1470b1632],
2	of	IN	O	of	_	0	SENT_14	[p1l1484t1592r1512b1623],
3	A	DT	O	a	det	5	SENT_14	[p1l1521t1593r1639b1623],
4	—	CD	NUMBER	—	num	5	SENT_14	[p1l1521t1593r1639b1623],
5	444C	NN	O	444c	prep_of	1	SENT_14	[p1l1521t1593r1639b1623],
6	was	VBD	O	be	auxpass	7	SENT_14	[p1l1653t1600r1708b1623],
7	performed	VBN	O	perform	_	0	SENT_14	[p1l1723t1592r1866b1632],
8	by	IN	O	by	_	0	SENT_14	[p1l1884t1592r1914b1632],
9	real	JJ	O	real	amod	14	SENT_14	[p1l1928t1592r2053b1623],
10	—	JJ	O	—	amod	14	SENT_14	[p1l1928t1592r2053b1623],
11	time	NN	O	time	nn	14	SENT_14	[p1l1928t1592r2053b1623],
12	polymerase	NN	O	polymerase	nn	14	SENT_14	[p1l109t1633r267b1673],
13	chain	NN	O	chain	nn	14	SENT_14	[p1l281t1633r354b1664],
14	reaction	NN	O	reaction	agent	7	SENT_14	[p1l369t1634r480b1664],
15	using	VBG	O	use	xcomp	7	SENT_14	[p1l496t1634r570b1673],
16	Taqman	NNP	MISC	Taqman	nn	17	SENT_14	[p1l579t1635r690b1673],
17	probes	NNS	O	probe	dobj	15	SENT_14	[p1l705t1633r805b1673],
18	.	.	O	.	_	0	SENT_14	[p1l705t1633r805b1673],

1	Atopy	NN	PERSON	atopy	nsubjpass	3	SENT_15	[p1l815t1635r899b1673],
2	was	VBD	O	be	auxpass	3	SENT_15	[p1l910t1642r965b1664],
3	deﬁned	VBN	O	deﬁned	_	0	SENT_15	[p1l979t1633r1082b1664],
4	as	IN	O	as	mark	9	SENT_15	[p1l1096t1642r1125b1664],
5	a	DT	O	a	det	8	SENT_15	[p1l1139t1642r1152b1664],
6	positive	JJ	O	positive	amod	8	SENT_15	[p1l1168t1634r1274b1673],
7	skin	NN	O	skin	nn	8	SENT_15	[p1l1288t1633r1341b1664],
8	test	NN	O	test	nsubj	9	SENT_15	[p1l1355t1637r1407b1664],
9	result	VBP	O	result	advcl	3	SENT_15	[p1l1420t1633r1497b1664],
10	to	TO	O	to	_	0	SENT_15	[p1l1508t1637r1535b1664],
11	any	DT	O	any	prep_to	9	SENT_15	[p1l1550t1642r1598b1673],
12	of	IN	O	of	_	0	SENT_15	[p1l1611t1633r1639b1664],
13	the	DT	O	the	det	15	SENT_15	[p1l1649t1633r1693b1664],
14	25	CD	NUMBER	25	num	15	SENT_15	[p1l1707t1635r1742b1664],
15	aeroallergens	NNS	O	aeroallergen	prep_of	11	SENT_15	[p1l1756t1633r1946b1673],
16	tested	VBN	O	test	partmod	15	SENT_15	[p1l1959t1633r2053b1664],
17	.	.	O	.	_	0	SENT_15	[p1l1959t1633r2053b1664],

1	Total	JJ	O	total	amod	4	SENT_16	[p1l107t1675r174b1706],
2	and	CC	O	and	_	0	SENT_16	[p1l188t1675r238b1706],
3	mite-speciﬁc	JJ	O	mite-speciﬁc	conj_and	1	SENT_16	[p1l253t1676r428b1715],
4	immunoglobulin	NN	O	immunoglobulin	nsubjpass	13	SENT_16	[p1l442t1675r670b1715],
5	(	NN	O	(	nn	6	SENT_16	[p1l683t1677r728b1715],
6	Ig	NN	O	ig	dep	4	SENT_16	[p1l683t1677r728b1715],
7	)	CD	NUMBER	)	num	9	SENT_16	[p1l683t1677r728b1715],
8	E	NN	O	e	nn	9	SENT_16	[p1l742t1677r755b1706],
9	levels	NNS	O	level	dep	4	SENT_16	[p1l769t1675r844b1706],
10	in	IN	O	in	_	0	SENT_16	[p1l857t1676r879b1706],
11	serum	NN	O	serum	prep_in	9	SENT_16	[p1l892t1684r975b1706],
12	were	VBD	O	be	auxpass	13	SENT_16	[p1l988t1684r1056b1706],
13	quantiﬁed	VBN	O	quantiﬁed	_	0	SENT_16	[p1l1069t1675r1210b1715],
14	using	VBG	O	use	xcomp	13	SENT_16	[p1l1224t1676r1298b1715],
15	an	DT	O	a	det	18	SENT_16	[p1l1310t1684r1342b1706],
16	enzyme-linked	JJ	O	enzyme-linked	amod	18	SENT_16	[p1l1356t1675r1556b1715],
17	immunosorbent	JJ	O	immunosorbent	amod	18	SENT_16	[p1l1571t1675r1793b1706],
18	assay	NN	O	assay	dobj	14	SENT_16	[p1l1805t1684r1886b1715],
19	.	.	O	.	_	0	SENT_16	[p1l1805t1684r1886b1715],

1	/	:	O	/	punct	2	SENT_17	[p1l109t1717r337b1748],
2	iesu/z	NN	O	iesu/z	dep	4	SENT_17	[p1l109t1717r337b1748],
3	‘	CD	NUMBER	‘	num	2	SENT_17	[p1l109t1717r337b1748],
4	s	NNS	O	s	_	0	SENT_17	[p1l109t1717r337b1748],
5	:	:	O	:	_	0	SENT_17	[p1l109t1717r337b1748],
6	A	DT	O	a	det	8	SENT_17	[p1l109t1717r337b1748],
7	—	JJ	O	—	amod	8	SENT_17	[p1l109t1717r337b1748],
8	444C	NN	O	444c	dep	4	SENT_17	[p1l109t1717r337b1748],
9	was	VBD	O	be	auxpass	10	SENT_17	[p1l349t1725r403b1748],
10	associated	VBN	O	associate	rcmod	8	SENT_17	[p1l416t1717r563b1748],
11	with	IN	O	with	_	0	SENT_17	[p1l576t1717r636b1748],
12	AIU	NNP	ORGANIZATION	AIU	prep_with	10	SENT_17	[p1l647t1717r764b1748],
13	.	.	O	.	_	0	SENT_17	[p1l647t1717r764b1748],

1	The	DT	O	the	det	3	SENT_18	[p1l647t1717r764b1748],
2	C	NN	O	c	nn	3	SENT_18	[p1l778t1718r795b1748],
3	allele	NN	O	allele	nsubj	6	SENT_18	[p1l808t1717r881b1748],
4	was	VBD	O	be	cop	6	SENT_18	[p1l893t1725r948b1748],
5	more	RBR	O	more	advmod	6	SENT_18	[p1l962t1725r1031b1748],
6	frequent	JJ	O	frequent	_	0	SENT_18	[p1l1043t1717r1163b1757],
7	in	IN	O	in	_	0	SENT_18	[p1l1176t1718r1198b1747],
8	patients	NNS	O	patient	prep_in	6	SENT_18	[p1l1213t1718r1324b1757],
9	with	IN	O	with	_	0	SENT_18	[p1l1336t1717r1397b1748],
10	the	DT	O	the	det	12	SENT_18	[p1l1410t1717r1454b1748],
11	cutaneous	JJ	O	cutaneous	amod	12	SENT_18	[p1l1467t1721r1612b1748],
12	pattern	NN	O	pattern	prep_with	8	SENT_18	[p1l1626t1721r1725b1757],
13	of	IN	O	of	_	0	SENT_18	[p1l1739t1717r1767b1748],
14	AIU	NNP	ORGANIZATION	AIU	prep_of	12	SENT_18	[p1l1775t1718r1825b1748],
15	and	CC	O	and	_	0	SENT_18	[p1l1840t1717r1890b1748],
16	in	IN	O	in	_	0	SENT_18	[p1l1905t1718r1926b1747],
17	patients	NNS	O	patient	prep_in	8	SENT_18	[p1l1942t1718r2053b1757],
18	with	IN	O	with	_	0	SENT_18	[p1l107t1758r167b1789],
19	low	JJ	O	low	amod	21	SENT_18	[p1l181t1758r230b1789],
20	skin	NN	O	skin	nn	21	SENT_18	[p1l240t1758r294b1789],
21	reactivity	NN	O	reactivity	prep_with	17	SENT_18	[p1l307t1759r433b1798],
22	to	TO	O	to	_	0	SENT_18	[p1l443t1762r470b1789],
23	histamine	NN	O	histamine	prep_to	6	SENT_18	[p1l483t1758r710b1789],
24	.	.	O	.	_	0	SENT_18	[p1l483t1758r710b1789],

1	There	EX	O	there	expl	2	SENT_19	[p1l483t1758r710b1789],
2	was	VBD	O	be	_	0	SENT_19	[p1l721t1767r775b1789],
3	no	DT	O	no	det	4	SENT_19	[p1l788t1767r821b1789],
4	association	NN	O	association	nsubj	2	SENT_19	[p1l833t1759r989b1789],
5	between	IN	O	between	_	0	SENT_19	[p1l1002t1758r1121b1789],
6	A	DT	O	a	det	8	SENT_19	[p1l1131t1760r1249b1789],
7	—	CD	NUMBER	—	num	8	SENT_19	[p1l1131t1760r1249b1789],
8	444C	NN	O	444c	prep_between	4	SENT_19	[p1l1131t1760r1249b1789],
9	and	CC	O	and	_	0	SENT_19	[p1l1261t1758r1311b1789],
10	asthma	NN	O	asthma	conj_and	4	SENT_19	[p1l1324t1758r1435b1794],
11	,	,	O	,	_	0	SENT_19	[p1l1324t1758r1435b1794],
12	atopy	NN	O	atopy	conj_or	10	SENT_19	[p1l1446t1762r1530b1798],
13	,	,	O	,	_	0	SENT_19	[p1l1446t1762r1530b1798],
14	or	CC	O	or	_	0	SENT_19	[p1l1542t1767r1569b1789],
15	total	JJ	O	total	amod	17	SENT_19	[p1l1579t1758r1642b1789],
16	IgE	NN	O	ige	nn	17	SENT_19	[p1l1654t1760r1696b1798],
17	levels	NNS	O	level	conj_and	4	SENT_19	[p1l1709t1758r1791b1789],
18	.	.	O	.	_	0	SENT_19	[p1l1709t1758r1791b1789],

1	Conclusion	NN	O	conclusion	_	0	SENT_20	[p1l1803t1758r2023b1789],
2	:	:	O	:	_	0	SENT_20	[p1l1803t1758r2023b1789],
3	The	DT	O	the	det	7	SENT_20	[p1l1803t1758r2023b1789],
4	C	NN	O	c	nn	7	SENT_20	[p1l2035t1760r2053b1789],
5	allele	NN	O	allele	nn	7	SENT_20	[p1l108t1800r180b1831],
6	oftheA-444C	NN	O	ofthea-444c	nn	7	SENT_20	[p1l191t1800r395b1831],
7	polymorphism	NN	O	polymorphism	nsubj	10	SENT_20	[p1l406t1800r603b1840],
8	is	VBZ	O	be	cop	10	SENT_20	[p1l615t1801r633b1831],
9	a	DT	O	a	det	10	SENT_20	[p1l643t1809r657b1831],
10	riskfactorforAIU	NN	O	riskfactorforaiu	dep	1	SENT_20	[p1l669t1800r909b1831],
11	in	IN	O	in	_	0	SENT_20	[p1l922t1801r943b1831],
12	our	PRP$	O	we	poss	13	SENT_20	[p1l955t1809r1000b1831],
13	population	NN	O	population	prep_in	10	SENT_20	[p1l1010t1800r1160b1840],
14	and	CC	O	and	_	0	SENT_20	[p1l1172t1800r1222b1831],
15	could	MD	O	could	aux	19	SENT_20	[p1l1233t1800r1307b1831],
16	be	VB	O	be	cop	19	SENT_20	[p1l1319t1800r1350b1831],
17	a	DT	O	a	det	19	SENT_20	[p1l1360t1809r1374b1831],
18	genetic	JJ	O	genetic	amod	19	SENT_20	[p1l1384t1801r1487b1840],
19	marker	NN	O	marker	conj_and	10	SENT_20	[p1l1498t1800r1594b1831],
20	for	IN	O	for	_	0	SENT_20	[p1l1602t1800r1640b1831],
21	this	DT	O	this	det	22	SENT_20	[p1l1649t1800r1698b1831],
22	phenotype	NN	O	phenotype	prep_for	19	SENT_20	[p1l1709t1800r1864b1840],
23	.	.	O	.	_	0	SENT_20	[p1l1709t1800r1864b1840],

1	Furthermore	RB	O	furthermore	advmod	10	SENT_21	[p1l1875t1800r2053b1836],
2	,	,	O	,	_	0	SENT_21	[p1l1875t1800r2053b1836],
3	this	DT	O	this	det	7	SENT_21	[p1l107t1842r156b1873],
4	single	JJ	O	single	amod	7	SENT_21	[p1l169t1842r410b1882],
5	—	NN	O	—	nn	7	SENT_21	[p1l169t1842r410b1882],
6	nucleotide	NN	O	nucleotide	nn	7	SENT_21	[p1l169t1842r410b1882],
7	polymorphism	NN	O	polymorphism	nsubjpass	10	SENT_21	[p1l423t1842r620b1882],
8	is	VBZ	O	be	auxpass	10	SENT_21	[p1l635t1843r653b1873],
9	mainly	RB	O	mainly	advmod	10	SENT_21	[p1l666t1842r757b1882],
10	associated	VBN	O	associate	_	0	SENT_21	[p1l769t1842r915b1873],
11	with	IN	O	with	_	0	SENT_21	[p1l927t1842r987b1873],
12	the	DT	O	the	det	15	SENT_21	[p1l1000t1842r1044b1873],
13	cutaneous	JJ	O	cutaneous	amod	15	SENT_21	[p1l1057t1846r1201b1873],
14	clinical	JJ	O	clinical	amod	15	SENT_21	[p1l1214t1842r1307b1873],
15	pattern	NN	O	pattern	prep_with	10	SENT_21	[p1l1321t1846r1421b1882],
16	and	CC	O	and	_	0	SENT_21	[p1l1434t1842r1484b1873],
17	with	IN	O	with	_	0	SENT_21	[p1l1497t1842r1557b1873],
18	low	JJ	O	low	amod	20	SENT_21	[p1l1571t1842r1620b1873],
19	skin	NN	O	skin	nn	20	SENT_21	[p1l1632t1842r1685b1873],
20	response	NN	O	response	prep_with	10	SENT_21	[p1l1699t1850r1823b1882],
21	to	TO	O	to	_	0	SENT_21	[p1l1835t1846r1862b1873],
22	histamine	NN	O	histamine	prep_to	10	SENT_21	[p1l1876t1842r2018b1873],
23	.	.	O	.	_	0	SENT_21	[p1l1876t1842r2018b1873],

1	Key	NN	O	key	nn	2	SENT_22	[p1l110t1906r159b1944],
2	words	NNS	O	word	_	0	SENT_22	[p1l169t1904r267b1935],
3	:	:	O	:	_	0	SENT_22	[p1l169t1904r267b1935],
4	ITC45	NN	O	itc45	dep	2	SENT_22	[p1l281t1906r365b1935],
5	.	.	O	.	_	0	SENT_22	[p1l281t1906r365b1935],

1	Histamine.Aspirin-induced	JJ	O	histamine.aspirin-induced	amod	2	SENT_23	[p1l379t1904r754b1944],
2	urticaria	NN	O	urticarium	_	0	SENT_23	[p1l769t1905r891b1935],
3	.	.	O	.	_	0	SENT_23	[p1l769t1905r891b1935],

1	Leukotrienes	NNS	O	leukotriene	_	0	SENT_24	[p1l904t1904r1088b1935],
2	.	.	O	.	_	0	SENT_24	[p1l904t1904r1088b1935],

1	NSAlDs	NNS	O	nsald	_	0	SENT_25	[p1l1101t1906r1211b1935],
2	.	.	O	.	_	0	SENT_25	[p1l1101t1906r1211b1935],

1	I	PRP	O	I	nsubj	2	SENT_26	[p1l108t2081r137b2110],
2	Resumen	VBP	O	resumen	dep	13	SENT_26	[p1l152t2080r301b2111],
3	/	:	O	/	punct	6	SENT_26	[p1l107t2142r304b2174],
4	4ntecea	CD	NUMBER	4ntecea	num	6	SENT_26	[p1l107t2142r304b2174],
5	’	CD	NUMBER	’	num	6	SENT_26	[p1l107t2142r304b2174],
6	entes	NNS	O	ente	dep	12	SENT_26	[p1l107t2142r304b2174],
7	:	:	O	:	_	0	SENT_26	[p1l107t2142r304b2174],
8	La	NNP	O	La	nn	11	SENT_26	[p1l315t2144r342b2173],
9	produccion	NNP	O	produccion	nn	11	SENT_26	[p1l359t2142r512b2183],
10	de	IN	O	de	amod	11	SENT_26	[p1l528t2143r560b2173],
11	Cisteinil	NNP	O	Cisteinil	dep	6	SENT_26	[p1l575t2143r685b2173],
12	leucotrienos	NNS	O	leucotrieno	dobj	2	SENT_26	[p1l701t2143r871b2173],
13	parece	VBP	O	parece	_	0	SENT_26	[p1l887t2151r978b2183],
14	estar	FW	O	estar	nn	18	SENT_26	[p1l993t2146r1061b2173],
15	alterada	FW	O	alterada	nn	18	SENT_26	[p1l1075t2142r1188b2173],
16	en	FW	O	en	nn	18	SENT_26	[p1l1204t2151r1235b2173],
17	los	FW	O	los	nn	18	SENT_26	[p1l1252t2143r1288b2173],
18	pacientes	FW	O	pacientes	dobj	13	SENT_26	[p1l1304t2144r1436b2183],
19	con	NN	O	con	nsubj	20	SENT_26	[p1l1450t2151r1498b2173],
20	hipersensibilidad	VBD	O	hipersensibilidad	rcmod	18	SENT_26	[p1l1514t2143r1750b2183],
21	a	DT	O	a	det	24	SENT_26	[p1l1765t2151r1779b2173],
22	la	NNP	O	la	nn	24	SENT_26	[p1l1796t2143r1816b2173],
23	aspirina	NNP	O	aspirina	nn	24	SENT_26	[p1l1832t2143r1941b2183],
24	y	NNP	O	y	nsubj	25	SENT_26	[p1l1956t2151r1970b2182],
25	otros	VBZ	O	otro	ccomp	20	SENT_26	[p1l1983t2147r2053b2173],
26	antiinﬁamatorios	NNS	O	antiinﬁamatorios	dobj	25	SENT_26	[p1l108t2185r348b2215],
27	no	DT	O	no	det	28	SENT_26	[p1l362t2193r394b2215],
28	esteroides	NNS	O	esteroide	nsubj	29	SENT_26	[p1l408t2184r550b2215],
29	(	VBP	O	(	rcmod	26	SENT_26	[p1l563t2186r697b2221],
30	NSAlDs	NNS	O	nsald	dobj	29	SENT_26	[p1l563t2186r697b2221],
31	)	CD	NUMBER	)	nsubj	13	SENT_26	[p1l563t2186r697b2221],
32	,	,	O	,	_	0	SENT_26	[p1l563t2186r697b2221],
33	sin	NN	O	sin	nn	34	SENT_26	[p1l709t2185r746b2215],
34	embargo	NN	O	embargo	appos	31	SENT_26	[p1l760t2184r884b2224],
35	no	DT	O	no	det	40	SENT_26	[p1l899t2193r931b2215],
36	se	FW	O	se	nn	40	SENT_26	[p1l945t2193r973b2215],
37	conocen	FW	O	conocen	nn	40	SENT_26	[p1l986t2193r1102b2215],
38	bien	FW	O	bien	nn	40	SENT_26	[p1l1117t2184r1174b2215],
39	los	FW	O	los	nn	40	SENT_26	[p1l1189t2184r1225b2215],
40	mecanismos	FW	O	mecanismos	dep	34	SENT_26	[p1l1240t2185r1412b2215],
41	subyacentes	NNS	O	subyacente	dep	34	SENT_26	[p1l1425t2184r1728b2224],
42	.	.	O	.	_	0	SENT_26	[p1l1425t2184r1728b2224],

1	A	DT	O	a	det	3	SENT_27	[p1l1425t2184r1728b2224],
2	|	NN	O	|	nn	3	SENT_27	[p1l1425t2184r1728b2224],
3	gunos	NNS	O	guno	_	0	SENT_27	[p1l1425t2184r1728b2224],
4	estudios	FW	O	estudios	nn	7	SENT_27	[p1l1741t2184r1857b2215],
5	sugieren	FW	O	sugieren	nn	7	SENT_27	[p1l1870t2185r1988b2224],
6	que	FW	O	que	nn	7	SENT_27	[p1l2002t2193r2053b2224],
7	el	FW	O	el	dep	3	SENT_27	[p1l108t2226r129b2257],
8	polimorﬁsmoA	NN	O	polimorﬁsmoa	nn	10	SENT_27	[p1l144t2226r455b2266],
9	—	CD	NUMBER	—	num	10	SENT_27	[p1l144t2226r455b2266],
10	444C	NN	O	444c	dep	7	SENT_27	[p1l144t2226r455b2266],
11	del	FW	O	del	nn	18	SENT_27	[p1l468t2226r507b2257],
12	gen	FW	O	gen	nn	18	SENT_27	[p1l520t2234r570b2266],
13	de	FW	O	de	nn	18	SENT_27	[p1l585t2226r616b2257],
14	la	FW	O	la	nn	18	SENT_27	[p1l630t2226r651b2257],
15	enzima	FW	O	enzima	nn	18	SENT_27	[p1l665t2227r764b2257],
16	Leucotrieno	FW	O	leucotrieno	nn	18	SENT_27	[p1l779t2227r942b2257],
17	C4	NN	O	c4	nn	18	SENT_27	[p1l955t2227r993b2257],
18	sintasa	NN	O	sintasa	dep	3	SENT_27	[p1l1005t2227r1101b2257],
19	(	CD	NUMBER	(	num	20	SENT_27	[p1l1115t2227r1219b2263],
20	LTC4S	NN	O	ltc4	dep	18	SENT_27	[p1l1115t2227r1219b2263],
21	)	CD	NUMBER	)	num	24	SENT_27	[p1l1115t2227r1219b2263],
22	juega	NN	O	juega	nn	24	SENT_27	[p1l1229t2227r1307b2266],
23	un	NN	O	un	nn	24	SENT_27	[p1l1322t2234r1353b2257],
24	papel	NN	O	papel	dep	3	SENT_27	[p1l1368t2226r1443b2266],
25	en	IN	O	en	_	0	SENT_27	[p1l1457t2234r1488b2257],
26	la	DT	O	la	det	30	SENT_27	[p1l1503t2226r1523b2257],
27	Urticaria	NNP	O	Urticaria	nn	30	SENT_27	[p1l1539t2227r1655b2257],
28	inducida	NN	O	inducida	nn	30	SENT_27	[p1l1668t2226r1787b2257],
29	por	NN	O	por	nn	30	SENT_27	[p1l1802t2234r1847b2266],
30	aspirina	NN	O	aspirina	prep_en	24	SENT_27	[p1l1859t2227r1968b2266],
31	(	CD	NUMBER	(	num	32	SENT_27	[p1l1982t2228r2053b2263],
32	AIU	NNP	ORGANIZATION	AIU	dep	3	SENT_27	[p1l1982t2228r2053b2263],
33	)	CD	NUMBER	)	num	32	SENT_27	[p1l1982t2228r2053b2263],
34	pero	NN	O	pero	dep	32	SENT_27	[p1l109t2276r169b2308],
35	esto	FW	O	esto	nn	34	SENT_27	[p1l184t2271r241b2298],
36	aun	FW	O	aun	nn	34	SENT_27	[p1l256t2267r306b2298],
37	es	FW	O	es	nn	34	SENT_27	[p1l322t2276r349b2298],
38	motivo	FW	O	motivo	nn	34	SENT_27	[p1l365t2269r459b2298],
39	de	FW	O	de	nn	34	SENT_27	[p1l474t2268r506b2298],
40	controversia	FW	O	controversia	dep	34	SENT_27	[p1l521t2268r701b2299],
41	.	.	O	.	_	0	SENT_27	[p1l521t2268r701b2299],

1	Objetivo	NNP	O	Objetivo	_	0	SENT_28	[p1l715t2267r840b2307],
2	:	:	O	:	_	0	SENT_28	[p1l715t2267r840b2307],
3	Evaluar	NNP	O	Evaluar	nn	4	SENT_28	[p1l855t2268r956b2298],
4	mediante	NNP	O	mediante	dep	1	SENT_28	[p1l971t2267r1101b2298],
5	un	NN	O	un	dep	4	SENT_28	[p1l1117t2276r1148b2298],
6	estudio	FW	O	estudio	nn	5	SENT_28	[p1l1164t2267r1265b2298],
7	de	FW	O	de	nn	5	SENT_28	[p1l1281t2268r1312b2298],
8	casos	FW	O	casos	nn	5	SENT_28	[p1l1327t2276r1403b2298],
9	y	FW	O	y	nn	5	SENT_28	[p1l1416t2276r1430b2307],
10	controles	FW	O	controles	nn	5	SENT_28	[p1l1443t2268r1571b2298],
11	si	FW	O	si	nn	5	SENT_28	[p1l1585t2268r1604b2298],
12	el	FW	O	el	nn	5	SENT_28	[p1l1619t2267r1640b2298],
13	polimorﬁsmo	FW	O	polimorﬁsmo	dep	5	SENT_28	[p1l1656t2268r1839b2308],
14	A	DT	O	a	det	16	SENT_28	[p1l1850t2269r1969b2298],
15	—	CD	NUMBER	—	num	16	SENT_28	[p1l1850t2269r1969b2298],
16	444C	NN	O	444c	dep	4	SENT_28	[p1l1850t2269r1969b2298],
17	de	FW	O	de	nn	18	SENT_28	[p1l1984t2268r2016b2298],
18	la	FW	O	la	advmod	19	SENT_28	[p1l2031t2268r2052b2298],
19	region	NN	O	region	rcmod	16	SENT_28	[p1l109t2309r195b2349],
20	promotora	FW	O	promotora	nn	19	SENT_28	[p1l209t2313r355b2349],
21	del	FW	O	del	nn	19	SENT_28	[p1l368t2309r408b2340],
22	gen	FW	O	gen	nn	19	SENT_28	[p1l420t2318r471b2349],
23	LTC4S	FW	O	ltc4s	nn	19	SENT_28	[p1l485t2311r567b2340],
24	se	FW	O	se	nn	19	SENT_28	[p1l579t2318r607b2340],
25	asocia	FW	O	asocia	dep	19	SENT_28	[p1l620t2310r706b2340],
26	con	NN	O	con	prep	19	SENT_28	[p1l720t2318r767b2340],
27	AIU	NNP	ORGANIZATION	AIU	nn	35	SENT_28	[p1l777t2311r827b2340],
28	yfenotipos	FW	O	yfenotipos	nn	35	SENT_28	[p1l840t2309r996b2349],
29	de	FW	O	de	nn	35	SENT_28	[p1l1008t2309r1040b2340],
30	atopia	FW	O	atopia	nn	35	SENT_28	[p1l1053t2310r1140b2349],
31	en	FW	O	en	nn	35	SENT_28	[p1l1153t2318r1184b2340],
32	una	FW	O	una	nn	35	SENT_28	[p1l1199t2318r1248b2340],
33	poblacion	FW	O	poblacion	nn	35	SENT_28	[p1l1263t2309r1398b2349],
34	de	FW	O	de	nn	35	SENT_28	[p1l1411t2309r1443b2340],
35	Venezuela	NNP	LOCATION	Venezuela	dep	26	SENT_28	[p1l1452t2309r1606b2340],
36	.	.	O	.	_	0	SENT_28	[p1l1452t2309r1606b2340],

1	Me	PRP	O	I	nsubj	2	SENT_29	[p1l109t2351r271b2382],
2	’	VBP	O	’	_	0	SENT_29	[p1l109t2351r271b2382],
3	roa’os	NNS	O	roa’os	dobj	2	SENT_29	[p1l109t2351r271b2382],
4	.	.	O	.	_	0	SENT_29	[p1l109t2351r271b2382],
5	'	''	O	'	_	0	SENT_29	[p1l109t2351r271b2382],

1	Se	NN	O	se	nn	2	SENT_30	[p1l109t2351r271b2382],
2	incluyeron	NN	O	incluyeron	nsubj	10	SENT_30	[p1l282t2351r420b2391],
3	1	CD	NUMBER	1	num	5	SENT_30	[p1l432t2353r441b2381],
4	10	CD	NUMBER	10	num	5	SENT_30	[p1l451t2352r484b2382],
5	pacientes	NNS	O	paciente	dep	2	SENT_30	[p1l495t2352r623b2391],
6	con	JJ	O	con	amod	8	SENT_30	[p1l633t2359r679b2382],
7	AIU	NNP	ORGANIZATION	AIU	nn	8	SENT_30	[p1l686t2353r736b2382],
8	y	NN	O	y	dep	2	SENT_30	[p1l746t2360r760b2391],
9	165	CD	NUMBER	165	dep	8	SENT_30	[p1l770t2352r821b2382],
10	controles	VBZ	O	controle	_	0	SENT_30	[p1l831t2351r956b2382],
11	no	DT	O	no	det	12	SENT_30	[p1l966t2359r998b2382],
12	alérgicos	NNS	O	alérgicos	dobj	10	SENT_30	[p1l1008t2351r1136b2391],
13	.	.	O	.	_	0	SENT_30	[p1l1008t2351r1136b2391],

1	La	NNP	O	La	nn	2	SENT_31	[p1l1146t2353r1173b2382],
2	AIU	NNP	O	AIU	nsubj	19	SENT_31	[p1l1181t2353r1230b2382],
3	se	FW	O	se	nn	14	SENT_31	[p1l1241t2359r1269b2382],
4	diagnostico	FW	O	diagnostico	nn	14	SENT_31	[p1l1279t2351r1436b2391],
5	por	FW	O	por	nn	14	SENT_31	[p1l1447t2359r1491b2391],
6	la	FW	O	la	nn	14	SENT_31	[p1l1501t2351r1521b2382],
7	historia	FW	O	historia	nn	14	SENT_31	[p1l1533t2351r1631b2382],
8	clinica	FW	O	clinica	nn	14	SENT_31	[p1l1642t2351r1725b2382],
9	y	FW	O	y	nn	14	SENT_31	[p1l1734t2360r1748b2391],
10	se	FW	O	se	nn	14	SENT_31	[p1l1757t2359r1784b2382],
11	conﬁrmo	FW	O	conﬁrmo	nn	14	SENT_31	[p1l1794t2351r1914b2382],
12	mediante	FW	O	mediante	nn	14	SENT_31	[p1l1925t2351r2053b2382],
13	pruebas	FW	O	pruebas	nn	14	SENT_31	[p1l109t2393r217b2433],
14	de	FW	O	de	dep	2	SENT_31	[p1l230t2392r261b2423],
15	provocation	NN	O	provocation	dep	2	SENT_31	[p1l275t2392r440b2433],
16	oral	JJ	O	oral	amod	18	SENT_31	[p1l454t2393r503b2423],
17	con	NN	O	con	nn	18	SENT_31	[p1l517t2401r563b2423],
18	NSAlDs	NNS	O	nsald	dep	15	SENT_31	[p1l578t2394r679b2423],
19	hechas	VBZ	O	hecha	_	0	SENT_31	[p1l693t2393r787b2423],
20	a	DT	O	a	det	26	SENT_31	[p1l799t2401r813b2423],
21	doble	JJ	O	doble	amod	26	SENT_31	[p1l827t2393r902b2423],
22	ciego	FW	O	ciego	nn	26	SENT_31	[p1l915t2394r987b2432],
23	y	FW	O	y	nn	26	SENT_31	[p1l999t2401r1012b2432],
24	controladas	FW	O	controladas	nn	26	SENT_31	[p1l1025t2392r1185b2423],
25	con	NN	O	con	nn	26	SENT_31	[p1l1198t2401r1244b2423],
26	placebo	NN	O	placebo	dobj	19	SENT_31	[p1l1259t2393r1371b2433],
27	.	.	O	.	_	0	SENT_31	[p1l1259t2393r1371b2433],

1	La	NNP	O	La	nn	2	SENT_32	[p1l1385t2394r1412b2423],
2	genotipiﬁcacion	NNP	O	genotipiﬁcacion	nsubj	15	SENT_32	[p1l1425t2392r1644b2433],
3	de	IN	O	de	amod	5	SENT_32	[p1l1658t2393r1690b2423],
4	A	DT	O	a	det	5	SENT_32	[p1l1699t2394r1815b2423],
5	—	NN	O	—	dep	2	SENT_32	[p1l1699t2394r1815b2423],
6	444C	FW	O	444c	nn	10	SENT_32	[p1l1699t2394r1815b2423],
7	se	FW	O	se	nn	10	SENT_32	[p1l1828t2401r1856b2423],
8	hizo	FW	O	hizo	nn	10	SENT_32	[p1l1870t2393r1923b2423],
9	con	NN	O	con	nn	10	SENT_32	[p1l1937t2401r1983b2423],
10	PCR	NN	O	pcr	dep	2	SENT_32	[p1l1999t2394r2054b2423],
11	en	IN	O	en	_	0	SENT_32	[p1l108t2443r139b2465],
12	tiempo	NN	O	tiempo	nn	14	SENT_32	[p1l150t2435r246b2474],
13	real	JJ	O	real	amod	14	SENT_32	[p1l258t2434r306b2465],
14	empleando	NN	O	empleando	prep_en	10	SENT_32	[p1l319t2434r472b2474],
15	sondas	VBZ	O	sonda	_	0	SENT_32	[p1l484t2434r580b2465],
16	Taqman	NNP	O	Taqman	dobj	15	SENT_32	[p1l588t2436r705b2474],
17	.	.	O	.	_	0	SENT_32	[p1l588t2436r705b2474],

1	Se	NN	O	se	nn	2	SENT_33	[p1l716t2436r746b2465],
2	considero	NN	O	considero	_	0	SENT_33	[p1l758t2434r889b2465],
3	atopia	NN	O	atopium	dep	2	SENT_33	[p1l901t2435r986b2474],
4	cuando	FW	O	cuando	nn	3	SENT_33	[p1l999t2434r1099b2465],
5	se	FW	O	se	nn	3	SENT_33	[p1l1120t2443r1147b2465],
6	encontro	FW	O	encontro	nn	3	SENT_33	[p1l1159t2434r1280b2465],
7	por	FW	O	por	nn	3	SENT_33	[p1l1293t2443r1337b2474],
8	lo	FW	O	lo	nn	3	SENT_33	[p1l1348t2434r1370b2465],
9	menos	FW	O	menos	nn	3	SENT_33	[p1l1383t2443r1472b2465],
10	una	FW	O	una	nn	3	SENT_33	[p1l1484t2443r1533b2465],
11	prueba	FW	O	prueba	nn	3	SENT_33	[p1l1546t2434r1640b2474],
12	cuténea	FW	O	cuténea	nn	3	SENT_33	[p1l1653t2434r1760b2465],
13	positiva	FW	O	positiva	nn	3	SENT_33	[p1l1774t2435r1876b2474],
14	entre	FW	O	entre	nn	3	SENT_33	[p1l1889t2438r1958b2465],
15	los	FW	O	los	dep	3	SENT_33	[p1l1971t2434r2007b2465],
16	25	CD	NUMBER	25	num	18	SENT_33	[p1l2018t2436r2052b2465],
17	alergenos	NNS	O	alergeno	nn	18	SENT_33	[p1l108t2476r241b2516],
18	probados	NNS	O	probado	dep	3	SENT_33	[p1l254t2476r388b2516],
19	.	.	O	.	_	0	SENT_33	[p1l254t2476r388b2516],

1	Los	NNP	O	Los	nsubj	2	SENT_34	[p1l400t2478r443b2507],
2	niveles	VBZ	O	nivele	_	0	SENT_34	[p1l456t2476r547b2507],
3	totales	FW	O	totales	nn	8	SENT_34	[p1l557t2476r650b2507],
4	y	FW	O	y	nn	8	SENT_34	[p1l660t2485r675b2516],
5	especiﬁcos	FW	O	especiﬁcos	nn	8	SENT_34	[p1l685t2476r833b2516],
6	de	FW	O	de	nn	8	SENT_34	[p1l845t2476r876b2507],
7	inmunoglobulina	FW	O	inmunoglobulina	nn	8	SENT_34	[p1l889t2476r1120b2516],
8	(	FW	O	(	dobj	2	SENT_34	[p1l1133t2478r1177b2516],
9	lg	NN	O	lg	dep	8	SENT_34	[p1l1133t2478r1177b2516],
10	)	CD	NUMBER	)	num	9	SENT_34	[p1l1133t2478r1177b2516],
11	E	NN	O	e	dep	9	SENT_34	[p1l1190t2478r1202b2506],
12	se	FW	O	se	nn	11	SENT_34	[p1l1214t2484r1242b2507],
13	cuantiﬁcaron	FW	O	cuantiﬁcaron	nn	11	SENT_34	[p1l1254t2477r1432b2507],
14	usando	FW	O	usando	dep	11	SENT_34	[p1l1445t2476r1544b2507],
15	un	NN	O	un	dep	9	SENT_34	[p1l1557t2484r1588b2507],
16	ensayo	FW	O	ensayo	nn	15	SENT_34	[p1l1601t2484r1695b2516],
17	inmuno	FW	O	inmuno	nn	15	SENT_34	[p1l1708t2476r1979b2507],
18	—	FW	O	—	nn	15	SENT_34	[p1l1708t2476r1979b2507],
19	enzimatico	FW	O	enzimatico	dep	15	SENT_34	[p1l1708t2476r1979b2507],
20	.	.	O	.	_	0	SENT_34	[p1l1708t2476r1979b2507],

1	/	:	O	/	punct	4	SENT_35	[p1l109t2518r288b2549],
2	iesu/taa	JJ	O	iesu/taa	amod	4	SENT_35	[p1l109t2518r288b2549],
3	’	NN	O	’	nn	4	SENT_35	[p1l109t2518r288b2549],
4	o5	NN	O	o5	_	0	SENT_35	[p1l109t2518r288b2549],
5	.	.	O	.	_	0	SENT_35	[p1l109t2518r288b2549],
6	'	''	O	'	_	0	SENT_35	[p1l109t2518r288b2549],

1	El	NNP	O	El	nn	3	SENT_36	[p1l109t2518r288b2549],
2	polimorﬁsmo	NNP	O	polimorﬁsmo	nn	3	SENT_36	[p1l301t2517r480b2558],
3	A-444C	NNP	O	A-444C	_	0	SENT_36	[p1l488t2519r604b2548],
4	se	FW	O	se	nn	8	SENT_36	[p1l615t2526r643b2548],
5	encontro	FW	O	encontro	nn	8	SENT_36	[p1l655t2517r775b2548],
6	asociado	FW	O	asociado	nn	8	SENT_36	[p1l787t2517r908b2548],
7	a	FW	O	a	nn	8	SENT_36	[p1l919t2526r933b2548],
8	la	FW	O	la	dep	3	SENT_36	[p1l946t2518r966b2548],
9	AIU	NNP	ORGANIZATION	AIU	dep	8	SENT_36	[p1l975t2519r1033b2548],
10	.	.	O	.	_	0	SENT_36	[p1l975t2519r1033b2548],

1	El	NNP	O	El	nn	4	SENT_37	[p1l1046t2518r1065b2548],
2	alelo	JJ	O	alelo	amod	4	SENT_37	[p1l1078t2518r1142b2548],
3	C	NN	O	c	nn	4	SENT_37	[p1l1154t2519r1172b2548],
4	fue	NN	O	fue	_	0	SENT_37	[p1l1182t2517r1225b2548],
5	mas	FW	O	mas	nn	11	SENT_37	[p1l1237t2517r1291b2548],
6	frecuente	FW	O	frecuente	nn	11	SENT_37	[p1l1301t2517r1430b2548],
7	en	FW	O	en	nn	11	SENT_37	[p1l1442t2526r1472b2548],
8	los	FW	O	los	nn	11	SENT_37	[p1l1486t2517r1521b2548],
9	pacientes	FW	O	pacientes	nn	11	SENT_37	[p1l1534t2518r1662b2558],
10	con	NN	O	con	nn	11	SENT_37	[p1l1674t2526r1720b2548],
11	el	NN	O	el	nn	12	SENT_37	[p1l1733t2518r1753b2548],
12	patron	NN	O	patron	dep	4	SENT_37	[p1l1766t2517r1854b2558],
13	cutaneo	NN	O	cutaneo	dep	12	SENT_37	[p1l1866t2517r1976b2548],
14	de	FW	O	de	nn	13	SENT_37	[p1l1988t2518r2019b2548],
15	la	FW	O	la	nn	13	SENT_37	[p1l2032t2518r2052b2548],
16	AIU	FW	ORGANIZATION	aiu	nn	13	SENT_37	[p1l107t2561r156b2590],
17	y	FW	O	y	nn	13	SENT_37	[p1l168t2568r182b2599],
18	en	FW	O	en	nn	13	SENT_37	[p1l193t2568r223b2590],
19	aquellos	FW	O	aquellos	dep	13	SENT_37	[p1l236t2559r350b2599],
20	con	NN	O	con	dep	4	SENT_37	[p1l362t2568r408b2590],
21	baja	FW	O	baja	nn	20	SENT_37	[p1l422t2559r477b2599],
22	reactividad	FW	O	reactividad	nn	20	SENT_37	[p1l491t2559r639b2590],
23	cutanea	FW	O	cutanea	nn	20	SENT_37	[p1l652t2559r759b2590],
24	a	FW	O	a	nn	20	SENT_37	[p1l772t2568r786b2590],
25	la	FW	O	la	dep	20	SENT_37	[p1l800t2559r820b2590],
26	histamina	NN	O	histamina	dep	20	SENT_37	[p1l834t2559r975b2590],
27	.	.	O	.	_	0	SENT_37	[p1l834t2559r975b2590],

1	No	DT	O	no	det	9	SENT_38	[p1l987t2561r1024b2590],
2	hubo	NN	O	hubo	nn	9	SENT_38	[p1l1037t2559r1105b2590],
3	asociacion	NN	O	asociacion	nn	9	SENT_38	[p1l1117t2559r1259b2590],
4	entre	NN	O	entre	nn	9	SENT_38	[p1l1272t2563r1341b2590],
5	A	NN	O	a	nn	9	SENT_38	[p1l1349t2561r1466b2590],
6	—	CD	NUMBER	—	num	9	SENT_38	[p1l1349t2561r1466b2590],
7	444C	NN	O	444c	nn	9	SENT_38	[p1l1349t2561r1466b2590],
8	y	NN	O	y	nn	9	SENT_38	[p1l1476t2568r1490b2599],
9	asma	NN	O	asma	_	0	SENT_38	[p1l1501t2568r1581b2595],
10	,	,	O	,	_	0	SENT_38	[p1l1501t2568r1581b2595],
11	atopia	NN	O	atopium	nn	13	SENT_38	[p1l1592t2560r1677b2599],
12	o	NN	O	o	nn	13	SENT_38	[p1l1690t2568r1705b2590],
13	niveles	NNS	O	nivele	appos	9	SENT_38	[p1l1718t2559r1809b2590],
14	de	IN	O	de	_	0	SENT_38	[p1l1821t2559r1852b2590],
15	IgE	NN	O	ige	nn	16	SENT_38	[p1l1864t2561r1905b2599],
16	total	NN	O	total	prep_de	13	SENT_38	[p1l1916t2559r1986b2590],
17	.	.	O	.	_	0	SENT_38	[p1l1916t2559r1986b2590],

1	Conc/us/ti	NN	O	conc/us/ti	nsubj	3	SENT_39	[p1l111t2601r291b2632],
2	/	:	O	/	punct	3	SENT_39	[p1l111t2601r291b2632],
3	7	CD	NUMBER	7	_	0	SENT_39	[p1l111t2601r291b2632],
4	.	.	O	.	_	0	SENT_39	[p1l111t2601r291b2632],
5	'	''	O	'	_	0	SENT_39	[p1l111t2601r291b2632],

1	El	NNP	O	El	nsubj	9	SENT_40	[p1l111t2601r291b2632],
2	alelo	JJ	O	alelo	amod	3	SENT_40	[p1l303t2601r367b2632],
3	C	NN	O	c	dep	1	SENT_40	[p1l379t2602r397b2632],
4	del	DT	O	del	det	5	SENT_40	[p1l408t2601r446b2632],
5	polimorﬁsmo	NN	O	polimorﬁsmo	dep	1	SENT_40	[p1l459t2601r638b2641],
6	A	DT	O	a	det	8	SENT_40	[p1l646t2602r763b2632],
7	—	NN	O	—	nn	8	SENT_40	[p1l646t2602r763b2632],
8	444C	NN	O	444c	dep	5	SENT_40	[p1l646t2602r763b2632],
9	es	VBZ	O	e	_	0	SENT_40	[p1l774t2609r801b2632],
10	un	NN	O	un	nn	15	SENT_40	[p1l813t2609r844b2632],
11	factor	NN	O	factor	nn	15	SENT_40	[p1l855t2601r935b2632],
12	de	FW	O	de	nn	15	SENT_40	[p1l946t2601r977b2632],
13	riesgo	FW	O	riesgo	nn	15	SENT_40	[p1l989t2602r1070b2641],
14	para	FW	O	para	nn	15	SENT_40	[p1l1082t2609r1140b2641],
15	AIU	NNP	ORGANIZATION	AIU	dep	9	SENT_40	[p1l1148t2603r1198b2632],
16	en	IN	O	en	_	0	SENT_40	[p1l1211t2609r1241b2632],
17	nuestra	FW	O	nuestra	prep_en	9	SENT_40	[p1l1254t2605r1353b2632],
18	poblacion	FW	O	poblacion	nn	27	SENT_40	[p1l1366t2601r1498b2641],
19	y	FW	O	y	nn	27	SENT_40	[p1l1509t2610r1523b2641],
20	podria	FW	O	podria	nn	27	SENT_40	[p1l1534t2601r1619b2641],
21	ser	FW	O	ser	nn	27	SENT_40	[p1l1631t2609r1670b2632],
22	un	FW	O	un	nn	27	SENT_40	[p1l1681t2609r1712b2632],
23	marcador	FW	O	marcador	nn	27	SENT_40	[p1l1725t2601r1855b2632],
24	genético	FW	O	genético	nn	27	SENT_40	[p1l1865t2601r1982b2641],
25	para	FW	O	para	nn	27	SENT_40	[p1l1994t2609r2052b2641],
26	este	FW	O	este	nn	27	SENT_40	[p1l108t2646r162b2673],
27	fenotipo	FW	O	fenotipo	dep	17	SENT_40	[p1l173t2642r421b2683],
28	.	.	O	.	_	0	SENT_40	[p1l173t2642r421b2683],

1	Ademas	NNP	PERSON	Ademas	_	0	SENT_41	[p1l173t2642r421b2683],
2	,	,	O	,	_	0	SENT_41	[p1l173t2642r421b2683],
3	este	FW	O	este	appos	1	SENT_41	[p1l433t2646r487b2673],
4	SNP	NN	ORGANIZATION	snp	nn	5	SENT_41	[p1l499t2644r553b2673],
5	esta	NN	O	esta	rcmod	3	SENT_41	[p1l565t2642r619b2673],
6	asociado	FW	O	asociado	nn	9	SENT_41	[p1l632t2643r753b2673],
7	principalmente	FW	O	principalmente	nn	9	SENT_41	[p1l766t2642r969b2683],
8	con	NN	O	con	nn	9	SENT_41	[p1l981t2651r1028b2673],
9	el	NN	O	el	dep	5	SENT_41	[p1l1040t2643r1061b2673],
10	patron	NN	O	patron	nn	13	SENT_41	[p1l1075t2642r1162b2683],
11	clinico	NN	O	clinico	nn	13	SENT_41	[p1l1175t2642r1259b2673],
12	cutaneo	NN	O	cutaneo	nn	13	SENT_41	[p1l1272t2642r1381b2673],
13	y	NN	O	y	dep	9	SENT_41	[p1l1392t2651r1406b2682],
14	con	NN	O	con	dep	9	SENT_41	[p1l1416t2651r1463b2673],
15	baja	FW	O	baja	nn	14	SENT_41	[p1l1476t2643r1532b2682],
16	respuesta	FW	O	respuesta	nn	14	SENT_41	[p1l1545t2646r1675b2683],
17	cutanea	FW	O	cutanea	dep	14	SENT_41	[p1l1688t2642r1796b2673],
18	a	FW	O	a	dep	19	SENT_41	[p1l1809t2651r1822b2673],
19	la	FW	O	la	dep	5	SENT_41	[p1l1836t2643r1856b2673],
20	histamina	NN	O	histamina	pobj	19	SENT_41	[p1l1870t2643r2011b2674],
21	.	.	O	.	_	0	SENT_41	[p1l1870t2643r2011b2674],

1	Palabras	FW	O	palabras	nn	2	SENT_42	[p1l109t2705r231b2736],
2	clavez	FW	O	clavez	dep	3	SENT_42	[p1l244t2705r326b2736],
3	LTC4S	NN	O	ltc4	_	0	SENT_42	[p1l339t2706r424b2736],
4	.	.	O	.	_	0	SENT_42	[p1l339t2706r424b2736],

1	Histamina	NNP	O	Histamina	_	0	SENT_43	[p1l437t2706r585b2736],
2	.	.	O	.	_	0	SENT_43	[p1l437t2706r585b2736],

1	Urticaria	NN	O	urticarium	nn	4	SENT_44	[p1l598t2706r715b2736],
2	inducida	NN	O	inducida	nn	4	SENT_44	[p1l729t2705r846b2736],
3	por	NN	O	por	nn	4	SENT_44	[p1l860t2714r905b2745],
4	aspirina	NN	O	aspirina	_	0	SENT_44	[p1l917t2706r1035b2745],
5	.	.	O	.	_	0	SENT_44	[p1l917t2706r1035b2745],

1	Leucotrienos	NNP	O	Leucotrienos	_	0	SENT_45	[p1l1048t2706r1232b2736],
2	.	.	O	.	_	0	SENT_45	[p1l1048t2706r1232b2736],

1	NSAIDs	NNS	MISC	nsaid	_	0	SENT_46	[p1l1246t2706r1355b2736],
2	.	.	O	.	_	0	SENT_46	[p1l1246t2706r1355b2736],

1	J	NNP	O	J	nn	5	SENT_47	[p1l58t2850r75b2873],
2	Investig	NNP	O	Investig	nn	5	SENT_47	[p1l81t2850r186b2879],
3	Allergol	NNP	O	Allergol	nn	5	SENT_47	[p1l193t2849r303b2879],
4	Clin	NNP	O	Clin	nn	5	SENT_47	[p1l313t2849r368b2873],
5	Immunol	NNP	O	Immunol	_	0	SENT_47	[p1l377t2849r495b2873],
6	2009	CD	DATE	2009	num	5	SENT_47	[p1l505t2849r578b2877],
7	;	:	O	;	_	0	SENT_47	[p1l505t2849r578b2877],
8	Vol	NNP	O	Vol	dep	5	SENT_47	[p1l588t2849r639b2873],
9	.	.	O	.	_	0	SENT_47	[p1l588t2849r639b2873],

1	19	CD	NUMBER	19	number	2	SENT_48	[p1l653t2849r728b2878],
2	(	CD	NUMBER	(	dep	13	SENT_48	[p1l653t2849r728b2878],
3	5	CD	NUMBER	5	num	4	SENT_48	[p1l653t2849r728b2878],
4	)	NN	O	)	dep	2	SENT_48	[p1l653t2849r728b2878],
5	:	:	O	:	_	0	SENT_48	[p1l653t2849r728b2878],
6	375-382	CD	NUMBER	375-382	num	10	SENT_48	[p1l741t2849r850b2873],
7	©	CD	NUMBER	©	num	10	SENT_48	[p1l1751t2849r1774b2873],
8	2009	CD	DATE	2009	num	10	SENT_48	[p1l1784t2849r1849b2873],
9	Esmon	NNP	O	Esmon	nn	10	SENT_48	[p1l1859t2849r1950b2873],
10	Publicidad	NNP	O	Publicidad	dep	2	SENT_48	[p1l1960t2849r2101b2873],
11	The	NNP	O	The	nn	12	SENT_48	[p1l745t2893r803b2919],
12	A	NNP	O	A	dep	10	SENT_48	[p1l811t2893r937b2919],
13	—	VBD	O	—	_	0	SENT_48	[p1l811t2893r937b2919],
14	444C	CD	NUMBER	444c	num	15	SENT_48	[p1l811t2893r937b2919],
15	SNP	NN	O	snp	dobj	13	SENT_48	[p1l949t2893r1016b2919],
16	and	CC	O	and	_	0	SENT_48	[p1l1025t2893r1078b2919],
17	Aspirin-Induced	JJ	O	aspirin-induced	amod	18	SENT_48	[p1l1086t2893r1331b2927],
18	Urticaria	NN	O	urticarium	conj_and	15	SENT_48	[p1l1341t2893r1474b2919],
19	376	CD	NUMBER	376	nsubj	13	SENT_48	[p1l2041t2894r2100b2922],

1	Introduction	NN	O	introduction	_	0	SENT_49	[p1l9t3111r644b3200],

1	Hypersensitivity	NN	O	hypersensitivity	nn	2	SENT_50	[p1l139t3341r725b3420],
2	reactions	NNS	O	reaction	nsubj	22	SENT_50	[p1l762t3341r1079b3402],
3	to	TO	O	to	_	0	SENT_50	[p1l1118t3350r1184b3402],
4	acetylsalicylic	JJ	O	acetylsalicylic	amod	7	SENT_50	[p1l1223t3341r1727b3420],
5	acid	NN	O	acid	nn	7	SENT_50	[p1l1767t3341r1912b3402],
6	(	NN	O	(	nn	7	SENT_50	[p1l1950t3341r2152b3417],
7	ASA	NN	O	asa	prep_to	2	SENT_50	[p1l1950t3341r2152b3417],
8	or	CC	O	or	_	0	SENT_50	[p1l9t3461r82b3503],
9	aspirin	NN	O	aspirin	nn	10	SENT_50	[p1l118t3441r383b3521],
10	)	NN	O	)	prep_to	2	SENT_50	[p1l118t3441r383b3521],
11	and	CC	O	and	_	0	SENT_50	[p1l424t3442r549b3503],
12	other	JJ	O	other	amod	15	SENT_50	[p1l585t3442r766b3503],
13	nonsteroidal	JJ	O	nonsteroidal	amod	15	SENT_50	[p1l801t3441r1238b3503],
14	anti	JJ	O	anti	amod	15	SENT_50	[p1l1277t3441r1915b3521],
15	—	NN	O	—	conj_and	7	SENT_50	[p1l1277t3441r1915b3521],
16	inﬂammatory	JJ	O	inﬂammatory	amod	17	SENT_50	[p1l1277t3441r1915b3521],
17	drugs	NNS	O	drug	nsubj	18	SENT_50	[p1l1953t3442r2144b3521],
18	(	VBP	O	(	rcmod	15	SENT_50	[p1l11t3543r97b3618],
19	N	NN	O	n	nn	20	SENT_50	[p1l11t3543r97b3618],
20	SAIDS	NN	O	said	dobj	18	SENT_50	[p1l100t3543r352b3618],
21	)	CD	NUMBER	)	num	20	SENT_50	[p1l100t3543r352b3618],
22	include	VBP	O	include	_	0	SENT_50	[p1l369t3542r614b3603],
23	several	JJ	O	several	amod	25	SENT_50	[p1l633t3542r866b3604],
24	clinical	JJ	O	clinical	amod	25	SENT_50	[p1l882t3542r1124b3603],
25	manifestations	NNS	O	manifestation	dobj	22	SENT_50	[p1l1139t3542r1624b3603],
26	such	JJ	O	such	_	0	SENT_50	[p1l1644t3542r1795b3603],
27	as	IN	O	as	_	0	SENT_50	[p1l1811t3562r1876b3603],
28	aspirinexacerbated	JJ	O	aspirinexacerbated	amod	30	SENT_50	[p1l1895t3542r2144b3622, p1l9t3644r415b3705],
29	respiratory	JJ	O	respiratory	amod	30	SENT_50	[p1l429t3644r796b3723],
30	disease	NN	O	disease	prep_such_as	25	SENT_50	[p1l814t3644r1058b3705],
31	(	CD	NUMBER	(	num	33	SENT_50	[p1l1077t3645r1382b3720],
32	AERD	NN	O	aerd	nn	33	SENT_50	[p1l1077t3645r1382b3720],
33	)	NN	O	)	dep	30	SENT_50	[p1l1077t3645r1382b3720],
34	,	,	O	,	_	0	SENT_50	[p1l1077t3645r1382b3720],
35	also	RB	O	also	advmod	30	SENT_50	[p1l1403t3644r1536b3705],
36	known	VBN	O	know	partmod	30	SENT_50	[p1l1553t3644r1786b3705],
37	as	IN	O	as	_	0	SENT_50	[p1l1805t3663r1870b3705],
38	aspirinintolerant	JJ	O	aspirinintolerant	prep_as	36	SENT_50	[p1l1890t3644r2144b3723, p2l8t17r336b79],

1	asthma/rhinosinusitis	NN	O	asthma/rhinosinusitis	nn	2	SENT_51	[p2l361t17r1133b93],
2	)	NN	O	)	nsubj	6	SENT_51	[p2l361t17r1133b93],
3	,	,	O	,	_	0	SENT_51	[p2l361t17r1133b93],
4	aspirin	NN	O	aspirin	nn	5	SENT_51	[p2l1162t17r1694b97],
5	—	NN	O	—	appos	2	SENT_51	[p2l1162t17r1694b97],
6	induced	VBD	O	induce	_	0	SENT_51	[p2l1162t17r1694b97],
7	urticaria	NN	O	urticarium	dobj	6	SENT_51	[p2l1716t17r2002b79],
8	and	CC	O	and	_	0	SENT_51	[p2l2026t17r2148b79],
9	angioedema	NN	O	angioedema	dobj	6	SENT_51	[p2l10t118r431b198],
10	(	CD	NUMBER	(	num	11	SENT_51	[p2l467t119r694b194],
11	AIU	NNP	ORGANIZATION	AIU	dep	7	SENT_51	[p2l467t119r694b194],
12	)	CD	NUMBER	)	num	11	SENT_51	[p2l467t119r694b194],
13	,	,	O	,	_	0	SENT_51	[p2l467t119r694b194],
14	and	CC	O	and	_	0	SENT_51	[p2l734t118r858b179],
15	anaphylaxis	NN	O	anaphylaxi	conj_and	7	SENT_51	[p2l894t118r1306b198],
16	[	CD	NUMBER	[	number	17	SENT_51	[p2l1349t119r1525b193],
17	1,2	CD	NUMBER	1,2	num	18	SENT_51	[p2l1349t119r1525b193],
18	]	NN	O	]	dep	15	SENT_51	[p2l1349t119r1525b193],
19	.	.	O	.	_	0	SENT_51	[p2l1349t119r1525b193],

1	Remarkably	RB	O	remarkably	advmod	8	SENT_52	[p2l1565t118r2004b198],
2	,	,	O	,	_	0	SENT_52	[p2l1565t118r2004b198],
3	the	DT	O	the	det	4	SENT_52	[p2l2042t118r2146b179],
4	characteristics	NNS	O	characteristic	nsubj	8	SENT_52	[p2l9t220r495b281],
5	of	IN	O	of	_	0	SENT_52	[p2l528t220r603b281],
6	AIU	NNP	ORGANIZATION	AIU	prep_of	4	SENT_52	[p2l623t220r775b281],
7	are	VBP	O	be	cop	8	SENT_52	[p2l807t239r909b281],
8	different	JJ	O	different	_	0	SENT_52	[p2l940t220r1232b281],
9	from	IN	O	from	_	0	SENT_52	[p2l1262t220r1429b281],
10	other	JJ	O	other	amod	13	SENT_52	[p2l1459t220r1635b281],
11	aspirin	NN	O	aspirin	nn	13	SENT_52	[p2l1665t220r1895b299],
12	hyperresponsiveness	NN	O	hyperresponsiveness	nn	13	SENT_52	[p2l1925t220r2144b299, p2l7t320r521b400],
13	phenotypes	NNS	O	phenotype	prep_from	8	SENT_52	[p2l545t320r954b400],
14	,	,	O	,	_	0	SENT_52	[p2l545t320r954b400],
15	suggesting	VBG	O	suggest	xcomp	8	SENT_52	[p2l984t320r1346b400],
16	that	IN	O	that	complm	20	SENT_52	[p2l1370t321r1498b382],
17	speciﬁc	NN	O	speciﬁc	nn	19	SENT_52	[p2l1524t320r1780b400],
18	biological	JJ	O	biological	amod	19	SENT_52	[p2l1804t320r2146b400],
19	interactions	NNS	O	interaction	nsubj	20	SENT_52	[p2l8t421r404b482],
20	underlie	VBP	O	underlie	ccomp	15	SENT_52	[p2l423t421r702b482],
21	its	PRP$	O	its	poss	22	SENT_52	[p2l720t421r797b482],
22	pathogenesis	NN	O	pathogenesis	dobj	20	SENT_52	[p2l815t421r1275b501],
23	.	.	O	.	_	0	SENT_52	[p2l815t421r1275b501],

1	This	DT	O	this	det	2	SENT_53	[p2l1295t421r1444b482],
2	disease	NN	O	disease	nsubj	17	SENT_53	[p2l1465t421r1709b482],
3	affects	VBZ	O	affect	_	0	SENT_53	[p2l1728t421r1950b482],
4	0.1	CD	PERCENT	0.1	num	5	SENT_53	[p2l1969t422r2143b483],
5	%	NN	PERCENT	%	dobj	3	SENT_53	[p2l1969t422r2143b483],
6	to	TO	O	to	_	0	SENT_53	[p2l8t532r73b584],
7	0.3	CD	PERCENT	0.3	num	8	SENT_53	[p2l93t523r266b584],
8	%	NN	PERCENT	%	prep_to	3	SENT_53	[p2l93t523r266b584],
9	of	IN	O	of	_	0	SENT_53	[p2l290t523r365b584],
10	the	DT	O	the	det	12	SENT_53	[p2l378t523r481b584],
11	general	JJ	O	general	amod	12	SENT_53	[p2l501t523r751b602],
12	population	NN	O	population	prep_of	8	SENT_53	[p2l768t523r1136b602],
13	[	CD	NUMBER	[	number	14	SENT_53	[p2l1161t523r1247b597],
14	3	CD	NUMBER	3	num	15	SENT_53	[p2l1161t523r1247b597],
15	]	NN	O	]	dep	12	SENT_53	[p2l1161t523r1247b597],
16	and	CC	O	and	_	0	SENT_53	[p2l1273t523r1395b584],
17	triggers	VBZ	O	trigger	conj_and	3	SENT_53	[p2l1413t523r1672b602],
18	or	CC	O	or	_	0	SENT_53	[p2l1693t542r1764b584],
19	aggravates	VBZ	O	aggravate	conj_and	3	SENT_53	[p2l1783t532r2145b602],
20	chronic	JJ	O	chronic	amod	21	SENT_53	[p2l9t624r257b685],
21	urticaria	NN	O	urticarium	dobj	19	SENT_53	[p2l274t624r552b685],
22	in	IN	O	in	_	0	SENT_53	[p2l566t624r631b684],
23	20	CD	PERCENT	20	num	24	SENT_53	[p2l647t624r980b685],
24	%	NN	PERCENT	%	prep_in	19	SENT_53	[p2l647t624r980b685],
25	.	.	O	.	_	0	SENT_53	[p2l647t624r980b685],

1	—	NN	O	—	_	0	SENT_54	[p2l647t624r980b685],
2	.	.	O	.	_	0	SENT_54	[p2l647t624r980b685],

1	40	CD	PERCENT	40	num	2	SENT_55	[p2l647t624r980b685],
2	%	NN	PERCENT	%	_	0	SENT_55	[p2l647t624r980b685],
3	of	IN	O	of	_	0	SENT_55	[p2l1001t624r1075b685],
4	patients	NNS	O	patient	prep_of	2	SENT_55	[p2l1083t624r1341b703],
5	[	CD	NUMBER	[	number	6	SENT_55	[p2l1365t624r1470b698],
6	4	CD	NUMBER	4	dep	2	SENT_55	[p2l1365t624r1470b698],
7	]	NN	O	]	dep	6	SENT_55	[p2l1365t624r1470b698],
8	.	.	O	.	_	0	SENT_55	[p2l1365t624r1470b698],

1	Based	VBN	O	base	_	0	SENT_56	[p2l1490t624r1697b685],
2	on	IN	O	on	prepc_based_on	11	SENT_56	[p2l1712t643r1795b685],
3	its	PRP$	O	its	poss	5	SENT_56	[p2l1810t624r1885b685],
4	clinical	JJ	O	clinical	amod	5	SENT_56	[p2l1904t624r2147b685],
5	manifestations	NNS	O	manifestation	pobj	11	SENT_56	[p2l8t724r531b797],
6	,	,	O	,	_	0	SENT_56	[p2l8t724r531b797],
7	NSAID	NN	O	nsaid	nn	8	SENT_56	[p2l568t725r831b786],
8	hypersensitivity	NN	O	hypersensitivity	nsubjpass	11	SENT_56	[p2l866t724r1418b804],
9	can	MD	O	can	aux	11	SENT_56	[p2l1454t744r1573b785],
10	be	VB	O	be	auxpass	11	SENT_56	[p2l1606t724r1686b785],
11	classiﬁed	VBN	O	classiﬁed	_	0	SENT_56	[p2l1722t724r2043b785],
12	as	IN	O	as	_	0	SENT_56	[p2l2078t744r2144b785],
13	cutaneous	JJ	O	cutaneous	prep_as	11	SENT_56	[p2l9t835r374b899],
14	,	,	O	,	_	0	SENT_56	[p2l9t835r374b899],
15	mixed	JJ	O	mixed	conj_and	13	SENT_56	[p2l412t826r648b898],
16	,	,	O	,	_	0	SENT_56	[p2l412t826r648b898],
17	respiratory	JJ	O	respiratory	prep_as	11	SENT_56	[p2l684t826r1075b905],
18	,	,	O	,	_	0	SENT_56	[p2l684t826r1075b905],
19	and	CC	O	and	_	0	SENT_56	[p2l1114t826r1238b887],
20	systemic	JJ	O	systemic	prep_as	11	SENT_56	[p2l1275t826r1593b905],
21	.	.	O	.	_	0	SENT_56	[p2l1275t826r1593b905],

1	The	DT	O	the	det	3	SENT_57	[p2l1631t826r1764b887],
2	cutaneous	JJ	O	cutaneous	amod	3	SENT_57	[p2l1800t835r2145b887],
3	pattern	NN	O	pattern	nsubjpass	5	SENT_57	[p2l7t936r245b1006],
4	is	VBZ	O	be	auxpass	5	SENT_57	[p2l278t927r331b988],
5	characterized	VBN	O	characterize	_	0	SENT_57	[p2l367t927r823b988],
6	by	IN	O	by	_	0	SENT_57	[p2l854t927r939b1006],
7	rash	NN	O	rash	nn	12	SENT_57	[p2l972t927r1132b999],
8	,	,	O	,	_	0	SENT_57	[p2l972t927r1132b999],
9	wheals	NN	O	wheal	dep	12	SENT_57	[p2l1169t927r1424b999],
10	,	,	O	,	_	0	SENT_57	[p2l1169t927r1424b999],
11	and/or	JJ	O	and/or	amod	12	SENT_57	[p2l1462t927r1680b988],
12	angioedema	NN	O	angioedema	agent	5	SENT_57	[p2l1713t927r2143b1006],
13	,	,	O	,	_	0	SENT_57	[p2l1713t927r2143b1006],
14	while	IN	O	while	mark	22	SENT_57	[p2l9t1027r197b1089],
15	upper	JJ	O	upper	amod	17	SENT_57	[p2l218t1047r415b1107],
16	respiratory	JJ	O	respiratory	amod	17	SENT_57	[p2l433t1027r804b1107],
17	tract	NN	O	tract	nsubjpass	22	SENT_57	[p2l825t1037r977b1088],
18	and	CC	O	and	_	0	SENT_57	[p2l998t1027r1120b1088],
19	skin	NN	O	skin	nn	20	SENT_57	[p2l1143t1027r1282b1088],
20	manifestations	NNS	O	manifestation	nsubjpass	22	SENT_57	[p2l1303t1027r1800b1088],
21	are	VBP	O	be	auxpass	22	SENT_57	[p2l1825t1047r1926b1088],
22	found	VBN	O	find	dep	12	SENT_57	[p2l1947t1027r2148b1088],
23	in	IN	O	in	_	0	SENT_57	[p2l8t1129r75b1189],
24	the	DT	O	the	det	26	SENT_57	[p2l110t1129r215b1190],
25	mixed	JJ	O	mixed	amod	26	SENT_57	[p2l251t1129r470b1190],
26	pattern	NN	O	pattern	prep_in	22	SENT_57	[p2l504t1138r765b1208],
27	.	.	O	.	_	0	SENT_57	[p2l504t1138r765b1208],

1	Although	IN	O	although	mark	8	SENT_58	[p2l801t1129r1132b1208],
2	the	DT	O	the	det	3	SENT_58	[p2l1168t1129r1273b1190],
3	pathogenesis	NN	O	pathogenesis	nsubjpass	8	SENT_58	[p2l1308t1129r1761b1208],
4	of	IN	O	of	_	0	SENT_58	[p2l1799t1129r1875b1190],
5	AIU	NNP	ORGANIZATION	AIU	prep_of	3	SENT_58	[p2l1900t1129r2054b1190],
6	is	VBZ	O	be	auxpass	8	SENT_58	[p2l2090t1129r2144b1190],
7	poorly	RB	O	poorly	advmod	8	SENT_58	[p2l7t1230r231b1309],
8	understood	VBN	O	understand	advcl	13	SENT_58	[p2l259t1230r659b1302],
9	,	,	O	,	_	0	SENT_58	[p2l259t1230r659b1302],
10	it	PRP	O	it	nsubjpass	13	SENT_58	[p2l691t1230r738b1291],
11	has	VBZ	O	have	aux	13	SENT_58	[p2l765t1230r877b1291],
12	been	VBN	O	be	auxpass	13	SENT_58	[p2l906t1230r1069b1291],
13	postulated	VBN	O	postulate	_	0	SENT_58	[p2l1096t1230r1449b1309],
14	that	IN	O	that	complm	23	SENT_58	[p2l1478t1230r1606b1291],
15	cross	JJ	O	cross	amod	17	SENT_58	[p2l1635t1230r2145b1291],
16	—	JJ	O	—	amod	17	SENT_58	[p2l1635t1230r2145b1291],
17	reactions	NNS	O	reaction	nsubj	23	SENT_58	[p2l1635t1230r2145b1291],
18	to	TO	O	to	_	0	SENT_58	[p2l8t1340r73b1391],
19	ASA	NN	O	asa	prep_to	17	SENT_58	[p2l91t1331r264b1392],
20	and	CC	O	and	_	0	SENT_58	[p2l284t1330r405b1391],
21	NSAIDS	NNS	O	nsaid	conj_and	19	SENT_58	[p2l427t1331r722b1392],
22	are	VBP	O	be	cop	23	SENT_58	[p2l749t1350r850b1391],
23	likely	JJ	O	likely	ccomp	13	SENT_58	[p2l873t1330r1066b1410],
24	to	TO	O	to	aux	26	SENT_58	[p2l1090t1340r1154b1391],
25	be	VB	O	be	cop	26	SENT_58	[p2l1177t1330r1257b1391],
26	due	JJ	O	due	xcomp	23	SENT_58	[p2l1282t1330r1403b1391],
27	to	TO	O	to	_	0	SENT_58	[p2l1427t1340r1491b1391],
28	a	DT	O	a	det	30	SENT_58	[p2l1517t1350r1553b1391],
29	pharmacological	JJ	O	pharmacological	amod	30	SENT_58	[p2l1574t1330r2146b1410],
30	mechanism	NN	O	mechanism	prep_to	26	SENT_58	[p2l8t1432r401b1493],
31	inﬂuenced	VBN	O	inﬂuenced	partmod	30	SENT_58	[p2l426t1432r784b1493],
32	by	IN	O	by	_	0	SENT_58	[p2l809t1432r894b1511],
33	genetic	JJ	O	genetic	amod	34	SENT_58	[p2l922t1432r1166b1511],
34	polymorphisms	NNS	O	polymorphism	agent	31	SENT_58	[p2l1193t1432r1727b1511],
35	involved	VBN	O	involve	partmod	34	SENT_58	[p2l1756t1432r2056b1493],
36	in	IN	O	in	_	0	SENT_58	[p2l2082t1432r2147b1492],
37	the	DT	O	the	det	38	SENT_58	[p2l8t1533r111b1594],
38	metabolism	NN	O	metabolism	prep_in	35	SENT_58	[p2l135t1533r536b1594],
39	of	IN	O	of	_	0	SENT_58	[p2l558t1533r633b1594],
40	arachidonic	JJ	O	arachidonic	amod	41	SENT_58	[p2l652t1533r1048b1594],
41	acid	NN	O	acid	prep_of	38	SENT_58	[p2l1074t1533r1230b1594],
42	.	.	O	.	_	0	SENT_58	[p2l1074t1533r1230b1594],

1	Several	JJ	O	several	amod	2	SENT_59	[p2l142t1633r390b1695],
2	lines	NNS	O	line	nsubj	6	SENT_59	[p2l419t1633r573b1694],
3	of	IN	O	of	_	0	SENT_59	[p2l605t1633r679b1694],
4	evidence	NN	O	evidence	prep_of	2	SENT_59	[p2l702t1633r999b1695],
5	strongly	RB	O	strongly	advmod	6	SENT_59	[p2l1031t1633r1301b1713],
6	support	VBP	O	support	_	0	SENT_59	[p2l1333t1643r1583b1713],
7	that	IN	O	that	complm	12	SENT_59	[p2l1610t1633r1735b1694],
8	in	IN	O	in	_	0	SENT_59	[p2l1763t1633r1827b1694],
9	sensitive	JJ	O	sensitive	amod	10	SENT_59	[p2l1858t1633r2146b1695],
10	individuals	NNS	O	individual	prep_in	12	SENT_59	[p2l8t1735r377b1796],
11	there	EX	O	there	expl	12	SENT_59	[p2l398t1735r564b1796],
12	is	VBZ	O	be	ccomp	6	SENT_59	[p2l583t1735r635b1796],
13	overexpression	NN	O	overexpression	nsubj	12	SENT_59	[p2l656t1735r1163b1814],
14	of	IN	O	of	_	0	SENT_59	[p2l1182t1735r1256b1796],
15	the	DT	O	the	det	16	SENT_59	[p2l1268t1735r1369b1796],
16	enzymes	NNS	O	enzyme	prep_of	13	SENT_59	[p2l1389t1754r1681b1814],
17	and	CC	O	and	_	0	SENT_59	[p2l1703t1735r1823b1796],
18	receptors	NNS	O	receptor	prep_of	13	SENT_59	[p2l1839t1744r2145b1814],
19	involved	VBN	O	involve	partmod	16	SENT_59	[p2l8t1836r310b1897],
20	in	IN	O	in	_	0	SENT_59	[p2l344t1836r409b1896],
21	the	DT	O	the	det	26	SENT_59	[p2l443t1836r547b1897],
22	cysteinyl	NN	O	cysteinyl	nn	26	SENT_59	[p2l582t1836r892b1915],
23	leukotriene	NN	O	leukotriene	nn	26	SENT_59	[p2l926t1836r1313b1897],
24	metabolic	JJ	O	metabolic	amod	26	SENT_59	[p2l1348t1836r1686b1897],
25	pathway	NN	O	pathway	nn	26	SENT_59	[p2l1720t1836r2013b1915],
26	[	NN	O	[	prep_in	19	SENT_59	[p2l2054t1836r2144b1910, p2l10t1936r96b2011],
27	46	CD	NUMBER	46	num	28	SENT_59	[p2l2054t1836r2144b1910, p2l10t1936r96b2011],
28	]	NN	O	]	dep	26	SENT_59	[p2l2054t1836r2144b1910, p2l10t1936r96b2011],
29	;	:	O	;	_	0	SENT_59	[p2l2054t1836r2144b1910, p2l10t1936r96b2011],
30	therefore	RB	O	therefore	advmod	26	SENT_59	[p2l131t1936r449b2009],
31	,	,	O	,	_	0	SENT_59	[p2l131t1936r449b2009],
32	the	DT	O	the	det	33	SENT_59	[p2l483t1936r584b1997],
33	inhibition	NN	O	inhibition	appos	13	SENT_59	[p2l615t1936r940b1997],
34	of	IN	O	of	_	0	SENT_59	[p2l971t1936r1045b1997],
35	cyclooxygenase	NN	O	cyclooxygenase	prep_of	33	SENT_59	[p2l1071t1936r1606b2016],
36	1	CD	NUMBER	1	number	37	SENT_59	[p2l1646t1937r1672b1997],
37	(	CD	NUMBER	(	num	39	SENT_59	[p2l1714t1937r2024b2012],
38	COX-1	NN	O	cox-1	nn	39	SENT_59	[p2l1714t1937r2024b2012],
39	)	NN	O	)	nsubj	44	SENT_59	[p2l1714t1937r2024b2012],
40	by	IN	O	by	_	0	SENT_59	[p2l2060t1936r2146b2016],
41	aspirin	NN	O	aspirin	prep_by	39	SENT_59	[p2l10t2038r255b2117],
42	and	CC	O	and	_	0	SENT_59	[p2l295t2038r422b2099],
43	NSAIDs	NNS	MISC	nsaid	conj_and	41	SENT_59	[p2l459t2038r766b2099],
44	shunts	VBZ	O	shunt	rcmod	33	SENT_59	[p2l810t2038r1034b2099],
45	arachidonic	JJ	O	arachidonic	amod	47	SENT_59	[p2l1077t2038r1497b2099],
46	acid	NN	O	acid	nn	47	SENT_59	[p2l1539t2038r1686b2099],
47	metabolism	NN	O	metabolism	dobj	44	SENT_59	[p2l1725t2038r2148b2099],
48	towards	IN	O	towards	_	0	SENT_59	[p2l8t2139r307b2200],
49	the	DT	O	the	det	51	SENT_59	[p2l354t2139r467b2200],
50	lipo-oxygenase	NN	O	lipo-oxygenase	nn	51	SENT_59	[p2l511t2139r1100b2218],
51	pathway	NN	O	pathway	prep_towards	47	SENT_59	[p2l1143t2139r1465b2218],
52	with	IN	O	with	_	0	SENT_59	[p2l1510t2139r1677b2200],
53	subsequent	JJ	O	subsequent	amod	54	SENT_59	[p2l1723t2139r2148b2218],
54	overproduction	NN	O	overproduction	prep_with	51	SENT_59	[p2l9t2239r544b2319],
55	of	IN	O	of	_	0	SENT_59	[p2l568t2239r644b2300],
56	leukotrienes	NNS	O	leukotriene	prep_of	54	SENT_59	[p2l662t2239r1108b2312],
57	,	,	O	,	_	0	SENT_59	[p2l662t2239r1108b2312],
58	as	IN	O	as	mark	59	SENT_59	[p2l1137t2259r1204b2300],
59	proposed	VBN	O	propose	advcl	44	SENT_59	[p2l1228t2239r1550b2319],
60	for	IN	O	for	_	0	SENT_59	[p2l1573t2239r1675b2300],
61	AERD	NNP	ORGANIZATION	AERD	prep_for	59	SENT_59	[p2l1691t2240r1927b2300],
62	in	IN	O	in	_	0	SENT_59	[p2l1952t2239r2019b2300],
63	the	DT	O	the	det	65	SENT_59	[p2l2042t2239r2146b2300],
64	cyclooxygenase	NN	O	cyclooxygenase	nn	65	SENT_59	[p2l9t2341r568b2420],
65	hypothesis	NN	O	hypothesis	prep_in	59	SENT_59	[p2l596t2341r969b2420],
66	[	IN	O	[	_	0	SENT_59	[p2l1007t2342r1118b2415],
67	7	CD	NUMBER	7	num	68	SENT_59	[p2l1007t2342r1118b2415],
68	]	NN	O	]	prep_[	59	SENT_59	[p2l1007t2342r1118b2415],
69	.	.	O	.	_	0	SENT_59	[p2l1007t2342r1118b2415],

1	Thus	RB	O	thus	advmod	6	SENT_60	[p2l1150t2341r1343b2413],
2	,	,	O	,	_	0	SENT_60	[p2l1150t2341r1343b2413],
3	it	PRP	O	it	nsubjpass	6	SENT_60	[p2l1375t2341r1423b2402],
4	has	VBZ	O	have	aux	6	SENT_60	[p2l1450t2341r1564b2402],
5	been	VBN	O	be	auxpass	6	SENT_60	[p2l1594t2341r1759b2402],
6	postulated	VBN	O	postulate	_	0	SENT_60	[p2l1786t2341r2147b2420],
7	that	IN	O	that	complm	24	SENT_60	[p2l8t2442r137b2503],
8	polymorphisms	NNS	O	polymorphism	nsubj	24	SENT_60	[p2l153t2442r690b2521],
9	that	WDT	O	that	nsubj	10	SENT_60	[p2l709t2442r838b2503],
10	increase	VBP	O	increase	rcmod	8	SENT_60	[p2l855t2442r1136b2503],
11	or	CC	O	or	_	0	SENT_60	[p2l1155t2461r1226b2503],
12	dysregulate	VBP	O	dysregulate	conj_or	10	SENT_60	[p2l1243t2442r1638b2521],
13	the	DT	O	the	det	14	SENT_60	[p2l1657t2442r1760b2503],
14	expression	NN	O	expression	dobj	10	SENT_60	[p2l1779t2442r2147b2521],
15	of	IN	O	of	_	0	SENT_60	[p2l9t2542r86b2603],
16	genes	NNS	O	gene	prep_of	14	SENT_60	[p2l118t2562r315b2622],
17	involved	VBN	O	involve	partmod	16	SENT_60	[p2l354t2542r665b2604],
18	in	IN	O	in	_	0	SENT_60	[p2l702t2542r769b2603],
19	leukotriene	NN	O	leukotriene	nn	20	SENT_60	[p2l805t2542r1205b2603],
20	production	NN	O	production	prep_in	17	SENT_60	[p2l1241t2542r1628b2622],
21	could	MD	O	could	aux	24	SENT_60	[p2l1665t2542r1861b2603],
22	be	VB	O	be	cop	24	SENT_60	[p2l1896t2542r1978b2603],
23	risk	NN	O	risk	nn	24	SENT_60	[p2l2014t2542r2149b2603],
24	factors	NNS	O	factor	ccomp	6	SENT_60	[p2l9t2644r247b2705],
25	for	IN	O	for	_	0	SENT_60	[p2l287t2644r390b2705],
26	aspirin	NN	O	aspirin	nn	27	SENT_60	[p2l426t2644r666b2723],
27	hypersensitivity	NN	O	hypersensitivity	prep_for	24	SENT_60	[p2l702t2644r1272b2723],
28	[	CD	NUMBER	[	number	29	SENT_60	[p2l1316t2644r1473b2718],
29	8,9	CD	NUMBER	8,9	num	30	SENT_60	[p2l1316t2644r1473b2718],
30	]	NN	O	]	dep	27	SENT_60	[p2l1316t2644r1473b2718],
31	and	CC	O	and	_	0	SENT_60	[p2l1518t2644r1643b2705],
32	inﬂuence	NN	O	inﬂuence	prep_for	24	SENT_60	[p2l1678t2644r2003b2705],
33	the	DT	O	the	det	34	SENT_60	[p2l2040t2644r2146b2705],
34	response	NN	O	response	dep	32	SENT_60	[p2l7t2764r306b2824],
35	to	TO	O	to	_	0	SENT_60	[p2l324t2754r388b2806],
36	antileukotriene	JJ	O	antileukotriene	amod	37	SENT_60	[p2l408t2745r918b2806],
37	drugs	NNS	O	drug	prep_to	24	SENT_60	[p2l936t2745r1140b2824],
38	.	.	O	.	_	0	SENT_60	[p2l936t2745r1140b2824],

1	Some	DT	O	some	det	2	SENT_61	[p2l1164t2745r1357b2806],
2	authors	NNS	O	author	nsubj	4	SENT_61	[p2l1376t2745r1623b2806],
3	have	VBP	O	have	aux	4	SENT_61	[p2l1641t2745r1802b2806],
4	described	VBN	O	describe	_	0	SENT_61	[p2l1821t2745r2147b2806],
5	overproduction	NN	O	overproduction	dobj	4	SENT_61	[p2l9t2845r580b2925],
6	of	IN	O	of	_	0	SENT_61	[p2l623t2845r701b2906],
7	leukotrienes	NNS	O	leukotriene	prep_of	5	SENT_61	[p2l736t2845r1193b2906],
8	and	CC	O	and	_	0	SENT_61	[p2l1238t2845r1367b2906],
9	prostaglandin	NN	O	prostaglandin	nn	10	SENT_61	[p2l1406t2845r1918b2925],
10	D2	NN	O	d2	prep_of	5	SENT_61	[p2l1958t2847r2048b2935],
11	as	IN	O	as	_	0	SENT_61	[p2l2075t2865r2144b2906],
12	common	JJ	O	common	amod	13	SENT_61	[p2l9t2966r314b3008],
13	alterations	NNS	O	alteration	prep_as	4	SENT_61	[p2l342t2947r702b3008],
14	in	IN	O	in	_	0	SENT_61	[p2l730t2947r796b3007],
15	AIU	NNP	ORGANIZATION	AIU	prep_in	13	SENT_61	[p2l818t2948r971b3008],
16	and	CC	O	and	_	0	SENT_61	[p2l1000t2947r1123b3008],
17	asthma	NN	O	asthma	nn	18	SENT_61	[p2l1150t2947r1397b3008],
18	[	NN	O	[	prep_as	4	SENT_61	[p2l1428t2947r1539b3021],
19	5	CD	NUMBER	5	num	20	SENT_61	[p2l1428t2947r1539b3021],
20	]	NN	O	]	dep	18	SENT_61	[p2l1428t2947r1539b3021],
21	.	.	O	.	_	0	SENT_61	[p2l1428t2947r1539b3021],

1	However	RB	O	however	advmod	5	SENT_62	[p2l1570t2948r1905b3019],
2	,	,	O	,	_	0	SENT_62	[p2l1570t2948r1905b3019],
3	recent	JJ	O	recent	amod	4	SENT_62	[p2l1933t2956r2148b3008],
4	evidence	NN	O	evidence	nsubj	5	SENT_62	[p2l9t3047r312b3109],
5	indicates	VBZ	O	indicate	_	0	SENT_62	[p2l329t3047r630b3109],
6	that	IN	O	that	complm	11	SENT_62	[p2l649t3047r777b3109],
7	these	DT	O	these	det	8	SENT_62	[p2l793t3047r967b3109],
8	interactions	NNS	O	interaction	nsubj	11	SENT_62	[p2l984t3047r1380b3109],
9	are	VBP	O	be	cop	11	SENT_62	[p2l1401t3067r1502b3109],
10	more	RBR	O	more	advmod	11	SENT_62	[p2l1519t3067r1695b3109],
11	complex	JJ	O	complex	ccomp	5	SENT_62	[p2l1713t3048r2007b3127],
12	and	CC	O	and	_	0	SENT_62	[p2l2026t3047r2148b3109],
13	different	JJ	O	different	amod	14	SENT_62	[p2l9t3148r303b3209],
14	polymorphisms	NNS	O	polymorphism	nsubj	16	SENT_62	[p2l318t3148r854b3228],
15	could	MD	O	could	aux	16	SENT_62	[p2l875t3148r1065b3209],
16	determine	VB	O	determine	conj_and	5	SENT_62	[p2l1083t3148r1425b3209],
17	different	JJ	O	different	amod	18	SENT_62	[p2l1445t3148r1738b3209],
18	phenotypes	NNS	O	phenotype	dobj	16	SENT_62	[p2l1754t3148r2145b3228],
19	of	IN	O	of	_	0	SENT_62	[p2l9t3250r85b3311],
20	aspirin	NN	O	aspirin	nn	21	SENT_62	[p2l106t3250r342b3329],
21	hypersensitivity	NN	O	hypersensitivity	prep_of	18	SENT_62	[p2l366t3250r926b3329],
22	(	CD	NUMBER	(	num	21	SENT_62	[p2l955t3251r1081b3329],
23	eg	FW	O	eg	tmod	16	SENT_62	[p2l955t3251r1081b3329],
24	,	,	O	,	_	0	SENT_62	[p2l955t3251r1081b3329],
25	asthma	NN	O	asthma	nn	28	SENT_62	[p2l1111t3250r1358b3311],
26	or	CC	O	or	_	0	SENT_62	[p2l1383t3269r1454b3311],
27	urticaria	NN	O	urticarium	nn	28	SENT_62	[p2l1477t3250r1795b3326],
28	)	NN	O	)	appos	23	SENT_62	[p2l1477t3250r1795b3326],
29	and	CC	O	and	_	0	SENT_62	[p2l1825t3250r1949b3311],
30	exert	VB	O	exert	conj_and	16	SENT_62	[p2l1974t3259r2148b3311],
31	their	PRP$	O	they	poss	32	SENT_62	[p2l8t3350r169b3412],
32	effects	NNS	O	effect	dobj	30	SENT_62	[p2l193t3350r420b3412],
33	in	IN	O	in	_	0	SENT_62	[p2l447t3350r513b3411],
34	some	DT	O	some	det	35	SENT_62	[p2l540t3370r720b3412],
35	populations	NNS	O	population	prep_in	30	SENT_62	[p2l744t3350r1151b3430],
36	but	CC	O	but	_	0	SENT_62	[p2l1177t3350r1289b3412],
37	not	RB	O	not	neg	40	SENT_62	[p2l1312t3360r1424b3412],
38	in	IN	O	in	_	0	SENT_62	[p2l1447t3350r1513b3411],
39	others	NNS	O	other	prep_in	37	SENT_62	[p2l1538t3350r1748b3412],
40	[	VBP	O	[	conj_but	16	SENT_62	[p2l1781t3351r2002b3425],
41	8,10	CD	NUMBER	8,10	number	42	SENT_62	[p2l1781t3351r2002b3425],
42	]	CD	NUMBER	]	dobj	40	SENT_62	[p2l1781t3351r2002b3425],
43	.	.	O	.	_	0	SENT_62	[p2l1781t3351r2002b3425],

1	Activation	NN	O	activation	nsubj	6	SENT_63	[p2l139t3451r509b3513],
2	of	IN	O	of	_	0	SENT_63	[p2l536t3451r612b3512],
3	cutaneous	JJ	O	cutaneous	amod	5	SENT_63	[p2l633t3461r980b3512],
4	mast	NN	O	mast	nn	5	SENT_63	[p2l1008t3461r1173b3512],
5	cells	NNS	O	cell	prep_of	1	SENT_63	[p2l1199t3451r1355b3512],
6	plays	VBZ	O	play	_	0	SENT_63	[p2l1383t3451r1565b3531],
7	a	DT	O	a	det	9	SENT_63	[p2l1596t3471r1632b3512],
8	central	JJ	O	central	amod	9	SENT_63	[p2l1657t3451r1894b3512],
9	role	NN	O	role	dobj	6	SENT_63	[p2l1919t3451r2054b3512],
10	in	IN	O	in	_	0	SENT_63	[p2l2081t3451r2147b3512],
11	the	DT	O	the	det	12	SENT_63	[p2l8t3553r112b3614],
12	pathophysiology	NN	O	pathophysiology	prep_in	9	SENT_63	[p2l128t3553r702b3632],
13	of	IN	O	of	_	0	SENT_63	[p2l722t3553r796b3614],
14	urticaria	NN	O	urticarium	prep_of	12	SENT_63	[p2l808t3553r1094b3614],
15	by	IN	O	by	_	0	SENT_63	[p2l1109t3553r1194b3632],
16	releasing	VBG	O	release	prepc_by	6	SENT_63	[p2l1211t3553r1520b3632],
17	pro	JJ	O	pro	amod	20	SENT_63	[p2l1538t3553r2146b3632],
18	—	NN	O	—	nn	20	SENT_63	[p2l1538t3553r2146b3632],
19	inﬂammatory	JJ	O	inﬂammatory	amod	20	SENT_63	[p2l1538t3553r2146b3632],
20	mediators	NNS	O	mediator	dobj	16	SENT_63	[p3l8t17r347b79],
21	including	VBG	O	include	_	0	SENT_63	[p3l367t17r693b97],
22	histamine	NN	O	histamine	prep_including	20	SENT_63	[p3l711t17r1066b90],
23	,	,	O	,	_	0	SENT_63	[p3l711t17r1066b90],
24	leukotrienes	NNS	O	leukotriene	prep_including	20	SENT_63	[p3l1088t17r1528b90],
25	,	,	O	,	_	0	SENT_63	[p3l1088t17r1528b90],
26	prostaglandin	NN	O	prostaglandin	nn	27	SENT_63	[p3l1549t17r2021b97],
27	D2	NN	O	d2	prep_including	20	SENT_63	[p3l2039t19r2143b107],
28	,	,	O	,	_	0	SENT_63	[p3l2039t19r2143b107],
29	cytokines	NNS	O	cytokine	prep_including	20	SENT_63	[p3l9t118r362b198],
30	,	,	O	,	_	0	SENT_63	[p3l9t118r362b198],
31	and	CC	O	and	_	0	SENT_63	[p3l391t118r515b179],
32	proteolytic	JJ	O	proteolytic	amod	33	SENT_63	[p3l537t118r916b198],
33	enzymes	NNS	O	enzyme	conj_and	22	SENT_63	[p3l942t138r1264b198],
34	.	.	O	.	_	0	SENT_63	[p3l942t138r1264b198],

1	Leukotriene	NN	O	leukotriene	nn	2	SENT_64	[p3l1292t118r1715b179],
2	C	NN	O	c	nsubj	22	SENT_64	[p3l1741t119r1795b180],
3	4	CD	NUMBER	4	num	4	SENT_64	[p3l1798t173r1822b208],
4	synthase	NN	O	synthase	nsubj	15	SENT_64	[p3l1849t118r2146b198],
5	is	VBZ	O	be	cop	8	SENT_64	[p3l8t220r65b281],
6	a	DT	O	a	det	8	SENT_64	[p3l109t239r145b281],
7	terminal	JJ	O	terminal	amod	8	SENT_64	[p3l184t220r491b281],
8	enzyme	NN	O	enzyme	rcmod	2	SENT_64	[p3l532t239r813b299],
9	in	IN	O	in	_	0	SENT_64	[p3l854t220r923b280],
10	the	DT	O	the	det	12	SENT_64	[p3l962t220r1072b281],
11	leukotriene	NN	O	leukotriene	nn	12	SENT_64	[p3l1112t220r1528b281],
12	pathway	NN	O	pathway	prep_in	8	SENT_64	[p3l1568t220r1878b299],
13	and	CC	O	and	_	0	SENT_64	[p3l1921t220r2049b281],
14	is	VBZ	O	be	cop	15	SENT_64	[p3l2088t220r2145b281],
15	responsible	JJ	O	responsible	rcmod	2	SENT_64	[p3l7t320r430b400],
16	for	IN	O	for	_	0	SENT_64	[p3l471t320r577b382],
17	the	DT	O	the	det	18	SENT_64	[p3l615t321r725b382],
18	production	NN	O	production	prep_for	15	SENT_64	[p3l764t320r1166b400],
19	of	IN	O	of	_	0	SENT_64	[p3l1207t320r1285b382],
20	cysteinyl	NN	O	cysteinyl	nn	21	SENT_64	[p3l1320t320r1653b400],
21	leukotrienes	NNS	O	leukotriene	prep_of	18	SENT_64	[p3l1694t320r2145b382],
22	(	VBP	O	(	_	0	SENT_64	[p3l11t422r238b511],
23	LTC4	NN	O	ltc4	dobj	22	SENT_64	[p3l11t422r238b511],
24	,	,	O	,	_	0	SENT_64	[p3l11t422r238b511],
25	LTD	NN	ORGANIZATION	ltd	appos	23	SENT_64	[p3l262t423r422b482],
26	4	CD	NUMBER	4	num	25	SENT_64	[p3l425t472r468b511],
27	,	,	O	,	_	0	SENT_64	[p3l425t472r468b511],
28	LTE4	NN	O	lte4	nn	29	SENT_64	[p3l493t422r718b511],
29	)	NN	O	)	appos	25	SENT_64	[p3l493t422r718b511],
30	,	,	O	,	_	0	SENT_64	[p3l493t422r718b511],
31	the	DT	O	the	det	32	SENT_64	[p3l742t421r847b482],
32	levels	NNS	O	level	appos	25	SENT_64	[p3l870t421r1070b482],
33	of	IN	O	of	_	0	SENT_64	[p3l1095t421r1171b482],
34	which	WDT	O	which	nsubjpass	37	SENT_64	[p3l1187t421r1400b483],
35	are	VBP	O	be	auxpass	37	SENT_64	[p3l1423t441r1526b482],
36	characteristically	RB	O	characteristically	advmod	37	SENT_64	[p3l1549t421r2146b501],
37	increased	VBN	O	increase	prepc_of	32	SENT_64	[p3l8t523r331b584],
38	in	IN	O	in	_	0	SENT_64	[p3l347t523r413b583],
39	urine	NN	O	urine	prep_in	37	SENT_64	[p3l428t523r621b596],
40	,	,	O	,	_	0	SENT_64	[p3l428t523r621b596],
41	eosinophils	NNS	O	eosinophil	conj_and	39	SENT_64	[p3l642t523r1048b602],
42	,	,	O	,	_	0	SENT_64	[p3l642t523r1048b602],
43	and	CC	O	and	_	0	SENT_64	[p3l1070t523r1191b584],
44	bronchial	JJ	O	bronchial	amod	46	SENT_64	[p3l1207t523r1529b584],
45	biopsy	NN	O	biopsy	nn	46	SENT_64	[p3l1546t523r1773b602],
46	specimens	NNS	O	specimen	conj_and	39	SENT_64	[p3l1794t523r2145b602],
47	from	IN	O	from	_	0	SENT_64	[p3l9t623r178b685],
48	patients	NNS	O	patient	prep_from	37	SENT_64	[p3l199t623r470b703],
49	with	IN	O	with	_	0	SENT_64	[p3l495t623r650b685],
50	aspirin	NN	O	aspirin	nn	52	SENT_64	[p3l674t623r910b703],
51	hypersensitivity	NN	O	hypersensitivity	nn	52	SENT_64	[p3l932t623r1493b703],
52	[	NN	O	[	prep_with	37	SENT_64	[p3l1523t624r1579b698],
53	1	CD	NUMBER	1	number	54	SENT_64	[p3l1523t624r1579b698],
54	1	CD	NUMBER	1	num	55	SENT_64	[p3l1595t624r1675b698],
55	]	NN	O	]	dep	37	SENT_64	[p3l1595t624r1675b698],
56	.	.	O	.	_	0	SENT_64	[p3l1595t624r1675b698],

1	Even	RB	O	even	advmod	6	SENT_65	[p3l1702t625r1882b685],
2	though	IN	O	though	dep	6	SENT_65	[p3l1905t623r2147b703],
3	the	DT	O	the	det	4	SENT_65	[p3l8t724r115b785],
4	results	NNS	O	result	nsubj	6	SENT_65	[p3l153t724r387b785],
5	are	VBP	O	be	cop	6	SENT_65	[p3l429t744r534b785],
6	controversial	JJ	O	controversial	advcl	16	SENT_65	[p3l574t724r1066b797],
7	,	,	O	,	_	0	SENT_65	[p3l574t724r1066b797],
8	transcriptional	JJ	O	transcriptional	amod	9	SENT_65	[p3l1108t724r1632b804],
9	regulation	NN	O	regulation	nsubjpass	16	SENT_65	[p3l1669t724r2037b804],
10	of	IN	O	of	_	0	SENT_65	[p3l2076t724r2153b785],
11	the	DT	O	the	det	13	SENT_65	[p3l8t826r115b887],
12	LTC4S	NN	O	ltc4	nn	13	SENT_65	[p3l150t826r400b888],
13	gene	NN	O	gene	prep_of	9	SENT_65	[p3l436t845r601b905],
14	could	MD	O	could	aux	16	SENT_65	[p3l640t826r837b887],
15	be	VB	O	be	auxpass	16	SENT_65	[p3l873t826r955b887],
16	inﬂuenced	VBN	O	inﬂuenced	dep	22	SENT_65	[p3l993t826r1366b887],
17	by	IN	O	by	_	0	SENT_65	[p3l1402t826r1488b905],
18	single	JJ	O	single	amod	21	SENT_65	[p3l1530t826r2146b905],
19	—	NN	O	—	nn	21	SENT_65	[p3l1530t826r2146b905],
20	nucleotide	NN	O	nucleotide	nn	21	SENT_65	[p3l1530t826r2146b905],
21	polymorphisms	NNS	O	polymorphism	agent	16	SENT_65	[p3l7t926r571b1006],
22	(	VBP	O	(	_	0	SENT_65	[p3l615t927r869b1002],
23	SNPs	NNS	O	snp	dobj	22	SENT_65	[p3l615t927r869b1002],
24	)	CD	NUMBER	)	nsubj	22	SENT_65	[p3l615t927r869b1002],
25	in	IN	O	in	_	0	SENT_65	[p3l911t926r979b987],
26	its	PRP$	O	its	poss	28	SENT_65	[p3l1017t926r1099b988],
27	promoter	NN	O	promoter	nn	28	SENT_65	[p3l1139t936r1473b1006],
28	region	NN	O	region	prep_in	24	SENT_65	[p3l1509t926r1762b1006],
29	,	,	O	,	_	0	SENT_65	[p3l1509t926r1762b1006],
30	including	VBG	O	include	_	0	SENT_65	[p3l1804t926r2145b1006],
31	a	DT	O	a	det	32	SENT_65	[p3l10t1047r46b1088],
32	transversion	NN	O	transversion	prep_including	24	SENT_65	[p3l83t1027r524b1088],
33	of	IN	O	of	prep	32	SENT_65	[p3l563t1027r640b1088],
34	adenine	NN	LOCATION	adenine	dep	48	SENT_65	[p3l674t1027r950b1088],
35	for	IN	O	for	_	0	SENT_65	[p3l989t1027r1092b1088],
36	cytosine	NN	O	cytosine	prep_for	34	SENT_65	[p3l1130t1027r1428b1107],
37	at	IN	O	at	_	0	SENT_65	[p3l1468t1037r1530b1088],
38	444	CD	NUMBER	444	num	39	SENT_65	[p3l1566t1028r1697b1088],
39	nucleotides	NNS	O	nucleotide	prep_at	36	SENT_65	[p3l1736t1027r2145b1088],
40	of	IN	O	of	_	0	SENT_65	[p3l9t1129r85b1190],
41	the	DT	O	the	det	43	SENT_65	[p3l116t1129r221b1190],
42	transcription	NN	O	transcription	nn	43	SENT_65	[p3l258t1129r705b1208],
43	start	NN	O	start	prep_of	39	SENT_65	[p3l744t1138r893b1190],
44	site	NN	O	site	dep	48	SENT_65	[p3l931t1129r1049b1190],
45	(	CD	NUMBER	(	num	44	SENT_65	[p3l1088t1129r1440b1205],
46	A	DT	O	a	det	48	SENT_65	[p3l1088t1129r1440b1205],
47	—	NN	O	—	nn	48	SENT_65	[p3l1088t1129r1440b1205],
48	444C	NN	O	444c	dep	33	SENT_65	[p3l1088t1129r1440b1205],
49	)	CD	NUMBER	)	number	50	SENT_65	[p3l1088t1129r1440b1205],
50	[	CD	NUMBER	[	dep	48	SENT_65	[p3l1485t1129r1642b1203],
51	12	CD	NUMBER	12	num	52	SENT_65	[p3l1485t1129r1642b1203],
52	]	NN	O	]	dep	50	SENT_65	[p3l1485t1129r1642b1203],
53	.	.	O	.	_	0	SENT_65	[p3l1485t1129r1642b1203],

1	In	IN	O	in	_	0	SENT_66	[p3l1682t1130r1754b1189],
2	white	JJ	O	white	amod	5	SENT_66	[p3l1791t1129r1984b1190],
3	and	CC	O	and	_	0	SENT_66	[p3l2023t1129r2147b1190],
4	Japanese	JJ	MISC	japanese	conj_and	2	SENT_66	[p3l8t1231r318b1309],
5	individuals	NNS	O	individual	prep_in	11	SENT_66	[p3l348t1229r756b1302],
6	,	,	O	,	_	0	SENT_66	[p3l348t1229r756b1302],
7	the	DT	O	the	det	9	SENT_66	[p3l788t1230r893b1291],
8	C	NN	O	c	nn	9	SENT_66	[p3l924t1230r977b1291],
9	allele	NN	O	allele	nsubjpass	11	SENT_66	[p3l1010t1229r1196b1291],
10	is	VBZ	O	be	auxpass	11	SENT_66	[p3l1226t1229r1279b1291],
11	associated	VBN	O	associate	_	0	SENT_66	[p3l1313t1229r1671b1291],
12	with	IN	O	with	_	0	SENT_66	[p3l1700t1229r1854b1291],
13	a	DT	O	a	det	16	SENT_66	[p3l1885t1249r1921b1291],
14	better	JJR	O	better	amod	16	SENT_66	[p3l1948t1230r2149b1291],
15	therapeutic	JJ	O	therapeutic	amod	16	SENT_66	[p3l8t1330r395b1410],
16	response	NN	O	response	prep_with	11	SENT_66	[p3l419t1350r725b1410],
17	to	TO	O	to	_	0	SENT_66	[p3l749t1340r814b1391],
18	leukotriene	NN	O	leukotriene	nn	20	SENT_66	[p3l839t1330r1231b1391],
19	receptor	NN	O	receptor	nn	20	SENT_66	[p3l1254t1340r1543b1410],
20	antagonists	NNS	O	antagonist	prep_to	11	SENT_66	[p3l1566t1330r1955b1410],
21	[	VBP	O	[	dep	20	SENT_66	[p3l1987t1331r2143b1405],
22	13	CD	NUMBER	13	num	23	SENT_66	[p3l1987t1331r2143b1405],
23	]	CD	NUMBER	]	dobj	21	SENT_66	[p3l1987t1331r2143b1405],
24	,	,	O	,	_	0	SENT_66	[p3l1987t1331r2143b1405],
25	and	CC	O	and	_	0	SENT_66	[p3l10t1432r134b1493],
26	this	DT	O	this	det	27	SENT_66	[p3l164t1432r286b1493],
27	polymorphism	NN	O	polymorphism	nsubjpass	30	SENT_66	[p3l318t1432r832b1511],
28	has	VBZ	O	have	aux	30	SENT_66	[p3l860t1432r974b1493],
29	been	VBN	O	be	auxpass	30	SENT_66	[p3l1005t1432r1171b1493],
30	studied	VBN	O	study	conj_and	11	SENT_66	[p3l1204t1432r1454b1493],
31	as	IN	O	as	_	0	SENT_66	[p3l1486t1451r1553b1493],
32	a	DT	O	a	det	34	SENT_66	[p3l1587t1451r1623b1493],
33	risk	NN	O	risk	nn	34	SENT_66	[p3l1651t1432r1784b1493],
34	factor	NN	O	factor	prep_as	30	SENT_66	[p3l1813t1432r2017b1493],
35	for	IN	O	for	_	0	SENT_66	[p3l2047t1432r2149b1493],
36	aspirin	NN	O	aspirin	nn	37	SENT_66	[p3l10t1532r245b1612],
37	hypersensitivity	NN	O	hypersensitivity	prep_for	34	SENT_66	[p3l264t1532r824b1612],
38	in	IN	O	in	_	0	SENT_66	[p3l844t1532r910b1593],
39	conditions	NNS	O	condition	prep_in	30	SENT_66	[p3l930t1532r1291b1594],
40	such	JJ	O	such	_	0	SENT_66	[p3l1315t1533r1472b1594],
41	as	IN	O	as	_	0	SENT_66	[p3l1492t1552r1559b1594],
42	AERD	NN	O	aerd	prep_such_as	39	SENT_66	[p3l1575t1533r1811b1593],
43	and	CC	O	and	_	0	SENT_66	[p3l1834t1533r1957b1594],
44	AIU	NNP	O	AIU	prep_such_as	39	SENT_66	[p3l1970t1533r2142b1594],
45	.	.	O	.	_	0	SENT_66	[p3l1970t1533r2142b1594],

1	Nevertheless	RB	O	nevertheless	advmod	8	SENT_67	[p3l8t1633r479b1706],
2	,	,	O	,	_	0	SENT_67	[p3l8t1633r479b1706],
3	the	DT	O	the	det	4	SENT_67	[p3l507t1633r612b1694],
4	results	NNS	O	result	nsubj	8	SENT_67	[p3l635t1633r862b1694],
5	are	VBP	O	be	cop	8	SENT_67	[p3l890t1653r993b1694],
6	still	RB	O	still	advmod	8	SENT_67	[p3l1021t1633r1148b1694],
7	contradictory	JJ	O	contradictory	amod	8	SENT_67	[p3l1173t1633r1638b1713],
8	[	NN	O	[	_	0	SENT_67	[p3l1669t1633r2008b1708],
9	5	CD	NUMBER	5	num	8	SENT_67	[p3l1669t1633r2008b1708],
10	,	,	O	,	_	0	SENT_67	[p3l1669t1633r2008b1708],
11	l4	NN	O	l4	nn	14	SENT_67	[p3l1669t1633r2008b1708],
12	—	CD	NUMBER	—	num	14	SENT_67	[p3l1669t1633r2008b1708],
13	l6	NN	O	l6	nn	14	SENT_67	[p3l1669t1633r2008b1708],
14	]	NN	O	]	appos	8	SENT_67	[p3l1669t1633r2008b1708],
15	.	.	O	.	_	0	SENT_67	[p3l1669t1633r2008b1708],

1	©	RB	O	©	dep	2	SENT_68	[p3l10t1880r61b1931],
2	2009	CD	DATE	2009	dep	4	SENT_68	[p3l84t1880r227b1932],
3	Esmon	NNP	O	Esmon	nn	4	SENT_68	[p3l249t1881r454b1931],
4	Publicidad	NNP	O	Publicidad	_	0	SENT_68	[p3l474t1880r790b1931],

1	In	IN	O	in	_	0	SENT_69	[p3l138t1973r210b2032],
2	a	DT	O	a	det	4	SENT_69	[p3l245t1991r281b2033],
3	Polish	JJ	MISC	polish	amod	4	SENT_69	[p3l314t1972r533b2033],
4	population	NN	O	population	prep_in	18	SENT_69	[p3l565t1972r959b2051],
5	,	,	O	,	_	0	SENT_69	[p3l565t1972r959b2051],
6	the	DT	O	the	det	7	SENT_69	[p3l997t1972r1102b2033],
7	frequency	NN	O	frequency	nsubj	18	SENT_69	[p3l1136t1972r1485b2051],
8	of	IN	O	of	_	0	SENT_69	[p3l1521t1972r1597b2033],
9	the	DT	O	the	det	11	SENT_69	[p3l1625t1972r1730b2033],
10	C	NN	O	c	nn	11	SENT_69	[p3l1765t1972r1819b2033],
11	allele	NN	O	allele	prep_of	7	SENT_69	[p3l1857t1972r2043b2033],
12	of	IN	O	of	_	0	SENT_69	[p3l2078t1972r2154b2033],
13	A	DT	O	a	det	15	SENT_69	[p3l7t2073r306b2134],
14	—	CD	NUMBER	—	num	15	SENT_69	[p3l7t2073r306b2134],
15	444C	NN	O	444c	prep_of	11	SENT_69	[p3l7t2073r306b2134],
16	was	VBD	O	be	cop	18	SENT_69	[p3l346t2092r480b2134],
17	signiﬁcantly	RB	O	signiﬁcantly	advmod	18	SENT_69	[p3l522t2073r963b2152],
18	higher	JJR	O	higher	_	0	SENT_69	[p3l1000t2073r1230b2152],
19	in	IN	O	in	_	0	SENT_69	[p3l1265t2073r1333b2133],
20	patients	NNS	O	patient	prep_in	18	SENT_69	[p3l1369t2073r1646b2152],
21	with	IN	O	with	_	0	SENT_69	[p3l1686t2073r1844b2134],
22	chronic	JJ	O	chronic	amod	24	SENT_69	[p3l1881t2073r2147b2134],
23	idiopathic	JJ	O	idiopathic	amod	24	SENT_69	[p3l7t2173r370b2253],
24	urticaria	NN	O	urticarium	prep_with	18	SENT_69	[p3l410t2173r716b2234],
25	who	WP	O	who	nsubj	26	SENT_69	[p3l754t2173r905b2235],
26	exhibited	VBD	O	exhibit	rcmod	24	SENT_69	[p3l946t2173r1284b2234],
27	a	DT	O	a	det	29	SENT_69	[p3l1324t2193r1360b2234],
28	positive	JJ	O	positive	amod	29	SENT_69	[p3l1397t2173r1685b2253],
29	response	NN	O	response	dobj	26	SENT_69	[p3l1724t2193r2042b2253],
30	to	TO	O	to	_	0	SENT_69	[p3l2081t2183r2147b2234],
31	aspirin	NN	O	aspirin	nn	32	SENT_69	[p3l8t2275r245b2354],
32	challenge	NN	O	challenge	prep_to	26	SENT_69	[p3l280t2275r614b2354],
33	[	CD	NUMBER	[	number	34	SENT_69	[p3l656t2275r744b2349],
34	5	CD	NUMBER	5	num	35	SENT_69	[p3l656t2275r744b2349],
35	]	NN	O	]	dep	32	SENT_69	[p3l656t2275r744b2349],
36	and	CC	O	and	_	0	SENT_69	[p3l788t2275r911b2336],
37	in	IN	O	in	_	0	SENT_69	[p3l946t2275r1013b2335],
38	patients	NNS	O	patient	prep_in	45	SENT_69	[p3l1046t2275r1317b2354],
39	with	IN	O	with	_	0	SENT_69	[p3l1355t2275r1509b2336],
40	aspirin-intolerant	JJ	O	aspirin-intolerant	amod	43	SENT_69	[p3l1546t2275r2150b2354],
41	asthma	NN	O	asthma	nn	43	SENT_69	[p3l8t2376r261b2437],
42	(	NN	O	(	nn	43	SENT_69	[p3l300t2376r512b2452],
43	AIA	NN	ORGANIZATION	aium	prep_with	38	SENT_69	[p3l300t2376r512b2452],
44	)	CD	NUMBER	)	number	45	SENT_69	[p3l300t2376r512b2452],
45	[	CD	NUMBER	[	conj_and	32	SENT_69	[p3l559t2376r719b2450],
46	12	CD	NUMBER	12	num	47	SENT_69	[p3l559t2376r719b2450],
47	]	NN	O	]	dep	45	SENT_69	[p3l559t2376r719b2450],
48	.	.	O	.	_	0	SENT_69	[p3l559t2376r719b2450],

1	In	IN	O	in	_	0	SENT_70	[p3l761t2377r834b2436],
2	addition	NN	O	addition	prep_in	11	SENT_70	[p3l873t2376r1185b2448],
3	,	,	O	,	_	0	SENT_70	[p3l873t2376r1185b2448],
4	susceptibility	NN	O	susceptibility	nsubj	11	SENT_70	[p3l1229t2376r1708b2455],
5	to	TO	O	to	_	0	SENT_70	[p3l1746t2385r1812b2437],
6	the	DT	O	the	det	8	SENT_70	[p3l1851t2376r1958b2437],
7	AIU	NNP	ORGANIZATION	AIU	nn	8	SENT_70	[p3l1992t2376r2148b2437],
8	phenotype	NN	O	phenotype	prep_to	4	SENT_70	[p3l6t2476r400b2556],
9	does	VBZ	O	do	aux	11	SENT_70	[p3l445t2476r612b2537],
10	not	RB	O	not	neg	11	SENT_70	[p3l657t2486r776b2537],
11	follow	VB	O	follow	_	0	SENT_70	[p3l817t2476r1062b2538],
12	a	DT	O	a	det	15	SENT_70	[p3l1107t2496r1144b2537],
13	clear	JJ	O	clear	amod	15	SENT_70	[p3l1186t2476r1370b2537],
14	Mendelian	JJ	MISC	mendelian	amod	15	SENT_70	[p3l1411t2476r1816b2537],
15	pattern	NN	O	pattern	dobj	11	SENT_70	[p3l1857t2486r2145b2556],
16	,	,	O	,	_	0	SENT_70	[p3l1857t2486r2145b2556],
17	but	CC	O	but	_	0	SENT_70	[p3l6t2578r121b2639],
18	the	DT	O	the	det	20	SENT_70	[p3l158t2578r266b2639],
19	C	NN	O	c	nn	20	SENT_70	[p3l306t2578r359b2639],
20	allele	NN	O	allele	nsubj	22	SENT_70	[p3l401t2578r594b2639],
21	is	VBZ	O	be	cop	22	SENT_70	[p3l633t2578r689b2639],
22	characteristically	RB	O	characteristically	conj_but	11	SENT_70	[p3l731t2578r1353b2657],
23	inherited	VBN	O	inherit	csubj	27	SENT_70	[p3l1392t2578r1715b2639],
24	in	IN	O	in	_	0	SENT_70	[p3l1753t2578r1820b2638],
25	affected	JJ	O	affected	amod	26	SENT_70	[p3l1860t2578r2149b2639],
26	individuals	NNS	O	individual	prep_in	23	SENT_70	[p3l7t2679r424b2740],
27	[	VBP	O	[	ccomp	22	SENT_70	[p3l474t2679r641b2753],
28	17	CD	NUMBER	17	num	29	SENT_70	[p3l474t2679r641b2753],
29	]	CD	NUMBER	]	dobj	27	SENT_70	[p3l474t2679r641b2753],
30	.	.	O	.	_	0	SENT_70	[p3l474t2679r641b2753],

1	By	IN	O	by	_	0	SENT_71	[p3l687t2680r790b2758],
2	contrast	NN	O	contrast	prep_by	10	SENT_71	[p3l833t2688r1151b2751],
3	,	,	O	,	_	0	SENT_71	[p3l833t2688r1151b2751],
4	Kim	NNP	PERSON	Kim	dep	7	SENT_71	[p3l1197t2679r1357b2739],
5	et	FW	O	et	nn	7	SENT_71	[p3l1398t2688r1463b2740],
6	al	FW	O	al	nn	7	SENT_71	[p3l1505t2679r1567b2740],
7	[	FW	O	[	dep	10	SENT_71	[p3l1615t2679r1756b2753],
8	18	CD	NUMBER	18	num	9	SENT_71	[p3l1615t2679r1756b2753],
9	]	NN	O	]	nsubj	10	SENT_71	[p3l1615t2679r1756b2753],
10	found	VBD	O	find	_	0	SENT_71	[p3l1803t2679r2019b2740],
11	no	DT	O	no	det	12	SENT_71	[p3l2059t2698r2147b2740],
12	association	NN	O	association	nsubjpass	26	SENT_71	[p3l8t2779r400b2840],
13	between	IN	O	between	_	0	SENT_71	[p3l435t2779r730b2841],
14	A	DT	O	a	det	16	SENT_71	[p3l761t2780r1058b2841],
15	—	CD	NUMBER	—	num	16	SENT_71	[p3l761t2780r1058b2841],
16	444C	NN	O	444c	prep_between	12	SENT_71	[p3l761t2780r1058b2841],
17	and	CC	O	and	_	0	SENT_71	[p3l1098t2779r1222b2840],
18	AIU	NNP	ORGANIZATION	AIU	nsubjpass	26	SENT_71	[p3l1253t2780r1408b2841],
19	in	IN	O	in	_	0	SENT_71	[p3l1445t2779r1511b2840],
20	Koreans	NNPS	LOCATION	Koreans	prep_in	18	SENT_71	[p3l1549t2781r1860b2851],
21	,	,	O	,	_	0	SENT_71	[p3l1549t2781r1860b2851],
22	and	CC	O	and	_	0	SENT_71	[p3l1901t2779r2026b2840],
23	no	DT	O	no	det	24	SENT_71	[p3l2062t2799r2146b2840],
24	association	NN	O	association	conj_and	12	SENT_71	[p3l8t2881r396b2942],
25	was	VBD	O	be	auxpass	26	SENT_71	[p3l416t2900r548b2942],
26	found	VBN	O	find	dep	10	SENT_71	[p3l570t2881r773b2942],
27	between	IN	O	between	_	0	SENT_71	[p3l792t2881r1084b2942],
28	this	DT	O	this	det	30	SENT_71	[p3l1104t2881r1226b2942],
29	SN	NN	O	sn	nn	30	SENT_71	[p3l1251t2881r1359b2942],
30	P	NN	O	p	prep_between	26	SENT_71	[p3l1361t2882r1408b2941],
31	and	CC	O	and	_	0	SENT_71	[p3l1426t2881r1549b2942],
32	the	DT	O	the	det	33	SENT_71	[p3l1568t2881r1673b2942],
33	phenotype	NN	O	phenotype	nsubj	37	SENT_71	[p3l1692t2881r2057b2960],
34	of	IN	O	of	_	0	SENT_71	[p3l2078t2881r2154b2942],
35	NSAID	NN	O	nsaid	nn	36	SENT_71	[p3l6t2982r583b3043],
36	—	NN	O	—	prep_of	33	SENT_71	[p3l6t2982r583b3043],
37	induced	VBD	O	induce	conj_and	26	SENT_71	[p3l6t2982r583b3043],
38	isolated	VBN	O	isolate	amod	40	SENT_71	[p3l603t2982r876b3043],
39	periorbital	JJ	O	periorbital	amod	40	SENT_71	[p3l895t2982r1261b3061],
40	angioedema	NN	O	angioedema	dobj	37	SENT_71	[p3l1284t2982r1707b3061],
41	in	IN	O	in	_	0	SENT_71	[p3l1726t2982r1793b3042],
42	a	DT	O	a	det	44	SENT_71	[p3l1816t3001r1852b3043],
43	Spanish	JJ	LOCATION	spanish	amod	44	SENT_71	[p3l1874t2982r2149b3061],
44	population	NN	O	population	prep_in	40	SENT_71	[p3l6t3082r382b3162],
45	[	CD	NUMBER	[	number	46	SENT_71	[p3l408t3083r564b3157],
46	19	CD	NUMBER	19	num	47	SENT_71	[p3l408t3083r564b3157],
47	]	NN	O	]	dep	44	SENT_71	[p3l408t3083r564b3157],
48	.	.	O	.	_	0	SENT_71	[p3l408t3083r564b3157],

1	The	DT	O	the	det	2	SENT_72	[p3l587t3082r721b3143],
2	objective	NN	O	objective	nsubj	6	SENT_72	[p3l743t3082r1062b3162],
3	of	IN	O	of	_	0	SENT_72	[p3l1084t3082r1160b3143],
4	this	DT	O	this	det	5	SENT_72	[p3l1174t3082r1297b3143],
5	study	NN	O	study	prep_of	2	SENT_72	[p3l1322t3082r1507b3162],
6	was	VBD	O	be	_	0	SENT_72	[p3l1528t3102r1660b3143],
7	to	TO	O	to	aux	8	SENT_72	[p3l1683t3092r1748b3143],
8	investigate	VB	O	investigate	xcomp	6	SENT_72	[p3l1769t3082r2148b3162],
9	the	DT	O	the	det	10	SENT_72	[p3l7t3184r112b3245],
10	distribution	NN	O	distribution	dobj	8	SENT_72	[p3l146t3184r550b3245],
11	of	IN	O	of	_	0	SENT_72	[p3l584t3184r659b3245],
12	A	DT	O	a	det	14	SENT_72	[p3l682t3184r976b3245],
13	—	CD	NUMBER	—	num	14	SENT_72	[p3l682t3184r976b3245],
14	444C	NN	O	444c	prep_of	10	SENT_72	[p3l682t3184r976b3245],
15	in	IN	O	in	_	0	SENT_72	[p3l1011t3184r1077b3244],
16	a	DT	O	a	det	18	SENT_72	[p3l1112t3203r1149b3245],
17	Venezuelan	JJ	MISC	venezuelan	amod	18	SENT_72	[p3l1179t3184r1583b3245],
18	population	NN	O	population	prep_in	8	SENT_72	[p3l1615t3184r1991b3263],
19	and	CC	O	and	_	0	SENT_72	[p3l2026t3184r2149b3245],
20	evaluate	VB	O	evaluate	conj_and	8	SENT_72	[p3l7t3285r298b3346],
21	its	PRP$	O	its	poss	22	SENT_72	[p3l331t3285r410b3346],
22	association	NN	O	association	dobj	20	SENT_72	[p3l448t3285r836b3346],
23	with	IN	O	with	_	0	SENT_72	[p3l869t3285r1024b3346],
24	AIU	NNP	ORGANIZATION	AIU	prep_with	20	SENT_72	[p3l1052t3285r1225b3357],
25	,	,	O	,	_	0	SENT_72	[p3l1052t3285r1225b3357],
26	the	DT	O	the	det	28	SENT_72	[p3l1262t3285r1367b3346],
27	clinical	JJ	O	clinical	amod	28	SENT_72	[p3l1401t3285r1658b3346],
28	pattern	NN	O	pattern	conj_and	24	SENT_72	[p3l1691t3294r1953b3364],
29	,	,	O	,	_	0	SENT_72	[p3l1691t3294r1953b3364],
30	drug	NN	O	drug	nn	31	SENT_72	[p3l1990t3285r2147b3364],
31	hypersensitivity	NN	O	hypersensitivity	conj_and	24	SENT_72	[p3l6t3385r581b3465],
32	,	,	O	,	_	0	SENT_72	[p3l6t3385r581b3465],
33	and	CC	O	and	_	0	SENT_72	[p3l610t3385r734b3446],
34	atopic	JJ	O	atopic	amod	35	SENT_72	[p3l760t3385r969b3465],
35	phenotypes	NNS	O	phenotype	prep_with	20	SENT_72	[p3l994t3385r1411b3465],
36	.	.	O	.	_	0	SENT_72	[p3l994t3385r1411b3465],

1	Methods	NNS	O	method	_	0	SENT_73	[p3l16t3632r465b3720],

1	Study	NNP	O	Study	nn	2	SENT_74	[p4l10t89r251b177],
2	Popu/a	NNP	O	Popu/a	_	0	SENT_74	[p4l269t89r550b177],
3	2	CD	NUMBER	2	number	4	SENT_74	[p4l557t91r716b157],
4	‘	CD	NUMBER	‘	dep	2	SENT_74	[p4l557t91r716b157],
5	/	:	O	/	punct	6	SENT_74	[p4l557t91r716b157],
6	on	IN	O	on	dep	4	SENT_74	[p4l557t91r716b157],

1	One	CD	NUMBER	one	num	4	SENT_75	[p4l140t251r285b312],
2	hundred	CD	NUMBER	hundred	num	4	SENT_75	[p4l324t250r622b311],
3	ten	CD	NUMBER	ten	num	4	SENT_75	[p4l660t260r769b311],
4	patients	NNS	O	patient	_	0	SENT_75	[p4l806t250r1088b330],
5	with	IN	O	with	_	0	SENT_75	[p4l1130t250r1289b311],
6	cross	JJ	O	cross	amod	9	SENT_75	[p4l1329t250r1836b311],
7	—	NN	O	—	nn	9	SENT_75	[p4l1329t250r1836b311],
8	reactive	JJ	O	reactive	amod	9	SENT_75	[p4l1329t250r1836b311],
9	aspirin	NN	O	aspirin	prep_with	4	SENT_75	[p4l1877t250r2151b330],
10	/	:	O	/	punct	4	SENT_75	[p4l1877t250r2151b330],
11	NSAID	NN	O	nsaid	nn	12	SENT_75	[p4l6t351r583b412],
12	—	NN	O	—	nsubj	13	SENT_75	[p4l6t351r583b412],
13	induced	VBD	O	induce	dep	4	SENT_75	[p4l6t351r583b412],
14	urticaria/angioedema	NN	O	urticaria/angioedema	nsubjpass	16	SENT_75	[p4l600t351r1344b430],
15	were	VBD	O	be	auxpass	16	SENT_75	[p4l1362t370r1531b412],
16	recruited	VBN	O	recruit	ccomp	13	SENT_75	[p4l1549t351r1861b412],
17	from	IN	O	from	_	0	SENT_75	[p4l1880t351r2050b412],
18	an	DT	O	a	det	21	SENT_75	[p4l2069t370r2149b412],
19	outpatient	NN	O	outpatient	nn	21	SENT_75	[p4l8t451r358b531],
20	allergology	NN	O	allergology	nn	21	SENT_75	[p4l386t451r781b531],
21	clinic	NN	O	clinic	prep_from	16	SENT_75	[p4l810t451r1001b512],
22	in	IN	O	in	_	0	SENT_75	[p4l1030t451r1096b512],
23	Caracas	NNP	LOCATION	Caracas	nn	25	SENT_75	[p4l1125t452r1419b524],
24	,	,	O	,	_	0	SENT_75	[p4l1125t452r1419b524],
25	Venezuela	NNP	LOCATION	Venezuela	prep_in	21	SENT_75	[p4l1448t451r1827b524],
26	,	,	O	,	_	0	SENT_75	[p4l1448t451r1827b524],
27	between	IN	O	between	_	0	SENT_75	[p4l1856t451r2149b513],
28	2003	CD	DATE	2003	prep_between	21	SENT_75	[p4l8t554r176b615],
29	and	CC	DATE	and	_	0	SENT_75	[p4l210t553r333b614],
30	2007	CD	DATE	2007	prep_between	21	SENT_75	[p4l361t554r551b614],
31	.	.	O	.	_	0	SENT_75	[p4l361t554r551b614],

1	Patients	NNS	O	patient	nsubj	18	SENT_76	[p4l583t553r857b614],
2	of	IN	O	of	_	0	SENT_76	[p4l888t553r964b614],
3	any	DT	O	any	det	4	SENT_76	[p4l987t573r1109b633],
4	age	NN	O	age	prep_of	1	SENT_76	[p4l1138t573r1256b633],
5	or	CC	O	or	_	0	SENT_76	[p4l1285t573r1356b614],
6	gender	NN	O	gender	conj_or	4	SENT_76	[p4l1383t553r1621b633],
7	with	IN	O	with	_	0	SENT_76	[p4l1647t553r1801b614],
8	a	DT	O	a	det	10	SENT_76	[p4l1830t573r1866b614],
9	clinical	JJ	O	clinical	amod	10	SENT_76	[p4l1892t553r2148b614],
10	history	NN	O	history	prep_with	4	SENT_76	[p4l6t654r253b733],
11	of	IN	O	of	_	0	SENT_76	[p4l291t654r368b715],
12	urticaria	NN	O	urticarium	prep_of	10	SENT_76	[p4l398t654r697b715],
13	and	CC	O	and	_	0	SENT_76	[p4l734t654r859b715],
14	angioedema	NN	O	angioedema	prep_of	10	SENT_76	[p4l898t654r1327b733],
15	triggered	VBN	O	trigger	partmod	1	SENT_76	[p4l1362t654r1684b733],
16	by	IN	O	by	_	0	SENT_76	[p4l1719t654r1806b733],
17	NSAIDS	NNPS	O	NSAIDS	agent	15	SENT_76	[p4l1843t654r2146b715],
18	underwent	VBD	O	undergo	_	0	SENT_76	[p4l6t754r378b816],
19	double	JJ	O	double	amod	23	SENT_76	[p4l406t754r853b815],
20	—	JJ	O	—	amod	23	SENT_76	[p4l406t754r853b815],
21	blind	JJ	O	blind	amod	23	SENT_76	[p4l406t754r853b815],
22	placebo	NN	O	placebo	nn	23	SENT_76	[p4l880t754r1540b834],
23	—	NN	O	—	dobj	18	SENT_76	[p4l880t754r1540b834],
24	controlled	VBN	O	control	partmod	23	SENT_76	[p4l880t754r1540b834],
25	oral	JJ	O	oral	amod	27	SENT_76	[p4l1568t754r1702b815],
26	provocation	NN	O	provocation	nn	27	SENT_76	[p4l1729t754r2149b834],
27	tests	NNS	O	test	dobj	24	SENT_76	[p4l7t865r159b917],
28	with	IN	O	with	_	0	SENT_76	[p4l182t856r337b917],
29	NSAIDs	NNS	MISC	nsaid	prep_with	24	SENT_76	[p4l357t856r675b918],
30	.	.	O	.	_	0	SENT_76	[p4l357t856r675b918],

1	Brieﬂy	NNP	O	Brieﬂy	nsubjpass	22	SENT_77	[p4l701t856r956b936],
2	,	,	O	,	_	0	SENT_77	[p4l701t856r956b936],
3	incremental	JJ	O	incremental	amod	4	SENT_77	[p4l980t856r1394b917],
4	doses	NNS	O	dose	appos	1	SENT_77	[p4l1416t856r1606b917],
5	of	IN	O	of	_	0	SENT_77	[p4l1631t856r1706b917],
6	aspirin	NN	O	aspirin	prep_of	4	SENT_77	[p4l1723t856r1959b936],
7	from	IN	O	from	_	0	SENT_77	[p4l1980t856r2150b917],
8	25	CD	NUMBER	25	num	9	SENT_77	[p4l8t956r88b1018],
9	mg	NN	O	mg	prep_from	6	SENT_77	[p4l124t976r233b1036],
10	to	TO	O	to	_	0	SENT_77	[p4l266t966r331b1018],
11	500	CD	NUMBER	500	num	12	SENT_77	[p4l365t956r493b1018],
12	mg	NN	O	mg	prep_to	9	SENT_77	[p4l525t976r634b1036],
13	or	CC	O	or	_	0	SENT_77	[p4l667t976r739b1018],
14	placebo	NN	O	placebo	conj_or	12	SENT_77	[p4l767t957r1059b1036],
15	,	,	O	,	_	0	SENT_77	[p4l767t957r1059b1036],
16	given	VBN	O	give	prep	6	SENT_77	[p4l1095t957r1288b1036],
17	on	IN	O	on	pcomp	16	SENT_77	[p4l1320t976r1405b1018],
18	different	JJ	O	different	amod	19	SENT_77	[p4l1437t957r1737b1018],
19	days	NNS	DURATION	day	pobj	17	SENT_77	[p4l1768t957r1945b1036],
20	,	,	O	,	_	0	SENT_77	[p4l1768t957r1945b1036],
21	were	VBD	O	be	auxpass	22	SENT_77	[p4l1980t976r2148b1018],
22	concealed	VBN	O	conceal	_	0	SENT_77	[p4l7t1057r367b1118],
23	in	IN	O	in	_	0	SENT_77	[p4l404t1057r472b1118],
24	identical	JJ	O	identical	amod	26	SENT_77	[p4l509t1057r819b1118],
25	opaque	JJ	O	opaque	amod	26	SENT_77	[p4l858t1077r1114b1137],
26	capsules	NNS	O	capsule	prep_in	22	SENT_77	[p4l1153t1057r1477b1137],
27	,	,	O	,	_	0	SENT_77	[p4l1153t1057r1477b1137],
28	and	CC	O	and	_	0	SENT_77	[p4l1519t1057r1645b1118],
29	administered	VBN	O	administer	conj_and	22	SENT_77	[p4l1685t1057r2149b1118],
30	1	CD	DURATION	1	num	31	SENT_77	[p4l15t1160r41b1219],
31	hour	NN	NUMBER	hour	npadvmod	32	SENT_77	[p4l75t1159r237b1220],
32	apart	RB	O	apart	advmod	29	SENT_77	[p4l264t1168r455b1239],
33	,	,	O	,	_	0	SENT_77	[p4l264t1168r455b1239],
34	with	IN	O	with	_	0	SENT_77	[p4l487t1159r641b1220],
35	4	CD	DURATION	4	num	36	SENT_77	[p4l667t1159r709b1219],
36	hours	NNS	NUMBER	hour	prep_with	29	SENT_77	[p4l736t1159r928b1220],
37	of	IN	O	of	_	0	SENT_77	[p4l959t1159r1035b1220],
38	observation	NN	O	observation	prep_of	36	SENT_77	[p4l1057t1159r1466b1220],
39	in	IN	O	in	_	0	SENT_77	[p4l1492t1159r1560b1219],
40	the	DT	O	the	det	41	SENT_77	[p4l1586t1159r1691b1220],
41	hospital	NN	O	hospital	prep_in	38	SENT_77	[p4l1718t1159r1996b1239],
42	and	CC	O	and	_	0	SENT_77	[p4l2026t1159r2149b1220],
43	a	DT	O	a	det	45	SENT_77	[p4l8t1279r45b1321],
44	telephone	NN	O	telephone	nn	45	SENT_77	[p4l69t1260r409b1339],
45	survey	NN	O	survey	prep_in	38	SENT_77	[p4l438t1279r667b1339],
46	24	CD	DATE	24	num	47	SENT_77	[p4l695t1260r778b1320],
47	hours	NNS	DATE	hour	tmod	29	SENT_77	[p4l804t1260r996b1321],
48	later	RB	DATE	later	advmod	47	SENT_77	[p4l1025t1260r1191b1321],
49	.	.	O	.	_	0	SENT_77	[p4l1025t1260r1191b1321],

1	Vital	JJ	O	vital	amod	2	SENT_78	[p4l1220t1260r1388b1321],
2	signs	NNS	O	sign	nsubj	7	SENT_78	[p4l1417t1260r1591b1339],
3	and	CC	O	and	_	0	SENT_78	[p4l1620t1260r1744b1321],
4	pulmonary	JJ	O	pulmonary	amod	5	SENT_78	[p4l1767t1260r2148b1339],
5	function	NN	O	function	conj_and	2	SENT_78	[p4l7t1360r296b1421],
6	(	RB	O	(	advmod	7	SENT_78	[p4l317t1360r565b1436],
7	forced	VBD	O	force	_	0	SENT_78	[p4l317t1360r565b1436],
8	expiratory	JJ	O	expiratory	amod	9	SENT_78	[p4l584t1360r939b1440],
9	volume	NN	O	volume	nsubj	17	SENT_78	[p4l958t1360r1218b1422],
10	in	IN	O	in	_	0	SENT_78	[p4l1237t1360r1303b1421],
11	1	CD	DURATION	1	prep_in	9	SENT_78	[p4l1330t1361r1355b1421],
12	second	JJ	NUMBER	second	amod	15	SENT_78	[p4l1384t1360r1623b1421],
13	[	NN	O	[	nn	15	SENT_78	[p4l1646t1362r1881b1450],
14	FEV1	NN	O	fev1	nn	15	SENT_78	[p4l1646t1362r1881b1450],
15	]	NN	O	]	dep	9	SENT_78	[p4l1646t1362r1881b1450],
16	,	,	O	,	_	0	SENT_78	[p4l1893t1411r1906b1433],
17	forced	VBD	O	force	ccomp	7	SENT_78	[p4l1928t1360r2149b1421],
18	vital	JJ	O	vital	amod	22	SENT_78	[p4l7t1462r161b1523],
19	capacity	NN	O	capacity	nn	22	SENT_78	[p4l194t1462r484b1542],
20	[	CD	NUMBER	[	num	22	SENT_78	[p4l524t1462r764b1536],
21	FVC	NN	O	fvc	nn	22	SENT_78	[p4l524t1462r764b1536],
22	]	NN	O	]	nsubjpass	43	SENT_78	[p4l524t1462r764b1536],
23	,	,	O	,	_	0	SENT_78	[p4l524t1462r764b1536],
24	forced	VBD	O	force	parataxis	43	SENT_78	[p4l800t1462r1024b1523],
25	expiratory	JJ	O	expiratory	amod	26	SENT_78	[p4l1056t1462r1415b1542],
26	ﬂow	NN	O	ﬂow	dobj	24	SENT_78	[p4l1449t1462r1615b1535],
27	,	,	O	,	_	0	SENT_78	[p4l1449t1462r1615b1535],
28	midexpiratory	JJ	O	midexpiratory	amod	29	SENT_78	[p4l1651t1462r2147b1542],
29	phase	NN	O	phase	dobj	24	SENT_78	[p4l6t1563r215b1642],
30	[	CD	NUMBER	[	num	32	SENT_78	[p4l262t1564r623b1653],
31	FEF25_75	NN	O	fef25_75	nn	32	SENT_78	[p4l262t1564r623b1653],
32	]	NN	O	]	dep	29	SENT_78	[p4l262t1564r623b1653],
33	,	,	O	,	_	0	SENT_78	[p4l262t1564r623b1653],
34	and	CC	O	and	_	0	SENT_78	[p4l669t1563r798b1624],
35	peak	JJ	O	peak	amod	37	SENT_78	[p4l837t1563r1012b1642],
36	expiratory	JJ	O	expiratory	amod	37	SENT_78	[p4l1051t1563r1432b1642],
37	ﬂow	NN	O	ﬂow	dobj	24	SENT_78	[p4l1474t1563r1640b1624],
38	[	CD	NUMBER	[	num	41	SENT_78	[p4l1687t1563r1929b1638],
39	PEF	NN	O	pef	nn	41	SENT_78	[p4l1687t1563r1929b1638],
40	]	CD	NUMBER	]	num	41	SENT_78	[p4l1687t1563r1929b1638],
41	)	NN	O	)	nsubj	24	SENT_78	[p4l1687t1563r1929b1638],
42	were	VBD	O	be	auxpass	43	SENT_78	[p4l1972t1582r2148b1624],
43	monitored	VBN	O	monitor	dep	17	SENT_78	[p4l7t1663r368b1724],
44	at	IN	O	at	_	0	SENT_78	[p4l401t1673r462b1724],
45	baseline	NN	O	baseline	prep_at	43	SENT_78	[p4l492t1663r779b1724],
46	and	CC	O	and	_	0	SENT_78	[p4l814t1663r938b1724],
47	hourly	JJ	SET	hourly	prep_at	43	SENT_78	[p4l969t1663r1198b1743],
48	for	IN	O	for	_	0	SENT_78	[p4l1231t1663r1332b1724],
49	4	CD	DURATION	4	num	50	SENT_78	[p4l1363t1664r1405b1724],
50	hours	NNS	NUMBER	hour	prep_for	43	SENT_78	[p4l1438t1663r1650b1736],
51	,	,	O	,	_	0	SENT_78	[p4l1438t1663r1650b1736],
52	and	CC	O	and	_	0	SENT_78	[p4l1688t1663r1812b1724],
53	the	DT	O	the	det	54	SENT_78	[p4l1844t1663r1948b1724],
54	skin	NN	O	skin	nsubjpass	63	SENT_78	[p4l1985t1663r2145b1736],
55	,	,	O	,	_	0	SENT_78	[p4l1985t1663r2145b1736],
56	nose	NN	O	nose	nsubjpass	63	SENT_78	[p4l7t1785r181b1837],
57	,	,	O	,	_	0	SENT_78	[p4l7t1785r181b1837],
58	eyes	NNS	O	eye	nsubjpass	63	SENT_78	[p4l202t1785r369b1845],
59	,	,	O	,	_	0	SENT_78	[p4l202t1785r369b1845],
60	and	CC	O	and	_	0	SENT_78	[p4l391t1765r513b1826],
61	thorax	NN	O	thorax	nsubjpass	63	SENT_78	[p4l529t1765r747b1826],
62	were	VBD	O	be	auxpass	63	SENT_78	[p4l764t1785r929b1826],
63	examined	VBN	O	examine	dep	17	SENT_78	[p4l948t1765r1280b1826],
64	at	IN	O	at	_	0	SENT_78	[p4l1299t1775r1358b1826],
65	the	DT	O	the	det	67	SENT_78	[p4l1373t1765r1476b1826],
66	same	JJ	O	same	amod	67	SENT_78	[p4l1497t1785r1669b1826],
67	intervals	NNS	O	interval	prep_at	63	SENT_78	[p4l1686t1765r1996b1826],
68	.	.	O	.	_	0	SENT_78	[p4l1686t1765r1996b1826],

1	The	DT	O	the	det	2	SENT_79	[p4l2016t1765r2148b1826],
2	presence	NN	O	presence	nsubjpass	29	SENT_79	[p4l6t1885r309b1945],
3	of	IN	O	of	_	0	SENT_79	[p4l329t1866r404b1927],
4	breathlessness	NN	O	breathlessness	prep_of	2	SENT_79	[p4l416t1866r931b1938],
5	,	,	O	,	_	0	SENT_79	[p4l416t1866r931b1938],
6	cough	NN	O	cough	appos	2	SENT_79	[p4l953t1866r1182b1945],
7	,	,	O	,	_	0	SENT_79	[p4l953t1866r1182b1945],
8	wheezing	VBG	O	wheeze	partmod	2	SENT_79	[p4l1204t1866r1554b1945],
9	,	,	O	,	_	0	SENT_79	[p4l1204t1866r1554b1945],
10	dysphonia	NN	O	dysphonium	conj_and	2	SENT_79	[p4l1576t1866r1950b1945],
11	,	,	O	,	_	0	SENT_79	[p4l1576t1866r1950b1945],
12	nasal	JJ	O	nasal	amod	15	SENT_79	[p4l1972t1866r2149b1927],
13	or	CC	O	or	_	0	SENT_79	[p4l8t1986r80b2027],
14	ocular	JJ	O	ocular	conj_or	12	SENT_79	[p4l101t1966r319b2027],
15	itching	NN	O	itching	appos	10	SENT_79	[p4l339t1966r601b2046],
16	,	,	O	,	_	0	SENT_79	[p4l339t1966r601b2046],
17	sneezing	VBG	O	sneeze	partmod	10	SENT_79	[p4l629t1966r951b2046],
18	,	,	O	,	_	0	SENT_79	[p4l629t1966r951b2046],
19	rhinorrhea	NN	O	rhinorrhea	appos	10	SENT_79	[p4l975t1966r1359b2039],
20	,	,	O	,	_	0	SENT_79	[p4l975t1966r1359b2039],
21	nasal	JJ	O	nasal	amod	22	SENT_79	[p4l1385t1966r1563b2027],
22	obstruction	NN	O	obstruction	appos	19	SENT_79	[p4l1586t1966r1998b2039],
23	,	,	O	,	_	0	SENT_79	[p4l1586t1966r1998b2039],
24	and	CC	O	and	_	0	SENT_79	[p4l2026t1966r2149b2027],
25	conjunctival	JJ	O	conjunctival	amod	26	SENT_79	[p4l7t2068r440b2148],
26	erythema	NN	O	erythema	nsubjpass	29	SENT_79	[p4l469t2068r796b2148],
27	was	VBD	O	be	auxpass	29	SENT_79	[p4l823t2088r955b2129],
28	speciﬁcally	RB	O	speciﬁcally	advmod	29	SENT_79	[p4l989t2068r1384b2148],
29	investigated	VBN	O	investigate	_	0	SENT_79	[p4l1413t2068r1838b2148],
30	at	IN	O	at	_	0	SENT_79	[p4l1867t2077r1928b2129],
31	every	DT	SET	every	det	34	SENT_79	[p4l1956t2088r2148b2148],
32	hourly	JJ	SET	hourly	amod	34	SENT_79	[p4l6t2169r234b2248],
33	physical	JJ	O	physical	amod	34	SENT_79	[p4l264t2169r556b2248],
34	examination	NN	O	examination	prep_at	29	SENT_79	[p4l588t2169r1038b2230],
35	.	.	O	.	_	0	SENT_79	[p4l588t2169r1038b2230],

1	For	IN	O	for	_	0	SENT_80	[p4l1074t2170r1196b2230],
2	urticaria	NN	O	urticarium	prep_for	12	SENT_80	[p4l1224t2169r1517b2230],
3	and	CC	O	and	_	0	SENT_80	[p4l1549t2169r1673b2230],
4	angioedema	NN	O	angioedema	conj_and	2	SENT_80	[p4l1705t2169r2145b2248],
5	,	,	O	,	_	0	SENT_80	[p4l1705t2169r2145b2248],
6	the	DT	O	the	det	7	SENT_80	[p4l7t2269r112b2330],
7	percentage	NN	O	percentage	nsubjpass	12	SENT_80	[p4l147t2279r527b2349],
8	of	IN	O	of	_	0	SENT_80	[p4l565t2269r641b2330],
9	skin	NN	O	skin	prep_of	7	SENT_80	[p4l673t2269r816b2330],
10	involved	VBN	O	involve	partmod	9	SENT_80	[p4l851t2269r1158b2331],
11	was	VBD	O	be	auxpass	12	SENT_80	[p4l1193t2289r1326b2331],
12	calculated	VBN	O	calculate	_	0	SENT_80	[p4l1364t2269r1720b2330],
13	as	IN	O	as	mark	14	SENT_80	[p4l1756t2289r1824b2330],
14	follows	VBZ	O	follow	advcl	12	SENT_80	[p4l1862t2269r2143b2331],
15	:	:	O	:	_	0	SENT_80	[p4l1862t2269r2143b2331],
16	head	NN	O	head	advmod	12	SENT_80	[p4l6t2371r171b2432],
17	and	CC	O	and	_	0	SENT_80	[p4l191t2371r314b2432],
18	neck	NN	O	neck	conj_and	16	SENT_80	[p4l332t2371r514b2443],
19	,	,	O	,	_	0	SENT_80	[p4l332t2371r514b2443],
20	30	CD	PERCENT	30	num	21	SENT_80	[p4l538t2371r715b2443],
21	%	NN	PERCENT	%	dobj	12	SENT_80	[p4l538t2371r715b2443],
22	;	:	O	;	_	0	SENT_80	[p4l538t2371r715b2443],
23	chest	NN	O	chest	dep	21	SENT_80	[p4l738t2371r934b2443],
24	,	,	O	,	_	0	SENT_80	[p4l738t2371r934b2443],
25	20	CD	PERCENT	20	num	26	SENT_80	[p4l957t2371r1135b2444],
26	%	NN	PERCENT	%	appos	23	SENT_80	[p4l957t2371r1135b2444],
27	;	:	O	;	_	0	SENT_80	[p4l957t2371r1135b2444],
28	abdomen	NNS	O	abdomen	conj_and	23	SENT_80	[p4l1159t2371r1495b2444],
29	,	,	O	,	_	0	SENT_80	[p4l1159t2371r1495b2444],
30	20	CD	PERCENT	20	num	31	SENT_80	[p4l1518t2371r1696b2443],
31	%	NN	PERCENT	%	appos	28	SENT_80	[p4l1518t2371r1696b2443],
32	;	:	O	;	_	0	SENT_80	[p4l1518t2371r1696b2443],
33	upper	JJ	O	upper	amod	34	SENT_80	[p4l1718t2391r1918b2451],
34	limbs	NNS	O	limb	conj_and	23	SENT_80	[p4l1935t2371r2146b2444],
35	,	,	O	,	_	0	SENT_80	[p4l1935t2371r2146b2444],
36	15	CD	PERCENT	15	num	37	SENT_80	[p4l15t2471r187b2544],
37	%	NN	PERCENT	%	appos	34	SENT_80	[p4l15t2471r187b2544],
38	;	:	O	;	_	0	SENT_80	[p4l15t2471r187b2544],
39	and	CC	O	and	_	0	SENT_80	[p4l221t2472r344b2533],
40	lower	JJR	O	lower	amod	41	SENT_80	[p4l371t2472r571b2533],
41	limbs	NNS	O	limb	dep	21	SENT_80	[p4l598t2472r810b2544],
42	,	,	O	,	_	0	SENT_80	[p4l598t2472r810b2544],
43	15	CD	PERCENT	15	num	44	SENT_80	[p4l850t2471r1017b2533],
44	%	NN	PERCENT	%	appos	41	SENT_80	[p4l850t2471r1017b2533],
45	.	.	O	.	_	0	SENT_80	[p4l850t2471r1017b2533],

1	The	DT	O	the	det	3	SENT_81	[p4l1049t2472r1183b2533],
2	test	NN	O	test	nn	3	SENT_81	[p4l1211t2481r1332b2533],
3	result	NN	O	result	nsubjpass	5	SENT_81	[p4l1359t2472r1554b2533],
4	was	VBD	O	be	auxpass	5	SENT_81	[p4l1581t2491r1713b2533],
5	regarded	VBN	O	regard	_	0	SENT_81	[p4l1742t2472r2050b2551],
6	as	IN	O	as	_	0	SENT_81	[p4l2079t2491r2146b2533],
7	positive	JJ	O	positive	prep_as	5	SENT_81	[p4l6t2572r279b2652],
8	for	IN	O	for	_	0	SENT_81	[p4l297t2572r397b2633],
9	urticaria	NN	O	urticarium	prep_for	5	SENT_81	[p4l413t2572r701b2633],
10	or	CC	O	or	_	0	SENT_81	[p4l718t2592r789b2633],
11	angioedema	NN	O	angioedema	prep_for	5	SENT_81	[p4l807t2572r1224b2652],
12	if	IN	O	if	mark	23	SENT_81	[p4l1240t2572r1297b2633],
13	20	CD	PERCENT	20	number	14	SENT_81	[p4l1310t2573r1463b2634],
14	%	NN	PERCENT	%	nsubjpass	23	SENT_81	[p4l1310t2573r1463b2634],
15	or	CC	O	or	_	0	SENT_81	[p4l1486t2592r1556b2633],
16	more	JJR	O	more	conj_or	14	SENT_81	[p4l1572t2592r1749b2633],
17	of	IN	O	of	_	0	SENT_81	[p4l1768t2572r1843b2633],
18	the	DT	O	the	det	21	SENT_81	[p4l1854t2572r1958b2633],
19	body	NN	O	body	nn	21	SENT_81	[p4l1975t2572r2148b2652],
20	surface	NN	O	surface	nn	21	SENT_81	[p4l10t2675r257b2737],
21	area	NN	O	area	prep_of	14	SENT_81	[p4l278t2695r421b2737],
22	was	VBD	O	be	auxpass	23	SENT_81	[p4l439t2695r570b2737],
23	affected	VBN	O	affect	advcl	5	SENT_81	[p4l593t2675r870b2737],
24	[	RB	O	[	advmod	23	SENT_81	[p4l894t2676r1048b2750],
25	20	CD	NUMBER	20	num	26	SENT_81	[p4l894t2676r1048b2750],
26	]	NN	O	]	dobj	23	SENT_81	[p4l894t2676r1048b2750],
27	.	.	O	.	_	0	SENT_81	[p4l894t2676r1048b2750],

1	Antihistamines	NNS	O	antihistamine	nsubjpass	7	SENT_82	[p4l1067t2675r1593b2737],
2	and	CC	O	and	_	0	SENT_82	[p4l1616t2675r1739b2737],
3	leukotriene	NN	O	leukotriene	nn	5	SENT_82	[p4l1757t2675r2148b2737],
4	receptor	NN	O	receptor	nn	5	SENT_82	[p4l6t2785r294b2855],
5	antagonists	NNS	O	antagonist	conj_and	1	SENT_82	[p4l313t2776r702b2855],
6	were	VBD	O	be	auxpass	7	SENT_82	[p4l723t2795r891b2837],
7	withheld	VBN	O	withhold	_	0	SENT_82	[p4l911t2776r1216b2837],
8	for	IN	O	for	_	0	SENT_82	[p4l1234t2776r1336b2837],
9	at	IN	DURATION	at	quantmod	11	SENT_82	[p4l1355t2785r1416b2837],
10	least	JJS	DURATION	least	mwe	9	SENT_82	[p4l1433t2776r1593b2837],
11	96	CD	DURATION	96	num	12	SENT_82	[p4l1612t2776r1694b2838],
12	hours	NNS	NUMBER	hour	prep_for	7	SENT_82	[p4l1714t2776r1906b2837],
13	before	IN	O	before	_	0	SENT_82	[p4l1926t2776r2148b2837],
14	testing	NN	O	testing	prep_before	7	SENT_82	[p4l7t2876r258b2956],
15	.	.	O	.	_	0	SENT_82	[p4l7t2876r258b2956],

1	Only	RB	O	only	advmod	18	SENT_83	[p4l300t2876r472b2956],
2	patients	NNS	O	patient	nsubjpass	18	SENT_83	[p4l507t2876r779b2956],
3	who	WP	O	who	nsubj	4	SENT_83	[p4l817t2876r965b2938],
4	reacted	VBD	O	react	rcmod	2	SENT_83	[p4l1001t2876r1256b2937],
5	to	TO	O	to	_	0	SENT_83	[p4l1291t2886r1356b2937],
6	at	IN	O	at	quantmod	8	SENT_83	[p4l1395t2886r1455b2937],
7	least	JJS	O	least	mwe	6	SENT_83	[p4l1490t2876r1651b2937],
8	2	CD	NUMBER	2	prep_to	4	SENT_83	[p4l1686t2877r1726b2937],
9	chemically	RB	O	chemically	advmod	18	SENT_83	[p4l1763t2876r2148b2956],
10	unrelated	JJ	O	unrelated	amod	11	SENT_83	[p4l6t2979r351b3041],
11	NSAIDS	NNPS	O	NSAIDS	nsubjpass	18	SENT_83	[p4l389t2980r700b3041],
12	(	CD	NUMBER	(	num	15	SENT_83	[p4l744t2979r1359b3055],
13	cross	NN	O	cross	nn	15	SENT_83	[p4l744t2979r1359b3055],
14	—	NN	O	—	nn	15	SENT_83	[p4l744t2979r1359b3055],
15	reactions	NNS	O	reaction	dep	11	SENT_83	[p4l744t2979r1359b3055],
16	)	CD	NUMBER	)	dep	11	SENT_83	[p4l744t2979r1359b3055],
17	were	VBD	O	be	auxpass	18	SENT_83	[p4l1402t2999r1576b3041],
18	included	VBN	O	include	_	0	SENT_83	[p4l1617t2979r1934b3041],
19	[	CD	NUMBER	[	number	20	SENT_83	[p4l1979t2980r2144b3054],
20	21	CD	NUMBER	21	num	21	SENT_83	[p4l1979t2980r2144b3054],
21	]	NN	O	]	dobj	18	SENT_83	[p4l1979t2980r2144b3054],
22	.	.	O	.	_	0	SENT_83	[p4l1979t2980r2144b3054],

1	Patients	NNS	O	patient	nsubjpass	32	SENT_84	[p4l7t3080r288b3141],
2	with	IN	O	with	_	0	SENT_84	[p4l327t3080r484b3141],
3	other	JJ	O	other	amod	4	SENT_84	[p4l522t3080r705b3141],
4	phenotypes	NNS	O	phenotype	prep_with	1	SENT_84	[p4l740t3080r1145b3159],
5	of	IN	O	of	_	0	SENT_84	[p4l1186t3080r1262b3141],
6	aspirin	NN	O	aspirin	nn	7	SENT_84	[p4l1296t3080r1537b3159],
7	hypersensitivity	NN	O	hypersensitivity	prep_of	4	SENT_84	[p4l1574t3080r2148b3159],
8	(	CD	NUMBER	(	num	11	SENT_84	[p4l9t3181r136b3260],
9	eg	FW	O	eg	nn	11	SENT_84	[p4l9t3181r136b3260],
10	,	,	O	,	_	0	SENT_84	[p4l9t3181r136b3260],
11	reactions	NNS	O	reaction	dep	7	SENT_84	[p4l166t3180r481b3241],
12	to	TO	O	to	dep	11	SENT_84	[p4l511t3190r576b3241],
13	a	DT	O	a	det	23	SENT_84	[p4l608t3200r644b3241],
14	single	JJ	O	single	amod	15	SENT_84	[p4l674t3180r879b3260],
15	NSAID	NN	O	nsaid	dep	23	SENT_84	[p4l907t3181r1193b3253],
16	,	,	O	,	_	0	SENT_84	[p4l907t3181r1193b3253],
17	AERD	NN	O	aerd	nn	21	SENT_84	[p4l1220t3181r1476b3253],
18	,	,	O	,	_	0	SENT_84	[p4l1220t3181r1476b3253],
19	chronic	JJ	O	chronic	amod	21	SENT_84	[p4l1509t3180r1768b3241],
20	idiopathic	JJ	O	idiopathic	amod	21	SENT_84	[p4l1798t3180r2147b3260],
21	urticaria	NN	O	urticarium	dep	15	SENT_84	[p4l6t3282r329b3355],
22	,	,	O	,	_	0	SENT_84	[p4l6t3282r329b3355],
23	anaphylaxis	NN	O	anaphylaxi	dep	11	SENT_84	[p4l373t3282r801b3362],
24	induced	VBN	O	induce	partmod	1	SENT_84	[p4l841t3282r1127b3343],
25	by	IN	O	by	_	0	SENT_84	[p4l1164t3282r1251b3362],
26	NSAIDS	NNPS	O	NSAIDS	agent	24	SENT_84	[p4l1290t3283r1626b3358],
27	)	CD	NUMBER	)	tmod	24	SENT_84	[p4l1290t3283r1626b3358],
28	and	CC	O	and	_	0	SENT_84	[p4l1669t3282r1795b3343],
29	pregnant	JJ	O	pregnant	amod	30	SENT_84	[p4l1832t3292r2150b3362],
30	women	NNS	O	woman	conj_and	27	SENT_84	[p4l7t3402r264b3444],
31	were	VBD	O	be	auxpass	32	SENT_84	[p4l292t3402r459b3444],
32	excluded	VBN	O	exclude	_	0	SENT_84	[p4l488t3383r821b3444],
33	.	.	O	.	_	0	SENT_84	[p4l488t3383r821b3444],

1	The	DT	O	the	det	3	SENT_85	[p4l851t3383r985b3444],
2	clinical	JJ	O	clinical	amod	3	SENT_85	[p4l1014t3383r1270b3444],
3	patterns	NNS	O	pattern	nsubjpass	8	SENT_85	[p4l1296t3392r1572b3462],
4	of	IN	O	of	_	0	SENT_85	[p4l1603t3383r1679b3444],
5	the	DT	O	the	det	6	SENT_85	[p4l1700t3383r1805b3444],
6	reactions	NNS	O	reaction	prep_of	3	SENT_85	[p4l1832t3383r2146b3444],
7	were	VBD	O	be	auxpass	8	SENT_85	[p4l7t3503r175b3545],
8	classiﬁed	VBN	O	classiﬁed	_	0	SENT_85	[p4l211t3483r536b3544],
9	as	IN	O	as	_	0	SENT_85	[p4l573t3503r639b3544],
10	cutaneous	JJ	O	cutaneous	amod	15	SENT_85	[p4l677t3493r1024b3544],
11	(	NN	O	(	nn	15	SENT_85	[p4l1064t3483r1383b3559],
12	urticaria	NN	O	urticarium	nn	15	SENT_85	[p4l1064t3483r1383b3559],
13	and/or	NN	O	and/or	nn	15	SENT_85	[p4l1418t3483r1641b3545],
14	angioedema	NN	O	angioedema	nn	15	SENT_85	[p4l1675t3483r2145b3563],
15	)	NN	O	)	prep_as	8	SENT_85	[p4l1675t3483r2145b3563],
16	,	,	O	,	_	0	SENT_85	[p4l1675t3483r2145b3563],
17	and	CC	O	and	_	0	SENT_85	[p4l8t3585r132b3646],
18	mixed	JJ	O	mixed	amod	22	SENT_85	[p4l149t3585r366b3646],
19	(	NN	O	(	nn	22	SENT_85	[p4l387t3585r702b3661],
20	urticaria	NN	O	urticarium	nn	22	SENT_85	[p4l387t3585r702b3661],
21	and/or	NN	O	and/or	nn	22	SENT_85	[p4l721t3585r942b3647],
22	angioedema	NN	O	angioedema	prep_as	8	SENT_85	[p4l960t3585r1380b3665],
23	plus	CC	O	plus	prep	22	SENT_85	[p4l1396t3585r1538b3665],
24	upper	JJ	O	upper	amod	28	SENT_85	[p4l1557t3605r1757b3665],
25	respiratory	JJ	O	respiratory	amod	28	SENT_85	[p4l1772t3585r2148b3665],
26	and/or	NN	O	and/or	nn	28	SENT_85	[p4l8t3686r232b3747],
27	ocular	JJ	O	ocular	amod	28	SENT_85	[p4l268t3686r487b3747],
28	symptoms	NNS	O	symptom	dep	23	SENT_85	[p4l524t3695r901b3765],
29	,	,	O	,	_	0	SENT_85	[p4l524t3695r901b3765],
30	including	VBG	O	include	conj_and	15	SENT_85	[p4l940t3686r1271b3765],
31	laryngeal	JJ	O	laryngeal	amod	33	SENT_85	[p4l1309t3686r1635b3765],
32	angioedema	NN	O	angioedema	nn	33	SENT_85	[p4l1673t3686r2145b3765],
33	)	NN	O	)	pobj	30	SENT_85	[p4l1673t3686r2145b3765],
34	,	,	O	,	_	0	SENT_85	[p4l1673t3686r2145b3765],

1	as	IN	O	as	mark	3	SENT_86	[p5l8t37r75b78],
2	previously	RB	DATE	previously	advmod	3	SENT_86	[p5l107t17r477b97],
3	described	VBN	O	describe	_	0	SENT_86	[p5l508t17r843b78],
4	[	NN	O	[	nn	6	SENT_86	[p5l879t18r991b92],
5	1	CD	NUMBER	1	num	6	SENT_86	[p5l879t18r991b92],
6	]	NN	O	]	dobj	3	SENT_86	[p5l879t18r991b92],
7	.	.	O	.	_	0	SENT_86	[p5l879t18r991b92],

1	High	JJ	O	high	amod	4	SENT_87	[p5l1025t17r1363b97],
2	—	NN	O	—	nn	4	SENT_87	[p5l1025t17r1363b97],
3	risk	NN	O	risk	nn	4	SENT_87	[p5l1025t17r1363b97],
4	patients	NNS	O	patient	nsubjpass	6	SENT_87	[p5l1390t17r1661b97],
5	were	VBD	O	be	auxpass	6	SENT_87	[p5l1693t37r1861b79],
6	deﬁned	VBN	O	deﬁned	_	0	SENT_87	[p5l1892t17r2149b78],
7	as	IN	O	as	_	0	SENT_87	[p5l8t139r75b180],
8	NSAID	NN	O	nsaid	prep_as	6	SENT_87	[p5l112t119r717b180],
9	—	CD	NUMBER	—	num	11	SENT_87	[p5l112t119r717b180],
10	sensitiVe	NN	O	sensitive	nn	11	SENT_87	[p5l112t119r717b180],
11	individuals	NNS	O	individual	nsubj	18	SENT_87	[p5l752t119r1139b180],
12	who	WP	O	who	nsubj	13	SENT_87	[p5l1176t119r1324b180],
13	reacted	VBD	O	react	rcmod	11	SENT_87	[p5l1359t119r1612b180],
14	to	TO	O	to	_	0	SENT_87	[p5l1646t129r1711b180],
15	weak	JJ	O	weak	amod	17	SENT_87	[p5l1747t119r1932b180],
16	COX	NN	O	cox	nn	17	SENT_87	[p5l1966t119r2148b180],
17	inhibitors	NNS	O	inhibitor	prep_to	13	SENT_87	[p5l7t220r340b281],
18	(	VBP	O	(	rcmod	8	SENT_87	[p5l369t220r953b299],
19	acetaminophen	NN	O	acetaminophen	nsubj	24	SENT_87	[p5l369t220r953b299],
20	)	CD	NUMBER	)	num	19	SENT_87	[p5l369t220r953b299],
21	or	CC	O	or	_	0	SENT_87	[p5l980t239r1052b281],
22	COX-2	NN	O	cox-2	nn	23	SENT_87	[p5l1074t220r1330b281],
23	inhibitors	NNS	O	inhibitor	conj_or	19	SENT_87	[p5l1353t220r1687b281],
24	(	VBP	O	(	ccomp	18	SENT_87	[p5l1715t220r2145b295],
25	nimesulide	NN	O	nimesulide	dobj	24	SENT_87	[p5l1715t220r2145b295],
26	,	,	O	,	_	0	SENT_87	[p5l1715t220r2145b295],

1	J	NNP	O	J	nn	5	SENT_88	[p5l384t468r422b519],
2	Investig	NNP	O	Investig	nn	5	SENT_88	[p5l436t468r670b532],
3	Allergol	NNP	O	Allergol	nn	5	SENT_88	[p5l685t466r930b532],
4	Clin	NNP	O	Clin	nn	5	SENT_88	[p5l953t466r1074b519],
5	Immunol	NNP	O	Immunol	_	0	SENT_88	[p5l1094t466r1359b518],
6	2009	CD	DATE	2009	num	5	SENT_88	[p5l1379t466r1542b527],
7	;	:	O	;	_	0	SENT_88	[p5l1379t466r1542b527],
8	Vol	NNP	O	Vol	dep	5	SENT_88	[p5l1564t466r1679b518],
9	.	.	O	.	_	0	SENT_88	[p5l1564t466r1679b518],

1	19	CD	NUMBER	19	num	2	SENT_89	[p5l1710t466r1877b530],
2	(	CD	NUMBER	(	_	0	SENT_89	[p5l1710t466r1877b530],
3	5	CD	NUMBER	5	num	4	SENT_89	[p5l1710t466r1877b530],
4	)	NN	O	)	dep	2	SENT_89	[p5l1710t466r1877b530],
5	:	:	O	:	_	0	SENT_89	[p5l1710t466r1877b530],
6	375-382	CD	NUMBER	375-382	dep	4	SENT_89	[p5l1905t466r2148b518],

1	377	CD	NUMBER	377	num	3	SENT_90	[p5l59t608r119b636],
2	M	NN	O	m	nn	3	SENT_90	[p5l896t608r929b633],
3	Sanchez-Borges	NNS	O	sanchez-borge	_	0	SENT_90	[p5l940t607r1189b641],
4	,	,	O	,	_	0	SENT_90	[p5l940t607r1189b641],
5	et	FW	O	et	nn	7	SENT_90	[p5l1201t611r1228b633],
6	al	FW	O	al	nn	7	SENT_90	[p5l1238t607r1263b633],
7	meloxicam	NN	O	meloxicam	appos	3	SENT_90	[p5l8t827r416b899],
8	,	,	O	,	_	0	SENT_90	[p5l8t827r416b899],
9	celecoxib	NN	O	celecoxib	appos	3	SENT_90	[p5l443t827r796b899],
10	,	,	O	,	_	0	SENT_90	[p5l443t827r796b899],
11	rofecoxib	NN	O	rofecoxib	nn	12	SENT_90	[p5l821t827r1205b903],
12	)	NN	O	)	appos	3	SENT_90	[p5l821t827r1205b903],
13	,	,	O	,	_	0	SENT_90	[p5l821t827r1205b903],
14	as	IN	O	as	advmod	15	SENT_90	[p5l1233t846r1300b888],
15	proposed	VBN	O	propose	partmod	12	SENT_90	[p5l1324t827r1646b906],
16	by	IN	O	by	_	0	SENT_90	[p5l1668t827r1754b906],
17	Matucci	NNP	PERSON	Matucci	agent	15	SENT_90	[p5l1777t827r2063b888],
18	et	FW	O	et	nn	20	SENT_90	[p5l2087t836r2149b888],
19	al	FW	O	al	nn	20	SENT_90	[p5l10t928r69b989],
20	[	FW	O	[	dobj	15	SENT_90	[p5l94t928r248b1002],
21	22	CD	NUMBER	22	num	22	SENT_90	[p5l94t928r248b1002],
22	]	NN	O	]	dep	12	SENT_90	[p5l94t928r248b1002],
23	.	.	O	.	_	0	SENT_90	[p5l94t928r248b1002],

1	Data	NNS	O	datum	nsubjpass	6	SENT_91	[p5l272t929r436b989],
2	from	IN	O	from	_	0	SENT_91	[p5l454t928r623b989],
3	clinical	JJ	O	clinical	amod	4	SENT_91	[p5l641t928r894b989],
4	records	NNS	O	record	prep_from	1	SENT_91	[p5l912t928r1166b989],
5	were	VBD	O	be	auxpass	6	SENT_91	[p5l1187t947r1354b989],
6	collected	VBN	O	collect	_	0	SENT_91	[p5l1374t928r1687b989],
7	(	RB	O	(	advmod	8	SENT_91	[p5l1708t928r1872b1007],
8	age	NN	O	age	dobj	6	SENT_91	[p5l1708t928r1872b1007],
9	,	,	O	,	_	0	SENT_91	[p5l1708t928r1872b1007],
10	gender	NN	O	gender	appos	8	SENT_91	[p5l1895t928r2144b1007],
11	,	,	O	,	_	0	SENT_91	[p5l1895t928r2144b1007],
12	drugs	NNS	O	drug	appos	8	SENT_91	[p5l9t1028r196b1108],
13	involved	VBN	O	involve	partmod	12	SENT_91	[p5l215t1028r514b1090],
14	in	IN	O	in	_	0	SENT_91	[p5l531t1028r596b1089],
15	previous	JJ	O	previous	amod	16	SENT_91	[p5l612t1028r904b1108],
16	reactions	NNS	O	reaction	prep_in	13	SENT_91	[p5l922t1028r1248b1101],
17	,	,	O	,	_	0	SENT_91	[p5l922t1028r1248b1101],
18	and	CC	O	and	_	0	SENT_91	[p5l1270t1028r1392b1089],
19	past	JJ	DATE	past	amod	22	SENT_91	[p5l1407t1038r1546b1108],
20	or	CC	O	or	_	0	SENT_91	[p5l1563t1048r1633b1089],
21	present	JJ	DATE	present	conj_or	19	SENT_91	[p5l1647t1038r1895b1108],
22	history	NN	O	history	nsubj	26	SENT_91	[p5l1910t1028r2147b1108],
23	of	IN	O	of	_	0	SENT_91	[p5l10t1130r85b1191],
24	allergic	JJ	O	allergic	amod	25	SENT_91	[p5l98t1130r350b1209],
25	diseases	NNS	O	disease	prep_of	22	SENT_91	[p5l370t1130r696b1206],
26	)	VBP	O	)	conj_and	6	SENT_91	[p5l370t1130r696b1206],
27	.	.	O	.	_	0	SENT_91	[p5l370t1130r696b1206],

1	One	CD	NUMBER	one	nsubjpass	16	SENT_92	[p5l720t1130r860b1191],
2	hundred	CD	NUMBER	hundred	number	3	SENT_92	[p5l878t1130r1161b1191],
3	sixty	CD	NUMBER	sixty	num	5	SENT_92	[p5l1181t1130r1502b1209],
4	—	NN	O	—	nn	5	SENT_92	[p5l1181t1130r1502b1209],
5	ﬁve	NN	O	ﬁve	npadvmod	6	SENT_92	[p5l1181t1130r1502b1209],
6	unrelated	JJ	O	unrelated	amod	1	SENT_92	[p5l1520t1130r1858b1202],
7	,	,	O	,	_	0	SENT_92	[p5l1520t1130r1858b1202],
8	healthy	JJ	O	healthy	dep	6	SENT_92	[p5l1878t1130r2144b1209],
9	,	,	O	,	_	0	SENT_92	[p5l1878t1130r2144b1209],
10	and	CC	O	and	_	0	SENT_92	[p5l10t1231r136b1292],
11	randomly	RB	O	randomly	advmod	14	SENT_92	[p5l171t1231r513b1310],
12	selected	VBN	O	select	amod	14	SENT_92	[p5l554t1231r839b1292],
13	control	NN	O	control	nn	14	SENT_92	[p5l876t1231r1128b1292],
14	participants	NNS	O	participant	conj_and	1	SENT_92	[p5l1164t1231r1582b1310],
15	were	VBD	O	be	auxpass	16	SENT_92	[p5l1621t1250r1792b1292],
16	recruited	VBN	O	recruit	_	0	SENT_92	[p5l1828t1231r2148b1292],
17	from	IN	O	from	_	0	SENT_92	[p5l9t1331r184b1392],
18	the	DT	O	the	det	20	SENT_92	[p5l221t1331r329b1392],
19	blood	NN	O	blood	nn	20	SENT_92	[p5l367t1331r574b1392],
20	bank	NN	O	bank	prep_from	16	SENT_92	[p5l611t1331r806b1404],
21	,	,	O	,	_	0	SENT_92	[p5l611t1331r806b1404],
22	Hospital	NNP	ORGANIZATION	Hospital	nn	25	SENT_92	[p5l849t1331r1156b1411],
23	Universitario	NNP	ORGANIZATION	Universitario	nn	25	SENT_92	[p5l1194t1331r1676b1393],
24	de	IN	ORGANIZATION	de	amod	25	SENT_92	[p5l1717t1331r1798b1392],
25	Caracas	NNP	ORGANIZATION	Caracas	appos	20	SENT_92	[p5l1838t1332r2142b1393],
26	.	.	O	.	_	0	SENT_92	[p5l1838t1332r2142b1393],

1	Patients	NNS	O	patient	nsubj	4	SENT_93	[p5l8t1433r283b1494],
2	and	CC	O	and	_	0	SENT_93	[p5l319t1433r442b1494],
3	controls	NNS	O	control	conj_and	1	SENT_93	[p5l475t1433r753b1494],
4	were	VBD	O	be	_	0	SENT_93	[p5l787t1452r955b1494],
5	from	IN	O	from	_	0	SENT_93	[p5l988t1433r1158b1494],
6	Caracas	NNP	LOCATION	Caracas	prep_from	4	SENT_93	[p5l1189t1433r1483b1505],
7	,	,	O	,	_	0	SENT_93	[p5l1189t1433r1483b1505],
8	whose	WP$	O	whose	poss	9	SENT_93	[p5l1519t1433r1741b1494],
9	population	NN	O	population	nsubj	12	SENT_93	[p5l1772t1433r2148b1512],
10	is	VBZ	O	be	cop	12	SENT_93	[p5l8t1534r63b1595],
11	a	DT	O	a	det	12	SENT_93	[p5l100t1553r136b1595],
12	mixture	NN	O	mixture	rcmod	6	SENT_93	[p5l168t1534r439b1595],
13	of	IN	O	of	_	0	SENT_93	[p5l474t1534r550b1595],
14	Spaniards	NNPS	O	Spaniards	prep_of	12	SENT_93	[p5l579t1534r940b1613],
15	,	,	O	,	_	0	SENT_93	[p5l579t1534r940b1613],
16	Africans	NNPS	MISC	Africans	prep_of	12	SENT_93	[p5l972t1534r1291b1606],
17	,	,	O	,	_	0	SENT_93	[p5l972t1534r1291b1606],
18	and	CC	O	and	_	0	SENT_93	[p5l1330t1534r1453b1595],
19	Native	JJ	MISC	native	amod	20	SENT_93	[p5l1485t1534r1717b1595],
20	Americans	NNPS	MISC	Americans	prep_of	12	SENT_93	[p5l1746t1534r2143b1595],
21	.	.	O	.	_	0	SENT_93	[p5l1746t1534r2143b1595],

1	The	DT	O	the	det	2	SENT_94	[p5l9t1634r142b1695],
2	study	NN	O	study	nsubjpass	4	SENT_94	[p5l164t1634r348b1714],
3	was	VBD	O	be	auxpass	4	SENT_94	[p5l368t1654r499b1696],
4	approved	VBN	O	approve	_	0	SENT_94	[p5l522t1634r844b1714],
5	by	IN	O	by	_	0	SENT_94	[p5l861t1634r947b1714],
6	the	DT	O	the	det	9	SENT_94	[p5l965t1634r1070b1695],
7	Institutional	JJ	ORGANIZATION	institutional	amod	9	SENT_94	[p5l1089t1634r1509b1695],
8	Review	NN	ORGANIZATION	review	nn	9	SENT_94	[p5l1528t1634r1793b1696],
9	Boards	NNS	ORGANIZATION	board	agent	4	SENT_94	[p5l1812t1634r2056b1695],
10	of	IN	ORGANIZATION	of	_	0	SENT_94	[p5l2077t1634r2153b1695],
11	Hospital	NNP	ORGANIZATION	Hospital	nn	14	SENT_94	[p5l9t1736r304b1815],
12	Universitario	NNP	ORGANIZATION	Universitario	nn	14	SENT_94	[p5l326t1736r788b1797],
13	de	IN	ORGANIZATION	de	amod	14	SENT_94	[p5l811t1736r890b1797],
14	Caracas	NNP	ORGANIZATION	Caracas	prep_of	9	SENT_94	[p5l914t1736r1187b1797],
15	and	CC	O	and	_	0	SENT_94	[p5l1213t1736r1336b1797],
16	Clinica	NNP	PERSON	Clinica	nn	18	SENT_94	[p5l1358t1736r1611b1797],
17	El	NNP	PERSON	El	nn	18	SENT_94	[p5l1630t1736r1706b1796],
18	Avila	NNP	PERSON	Avila	prep_of	9	SENT_94	[p5l1724t1736r1928b1797],
19	.	.	O	.	_	0	SENT_94	[p5l1724t1736r1928b1797],

1	A	DT	O	a	det	4	SENT_95	[p5l1949t1736r2011b1796],
2	full	JJ	O	full	amod	4	SENT_95	[p5l2028t1736r2147b1797],
3	verbal	JJ	O	verbal	amod	4	SENT_95	[p5l9t1837r226b1898],
4	explanation	NN	O	explanation	nsubjpass	9	SENT_95	[p5l247t1837r655b1916],
5	of	IN	O	of	_	0	SENT_95	[p5l676t1837r752b1898],
6	the	DT	O	the	det	7	SENT_95	[p5l767t1837r871b1898],
7	investigation	NN	O	investigation	prep_of	4	SENT_95	[p5l892t1837r1345b1916],
8	was	VBD	O	be	auxpass	9	SENT_95	[p5l1365t1856r1497b1898],
9	given	VBN	O	give	_	0	SENT_95	[p5l1521t1837r1732b1916],
10	,	,	O	,	_	0	SENT_95	[p5l1521t1837r1732b1916],
11	and	CC	O	and	_	0	SENT_95	[p5l1757t1837r1881b1898],
12	written	VBN	O	write	amod	14	SENT_95	[p5l1901t1837r2148b1898],
13	informed	JJ	O	informed	amod	14	SENT_95	[p5l9t1937r330b1998],
14	consent	NN	O	consent	nsubjpass	16	SENT_95	[p5l354t1947r621b1998],
15	was	VBD	O	be	auxpass	16	SENT_95	[p5l645t1957r777b1999],
16	obtained	VBN	O	obtain	conj_and	9	SENT_95	[p5l804t1937r1105b1998],
17	from	IN	O	from	_	0	SENT_95	[p5l1129t1937r1298b1998],
18	all	DT	O	all	det	19	SENT_95	[p5l1323t1937r1407b1998],
19	participants	NNS	O	participant	prep_from	16	SENT_95	[p5l1431t1937r1857b2017],
20	.	.	O	.	_	0	SENT_95	[p5l1431t1937r1857b2017],

1	Genotyp/ng	NN	O	genotyp/ng	_	0	SENT_96	[p5l21t2131r508b2218],

1	Genomic	JJ	O	genomic	amod	2	SENT_97	[p5l141t2290r474b2352],
2	DNA	NN	O	dna	nsubjpass	4	SENT_97	[p5l516t2291r710b2352],
3	was	VBD	O	be	auxpass	4	SENT_97	[p5l746t2310r883b2351],
4	extracted	VBN	O	extract	_	0	SENT_97	[p5l927t2290r1268b2351],
5	from	IN	O	from	_	0	SENT_97	[p5l1308t2290r1486b2351],
6	peripheral	JJ	O	peripheral	amod	9	SENT_97	[p5l1524t2290r1903b2370],
7	white	JJ	O	white	amod	9	SENT_97	[p5l1944t2290r2147b2352],
8	blood	NN	O	blood	nn	9	SENT_97	[p5l8t2392r207b2453],
9	cells	NNS	O	cell	prep_from	4	SENT_97	[p5l240t2392r396b2453],
10	using	VBG	O	use	partmod	9	SENT_97	[p5l431t2392r619b2472],
11	the	DT	O	the	det	13	SENT_97	[p5l652t2392r757b2453],
12	salting	VBG	O	salt	amod	13	SENT_97	[p5l793t2392r1166b2472],
13	—	NN	O	—	dobj	10	SENT_97	[p5l793t2392r1166b2472],
14	out	IN	O	out	_	0	SENT_97	[p5l793t2392r1166b2472],
15	method	NN	O	method	nn	16	SENT_97	[p5l1197t2392r1459b2453],
16	[	NN	O	[	prep_out	10	SENT_97	[p5l1498t2393r1653b2466],
17	23	CD	NUMBER	23	num	18	SENT_97	[p5l1498t2393r1653b2466],
18	]	NN	O	]	dep	16	SENT_97	[p5l1498t2393r1653b2466],
19	.	.	O	.	_	0	SENT_97	[p5l1498t2393r1653b2466],

1	The	DT	O	the	det	5	SENT_98	[p5l1689t2392r1823b2453],
2	A	NN	O	a	nn	5	SENT_98	[p5l1851t2392r2146b2454],
3	—	NN	O	—	nn	5	SENT_98	[p5l1851t2392r2146b2454],
4	444C	NN	O	444c	nn	5	SENT_98	[p5l1851t2392r2146b2454],
5	polymorphism	NN	O	polymorphism	nsubjpass	7	SENT_98	[p5l8t2493r507b2572],
6	was	VBD	O	be	auxpass	7	SENT_98	[p5l522t2512r651b2554],
7	genotyped	VBN	O	genotype	_	0	SENT_98	[p5l670t2493r1024b2572],
8	using	VBG	O	use	xcomp	7	SENT_98	[p5l1038t2493r1221b2572],
9	the	DT	O	the	det	14	SENT_98	[p5l1238t2493r1340b2554],
10	TaqMan	NNP	O	TaqMan	nn	14	SENT_98	[p5l1355t2494r1638b2572],
11	5	CD	NUMBER	5	num	14	SENT_98	[p5l1655t2493r1691b2554],
12	’	CD	NUMBER	’	num	14	SENT_98	[p5l1702t2493r1715b2515],
13	exonuclease	NN	O	exonuclease	nn	14	SENT_98	[p5l1733t2493r2147b2554],
14	assay	NN	O	assay	iobj	8	SENT_98	[p5l10t2613r193b2673],
15	[	CD	NUMBER	[	number	16	SENT_98	[p5l217t2594r369b2668],
16	24	CD	NUMBER	24	num	17	SENT_98	[p5l217t2594r369b2668],
17	]	NN	O	]	dobj	8	SENT_98	[p5l217t2594r369b2668],
18	.	.	O	.	_	0	SENT_98	[p5l217t2594r369b2668],

1	The	DT	O	the	nsubj	2	SENT_99	[p5l389t2593r522b2654],
2	validated	VBN	O	validate	_	0	SENT_99	[p5l540t2593r854b2655],
3	assay	NN	O	assay	nn	6	SENT_99	[p5l872t2613r1055b2673],
4	(	CD	NUMBER	(	num	6	SENT_99	[p5l1075t2594r1189b2669],
5	ID	NN	O	id	nn	6	SENT_99	[p5l1075t2594r1189b2669],
6	C_644967_l0	NN	O	c_644967_l0	tmod	2	SENT_99	[p5l1209t2593r1714b2666],
7	,	,	O	,	_	0	SENT_99	[p5l1209t2593r1714b2666],
8	rs	NNS	O	r	appos	6	SENT_99	[p5l1734t2613r1812b2654],
9	.	.	O	.	_	0	SENT_99	[p5l1734t2613r1812b2654],

1	1800469	CD	NUMBER	1800469	num	2	SENT_100	[p5l1826t2593r2144b2669],
2	)	NN	O	)	nsubjpass	4	SENT_100	[p5l1826t2593r2144b2669],
3	was	VBD	O	be	auxpass	4	SENT_100	[p5l9t2715r139b2756],
4	designed	VBN	O	design	_	0	SENT_100	[p5l159t2695r462b2775],
5	and	CC	O	and	_	0	SENT_100	[p5l480t2695r602b2756],
6	manufactured	VBN	O	manufacture	conj_and	4	SENT_100	[p5l618t2695r1090b2756],
7	by	IN	O	by	_	0	SENT_100	[p5l1105t2695r1190b2775],
8	Applied	NNP	ORGANIZATION	Applied	nn	12	SENT_100	[p5l1202t2695r1478b2775],
9	Biosystems	NNP	ORGANIZATION	Biosystems	nn	12	SENT_100	[p5l1495t2695r1887b2775],
10	(	NNP	O	(	nn	12	SENT_100	[p5l1909t2696r2149b2771],
11	Foster	NNP	LOCATION	Foster	nn	12	SENT_100	[p5l1909t2696r2149b2771],
12	City	NNP	LOCATION	City	agent	4	SENT_100	[p5l10t2796r171b2875],
13	,	,	O	,	_	0	SENT_100	[p5l10t2796r171b2875],
14	California	NNP	LOCATION	California	nn	16	SENT_100	[p5l201t2796r573b2868],
15	,	,	O	,	_	0	SENT_100	[p5l201t2796r573b2868],
16	USA	NNP	LOCATION	USA	appos	12	SENT_100	[p5l601t2796r822b2872],
17	)	CD	NUMBER	)	num	16	SENT_100	[p5l601t2796r822b2872],
18	.	.	O	.	_	0	SENT_100	[p5l601t2796r822b2872],

1	The	DT	O	the	det	4	SENT_101	[p5l851t2796r984b2857],
2	chosen	VBN	O	choose	amod	4	SENT_101	[p5l1011t2796r1252b2857],
3	reporter	NN	O	reporter	nn	4	SENT_101	[p5l1277t2805r1555b2875],
4	ﬂuorophores	NNS	O	ﬂuorophores	nsubj	11	SENT_101	[p5l1580t2796r2019b2875],
5	for	IN	O	for	_	0	SENT_101	[p5l2047t2796r2149b2857],
6	the	DT	O	the	det	9	SENT_101	[p5l9t2897r113b2958],
7	TaqMan	NNP	O	TaqMan	nn	9	SENT_101	[p5l130t2898r418b2976],
8	GB	NNP	O	GB	nn	9	SENT_101	[p5l437t2897r551b2958],
9	probes	NNS	O	probe	prep_for	4	SENT_101	[p5l573t2896r802b2976],
10	were	VBD	O	be	cop	11	SENT_101	[p5l823t2916r990b2958],
11	VIC	NNP	O	VIC	_	0	SENT_101	[p5l1007t2897r1154b2958],
12	for	IN	O	for	_	0	SENT_101	[p5l1173t2896r1275b2958],
13	detecting	VBG	O	detect	prepc_for	11	SENT_101	[p5l1292t2896r1607b2976],
14	the	DT	O	the	det	16	SENT_101	[p5l1627t2897r1731b2958],
15	A	NN	O	a	nn	16	SENT_101	[p5l1744t2897r1806b2957],
16	allele	NN	O	allele	dobj	13	SENT_101	[p5l1821t2897r2005b2958],
17	and	CC	O	and	_	0	SENT_101	[p5l2025t2896r2149b2958],
18	6-carboxyﬂuorescein	JJ	O	6-carboxyﬂuorescein	amod	21	SENT_101	[p5l10t2998r750b3078],
19	(	NN	O	(	nn	21	SENT_101	[p5l773t2999r1008b3074],
20	FAM	NN	O	fam	nn	21	SENT_101	[p5l773t2999r1008b3074],
21	)	NN	O	)	dobj	13	SENT_101	[p5l773t2999r1008b3074],
22	for	IN	O	for	_	0	SENT_101	[p5l1033t2998r1134b3059],
23	the	DT	O	the	det	25	SENT_101	[p5l1154t2998r1259b3059],
24	C	NN	O	c	nn	25	SENT_101	[p5l1281t2999r1335b3060],
25	allele	NN	O	allele	prep_for	21	SENT_101	[p5l1360t2998r1564b3059],
26	.	.	O	.	_	0	SENT_101	[p5l1360t2998r1564b3059],

1	The	DT	O	the	det	4	SENT_102	[p5l1588t2998r1722b3059],
2	polymerase	NN	O	polymerase	nn	4	SENT_102	[p5l1743t2998r2147b3078],
3	chain	NN	O	chain	nn	4	SENT_102	[p5l9t3099r200b3160],
4	reaction	NN	O	reaction	nsubjpass	6	SENT_102	[p5l236t3099r524b3160],
5	was	VBD	O	be	auxpass	6	SENT_102	[p5l562t3118r695b3160],
6	performed	VBN	O	perform	_	0	SENT_102	[p5l733t3099r1106b3178],
7	in	IN	O	in	_	0	SENT_102	[p5l1141t3099r1209b3159],
8	a	DT	O	a	det	10	SENT_102	[p5l1248t3118r1284b3160],
9	ﬁnal	JJ	O	ﬁnal	amod	10	SENT_102	[p5l1320t3099r1476b3160],
10	volume	NN	O	volume	prep_in	6	SENT_102	[p5l1513t3099r1778b3160],
11	of	IN	O	of	_	0	SENT_102	[p5l1816t3099r1893b3160],
12	10	CD	NUMBER	10	num	13	SENT_102	[p5l1933t3099r2010b3160],
13	ILL	NN	O	ill	prep_of	10	SENT_102	[p5l2049t3100r2151b3179],
14	containing	VBG	O	contain	xcomp	6	SENT_102	[p5l10t3199r377b3279],
15	2	CD	NUMBER	2	num	16	SENT_102	[p5l404t3200r444b3260],
16	ILL	NN	O	ill	dobj	14	SENT_102	[p5l471t3201r572b3279],
17	of	IN	O	of	_	0	SENT_102	[p5l595t3199r671b3261],
18	DNA	NN	O	dna	nn	19	SENT_102	[p5l690t3200r879b3261],
19	(	NN	O	(	prep_of	16	SENT_102	[p5l901t3200r1013b3275],
20	10	CD	NUMBER	10	num	22	SENT_102	[p5l901t3200r1013b3275],
21	ng	NN	O	ng	nn	22	SENT_102	[p5l1039t3200r1172b3279],
22	)	NN	O	)	tmod	14	SENT_102	[p5l1039t3200r1172b3279],
23	,	,	O	,	_	0	SENT_102	[p5l1039t3200r1172b3279],
24	5	CD	NUMBER	5	num	25	SENT_102	[p5l1202t3199r1238b3261],
25	ILL	NN	O	ill	appos	22	SENT_102	[p5l1269t3201r1370b3279],
26	of	IN	O	of	_	0	SENT_102	[p5l1393t3199r1468b3261],
27	2X	NNP	O	2X	nn	31	SENT_102	[p5l1489t3200r1593b3260],
28	Universal	NNP	O	Universal	nn	31	SENT_102	[p5l1618t3199r1958b3261],
29	PCR	NN	O	pcr	nn	31	SENT_102	[p5l1983t3200r2148b3261],
30	Master	NN	O	master	nn	31	SENT_102	[p5l8t3303r253b3362],
31	Mix	NNP	O	Mix	prep_of	25	SENT_102	[p5l273t3301r436b3373],
32	,	,	O	,	_	0	SENT_102	[p5l273t3301r436b3373],
33	0.5	CD	NUMBER	0.5	num	34	SENT_102	[p5l462t3301r565b3363],
34	ILL	NN	O	ill	appos	31	SENT_102	[p5l593t3303r693b3381],
35	of	IN	O	of	_	0	SENT_102	[p5l713t3301r789b3362],
36	the	DT	O	the	prep_of	34	SENT_102	[p5l805t3301r910b3362],
37	validated	VBN	O	validate	partmod	36	SENT_102	[p5l933t3301r1253b3362],
38	assay	NN	O	assay	nn	39	SENT_102	[p5l1277t3321r1463b3381],
39	20X	NN	O	20x	dobj	37	SENT_102	[p5l1487t3302r1653b3373],
40	,	,	O	,	_	0	SENT_102	[p5l1487t3302r1653b3373],
41	and	CC	O	and	_	0	SENT_102	[p5l1680t3301r1804b3362],
42	2.5	CD	NUMBER	2.5	num	43	SENT_102	[p5l1827t3301r1929b3363],
43	ILL	NN	O	ill	conj_and	34	SENT_102	[p5l1957t3303r2057b3381],
44	of	IN	O	of	_	0	SENT_102	[p5l2077t3301r2153b3362],
45	distilled	JJ	O	distilled	amod	46	SENT_102	[p5l10t3402r291b3463],
46	water	NN	O	water	prep_of	43	SENT_102	[p5l320t3411r525b3463],
47	.	.	O	.	_	0	SENT_102	[p5l320t3411r525b3463],

1	Thermal	JJ	O	thermal	amod	3	SENT_103	[p5l558t3402r853b3463],
2	cycling	NN	O	cycling	nn	3	SENT_103	[p5l883t3402r1139b3481],
3	conditions	NNS	O	condition	nsubj	4	SENT_103	[p5l1170t3402r1531b3463],
4	were	VBD	O	be	_	0	SENT_103	[p5l1563t3421r1731b3463],
5	as	IN	O	as	mark	6	SENT_103	[p5l1763t3421r1830b3463],
6	follows	VBZ	O	follow	advcl	4	SENT_103	[p5l1862t3402r2141b3463],
7	:	:	O	:	_	0	SENT_103	[p5l1862t3402r2141b3463],
8	AmpErase	NNP	O	AmpErase	nn	10	SENT_103	[p5l9t3503r377b3582],
9	UNG	NNP	O	UNG	nn	10	SENT_103	[p5l399t3503r588b3564],
10	activation	NN	O	activation	dobj	6	SENT_103	[p5l610t3502r953b3564],
11	at	IN	O	at	_	0	SENT_103	[p5l976t3512r1036b3564],
12	50	CD	NUMBER	50	number	13	SENT_103	[p5l1058t3502r1226b3564],
13	°	CD	NUMBER	°	num	14	SENT_103	[p5l1058t3502r1226b3564],
14	C	NN	O	c	prep_at	10	SENT_103	[p5l1058t3502r1226b3564],
15	for	IN	O	for	_	0	SENT_103	[p5l1249t3502r1351b3564],
16	2	CD	DURATION	2	num	17	SENT_103	[p5l1371t3503r1411b3563],
17	minutes	NNS	NUMBER	minute	prep_for	14	SENT_103	[p5l1433t3502r1707b3564],
18	followed	VBN	O	follow	partmod	17	SENT_103	[p5l1730t3502r2041b3564],
19	by	IN	O	by	_	0	SENT_103	[p5l2061t3502r2147b3582],
20	AmpliTaq	NNP	ORGANIZATION	AmpliTaq	nn	23	SENT_103	[p5l9t3604r363b3684],
21	Gold	NNP	O	Gold	nn	23	SENT_103	[p5l388t3604r561b3666],
22	DNA	NNP	O	DNA	nn	23	SENT_103	[p5l585t3605r774b3665],
23	pre-incubation	NN	O	pre-incubation	agent	18	SENT_103	[p5l793t3604r1306b3684],
24	at	IN	O	at	_	0	SENT_103	[p5l1332t3613r1392b3665],
25	95	CD	NUMBER	95	number	26	SENT_103	[p5l1418t3604r1586b3666],
26	°	CD	NUMBER	°	num	27	SENT_103	[p5l1418t3604r1586b3666],
27	C	NN	O	c	prep_at	18	SENT_103	[p5l1418t3604r1586b3666],
28	for	IN	O	for	_	0	SENT_103	[p5l1613t3604r1715b3665],
29	10	CD	DURATION	10	num	30	SENT_103	[p5l1747t3605r1823b3665],
30	minutes	NNS	NUMBER	minute	prep_for	27	SENT_103	[p5l1848t3604r2144b3676],
31	,	,	O	,	_	0	SENT_103	[p5l1848t3604r2144b3676],
32	50	CD	NUMBER	50	num	33	SENT_103	[p5l10t3704r95b3766],
33	cycles	NNS	O	cycle	conj_and	27	SENT_103	[p5l134t3705r353b3784],
34	of	IN	O	of	_	0	SENT_103	[p5l394t3705r471b3766],
35	15	CD	DURATION	15	num	36	SENT_103	[p5l511t3705r585b3766],
36	seconds	NNS	NUMBER	seconds	prep_of	33	SENT_103	[p5l630t3705r907b3766],
37	at	IN	O	at	_	0	SENT_103	[p5l949t3714r1010b3766],
38	92	CD	NUMBER	92	number	39	SENT_103	[p5l1048t3705r1240b3777],
39	°	CD	NUMBER	°	num	40	SENT_103	[p5l1048t3705r1240b3777],
40	C	NN	O	c	prep_at	36	SENT_103	[p5l1048t3705r1240b3777],
41	,	,	O	,	_	0	SENT_103	[p5l1048t3705r1240b3777],
42	and	CC	O	and	_	0	SENT_103	[p5l1283t3705r1409b3766],
43	60	CD	NUMBER	60	num	45	SENT_103	[p5l1447t3705r1619b3766],
44	°	NN	O	°	nn	45	SENT_103	[p5l1447t3705r1619b3766],
45	C	NN	O	c	conj_and	27	SENT_103	[p5l1447t3705r1619b3766],
46	for	IN	O	for	_	0	SENT_103	[p5l1658t3705r1762b3766],
47	1	CD	DURATION	1	num	48	SENT_103	[p5l1806t3705r1832b3765],
48	minute	NN	NUMBER	minute	prep_for	45	SENT_103	[p5l1877t3705r2142b3766],
49	.	.	O	.	_	0	SENT_103	[p5l1877t3705r2142b3766],

1	After	IN	O	after	_	0	SENT_104	[p6l9t17r194b79],
2	ampliﬁcation	NN	O	ampliﬁcation	prep_after	9	SENT_104	[p6l227t17r706b97],
3	,	,	O	,	_	0	SENT_104	[p6l227t17r706b97],
4	endpoint	NN	O	endpoint	nn	5	SENT_104	[p6l744t17r1050b97],
5	detection	NN	O	detection	nsubjpass	9	SENT_104	[p6l1084t17r1403b79],
6	of	IN	O	of	_	0	SENT_104	[p6l1438t17r1514b79],
7	ﬂuorescence	NN	O	ﬂuorescence	prep_of	5	SENT_104	[p6l1543t17r1979b79],
8	was	VBD	O	be	auxpass	9	SENT_104	[p6l2013t37r2145b79],
9	performed	VBN	O	perform	_	0	SENT_104	[p6l8t119r374b199],
10	at	IN	O	at	_	0	SENT_104	[p6l408t128r468b180],
11	60	CD	NUMBER	60	number	12	SENT_104	[p6l502t119r689b181],
12	°	CD	NUMBER	°	prep_at	9	SENT_104	[p6l502t119r689b181],
13	C.	NNP	MISC	C.	nn	14	SENT_104	[p6l502t119r689b181],
14	Automatic	NNP	MISC	Automatic	nsubjpass	17	SENT_104	[p6l722t119r1090b180],
15	calling	VBG	O	call	partmod	14	SENT_104	[p6l1125t119r1360b199],
16	was	VBD	O	be	auxpass	17	SENT_104	[p6l1395t139r1527b180],
17	performed	VBN	O	perform	rcmod	12	SENT_104	[p6l1560t119r1926b199],
18	using	VBG	O	use	xcomp	17	SENT_104	[p6l1958t119r2146b199],
19	7300	CD	NUMBER	7300	num	22	SENT_104	[p6l9t220r182b281],
20	system	NN	O	system	nn	22	SENT_104	[p6l208t229r449b299],
21	SDS	NN	O	sd	nn	22	SENT_104	[p6l473t220r625b281],
22	software	NN	O	software	dobj	18	SENT_104	[p6l655t220r952b281],
23	in	IN	O	in	_	0	SENT_104	[p6l975t220r1042b280],
24	a	DT	O	a	det	33	SENT_104	[p6l1066t239r1102b281],
25	7300	CD	DATE	7300	num	28	SENT_104	[p6l1124t220r1297b281],
26	Real	JJ	MISC	real	amod	28	SENT_104	[p6l1320t220r1479b281],
27	Time	NNP	MISC	Time	nn	28	SENT_104	[p6l1500t220r1680b281],
28	PCR	NN	MISC	pcr	nn	33	SENT_104	[p6l1704t220r1868b281],
29	System	NNP	MISC	System	nn	32	SENT_104	[p6l1893t220r2149b299],
30	(	NNP	O	(	nn	32	SENT_104	[p6l11t320r320b400],
31	Applied	NNP	O	Applied	nn	32	SENT_104	[p6l11t320r320b400],
32	Biosystems	NNP	O	Biosystems	dep	28	SENT_104	[p6l353t320r803b400],
33	)	NN	O	)	prep_in	18	SENT_104	[p6l353t320r803b400],
34	.	.	O	.	_	0	SENT_104	[p6l353t320r803b400],

1	Nontemplate	JJ	O	nontemplate	amod	2	SENT_105	[p6l842t321r1294b400],
2	controls	NNS	O	control	nsubjpass	4	SENT_105	[p6l1329t320r1608b382],
3	were	VBD	O	be	auxpass	4	SENT_105	[p6l1644t340r1812b382],
4	included	VBN	O	include	_	0	SENT_105	[p6l1847t320r2148b382],
5	in	IN	O	in	_	0	SENT_105	[p6l9t422r75b482],
6	each	DT	O	each	det	7	SENT_105	[p6l100t422r259b483],
7	run	NN	O	run	prep_in	4	SENT_105	[p6l281t442r398b483],
8	and	CC	O	and	_	0	SENT_105	[p6l424t422r547b483],
9	the	DT	O	the	det	10	SENT_105	[p6l571t422r675b483],
10	reproducibility	NN	O	reproducibility	prep_in	4	SENT_105	[p6l699t422r1220b502],
11	of	IN	O	of	_	0	SENT_105	[p6l1247t422r1322b483],
12	30	CD	NUMBER	30	num	13	SENT_105	[p6l1343t423r1426b483],
13	samples	NNS	O	sample	prep_of	10	SENT_105	[p6l1454t422r1730b502],
14	repeated	VBN	O	repeat	partmod	13	SENT_105	[p6l1755t422r2053b502],
15	as	IN	O	as	mark	20	SENT_105	[p6l2078t442r2145b483],
16	genotyping	NN	O	genotyping	nn	17	SENT_105	[p6l10t523r401b602],
17	controls	NNS	O	control	nsubj	20	SENT_105	[p6l428t523r706b584],
18	was	VBD	O	be	cop	20	SENT_105	[p6l733t542r865b584],
19	100	CD	PERCENT	100	num	20	SENT_105	[p6l900t523r1111b584],
20	%	NN	PERCENT	%	advcl	14	SENT_105	[p6l900t523r1111b584],
21	.	.	O	.	_	0	SENT_105	[p6l900t523r1111b584],

1	Quam	NNP	O	Quam	_	0	SENT_106	[p6l21t728r610b809],
2	‘	NNP	O	‘	rcmod	1	SENT_106	[p6l21t728r610b809],
3	/	:	O	/	punct	4	SENT_106	[p6l21t728r610b809],
4	ﬂcaz	NN	O	ﬂcaz	dep	2	SENT_106	[p6l21t728r610b809],
5	‘	CD	NUMBER	‘	num	4	SENT_106	[p6l21t728r610b809],
6	/	:	O	/	punct	4	SENT_106	[p6l21t728r610b809],
7	'	''	O	'	_	0	SENT_106	[p6l21t728r610b809],
8	0/7	CD	NUMBER	0/7	dep	2	SENT_106	[p6l21t728r610b809],
9	of	IN	O	of	_	0	SENT_106	[p6l640t726r747b795],
10	7	CD	NUMBER	7	prep_of	1	SENT_106	[p6l761t726r962b795],
11	'	''	O	'	_	0	SENT_106	[p6l761t726r962b795],
12	0z	JJ	O	0z	amod	13	SENT_106	[p6l761t726r962b795],
13	‘	NN	O	‘	dep	1	SENT_106	[p6l761t726r962b795],
14	a	DT	O	a	dep	13	SENT_106	[p6l761t726r962b795],
15	/	:	O	/	punct	18	SENT_106	[p6l761t726r962b795],
16	and	CC	O	and	dep	18	SENT_106	[p6l977t726r1142b795],
17	Spec/Dc	JJ	O	spec/dc	amod	18	SENT_106	[p6l1155t728r1470b815],
18	Immunog/obu	NN	O	immunog/obu	dep	14	SENT_106	[p6l10t823r698b912],
19	/	:	O	/	punct	18	SENT_106	[p6l10t823r698b912],
20	/	:	O	/	punct	23	SENT_106	[p6l10t823r698b912],
21	n	NN	O	n	nn	23	SENT_106	[p6l10t823r698b912],
22	(	CD	NUMBER	(	num	23	SENT_106	[p6l725t827r863b912],
23	lg	NN	O	lg	dep	14	SENT_106	[p6l725t827r863b912],
24	)	CD	NUMBER	)	num	25	SENT_106	[p6l725t827r863b912],
25	E	NN	O	e	dep	23	SENT_106	[p6l887t827r944b891],

1	Total	JJ	O	total	amod	2	SENT_107	[p6l140t984r309b1045],
2	IgE	NN	O	ige	nsubjpass	4	SENT_107	[p6l324t986r444b1064],
3	was	VBD	O	be	auxpass	4	SENT_107	[p6l459t1004r588b1045],
4	determined	VBN	O	determine	_	0	SENT_107	[p6l605t984r980b1045],
5	using	VBG	O	use	xcomp	4	SENT_107	[p6l994t984r1174b1064],
6	a	DT	O	a	det	9	SENT_107	[p6l1191t1004r1228b1045],
7	commercial	JJ	O	commercial	amod	9	SENT_107	[p6l1242t984r1636b1045],
8	enzyme	NN	O	enzyme	nn	9	SENT_107	[p6l1651t984r2148b1064],
9	—	NN	O	—	dobj	5	SENT_107	[p6l1651t984r2148b1064],
10	linked	VBN	O	link	partmod	9	SENT_107	[p6l1651t984r2148b1064],
11	immuno	NN	O	immuno	nn	13	SENT_107	[p6l9t1085r294b1146],
12	sorbent	NN	O	sorbent	nn	13	SENT_107	[p6l317t1085r567b1146],
13	assay	NN	O	assay	dobj	10	SENT_107	[p6l586t1104r768b1164],
14	(	CD	NUMBER	(	num	15	SENT_107	[p6l791t1085r1085b1161],
15	ELISA	NN	ORGANIZATION	elisa	amod	13	SENT_107	[p6l791t1085r1085b1161],
16	)	CD	NUMBER	)	number	17	SENT_107	[p6l791t1085r1085b1161],
17	(	CD	NUMBER	(	dep	15	SENT_107	[p6l1110t1085r1695b1161],
18	RIDASCREEN	NNP	O	RIDASCREEN	dep	17	SENT_107	[p6l1110t1085r1695b1161],
19	,	,	O	,	_	0	SENT_107	[p6l1110t1085r1695b1161],
20	R-Biopharm	NNP	O	R-Biopharm	nn	25	SENT_107	[p6l1717t1085r2149b1164],
21	AG	NNP	O	AG	nn	25	SENT_107	[p6l9t1186r153b1258],
22	,	,	O	,	_	0	SENT_107	[p6l9t1186r153b1258],
23	Darmstadt	NNP	LOCATION	Darmstadt	appos	25	SENT_107	[p6l193t1185r582b1258],
24	,	,	O	,	_	0	SENT_107	[p6l193t1185r582b1258],
25	Germany	NNP	LOCATION	Germany	appos	17	SENT_107	[p6l623t1186r977b1265],
26	)	CD	NUMBER	)	num	25	SENT_107	[p6l623t1186r977b1265],
27	in	IN	O	in	_	0	SENT_107	[p6l1017t1185r1083b1246],
28	all	DT	O	all	det	29	SENT_107	[p6l1122t1185r1206b1247],
29	participants	NNS	O	participant	prep_in	25	SENT_107	[p6l1242t1185r1656b1265],
30	according	VBG	O	accord	_	0	SENT_107	[p6l1697t1185r2043b1265],
31	to	TO	O	to	prepc_according_to	29	SENT_107	[p6l2081t1195r2146b1247],
32	the	DT	O	the	det	33	SENT_107	[p6l9t1287r117b1348],
33	manufacturer	NN	O	manufacturer	poss	35	SENT_107	[p6l158t1287r713b1348],
34	’s	POS	O	’s	_	0	SENT_107	[p6l158t1287r713b1348],
35	instructions	NNS	O	instruction	pobj	29	SENT_107	[p6l755t1287r1207b1348],
36	.	.	O	.	_	0	SENT_107	[p6l755t1287r1207b1348],

1	Since	IN	O	since	mark	10	SENT_108	[p6l1254t1287r1453b1349],
2	Blomia	NN	O	blomium	nn	3	SENT_108	[p6l1491t1287r1755b1348],
3	tropicalis	NN	O	tropicali	nsubj	10	SENT_108	[p6l1798t1287r2146b1366],
4	and	CC	O	and	_	0	SENT_108	[p6l11t1388r134b1449],
5	Dermatophagoides	JJ	O	dermatophagoides	amod	6	SENT_108	[p6l167t1388r842b1466],
6	pteronyssinus	NN	O	pteronyssinus	nsubj	10	SENT_108	[p6l871t1390r1357b1466],
7	are	VBP	O	be	cop	10	SENT_108	[p6l1396t1407r1498b1449],
8	the	DT	O	the	det	10	SENT_108	[p6l1535t1388r1639b1449],
9	main	JJ	O	main	amod	10	SENT_108	[p6l1676t1388r1850b1449],
10	sources	NNS	O	source	csubj	16	SENT_108	[p6l1888t1407r2145b1449],
11	of	IN	O	of	_	0	SENT_108	[p6l10t1488r86b1550],
12	sensitization	NN	O	sensitization	prep_of	10	SENT_108	[p6l121t1488r569b1550],
13	in	IN	O	in	_	0	SENT_108	[p6l606t1488r673b1549],
14	tropical	JJ	O	tropical	amod	15	SENT_108	[p6l711t1488r984b1568],
15	environments	NNS	O	environment	prep_in	12	SENT_108	[p6l1022t1488r1508b1550],
16	[	VBP	O	[	_	0	SENT_108	[p6l1554t1488r1660b1563],
17	25	CD	NUMBER	25	num	19	SENT_108	[p6l1554t1488r1660b1563],
18	-27	CD	NUMBER	-27	num	19	SENT_108	[p6l1670t1489r1835b1563],
19	]	NN	O	]	dobj	16	SENT_108	[p6l1670t1489r1835b1563],
20	,	,	O	,	_	0	SENT_108	[p6l1670t1489r1835b1563],
21	and	CC	O	and	_	0	SENT_108	[p6l1878t1488r2003b1550],
22	the	DT	O	the	det	23	SENT_108	[p6l2040t1489r2147b1550],
23	prevalence	NN	O	prevalence	nsubj	31	SENT_108	[p6l8t1590r379b1670],
24	of	IN	O	of	_	0	SENT_108	[p6l403t1590r477b1651],
25	IgE	NN	O	ige	nn	26	SENT_108	[p6l493t1592r616b1670],
26	sensitization	NN	O	sensitization	prep_of	23	SENT_108	[p6l641t1590r1065b1651],
27	to	TO	O	to	_	0	SENT_108	[p6l1086t1599r1151b1651],
28	these	DT	O	these	det	29	SENT_108	[p6l1173t1590r1348b1651],
29	allergens	NNS	O	allergen	prep_to	26	SENT_108	[p6l1372t1590r1675b1670],
30	is	VBZ	O	be	cop	31	SENT_108	[p6l1698t1590r1752b1651],
31	frequent	JJ	O	frequent	conj_and	16	SENT_108	[p6l1776t1590r2062b1670],
32	in	IN	O	in	_	0	SENT_108	[p6l2082t1590r2148b1650],
33	allergic	JJ	O	allergic	amod	34	SENT_108	[p6l11t1691r254b1770],
34	patients	NNS	O	patient	prep_in	31	SENT_108	[p6l270t1691r527b1770],
35	from	IN	O	from	_	0	SENT_108	[p6l545t1691r709b1752],
36	Venezuela	NNP	LOCATION	Venezuela	prep_from	31	SENT_108	[p6l721t1691r1067b1752],
37	(	CD	PERCENT	(	number	42	SENT_108	[p6l1084t1691r1322b1767],
38	91.6	CD	PERCENT	91.6	number	42	SENT_108	[p6l1084t1691r1322b1767],
39	%	NN	PERCENT	%	dep	42	SENT_108	[p6l1084t1691r1322b1767],
40	and	CC	O	and	_	0	SENT_108	[p6l1343t1691r1463b1752],
41	97.2	CD	PERCENT	97.2	conj_and	42	SENT_108	[p6l1479t1691r1623b1753],
42	%	NN	PERCENT	%	dep	36	SENT_108	[p6l1643t1691r1726b1764],
43	,	,	O	,	_	0	SENT_108	[p6l1643t1691r1726b1764],
44	respectively	RB	O	respectively	advmod	36	SENT_108	[p6l1744t1691r2147b1770],
45	[	CD	NUMBER	[	number	46	SENT_108	[p6l15t1792r295b1867],
46	28,29	CD	NUMBER	28,29	dep	36	SENT_108	[p6l15t1792r295b1867],
47	]	CD	NUMBER	]	num	48	SENT_108	[p6l15t1792r295b1867],
48	)	NN	O	)	dep	46	SENT_108	[p6l15t1792r295b1867],
49	,	,	O	,	_	0	SENT_108	[p6l15t1792r295b1867],
50	speciﬁc	JJ	O	speciﬁc	acomp	31	SENT_108	[p6l316t1791r566b1871],
51	IgE	NN	O	ige	nn	54	SENT_108	[p6l583t1793r703b1871],
52	(	CD	NUMBER	(	num	54	SENT_108	[p6l721t1792r922b1871],
53	sIgE	NN	O	sige	nn	54	SENT_108	[p6l721t1792r922b1871],
54	)	NN	O	)	nsubjpass	60	SENT_108	[p6l721t1792r922b1871],
55	against	IN	O	against	_	0	SENT_108	[p6l942t1791r1176b1871],
56	these	DT	O	these	det	58	SENT_108	[p6l1190t1792r1360b1853],
57	2	CD	NUMBER	2	num	58	SENT_108	[p6l1376t1792r1416b1852],
58	mites	NNS	O	mite	prep_against	54	SENT_108	[p6l1431t1791r1610b1853],
59	was	VBD	O	be	auxpass	60	SENT_108	[p6l1627t1811r1755b1853],
60	determined	VBN	O	determine	ccomp	50	SENT_108	[p6l1773t1791r2148b1853],
61	by	IN	O	by	_	0	SENT_108	[p6l8t1893r93b1973],
62	indirect	JJ	O	indirect	amod	63	SENT_108	[p6l122t1893r384b1954],
63	ELISA	NN	LOCATION	elisa	agent	60	SENT_108	[p6l411t1893r673b1966],
64	,	,	O	,	_	0	SENT_108	[p6l411t1893r673b1966],
65	as	IN	O	as	mark	66	SENT_108	[p6l707t1913r772b1954],
66	described	VBN	O	describe	advcl	60	SENT_108	[p6l804t1893r1132b1954],
67	previously	RB	DATE	previously	advmod	66	SENT_108	[p6l1159t1893r1521b1973],
68	[	CD	NUMBER	[	num	70	SENT_108	[p6l1557t1894r1708b1967],
69	30	CD	NUMBER	30	num	70	SENT_108	[p6l1557t1894r1708b1967],
70	]	NN	O	]	dobj	66	SENT_108	[p6l1557t1894r1708b1967],
71	.	.	O	.	_	0	SENT_108	[p6l1557t1894r1708b1967],

1	Absorbance	NN	PERSON	absorbance	nsubjpass	23	SENT_109	[p6l1737t1893r2147b1954],
2	was	VBD	O	be	auxpass	3	SENT_109	[p6l9t2013r139b2055],
3	measured	VBN	O	measure	_	0	SENT_109	[p6l169t1994r498b2055],
4	at	IN	O	at	_	0	SENT_109	[p6l527t2003r587b2055],
5	405	CD	NUMBER	405	num	6	SENT_109	[p6l613t1994r737b2055],
6	nm	NN	O	nm	prep_at	3	SENT_109	[p6l768t2013r879b2054],
7	using	VBG	O	use	partmod	6	SENT_109	[p6l904t1994r1089b2073],
8	a	DT	O	a	det	12	SENT_109	[p6l1119t2013r1156b2055],
9	Spectrophotometer	NN	O	spectrophotometer	nn	12	SENT_109	[p6l1184t1994r1836b2073],
10	(	NN	O	(	nn	12	SENT_109	[p6l1865t1994r2149b2073],
11	Spectra	NNP	O	Spectra	nn	12	SENT_109	[p6l1865t1994r2149b2073],
12	MAX	NNP	O	MAX	dobj	7	SENT_109	[p6l8t2095r210b2155],
13	250	CD	NUMBER	250	num	15	SENT_109	[p6l231t2094r357b2156],
14	Molecular	JJ	O	molecular	amod	15	SENT_109	[p6l377t2094r732b2156],
15	Device	NN	O	device	tmod	7	SENT_109	[p6l750t2094r992b2156],
16	Sunnyvale	NNP	LOCATION	Sunnyvale	nn	20	SENT_109	[p6l1015t2095r1393b2174],
17	,	,	O	,	_	0	SENT_109	[p6l1015t2095r1393b2174],
18	Califomia	NNP	LOCATION	Califomia	appos	20	SENT_109	[p6l1417t2094r1781b2167],
19	,	,	O	,	_	0	SENT_109	[p6l1417t2094r1781b2167],
20	USA	NNP	LOCATION	USA	dep	15	SENT_109	[p6l1804t2095r2002b2170],
21	)	CD	NUMBER	)	num	20	SENT_109	[p6l1804t2095r2002b2170],
22	and	CC	O	and	_	0	SENT_109	[p6l2026t2094r2148b2156],
23	expressed	VBN	O	express	conj_and	3	SENT_109	[p6l10t2196r347b2276],
24	as	IN	O	as	_	0	SENT_109	[p6l368t2216r434b2257],
25	optical	JJ	O	optical	amod	28	SENT_109	[p6l458t2196r689b2276],
26	density	NN	O	density	nn	28	SENT_109	[p6l710t2196r955b2276],
27	(	NN	O	(	nn	28	SENT_109	[p6l979t2197r1154b2272],
28	OD	NN	O	od	prep_as	23	SENT_109	[p6l979t2197r1154b2272],
29	)	CD	NUMBER	)	num	30	SENT_109	[p6l979t2197r1154b2272],
30	units	NNS	O	unit	dobj	3	SENT_109	[p6l1177t2196r1359b2257],
31	.	.	O	.	_	0	SENT_109	[p6l1177t2196r1359b2257],

1	Samples	NNS	O	sample	nsubjpass	3	SENT_110	[p6l1386t2196r1673b2276],
2	were	VBD	O	be	auxpass	3	SENT_110	[p6l1696t2216r1860b2258],
3	assayed	VBN	O	assay	_	0	SENT_110	[p6l1883t2196r2148b2276],
4	in	IN	O	in	_	0	SENT_110	[p6l9t2297r74b2357],
5	duplicate	VB	O	duplicate	prepc_in	3	SENT_110	[p6l99t2297r429b2376],
6	,	,	O	,	_	0	SENT_110	[p6l99t2297r429b2376],
7	and	CC	O	and	_	0	SENT_110	[p6l458t2297r580b2358],
8	levels	NNS	O	level	nsubjpass	26	SENT_110	[p6l603t2297r799b2358],
9	of	IN	O	of	_	0	SENT_110	[p6l826t2297r901b2358],
10	sIgE	NN	O	sige	prep_of	8	SENT_110	[p6l922t2298r1076b2376],
11	above	IN	O	above	_	0	SENT_110	[p6l1101t2297r1303b2358],
12	0.142	CD	NUMBER	0.142	num	13	SENT_110	[p6l1329t2297r1519b2358],
13	OD	NN	O	od	prep_above	10	SENT_110	[p6l1545t2297r1666b2358],
14	(	CD	NUMBER	(	num	16	SENT_110	[p6l1695t2298r1906b2373],
15	mean	NN	O	mean	nn	16	SENT_110	[p6l1695t2298r1906b2373],
16	OD	NN	O	od	dep	13	SENT_110	[p6l1931t2297r2051b2358],
17	of	IN	O	of	_	0	SENT_110	[p6l2078t2297r2153b2358],
18	5	CD	NUMBER	5	num	20	SENT_110	[p6l10t2397r46b2459],
19	nonatopic	JJ	O	nonatopic	amod	20	SENT_110	[p6l73t2397r409b2477],
20	participants	NNS	O	participant	prep_of	16	SENT_110	[p6l433t2397r830b2477],
21	+	CC	O	+	_	0	SENT_110	[p6l856t2413r901b2458],
22	3	CD	NUMBER	3	num	24	SENT_110	[p6l927t2398r962b2459],
23	SD	NN	O	sd	nn	24	SENT_110	[p6l991t2398r1124b2473],
24	)	NN	O	)	conj_+	20	SENT_110	[p6l991t2398r1124b2473],
25	were	VBD	O	be	auxpass	26	SENT_110	[p6l1150t2417r1315b2459],
26	considered	VBN	O	consider	conj_and	3	SENT_110	[p6l1339t2397r1709b2459],
27	positive	JJ	O	positive	acomp	26	SENT_110	[p6l1730t2397r2018b2477],
28	.	.	O	.	_	0	SENT_110	[p6l1730t2397r2018b2477],

1	5	CD	NUMBER	5	_	0	SENT_111	[p6l12t2599r184b2667],
2	/	:	O	/	punct	3	SENT_111	[p6l12t2599r184b2667],
3	(	CD	NUMBER	(	dep	1	SENT_111	[p6l12t2599r184b2667],
4	/	:	O	/	punct	3	SENT_111	[p6l12t2599r184b2667],
5	/	:	O	/	punct	6	SENT_111	[p6l12t2599r184b2667],
6	7	CD	NUMBER	7	dep	1	SENT_111	[p6l12t2599r184b2667],
7	Tests	NNS	O	test	dep	1	SENT_111	[p6l223t2602r406b2667],

1	Speciﬁc	JJ	O	speciﬁc	amod	3	SENT_112	[p6l142t2760r418b2839],
2	IgE	NN	O	ige	nn	3	SENT_112	[p6l437t2761r562b2839],
3	reactivity	NN	O	reactivity	nsubjpass	8	SENT_112	[p6l579t2760r907b2839],
4	to	TO	O	to	_	0	SENT_112	[p6l926t2769r991b2821],
5	common	JJ	O	common	amod	6	SENT_112	[p6l1011t2779r1315b2821],
6	allergens	NNS	O	allergen	prep_to	3	SENT_112	[p6l1335t2760r1642b2839],
7	was	VBD	O	be	auxpass	8	SENT_112	[p6l1663t2779r1794b2821],
8	evaluated	VBN	O	evaluate	_	0	SENT_112	[p6l1816t2760r2148b2821],
9	using	VBG	O	use	xcomp	8	SENT_112	[p6l8t2860r195b2940],
10	skin	NN	O	skin	nn	12	SENT_112	[p6l218t2860r359b2922],
11	prick	NN	O	prick	nn	12	SENT_112	[p6l376t2860r557b2940],
12	tests	NNS	O	test	dobj	9	SENT_112	[p6l573t2870r724b2922],
13	to	TO	O	to	_	0	SENT_112	[p6l745t2870r810b2922],
14	a	DT	O	a	det	15	SENT_112	[p6l832t2880r868b2922],
15	battery	NN	O	battery	prep_to	9	SENT_112	[p6l884t2861r1125b2940],
16	of	IN	O	of	_	0	SENT_112	[p6l1145t2860r1221b2922],
17	25	CD	NUMBER	25	num	18	SENT_112	[p6l1235t2860r1315b2922],
18	aeroallergens	NNS	O	aeroallergen	prep_of	15	SENT_112	[p6l1339t2860r1798b2940],
19	including	VBG	O	include	prep	9	SENT_112	[p6l1819t2860r2146b2940],

1	J	NNP	O	J	nn	5	SENT_113	[p6l7t3109r44b3160],
2	Investig	NNP	O	Investig	nn	5	SENT_113	[p6l58t3109r292b3173],
3	Allergol	NNP	O	Allergol	nn	5	SENT_113	[p6l307t3107r551b3173],
4	Clin	NNP	O	Clin	nn	5	SENT_113	[p6l574t3107r695b3160],
5	Immunol	NNP	O	Immunol	_	0	SENT_113	[p6l715t3107r980b3159],
6	2009	CD	DATE	2009	num	5	SENT_113	[p6l1000t3107r1163b3168],
7	;	:	O	;	_	0	SENT_113	[p6l1000t3107r1163b3168],
8	Vol	NNP	O	Vol	dep	5	SENT_113	[p6l1185t3107r1299b3159],
9	.	.	O	.	_	0	SENT_113	[p6l1185t3107r1299b3159],

1	19	CD	NUMBER	19	number	2	SENT_114	[p6l1331t3107r1498b3171],
2	(	CD	NUMBER	(	nsubj	33	SENT_114	[p6l1331t3107r1498b3171],
3	5	CD	NUMBER	5	num	4	SENT_114	[p6l1331t3107r1498b3171],
4	)	NN	O	)	dep	2	SENT_114	[p6l1331t3107r1498b3171],
5	:	:	O	:	_	0	SENT_114	[p6l1331t3107r1498b3171],
6	375-382	CD	NUMBER	375-382	num	7	SENT_114	[p6l1525t3107r1767b3159],
7	mites	NNS	O	mite	conj_and	2	SENT_114	[p6l7t3200r194b3261],
8	(	NN	O	(	nn	10	SENT_114	[p6l230t3200r317b3276],
9	D	NN	O	d	nn	10	SENT_114	[p6l230t3200r317b3276],
10	pteronyssinus	NN	O	pteronyssinus	dep	7	SENT_114	[p6l340t3202r827b3278],
11	and	CC	O	and	_	0	SENT_114	[p6l860t3200r984b3261],
12	B	NN	O	b	nn	13	SENT_114	[p6l1012t3202r1065b3260],
13	tropicalis	NNS	O	tropicali	conj_and	2	SENT_114	[p6l1098t3200r1448b3278],
14	,	,	O	,	_	0	SENT_114	[p6l1098t3200r1448b3278],
15	CBF	NN	O	cbf	nn	16	SENT_114	[p6l1483t3200r1647b3262],
16	Leti	NNP	PERSON	Leti	appos	13	SENT_114	[p6l1676t3200r1836b3273],
17	,	,	O	,	_	0	SENT_114	[p6l1676t3200r1836b3273],
18	Madrid	NNP	LOCATION	Madrid	appos	13	SENT_114	[p6l1869t3200r2145b3273],
19	,	,	O	,	_	0	SENT_114	[p6l1869t3200r2145b3273],
20	Spain	NNP	LOCATION	Spain	nn	21	SENT_114	[p6l9t3301r269b3380],
21	)	NNP	O	)	appos	13	SENT_114	[p6l9t3301r269b3380],
22	,	,	O	,	_	0	SENT_114	[p6l9t3301r269b3380],
23	cockroach	NN	O	cockroach	appos	13	SENT_114	[p6l314t3301r715b3373],
24	,	,	O	,	_	0	SENT_114	[p6l314t3301r715b3373],
25	cat	NN	O	cat	conj_and	23	SENT_114	[p6l760t3310r866b3362],
26	and	CC	O	and	_	0	SENT_114	[p6l908t3301r1037b3362],
27	dog	NN	O	dog	conj_and	23	SENT_114	[p6l1077t3301r1211b3380],
28	dander	JJ	O	dander	amod	23	SENT_114	[p6l1253t3301r1521b3373],
29	,	,	O	,	_	0	SENT_114	[p6l1253t3301r1521b3373],
30	feathers	NNS	O	feather	appos	13	SENT_114	[p6l1565t3301r1881b3373],
31	,	,	O	,	_	0	SENT_114	[p6l1565t3301r1881b3373],
32	molds	NNS	O	mold	appos	30	SENT_114	[p6l1925t3301r2146b3362],
33	(	VBP	O	(	_	0	SENT_114	[p6l10t3401r438b3477],
34	Penicillium	NNP	ORGANIZATION	Penicillium	nn	43	SENT_114	[p6l10t3401r438b3477],
35	,	,	O	,	_	0	SENT_114	[p6l10t3401r438b3477],
36	Aspergillus	NNP	O	Aspergillus	appos	43	SENT_114	[p6l454t3401r855b3480],
37	,	,	O	,	_	0	SENT_114	[p6l454t3401r855b3480],
38	Cladosporium	NNP	O	Cladosporium	appos	43	SENT_114	[p6l883t3401r1378b3480],
39	,	,	O	,	_	0	SENT_114	[p6l883t3401r1378b3480],
40	Alternaria	NNP	LOCATION	Alternaria	appos	43	SENT_114	[p6l1394t3401r1765b3473],
41	,	,	O	,	_	0	SENT_114	[p6l1394t3401r1765b3473],
42	Rhizopus	NNP	O	Rhizopus	appos	43	SENT_114	[p6l1786t3401r2145b3480],
43	)	NNP	O	)	nsubj	76	SENT_114	[p6l1786t3401r2145b3480],
44	,	,	O	,	_	0	SENT_114	[p6l1786t3401r2145b3480],
45	bermuda	NNP	O	bermuda	nn	49	SENT_114	[p6l6t3503r318b3564],
46	(	NNP	O	(	nn	49	SENT_114	[p6l356t3503r701b3581],
47	Cynodon	NNP	O	Cynodon	nn	49	SENT_114	[p6l356t3503r701b3581],
48	daczylon	NN	O	daczylon	nn	49	SENT_114	[p6l739t3503r1093b3581],
49	)	NN	O	)	appos	43	SENT_114	[p6l739t3503r1093b3581],
50	,	,	O	,	_	0	SENT_114	[p6l739t3503r1093b3581],
51	rye	NN	O	rye	nn	52	SENT_114	[p6l1132t3522r1243b3582],
52	grass	NN	O	grass	appos	43	SENT_114	[p6l1282t3522r1459b3582],
53	(	CD	NUMBER	(	num	55	SENT_114	[p6l1501t3503r1778b3579],
54	Lolium	NN	O	lolium	nn	55	SENT_114	[p6l1501t3503r1778b3579],
55	perenne	NN	O	perenne	dep	52	SENT_114	[p6l1806t3504r2145b3581],
56	)	CD	NUMBER	)	dep	52	SENT_114	[p6l1806t3504r2145b3581],
57	,	,	O	,	_	0	SENT_114	[p6l1806t3504r2145b3581],
58	timothy	JJ	O	timothy	amod	62	SENT_114	[p6l7t3604r272b3683],
59	(	NN	O	(	nn	62	SENT_114	[p6l293t3604r580b3679],
60	Phleum	NN	O	phleum	nn	62	SENT_114	[p6l293t3604r580b3679],
61	pratense	NN	O	pratense	nn	62	SENT_114	[p6l589t3604r937b3682],
62	)	NN	O	)	appos	43	SENT_114	[p6l589t3604r937b3682],
63	,	,	O	,	_	0	SENT_114	[p6l589t3604r937b3682],
64	ragweed	NN	O	ragweed	appos	43	SENT_114	[p6l957t3604r1248b3683],
65	(	CD	NUMBER	(	num	68	SENT_114	[p6l1267t3604r1622b3679],
66	Ambrosia	NNP	O	Ambrosia	nn	68	SENT_114	[p6l1267t3604r1622b3679],
67	artemisiifolia	NN	O	artemisiifolium	nn	68	SENT_114	[p6l1640t3604r2145b3682],
68	)	NN	O	)	dep	64	SENT_114	[p6l1640t3604r2145b3682],
69	,	,	O	,	_	0	SENT_114	[p6l1640t3604r2145b3682],
70	Chenopodium	NN	O	chenopodium	nn	71	SENT_114	[p6l11t3704r551b3783],
71	album	NN	O	album	appos	43	SENT_114	[p6l597t3704r860b3777],
72	,	,	O	,	_	0	SENT_114	[p6l597t3704r860b3777],
73	Plantago	NN	PERSON	plantago	nn	74	SENT_114	[p6l908t3704r1265b3783],
74	lanceolata	NN	O	lanceola	appos	43	SENT_114	[p6l1314t3704r1752b3777],
75	,	,	O	,	_	0	SENT_114	[p6l1314t3704r1752b3777],
76	mugwort	NN	O	mugwort	xcomp	33	SENT_114	[p6l1801t3714r2150b3784],

1	(	NN	O	(	nn	4	SENT_115	[p7l10t19r376b94],
2	Artemisia	NN	O	artemisia	nn	4	SENT_115	[p7l10t19r376b94],
3	vulgaris	NN	O	vulgari	nn	4	SENT_115	[p7l407t18r741b96],
4	)	NN	O	)	_	0	SENT_115	[p7l407t18r741b96],
5	,	,	O	,	_	0	SENT_115	[p7l407t18r741b96],
6	Amarcmthus	NNP	O	Amarcmthus	appos	4	SENT_115	[p7l768t18r1221b91],
7	,	,	O	,	_	0	SENT_115	[p7l768t18r1221b91],
8	Pinus	NNP	O	Pinus	nn	9	SENT_115	[p7l1253t20r1452b79],
9	radiata	NNP	O	radiata	appos	4	SENT_115	[p7l1485t18r1758b90],
10	,	,	O	,	_	0	SENT_115	[p7l1485t18r1758b90],
11	sycamore	NN	O	sycamore	appos	4	SENT_115	[p7l1794t37r2145b97],
12	,	,	O	,	_	0	SENT_115	[p7l1794t37r2145b97],
13	cypress	NN	O	cypress	conj_and	11	SENT_115	[p7l8t138r287b198],
14	,	,	O	,	_	0	SENT_115	[p7l8t138r287b198],
15	juniper	NN	O	juniper	conj_and	11	SENT_115	[p7l302t119r571b198],
16	,	,	O	,	_	0	SENT_115	[p7l302t119r571b198],
17	acacia	NN	O	acacia	conj_and	11	SENT_115	[p7l595t119r811b180],
18	and	CC	O	and	_	0	SENT_115	[p7l831t119r954b180],
19	eucalyptus	NN	O	eucalyptus	conj_and	11	SENT_115	[p7l973t119r1343b198],
20	(	CD	NUMBER	(	dep	4	SENT_115	[p7l1367t119r1478b195],
21	all	DT	O	all	advmod	22	SENT_115	[p7l1367t119r1478b195],
22	from	IN	O	from	dep	4	SENT_115	[p7l1498t119r1668b180],
23	ALK	NNP	O	ALK	pobj	22	SENT_115	[p7l1680t119r2145b191],
24	.	.	O	.	_	0	SENT_115	[p7l1680t119r2145b191],

1	—	NN	O	—	_	0	SENT_116	[p7l1680t119r2145b191],
2	.	.	O	.	_	0	SENT_116	[p7l1680t119r2145b191],

1	Abello	NNP	PERSON	Abello	_	0	SENT_117	[p7l1680t119r2145b191],
2	,	,	O	,	_	0	SENT_117	[p7l1680t119r2145b191],
3	Madrid	NNP	LOCATION	Madrid	nn	5	SENT_117	[p7l7t219r291b292],
4	,	,	O	,	_	0	SENT_117	[p7l7t219r291b292],
5	Spain	NNP	LOCATION	Spain	appos	1	SENT_117	[p7l334t219r585b299],
6	)	CD	NUMBER	)	num	5	SENT_117	[p7l334t219r585b299],
7	.	.	O	.	_	0	SENT_117	[p7l334t219r585b299],

1	After	IN	O	after	_	0	SENT_118	[p7l623t219r813b280],
2	15	CD	DURATION	15	num	3	SENT_118	[p7l858t219r933b281],
3	minutes	NNS	NUMBER	minute	prep_after	20	SENT_118	[p7l975t219r1279b292],
4	,	,	O	,	_	0	SENT_118	[p7l975t219r1279b292],
5	a	DT	O	a	det	7	SENT_118	[p7l1322t239r1358b280],
6	wheal	JJ	O	wheal	amod	7	SENT_118	[p7l1395t219r1608b281],
7	size	NN	O	size	nsubjpass	20	SENT_118	[p7l1649t219r1784b280],
8	of	IN	O	of	_	0	SENT_118	[p7l1824t219r1901b280],
9	3	CD	NUMBER	3	num	10	SENT_118	[p7l1936t220r1970b281],
10	mm	NN	O	mm	prep_of	7	SENT_118	[p7l2013t239r2150b280],
11	or	CC	O	or	_	0	SENT_118	[p7l8t340r80b382],
12	greater	JJR	O	greater	conj_or	10	SENT_118	[p7l114t330r357b400],
13	than	IN	O	than	_	0	SENT_118	[p7l390t321r540b382],
14	that	DT	O	that	prep_than	12	SENT_118	[p7l575t321r706b382],
15	of	IN	O	of	_	0	SENT_118	[p7l741t321r817b382],
16	the	DT	O	the	det	18	SENT_118	[p7l846t321r951b382],
17	negative	JJ	O	negative	amod	18	SENT_118	[p7l986t321r1282b400],
18	control	NN	O	control	prep_of	14	SENT_118	[p7l1318t321r1565b382],
19	was	VBD	O	be	auxpass	20	SENT_118	[p7l1600t340r1732b382],
20	considered	VBN	O	consider	_	0	SENT_118	[p7l1770t321r2150b382],
21	positive	JJ	O	positive	acomp	20	SENT_118	[p7l6t422r303b501],
22	,	,	O	,	_	0	SENT_118	[p7l6t422r303b501],
23	and	CC	O	and	_	0	SENT_118	[p7l342t422r466b483],
24	atopy	NN	O	atopy	nsubjpass	26	SENT_118	[p7l500t431r692b501],
25	was	VBD	O	be	auxpass	26	SENT_118	[p7l727t441r859b483],
26	deﬁned	VBN	O	deﬁned	conj_and	20	SENT_118	[p7l896t422r1153b483],
27	as	IN	O	as	_	0	SENT_118	[p7l1187t441r1255b483],
28	a	DT	O	a	det	30	SENT_118	[p7l1292t441r1329b483],
29	positive	JJ	O	positive	amod	30	SENT_118	[p7l1360t422r1638b501],
30	reaction	NN	O	reaction	prep_as	26	SENT_118	[p7l1671t422r1954b483],
31	to	TO	O	to	_	0	SENT_118	[p7l1987t431r2053b483],
32	at	IN	O	at	quantmod	34	SENT_118	[p7l2089t431r2150b483],
33	least	JJS	O	least	mwe	32	SENT_118	[p7l7t522r168b583],
34	1	CD	NUMBER	1	num	35	SENT_118	[p7l193t523r219b583],
35	allergen	NN	O	allergen	prep_to	26	SENT_118	[p7l247t522r542b602],
36	.	.	O	.	_	0	SENT_118	[p7l247t522r542b602],

1	Histamine	NN	O	histamine	nn	2	SENT_119	[p7l566t522r925b583],
2	phosphate	NN	O	phosphate	_	0	SENT_119	[p7l943t522r1298b602],
3	1	CD	NUMBER	1	num	4	SENT_119	[p7l1325t523r1351b583],
4	mg/mL	NN	O	mg/ml	dep	2	SENT_119	[p7l1378t523r1634b602],
5	(	CD	NUMBER	(	num	6	SENT_119	[p7l1653t522r2145b598],
6	ALK	NN	O	alk	dep	4	SENT_119	[p7l1653t522r2145b598],
7	.	.	O	.	_	0	SENT_119	[p7l1653t522r2145b598],

1	—	NN	O	—	_	0	SENT_120	[p7l1653t522r2145b598],
2	.	.	O	.	_	0	SENT_120	[p7l1653t522r2145b598],

1	Abell	NNP	PERSON	Abell	nsubjpass	11	SENT_121	[p7l1653t522r2145b598],
2	(	CD	NUMBER	(	number	3	SENT_121	[p7l1653t522r2145b598],
3	’	CD	NUMBER	’	num	4	SENT_121	[p7l1653t522r2145b598],
4	)	NN	O	)	dep	1	SENT_121	[p7l1653t522r2145b598],
5	,	,	O	,	_	0	SENT_121	[p7l1653t522r2145b598],
6	Madrid	NNP	LOCATION	Madrid	nn	9	SENT_121	[p7l7t624r283b696],
7	,	,	O	,	_	0	SENT_121	[p7l7t624r283b696],
8	Spain	NNP	LOCATION	Spain	appos	9	SENT_121	[p7l320t624r542b703],
9	)	NNP	O	)	appos	1	SENT_121	[p7l320t624r542b703],
10	was	VBD	O	be	auxpass	11	SENT_121	[p7l576t643r708b685],
11	used	VBN	O	use	_	0	SENT_121	[p7l740t624r900b685],
12	as	IN	O	as	_	0	SENT_121	[p7l932t643r999b685],
13	a	DT	O	a	det	15	SENT_121	[p7l1034t643r1070b685],
14	positive	JJ	O	positive	amod	15	SENT_121	[p7l1098t624r1376b703],
15	control	NN	O	control	prep_as	11	SENT_121	[p7l1408t624r1673b696],
16	,	,	O	,	_	0	SENT_121	[p7l1408t624r1673b696],
17	and	CC	O	and	_	0	SENT_121	[p7l1709t624r1832b685],
18	glycerol	NN	O	glycerol	nn	20	SENT_121	[p7l1863t624r2149b703],
19	saline	NN	O	saline	nn	20	SENT_121	[p7l10t725r213b786],
20	solution	NN	O	solution	prep_as	11	SENT_121	[p7l254t725r538b786],
21	as	IN	O	as	_	0	SENT_121	[p7l576t744r644b786],
22	a	DT	O	a	det	24	SENT_121	[p7l685t744r721b786],
23	negative	JJ	O	negative	amod	24	SENT_121	[p7l756t725r1057b804],
24	control	NN	O	control	prep_as	20	SENT_121	[p7l1095t725r1364b786],
25	.	.	O	.	_	0	SENT_121	[p7l1095t725r1364b786],

1	Antihistamines	NNS	O	antihistamine	nsubjpass	3	SENT_122	[p7l1400t725r1939b786],
2	were	VBD	O	be	auxpass	3	SENT_122	[p7l1978t744r2149b786],
3	omitted	VBN	O	omit	_	0	SENT_122	[p7l8t825r275b886],
4	at	IN	DURATION	at	quantmod	6	SENT_122	[p7l301t835r361b886],
5	least	JJS	DURATION	least	mwe	4	SENT_122	[p7l385t825r545b886],
6	96	CD	DURATION	96	num	7	SENT_122	[p7l569t825r652b887],
7	hours	NNS	NUMBER	hour	tmod	3	SENT_122	[p7l677t825r869b886],
8	before	IN	O	before	_	0	SENT_122	[p7l895t825r1118b886],
9	skin	NN	O	skin	nn	10	SENT_122	[p7l1146t825r1288b886],
10	testing	NN	O	testing	prep_before	3	SENT_122	[p7l1312t825r1562b905],
11	.	.	O	.	_	0	SENT_122	[p7l1312t825r1562b905],

1	Sta	FW	O	sta	_	0	SENT_123	[p7l11t1020r139b1086],
2	z	SYM	O	z	dep	3	SENT_123	[p7l146t1017r415b1086],
3	‘	CD	NUMBER	‘	rcmod	1	SENT_123	[p7l146t1017r415b1086],
4	/	:	O	/	prep	1	SENT_123	[p7l146t1017r415b1086],
5	'	''	O	'	_	0	SENT_123	[p7l146t1017r415b1086],
6	5z	JJ	O	5z	amod	7	SENT_123	[p7l146t1017r415b1086],
7	‘	NN	O	‘	dep	4	SENT_123	[p7l146t1017r415b1086],
8	/	:	O	/	punct	9	SENT_123	[p7l146t1017r415b1086],
9	ca	MD	O	can	dep	1	SENT_123	[p7l146t1017r415b1086],
10	/	:	O	/	punct	9	SENT_123	[p7l146t1017r415b1086],
11	A	DT	O	a	det	12	SENT_123	[p7l423t1021r485b1085],
12	na/ys/5	NN	O	na/ys/5	dep	1	SENT_123	[p7l494t1017r760b1106],

1	Statistical	JJ	O	statistical	amod	2	SENT_124	[p7l141t1178r464b1240],
2	analyses	NNS	O	analysis	nsubjpass	10	SENT_124	[p7l481t1179r760b1258],
3	for	IN	O	for	_	0	SENT_124	[p7l777t1178r875b1240],
4	the	DT	O	the	det	5	SENT_124	[p7l888t1179r989b1240],
5	case	NN	O	case	prep_for	2	SENT_124	[p7l1006t1179r1411b1240],
6	—	CD	NUMBER	—	num	8	SENT_124	[p7l1006t1179r1411b1240],
7	control	NN	O	control	nn	8	SENT_124	[p7l1006t1179r1411b1240],
8	study	NN	O	study	dep	5	SENT_124	[p7l1430t1179r1606b1258],
9	were	VBD	O	be	auxpass	10	SENT_124	[p7l1623t1198r1785b1240],
10	performed	VBN	O	perform	_	0	SENT_124	[p7l1799t1178r2150b1258],
11	using	VBG	O	use	xcomp	10	SENT_124	[p7l7t1280r189b1360],
12	SPSS	NNP	ORGANIZATION	SPSS	dobj	11	SENT_124	[p7l208t1280r390b1342],
13	v.	CC	O	v.	prep	12	SENT_124	[p7l410t1281r547b1342],
14	13	CD	NUMBER	13	num	15	SENT_124	[p7l410t1281r547b1342],
15	software	NN	O	software	dep	13	SENT_124	[p7l570t1280r873b1341],
16	.	.	O	.	_	0	SENT_124	[p7l570t1280r873b1341],

1	Demographic	JJ	MISC	demographic	amod	2	SENT_125	[p7l893t1280r1354b1360],
2	characteristics	NNS	O	characteristic	nsubjpass	6	SENT_125	[p7l1372t1280r1849b1341],
3	between	IN	O	between	_	0	SENT_125	[p7l1866t1280r2149b1341],
4	groups	NNS	O	group	prep_between	2	SENT_125	[p7l8t1401r238b1461],
5	were	VBD	O	be	auxpass	6	SENT_125	[p7l268t1400r433b1443],
6	compared	VBN	O	compare	_	0	SENT_125	[p7l461t1381r800b1461],
7	using	VBG	O	use	xcomp	6	SENT_125	[p7l826t1381r1010b1461],
8	the	DT	O	the	det	10	SENT_125	[p7l1038t1381r1141b1443],
9	X2	NN	O	x2	nn	10	SENT_125	[p7l1168t1377r1240b1462],
10	tests	NNS	O	test	nsubj	15	SENT_125	[p7l1267t1390r1416b1443],
11	and	CC	O	and	_	0	SENT_125	[p7l1446t1381r1568b1443],
12	t	NN	O	t	nn	13	SENT_125	[p7l1596t1393r1620b1443],
13	test	NN	O	test	conj_and	10	SENT_125	[p7l1643t1390r1762b1443],
14	as	IN	O	as	advmod	15	SENT_125	[p7l1790t1401r1856b1443],
15	needed	VBN	O	need	ccomp	7	SENT_125	[p7l1884t1381r2144b1443],
16	.	.	O	.	_	0	SENT_125	[p7l1884t1381r2144b1443],

1	The	DT	O	the	det	2	SENT_126	[p7l7t1482r140b1543],
2	Hardy	NNP	O	Hardy	_	0	SENT_126	[p7l175t1482r751b1562],
3	.	.	O	.	_	0	SENT_126	[p7l175t1482r751b1562],

1	—	NN	O	—	_	0	SENT_127	[p7l175t1482r751b1562],
2	.	.	O	.	_	0	SENT_127	[p7l175t1482r751b1562],

1	Weinberg	NNP	PERSON	Weinberg	nn	2	SENT_128	[p7l175t1482r751b1562],
2	equilibrium	NN	O	equilibrium	nsubjpass	4	SENT_128	[p7l787t1482r1190b1562],
3	was	VBD	O	be	auxpass	4	SENT_128	[p7l1223t1502r1354b1544],
4	tested	VBN	O	test	_	0	SENT_128	[p7l1390t1482r1591b1543],
5	in	IN	O	in	_	0	SENT_128	[p7l1624t1482r1690b1543],
6	patients	NNS	O	patient	prep_in	4	SENT_128	[p7l1723t1482r1989b1562],
7	and	CC	O	and	_	0	SENT_128	[p7l2027t1482r2150b1543],
8	controls	NNS	O	control	prep_in	4	SENT_128	[p7l8t1584r292b1645],
9	by	IN	O	by	_	0	SENT_128	[p7l331t1584r418b1664],
10	the	DT	O	the	det	13	SENT_128	[p7l456t1584r562b1645],
11	Markov	NNP	PERSON	Markov	nn	13	SENT_128	[p7l599t1584r880b1645],
12	Chain	NNP	O	Chain	nn	13	SENT_128	[p7l919t1584r1130b1646],
13	method	NN	O	method	agent	4	SENT_128	[p7l1166t1584r1434b1645],
14	using	VBG	O	use	xcomp	4	SENT_128	[p7l1470t1584r1661b1664],
15	ARLEQUIN	NNP	O	ARLEQUIN	nn	17	SENT_128	[p7l1695t1585r2149b1660],
16	software	NN	O	software	nn	17	SENT_128	[p7l10t1685r302b1746],
17	(	NN	O	(	nsubj	18	SENT_128	[p7l326t1685r660b1760],
18	available	JJ	O	available	xcomp	14	SENT_128	[p7l326t1685r660b1760],
19	at	IN	O	at	_	0	SENT_128	[p7l684t1694r743b1746],
20	http://lgb.unige.ch/arlequin/	JJ	O	http://lgb.unige.ch/arlequin/	amod	21	SENT_128	[p7l763t1685r1766b1764],
21	)	NN	O	)	prep_at	18	SENT_128	[p7l763t1685r1766b1764],
22	.	.	O	.	_	0	SENT_128	[p7l763t1685r1766b1764],

1	Allele	NN	O	allele	nn	4	SENT_129	[p7l1788t1685r2000b1746],
2	and	CC	O	and	_	0	SENT_129	[p7l2026t1685r2149b1746],
3	genotype	NN	O	genotype	conj_and	1	SENT_129	[p7l8t1795r320b1865],
4	frequencies	NNS	O	frequency	nsubjpass	13	SENT_129	[p7l338t1785r729b1865],
5	were	VBD	O	be	auxpass	6	SENT_129	[p7l748t1805r913b1847],
6	compared	VBN	O	compare	_	0	SENT_129	[p7l931t1785r1269b1865],
7	using	VBG	O	use	xcomp	6	SENT_129	[p7l1284t1785r1468b1865],
8	the	DT	O	the	det	11	SENT_129	[p7l1486t1785r1589b1846],
9	Fisher	NNP	O	Fisher	nn	11	SENT_129	[p7l1606t1785r1821b1846],
10	exact	JJ	O	exact	amod	11	SENT_129	[p7l1837t1795r2016b1846],
11	test	NN	O	test	dobj	7	SENT_129	[p7l2032t1795r2150b1846],
12	and	CC	O	and	_	0	SENT_129	[p7l9t1887r133b1948],
13	adjusted	VBN	O	adjust	conj_and	6	SENT_129	[p7l157t1887r448b1967],
14	for	IN	O	for	_	0	SENT_129	[p7l471t1887r573b1948],
15	covariates	NNS	O	covariate	prep_for	13	SENT_129	[p7l596t1887r948b1948],
16	by	IN	O	by	_	0	SENT_129	[p7l972t1887r1058b1967],
17	logistic	JJ	O	logistic	amod	18	SENT_129	[p7l1083t1887r1338b1967],
18	regression	NN	O	regression	prep_by	13	SENT_129	[p7l1363t1887r1741b1967],
19	.	.	O	.	_	0	SENT_129	[p7l1363t1887r1741b1967],

1	Parametric	NNP	ORGANIZATION	Parametric	nsubjpass	6	SENT_130	[p7l1769t1887r2147b1948],
2	and	CC	O	and	_	0	SENT_130	[p7l9t1988r133b2049],
3	nonparametric	JJ	O	nonparametric	amod	4	SENT_130	[p7l154t1988r659b2067],
4	tests	NNS	O	test	conj_and	1	SENT_130	[p7l683t1997r835b2049],
5	were	VBD	O	be	auxpass	6	SENT_130	[p7l859t2007r1027b2049],
6	used	VBN	O	use	_	0	SENT_130	[p7l1049t1988r1210b2049],
7	to	TO	O	to	aux	8	SENT_130	[p7l1231t1997r1296b2049],
8	evaluate	VB	O	evaluate	xcomp	6	SENT_130	[p7l1320t1988r1610b2049],
9	the	DT	O	the	det	10	SENT_130	[p7l1632t1988r1737b2049],
10	association	NN	O	association	dobj	8	SENT_130	[p7l1762t1988r2149b2049],
11	between	IN	O	between	_	0	SENT_130	[p7l6t2088r299b2150],
12	the	DT	O	the	det	13	SENT_130	[p7l328t2088r433b2149],
13	genotypes	NNS	O	genotype	prep_between	10	SENT_130	[p7l464t2098r815b2168],
14	and	CC	O	and	_	0	SENT_130	[p7l849t2088r972b2149],
15	total	JJ	O	total	amod	19	SENT_130	[p7l1001t2088r1155b2149],
16	and	CC	O	and	_	0	SENT_130	[p7l1186t2088r1310b2149],
17	speciﬁc	JJ	O	speciﬁc	conj_and	15	SENT_130	[p7l1342t2088r1604b2168],
18	IgE	NN	O	ige	nn	19	SENT_130	[p7l1635t2090r1760b2168],
19	levels	NNS	O	level	conj_and	13	SENT_130	[p7l1789t2088r2009b2149],
20	.	.	O	.	_	0	SENT_130	[p7l1789t2088r2009b2149],

1	All	DT	O	all	det	2	SENT_131	[p7l2038t2088r2149b2149],
2	analyses	NNS	O	analysis	nsubj	4	SENT_131	[p7l9t2190r301b2270],
3	were	VBD	O	be	cop	4	SENT_131	[p7l323t2210r490b2251],
4	ﬁrst	NN	O	ﬁrst	_	0	SENT_131	[p7l511t2190r646b2251],
5	conducted	VBN	O	conduct	partmod	4	SENT_131	[p7l664t2190r1024b2251],
6	under	IN	O	under	_	0	SENT_131	[p7l1042t2190r1242b2251],
7	a	DT	O	a	det	10	SENT_131	[p7l1262t2210r1298b2251],
8	general	JJ	O	general	amod	10	SENT_131	[p7l1316t2190r1572b2270],
9	genotype	NN	O	genotype	nn	10	SENT_131	[p7l1593t2200r1911b2270],
10	model	NN	O	model	prep_under	5	SENT_131	[p7l1931t2190r2149b2251],
11	and	CC	O	and	_	0	SENT_131	[p7l9t2291r131b2352],
12	subsequently	RB	O	subsequently	advmod	5	SENT_131	[p7l151t2291r597b2370],
13	under	IN	O	under	_	0	SENT_131	[p7l614t2291r812b2352],
14	an	DT	O	a	det	18	SENT_131	[p7l830t2310r908b2352],
15	additive	JJ	O	additive	amod	18	SENT_131	[p7l927t2291r1201b2352],
16	or	CC	O	or	_	0	SENT_131	[p7l1220t2310r1291b2352],
17	recessive	JJ	O	recessive	conj_or	15	SENT_131	[p7l1305t2291r1621b2352],
18	model	NN	O	model	conj_and	10	SENT_131	[p7l1638t2291r1853b2352],
19	that	WDT	O	that	nsubj	22	SENT_131	[p7l1871t2291r2000b2352],
20	was	VBD	O	be	cop	22	SENT_131	[p7l2016t2310r2147b2352],
21	most	RBS	O	most	advmod	22	SENT_131	[p7l7t2401r178b2452],
22	compatible	JJ	O	compatible	rcmod	18	SENT_131	[p7l200t2391r588b2471],
23	with	IN	O	with	_	0	SENT_131	[p7l611t2391r766b2453],
24	the	DT	O	the	det	26	SENT_131	[p7l787t2391r892b2452],
25	general	JJ	O	general	amod	26	SENT_131	[p7l917t2391r1172b2471],
26	model	NN	O	model	prep_with	22	SENT_131	[p7l1195t2391r1430b2452],
27	.	.	O	.	_	0	SENT_131	[p7l1195t2391r1430b2452],

1	Considering	VBG	O	consider	ccomp	19	SENT_132	[p7l1458t2391r1885b2471],
2	a	DT	O	a	det	5	SENT_132	[p7l1910t2411r1946b2452],
3	0.3	CD	PERCENT	0.3	number	4	SENT_132	[p7l1968t2392r2145b2453],
4	%	NN	PERCENT	%	amod	5	SENT_132	[p7l1968t2392r2145b2453],
5	frequency	NN	O	frequency	dobj	1	SENT_132	[p7l7t2493r352b2573],
6	of	IN	O	of	_	0	SENT_132	[p7l372t2493r447b2554],
7	AIU	NNP	ORGANIZATION	AIU	prep_of	5	SENT_132	[p7l455t2494r608b2555],
8	and	CC	O	and	_	0	SENT_132	[p7l627t2493r750b2554],
9	including	VBG	O	include	ccomp	19	SENT_132	[p7l767t2493r1093b2573],
10	our	PRP$	O	we	poss	15	SENT_132	[p7l1113t2513r1228b2554],
11	sample	NN	O	sample	nn	15	SENT_132	[p7l1247t2493r1488b2573],
12	size	NN	O	size	nn	15	SENT_132	[p7l1510t2493r1639b2554],
13	(	NN	O	(	nn	15	SENT_132	[p7l1661t2494r1811b2569],
14	110	CD	NUMBER	110	num	15	SENT_132	[p7l1661t2494r1811b2569],
15	patients	NNS	O	patient	dobj	9	SENT_132	[p7l1829t2493r2145b2573],
16	)	RB	O	)	advmod	9	SENT_132	[p7l1829t2493r2145b2573],
17	,	,	O	,	_	0	SENT_132	[p7l1829t2493r2145b2573],
18	we	PRP	O	we	nsubj	19	SENT_132	[p7l7t2613r106b2655],
19	obtained	VBD	O	obtain	_	0	SENT_132	[p7l126t2594r423b2655],
20	a	DT	O	a	det	23	SENT_132	[p7l442t2613r478b2655],
21	79.1	CD	PERCENT	79.1	number	22	SENT_132	[p7l496t2594r714b2656],
22	%	NN	PERCENT	%	amod	23	SENT_132	[p7l496t2594r714b2656],
23	power	NN	O	power	dobj	19	SENT_132	[p7l735t2613r954b2673],
24	to	TO	O	to	aux	25	SENT_132	[p7l970t2603r1034b2655],
25	detect	VB	O	detect	xcomp	19	SENT_132	[p7l1055t2594r1260b2655],
26	a	DT	O	a	det	29	SENT_132	[p7l1279t2613r1315b2655],
27	genetic	JJ	O	genetic	amod	29	SENT_132	[p7l1332t2594r1579b2673],
28	odds	NNS	O	odds	nn	29	SENT_132	[p7l1599t2594r1759b2655],
29	ratio	NN	O	ratio	dobj	25	SENT_132	[p7l1778t2594r1935b2655],
30	of	IN	O	of	_	0	SENT_132	[p7l1955t2594r2030b2655],
31	1.9	CD	NUMBER	1.9	prep_of	29	SENT_132	[p7l2051t2594r2147b2656],
32	with	IN	O	with	_	0	SENT_132	[p7l7t2695r162b2757],
33	a	DT	O	a	det	40	SENT_132	[p7l185t2715r221b2757],
34	95	CD	PERCENT	95	number	35	SENT_132	[p7l243t2695r397b2758],
35	%	NN	PERCENT	%	amod	40	SENT_132	[p7l243t2695r397b2758],
36	conﬁdence	NN	O	conﬁdence	nn	40	SENT_132	[p7l423t2695r801b2757],
37	interval	NN	O	interval	nn	40	SENT_132	[p7l823t2695r1090b2757],
38	(	CD	NUMBER	(	num	40	SENT_132	[p7l1115t2696r1253b2771],
39	CI	NN	O	ci	nn	40	SENT_132	[p7l1115t2696r1253b2771],
40	)	NN	O	)	prep_with	25	SENT_132	[p7l1115t2696r1253b2771],
41	at	IN	O	at	_	0	SENT_132	[p7l1280t2705r1340b2757],
42	an	DT	O	a	det	44	SENT_132	[p7l1362t2715r1442b2757],
43	oc	NN	O	oc	nn	44	SENT_132	[p7l1465t2711r1517b2758],
44	level	NN	O	level	prep_at	40	SENT_132	[p7l1538t2695r1706b2757],
45	of	IN	O	of	_	0	SENT_132	[p7l1730t2695r1805b2757],
46	.05	CD	NUMBER	.05	prep_of	44	SENT_132	[p7l1826t2695r1925b2757],
47	under	IN	O	under	_	0	SENT_132	[p7l1950t2695r2150b2757],
48	an	DT	O	a	det	50	SENT_132	[p7l9t2817r88b2858],
49	additive	JJ	O	additive	amod	50	SENT_132	[p7l114t2797r393b2858],
50	model	NN	O	model	prep_under	25	SENT_132	[p7l418t2797r654b2858],
51	.	.	O	.	_	0	SENT_132	[p7l418t2797r654b2858],

1	The	DT	O	the	det	3	SENT_133	[p7l682t2797r816b2858],
2	signiﬁcance	NN	O	signiﬁcance	nn	3	SENT_133	[p7l843t2797r1259b2877],
3	level	NN	O	level	nsubjpass	5	SENT_133	[p7l1284t2797r1453b2858],
4	was	VBD	O	be	auxpass	5	SENT_133	[p7l1477t2817r1610b2858],
5	set	VBN	O	set	_	0	SENT_133	[p7l1639t2806r1733b2858],
6	at	IN	O	at	_	0	SENT_133	[p7l1758t2806r1819b2858],
7	P	NN	O	p	prep_at	5	SENT_133	[p7l1840t2797r2070b2859],
8	<	VBG	O	<	xcomp	5	SENT_133	[p7l1840t2797r2070b2859],
9	.05	CD	NUMBER	.05	dobj	8	SENT_133	[p7l1840t2797r2070b2859],
10	.	.	O	.	_	0	SENT_133	[p7l1840t2797r2070b2859],

1	Results	NNS	O	result	_	0	SENT_134	[p7l16t3044r373b3133],

1	The	DT	O	the	det	3	SENT_135	[p7l139t3274r277b3335],
2	clinical	JJ	O	clinical	amod	3	SENT_135	[p7l319t3274r590b3335],
3	characteristics	NNS	O	characteristic	nsubjpass	9	SENT_135	[p7l631t3274r1162b3335],
4	of	IN	O	of	_	0	SENT_135	[p7l1205t3274r1283b3335],
5	patients	NNS	O	patient	prep_of	3	SENT_135	[p7l1316t3274r1602b3353],
6	with	IN	O	with	_	0	SENT_135	[p7l1645t3274r1806b3335],
7	AIU	NNP	ORGANIZATION	AIU	prep_with	5	SENT_135	[p7l1841t3274r1999b3335],
8	are	VBP	O	be	auxpass	9	SENT_135	[p7l2041t3293r2149b3335],
9	shown	VBN	O	show	_	0	SENT_135	[p7l10t3374r235b3436],
10	in	IN	O	in	_	0	SENT_135	[p7l267t3374r334b3435],
11	Table	NNP	O	Table	prep_in	9	SENT_135	[p7l365t3374r556b3435],
12	1	CD	NUMBER	1	num	11	SENT_135	[p7l598t3375r649b3435],
13	.	.	O	.	_	0	SENT_135	[p7l598t3375r649b3435],

1	Mean	NN	O	mean	nn	3	SENT_136	[p7l685t3376r885b3435],
2	(	CD	NUMBER	(	num	3	SENT_136	[p7l920t3375r1083b3450],
3	SD	NN	O	sd	nsubj	8	SENT_136	[p7l920t3375r1083b3450],
4	)	CD	NUMBER	)	num	5	SENT_136	[p7l920t3375r1083b3450],
5	age	NN	O	age	dep	3	SENT_136	[p7l1121t3394r1238b3454],
6	was	VBD	O	be	cop	8	SENT_136	[p7l1272t3394r1404b3436],
7	31.4	CD	NUMBER	31.4	number	8	SENT_136	[p7l1441t3375r1590b3436],
8	(	CD	NUMBER	(	dep	22	SENT_136	[p7l1626t3375r1831b3450],
9	12.1	CD	NUMBER	12.1	number	10	SENT_136	[p7l1626t3375r1831b3450],
10	)	CD	NUMBER	)	num	11	SENT_136	[p7l1626t3375r1831b3450],
11	years	NNS	NUMBER	year	npadvmod	8	SENT_136	[p7l1866t3394r2048b3454],
12	in	IN	O	in	_	0	SENT_136	[p7l2083t3374r2149b3435],
13	patients	NNS	O	patient	prep_in	8	SENT_136	[p7l6t3476r286b3556],
14	and	CC	O	and	_	0	SENT_136	[p7l328t3476r454b3537],
15	34.9	CD	NUMBER	34.9	num	16	SENT_136	[p7l495t3476r645b3538],
16	(	NN	O	(	dep	22	SENT_136	[p7l688t3477r900b3552],
17	10.1	CD	NUMBER	10.1	number	18	SENT_136	[p7l688t3477r900b3552],
18	)	CD	NUMBER	)	num	19	SENT_136	[p7l688t3477r900b3552],
19	years	NNS	NUMBER	year	tmod	16	SENT_136	[p7l941t3496r1128b3556],
20	in	IN	O	in	_	0	SENT_136	[p7l1168t3476r1236b3536],
21	controls	NNS	O	control	prep_in	8	SENT_136	[p7l1274t3476r1562b3537],
22	(	VBP	O	(	_	0	SENT_136	[p7l1605t3476r1899b3552],
23	P	NN	O	p	nsubj	24	SENT_136	[p7l1605t3476r1899b3552],
24	=	JJ	O	=	xcomp	22	SENT_136	[p7l1605t3476r1899b3552],
25	.05	CD	NUMBER	.05	num	26	SENT_136	[p7l1605t3476r1899b3552],
26	)	NN	O	)	nsubj	22	SENT_136	[p7l1605t3476r1899b3552],
27	.	.	O	.	_	0	SENT_136	[p7l1605t3476r1899b3552],

1	There	EX	O	there	expl	2	SENT_137	[p7l1940t3476r2148b3537],
2	were	VBD	O	be	_	0	SENT_137	[p7l7t3596r175b3638],
3	more	JJR	O	more	amod	4	SENT_137	[p7l210t3596r388b3638],
4	females	NNS	O	female	nsubj	2	SENT_137	[p7l423t3577r693b3638],
5	in	IN	O	in	_	0	SENT_137	[p7l729t3577r796b3637],
6	the	DT	O	the	det	8	SENT_137	[p7l829t3577r934b3638],
7	patient	NN	O	patient	nn	8	SENT_137	[p7l968t3577r1208b3656],
8	group	NN	O	group	prep_in	4	SENT_137	[p7l1242t3596r1443b3656],
9	than	IN	O	than	dep	16	SENT_137	[p7l1478t3577r1628b3638],
10	in	IN	O	in	_	0	SENT_137	[p7l1662t3577r1728b3637],
11	the	DT	O	the	det	13	SENT_137	[p7l1762t3577r1867b3638],
12	control	NN	O	control	nn	13	SENT_137	[p7l1902t3577r2149b3638],
13	group	NN	O	group	prep_in	9	SENT_137	[p7l8t3697r227b3757],
14	(	CD	PERCENT	(	number	15	SENT_137	[p7l275t3677r545b3753],
15	55.7	CD	PERCENT	55.7	num	16	SENT_137	[p7l275t3677r545b3753],
16	%	NN	PERCENT	%	dep	8	SENT_137	[p7l275t3677r545b3753],
17	vs	CC	O	vs	_	0	SENT_137	[p7l593t3697r671b3738],
18	44.3	CD	PERCENT	44.3	num	19	SENT_137	[p7l717t3678r983b3750],
19	%	NN	PERCENT	%	conj_vs	4	SENT_137	[p7l717t3678r983b3750],
20	,	,	O	,	_	0	SENT_137	[p7l717t3678r983b3750],
21	P	NN	O	p	appos	19	SENT_137	[p7l1029t3678r1413b3753],
22	=	JJ	O	=	amod	21	SENT_137	[p7l1029t3678r1413b3753],
23	.	.	O	.	_	0	SENT_137	[p7l1029t3678r1413b3753],

1	oool	NN	O	oool	nn	2	SENT_138	[p7l1029t3678r1413b3753],
2	)	NN	O	)	nsubjpass	10	SENT_138	[p7l1029t3678r1413b3753],
3	,	,	O	,	_	0	SENT_138	[p7l1029t3678r1413b3753],
4	and	CC	O	and	_	0	SENT_138	[p7l1462t3677r1595b3738],
5	consequently	RB	O	consequently	advmod	2	SENT_138	[p7l1639t3677r2148b3757],
6	all	PDT	O	all	predet	8	SENT_138	[p8l9t18r97b79],
7	the	DT	O	the	det	8	SENT_138	[p8l136t18r245b79],
8	analyses	NNS	O	analysis	conj_and	2	SENT_138	[p8l287t18r593b98],
9	were	VBD	O	be	auxpass	10	SENT_138	[p8l635t38r809b79],
10	adjusted	VBN	O	adjust	_	0	SENT_138	[p8l851t18r1155b98],
11	for	IN	O	for	_	0	SENT_138	[p8l1194t18r1300b79],
12	these	DT	O	these	det	13	SENT_138	[p8l1338t18r1524b79],
13	covariates	NNS	O	covariate	prep_for	10	SENT_138	[p8l1565t18r1956b79],
14	.	.	O	.	_	0	SENT_138	[p8l1565t18r1956b79],

1	One	CD	NUMBER	one	num	2	SENT_139	[p8l2001t18r2148b80],
2	hundred	CD	NUMBER	hundred	dep	11	SENT_139	[p8l7t119r294b180],
3	ninety	CD	NUMBER	ninety	number	4	SENT_139	[p8l323t119r697b198],
4	—	CD	NUMBER	—	dep	2	SENT_139	[p8l323t119r697b198],
5	one	CD	NUMBER	one	num	6	SENT_139	[p8l323t119r697b198],
6	patients	NNS	O	patient	dep	4	SENT_139	[p8l726t119r997b198],
7	(	IN	O	(	_	0	SENT_139	[p8l1031t119r1310b195],
8	91.8	CD	PERCENT	91.8	num	9	SENT_139	[p8l1031t119r1310b195],
9	%	NN	PERCENT	%	prep_(	4	SENT_139	[p8l1031t119r1310b195],
10	)	CD	NUMBER	)	nsubj	11	SENT_139	[p8l1031t119r1310b195],
11	had	VBD	O	have	_	0	SENT_139	[p8l1342t119r1468b180],
12	a	DT	O	a	det	13	SENT_139	[p8l1499t138r1535b180],
13	history	NN	O	history	dobj	11	SENT_139	[p8l1563t119r1805b198],
14	of	IN	O	of	_	0	SENT_139	[p8l1836t119r1912b180],
15	atopic	JJ	O	atopic	amod	16	SENT_139	[p8l1938t119r2147b198],
16	diseases	NNS	O	disease	prep_of	13	SENT_139	[p8l8t219r312b292],
17	,	,	O	,	_	0	SENT_139	[p8l8t219r312b292],
18	and	CC	O	and	_	0	SENT_139	[p8l352t219r475b280],
19	most	JJS	O	most	amod	20	SENT_139	[p8l509t229r679b280],
20	patients	NNS	O	patient	nsubj	21	SENT_139	[p8l711t219r982b299],
21	had	VBD	O	have	conj_and	11	SENT_139	[p8l1017t219r1144b280],
22	positive	JJ	O	positive	amod	24	SENT_139	[p8l1176t219r1454b299],
23	skin	NN	O	skin	nn	24	SENT_139	[p8l1491t219r1633b280],
24	test	NN	O	test	dobj	21	SENT_139	[p8l1666t229r1788b280],
25	results	VBZ	O	result	rcmod	24	SENT_139	[p8l1820t219r2046b280],
26	to	TO	O	to	_	0	SENT_139	[p8l2083t229r2148b280],
27	aeroallergens	NNS	O	aeroallergen	prep_to	25	SENT_139	[p8l9t321r508b401],
28	.	.	O	.	_	0	SENT_139	[p8l9t321r508b401],

1	The	DT	O	the	det	3	SENT_140	[p8l549t321r686b382],
2	clinical	JJ	O	clinical	amod	3	SENT_140	[p8l726t321r992b382],
3	patterns	NNS	O	pattern	nsubjpass	8	SENT_140	[p8l1029t330r1314b401],
4	of	IN	O	of	_	0	SENT_140	[p8l1355t321r1433b382],
5	the	DT	O	the	det	6	SENT_140	[p8l1465t321r1572b382],
6	reactions	NNS	O	reaction	prep_of	3	SENT_140	[p8l1610t321r1936b382],
7	were	VBD	O	be	auxpass	8	SENT_140	[p8l1976t341r2148b383],
8	mixed	VBN	O	mix	_	0	SENT_140	[p8l7t422r226b483],
9	in	IN	O	in	_	0	SENT_140	[p8l256t422r323b482],
10	64	CD	NUMBER	64	num	11	SENT_140	[p8l356t422r439b483],
11	patients	NNS	O	patient	prep_in	8	SENT_140	[p8l470t422r741b501],
12	(	IN	O	(	_	0	SENT_140	[p8l777t421r1056b498],
13	58.2	CD	PERCENT	58.2	num	14	SENT_140	[p8l777t421r1056b498],
14	%	NN	PERCENT	%	prep_(	8	SENT_140	[p8l777t421r1056b498],
15	)	CD	NUMBER	)	dep	14	SENT_140	[p8l777t421r1056b498],
16	and	CC	O	and	_	0	SENT_140	[p8l1092t422r1215b483],
17	cutaneous	JJ	O	cutaneous	amod	22	SENT_140	[p8l1247t431r1595b483],
18	in	IN	O	in	_	0	SENT_140	[p8l1628t422r1694b482],
19	46	CD	PERCENT	46	prep_in	17	SENT_140	[p8l1725t422r1810b483],
20	(	CD	PERCENT	(	number	21	SENT_140	[p8l1845t422r2144b498],
21	41.8	CD	PERCENT	41.8	num	22	SENT_140	[p8l1845t422r2144b498],
22	%	NN	PERCENT	%	conj_and	14	SENT_140	[p8l1845t422r2144b498],
23	)	CD	NUMBER	)	dep	22	SENT_140	[p8l1845t422r2144b498],
24	.	.	O	.	_	0	SENT_140	[p8l1845t422r2144b498],

1	Fifty	CD	NUMBER	fifty	num	2	SENT_141	[p8l7t522r176b602],
2	patients	NNS	O	patient	nsubj	21	SENT_141	[p8l196t522r467b602],
3	(	IN	O	(	_	0	SENT_141	[p8l492t522r771b598],
4	45.5	CD	PERCENT	45.5	num	5	SENT_141	[p8l492t522r771b598],
5	%	NN	PERCENT	%	prep_(	8	SENT_141	[p8l492t522r771b598],
6	)	CD	NUMBER	)	nsubjpass	8	SENT_141	[p8l492t522r771b598],
7	were	VBD	O	be	auxpass	8	SENT_141	[p8l795t542r963b584],
8	classiﬁed	VBN	O	classiﬁed	rcmod	2	SENT_141	[p8l985t522r1310b583],
9	as	RB	O	as	prep	8	SENT_141	[p8l1332t542r1400b583],
10	high	JJ	O	high	amod	13	SENT_141	[p8l1422t522r1741b602],
11	—	NN	O	—	nn	13	SENT_141	[p8l1422t522r1741b602],
12	risk	NN	O	risk	nn	13	SENT_141	[p8l1422t522r1741b602],
13	individuals	NNS	O	individual	nsubj	14	SENT_141	[p8l1759t522r2146b584],
14	reacting	VBG	O	react	dep	9	SENT_141	[p8l6t624r290b704],
15	to	TO	O	to	_	0	SENT_141	[p8l328t633r393b685],
16	weak	JJ	O	weak	amod	18	SENT_141	[p8l431t624r617b685],
17	COX-1	NN	O	cox-1	nn	18	SENT_141	[p8l653t624r903b686],
18	inhibitors	NNS	O	inhibitor	prep_to	14	SENT_141	[p8l946t624r1283b685],
19	and	CC	O	and	_	0	SENT_141	[p8l1323t624r1448b685],
20	5	CD	NUMBER	5	conj_and	18	SENT_141	[p8l1485t624r1521b686],
21	had	VBD	O	have	_	0	SENT_141	[p8l1560t624r1688b685],
22	a	DT	O	a	det	23	SENT_141	[p8l1725t644r1761b685],
23	history	NN	O	history	dobj	21	SENT_141	[p8l1795t624r2040b704],
24	of	IN	O	of	_	0	SENT_141	[p8l2078t624r2154b685],
25	anaphylaxis	NN	O	anaphylaxi	prep_of	23	SENT_141	[p8l9t725r450b804],
26	triggered	VBN	O	trigger	partmod	25	SENT_141	[p8l493t725r830b804],
27	by	IN	O	by	_	0	SENT_141	[p8l870t725r958b804],
28	mite	JJ	O	mite	amod	29	SENT_141	[p8l999t725r1701b786],
29	—	NN	O	—	agent	26	SENT_141	[p8l999t725r1701b786],
30	contaminated	VBN	O	contaminate	partmod	29	SENT_141	[p8l999t725r1701b786],
31	foods	NNS	O	food	dobj	30	SENT_141	[p8l1742t725r1965b786],
32	.	.	O	.	_	0	SENT_141	[p8l1742t725r1965b786],

1	The	DT	O	the	det	3	SENT_142	[p8l2009t725r2149b786],
2	medical	JJ	O	medical	amod	3	SENT_142	[p8l7t825r279b886],
3	history	NN	O	history	nsubj	4	SENT_142	[p8l296t825r534b905],
4	revealed	VBD	O	reveal	_	0	SENT_142	[p8l551t825r844b887],
5	that	IN	O	that	complm	9	SENT_142	[p8l861t825r990b886],
6	several	JJ	O	several	amod	7	SENT_142	[p8l1009t825r1248b886],
7	NSAIDS	NNS	MISC	nsaid	nsubjpass	9	SENT_142	[p8l1265t826r1562b887],
8	were	VBD	O	be	auxpass	9	SENT_142	[p8l1581t845r1748b887],
9	involved	VBN	O	involve	ccomp	4	SENT_142	[p8l1765t825r2067b887],
10	in	IN	O	in	_	0	SENT_142	[p8l2084t825r2149b886],
11	the	DT	O	the	det	13	SENT_142	[p8l7t927r111b988],
12	urticaria/angioedema	NN	O	urticaria/angioedema	nn	13	SENT_142	[p8l128t927r862b1007],
13	reactions	NNS	O	reaction	prep_in	9	SENT_142	[p8l877t927r1208b999],
14	,	,	O	,	_	0	SENT_142	[p8l877t927r1208b999],
15	the	DT	O	the	det	18	SENT_142	[p8l1228t927r1332b988],
16	most	RBS	O	most	advmod	18	SENT_142	[p8l1351t936r1519b988],
17	common	JJ	O	common	amod	18	SENT_142	[p8l1537t947r1839b988],
18	inducers	NNS	O	inducer	appos	13	SENT_142	[p8l1857t927r2147b988],
19	being	VBG	O	be	cop	20	SENT_142	[p8l6t1028r196b1107],
20	ibuprofen	NN	O	ibuprofen	xcomp	9	SENT_142	[p8l214t1028r548b1107],
21	(	CD	PERCENT	(	number	22	SENT_142	[p8l568t1028r862b1104],
22	70.9	CD	PERCENT	70.9	num	23	SENT_142	[p8l568t1028r862b1104],
23	%	NN	PERCENT	%	dep	20	SENT_142	[p8l568t1028r862b1104],
24	)	CD	NUMBER	)	dep	20	SENT_142	[p8l568t1028r862b1104],
25	,	,	O	,	_	0	SENT_142	[p8l568t1028r862b1104],
26	aspirin	NN	O	aspirin	conj_and	20	SENT_142	[p8l884t1028r1115b1107],
27	(	CD	PERCENT	(	number	28	SENT_142	[p8l1135t1028r1429b1104],
28	67.3	CD	PERCENT	67.3	num	29	SENT_142	[p8l1135t1028r1429b1104],
29	%	NN	PERCENT	%	dep	26	SENT_142	[p8l1135t1028r1429b1104],
30	)	CD	NUMBER	)	dep	26	SENT_142	[p8l1135t1028r1429b1104],
31	,	,	O	,	_	0	SENT_142	[p8l1135t1028r1429b1104],
32	pyrazolone	NN	O	pyrazolone	conj_and	20	SENT_142	[p8l1449t1028r1831b1107],
33	(	CD	PERCENT	(	number	34	SENT_142	[p8l1851t1028r2145b1104],
34	44.5	CD	PERCENT	44.5	num	35	SENT_142	[p8l1851t1028r2145b1104],
35	%	NN	PERCENT	%	dep	32	SENT_142	[p8l1851t1028r2145b1104],
36	)	CD	NUMBER	)	dep	32	SENT_142	[p8l1851t1028r2145b1104],
37	,	,	O	,	_	0	SENT_142	[p8l1851t1028r2145b1104],
38	paracetamol	NNP	O	paracetamol	conj_and	20	SENT_142	[p8l6t1128r428b1208],
39	(	CD	PERCENT	(	number	40	SENT_142	[p8l448t1128r743b1204],
40	33.6	CD	PERCENT	33.6	num	41	SENT_142	[p8l448t1128r743b1204],
41	%	NN	PERCENT	%	dep	38	SENT_142	[p8l448t1128r743b1204],
42	)	CD	NUMBER	)	dep	38	SENT_142	[p8l448t1128r743b1204],
43	,	,	O	,	_	0	SENT_142	[p8l448t1128r743b1204],
44	diclofenac	NN	O	diclofenac	xcomp	9	SENT_142	[p8l765t1128r1121b1189],
45	(	CD	PERCENT	(	number	46	SENT_142	[p8l1142t1129r1437b1204],
46	30.9	CD	PERCENT	30.9	num	47	SENT_142	[p8l1142t1129r1437b1204],
47	%	NN	PERCENT	%	dep	44	SENT_142	[p8l1142t1129r1437b1204],
48	)	CD	NUMBER	)	dep	44	SENT_142	[p8l1142t1129r1437b1204],
49	,	,	O	,	_	0	SENT_142	[p8l1142t1129r1437b1204],
50	ketoprofen	NN	O	ketoprofen	xcomp	9	SENT_142	[p8l1457t1128r1831b1208],
51	(	CD	PERCENT	(	number	52	SENT_142	[p8l1851t1129r2145b1204],
52	20.9	CD	PERCENT	20.9	num	53	SENT_142	[p8l1851t1129r2145b1204],
53	%	NN	PERCENT	%	dep	50	SENT_142	[p8l1851t1129r2145b1204],
54	)	CD	NUMBER	)	dep	50	SENT_142	[p8l1851t1129r2145b1204],
55	,	,	O	,	_	0	SENT_142	[p8l1851t1129r2145b1204],
56	and	CC	O	and	_	0	SENT_142	[p8l9t1231r133b1293],
57	nimesulide	JJ	O	nimesulide	amod	58	SENT_142	[p8l156t1231r541b1293],
58	(	NN	O	(	xcomp	9	SENT_142	[p8l568t1231r867b1307],
59	13.6	CD	PERCENT	13.6	num	60	SENT_142	[p8l568t1231r867b1307],
60	%	NN	PERCENT	%	dep	58	SENT_142	[p8l568t1231r867b1307],
61	)	CD	NUMBER	)	dep	58	SENT_142	[p8l568t1231r867b1307],
62	.	.	O	.	_	0	SENT_142	[p8l568t1231r867b1307],

1	Genotype	NN	O	genotype	nn	2	SENT_143	[p8l140t1332r502b1411],
2	distribution	NN	O	distribution	nsubj	5	SENT_143	[p8l546t1332r987b1393],
3	did	VBD	O	do	aux	5	SENT_143	[p8l1030t1332r1147b1393],
4	not	RB	O	not	neg	5	SENT_143	[p8l1188t1341r1307b1393],
5	deviate	VB	O	deviate	_	0	SENT_143	[p8l1349t1332r1620b1393],
6	from	IN	O	from	_	0	SENT_143	[p8l1663t1332r1844b1393],
7	HardyWeinberg	NNP	O	HardyWeinberg	nn	8	SENT_143	[p8l1885t1332r2146b1411, p8l6t1432r342b1512],
8	expectancy	NN	O	expectancy	prep_from	5	SENT_143	[p8l374t1442r767b1512],
9	among	IN	O	among	_	0	SENT_143	[p8l799t1452r1033b1512],
10	patients	NNS	O	patient	prep_among	5	SENT_143	[p8l1063t1432r1333b1512],
11	or	CC	O	or	_	0	SENT_143	[p8l1366t1452r1437b1493],
12	controls	NNS	O	control	conj_or	10	SENT_143	[p8l1466t1432r1764b1493],
13	.	.	O	.	_	0	SENT_143	[p8l1466t1432r1764b1493],

1	The	DT	O	the	det	2	SENT_144	[p8l1796t1432r1930b1493],
2	allele	NN	O	allele	_	0	SENT_144	[p8l1962t1432r2149b1493],

1	©	RB	O	©	dep	2	SENT_145	[p8l1368t1679r1419b1731],
2	2009	CD	DATE	2009	dep	4	SENT_145	[p8l1443t1679r1586b1731],
3	Esmon	NNP	O	Esmon	nn	4	SENT_145	[p8l1608t1680r1813b1730],
4	Publicidad	NNP	O	Publicidad	_	0	SENT_145	[p8l1833t1679r2150b1730],

1	The	DT	O	the	det	3	SENT_146	[p8l745t1806r803b1832],
2	A	NN	O	a	nn	3	SENT_146	[p8l811t1806r937b1832],
3	—	NN	O	—	_	0	SENT_146	[p8l811t1806r937b1832],
4	444C	CD	NUMBER	444c	num	5	SENT_146	[p8l811t1806r937b1832],
5	SNP	NN	O	snp	dep	3	SENT_146	[p8l949t1806r1016b1832],
6	and	CC	O	and	_	0	SENT_146	[p8l1025t1806r1078b1832],
7	Aspirin-Induced	JJ	O	aspirin-induced	amod	8	SENT_146	[p8l1086t1806r1331b1840],
8	Urticaria	NN	O	urticarium	dep	3	SENT_146	[p8l1341t1806r1474b1832],
9	378	CD	NUMBER	378	dep	3	SENT_146	[p8l2041t1807r2100b1835],

1	Table	NNP	O	Table	_	0	SENT_147	[p8l9t2012r157b2071],
2	1	CD	NUMBER	1	dep	1	SENT_147	[p8l184t2015r229b2071],
3	.	.	O	.	_	0	SENT_147	[p8l184t2015r229b2071],

1	Clinical	JJ	O	clinical	amod	2	SENT_148	[p8l256t2012r449b2071],
2	Characteristics	NNS	O	characteristic	_	0	SENT_148	[p8l476t2012r873b2071],
3	of	IN	O	of	_	0	SENT_148	[p8l898t2011r952b2071],
4	the	DT	O	the	det	5	SENT_148	[p8l969t2012r1055b2071],
5	Patients	NNS	O	patient	prep_of	2	SENT_148	[p8l1082t2014r1294b2071],

1	Age	NNP	O	Age	_	0	SENT_149	[p8l9t2196r151b2266],
2	,	,	O	,	_	0	SENT_149	[p8l9t2196r151b2266],
3	y	NN	O	y	appos	1	SENT_149	[p8l175t2213r223b2266],
4	,	,	O	,	_	0	SENT_149	[p8l175t2213r223b2266],
5	mean	VB	O	mean	ccomp	57	SENT_149	[p8l247t2213r411b2250],
6	(	JJ	O	(	amod	8	SENT_149	[p8l435t2196r596b2262],
7	SD	NN	O	sd	nn	8	SENT_149	[p8l435t2196r596b2262],
8	)	NN	O	)	dobj	5	SENT_149	[p8l435t2196r596b2262],
9	,	,	O	,	_	0	SENT_149	[p8l435t2196r596b2262],
10	range	NN	O	range	dep	27	SENT_149	[p8l619t2213r788b2266],
11	31.4	CD	NUMBER	31.4	num	10	SENT_149	[p8l1356t2196r1485b2250],
12	(	CD	NUMBER	(	number	13	SENT_149	[p8l1509t2195r1883b2262],
13	12.1	CD	NUMBER	12.1	num	14	SENT_149	[p8l1509t2195r1883b2262],
14	)	NN	O	)	dep	10	SENT_149	[p8l1509t2195r1883b2262],
15	,11	CD	NUMBER	,11	num	18	SENT_149	[p8l1509t2195r1883b2262],
16	—	CD	NUMBER	—	num	18	SENT_149	[p8l1509t2195r1883b2262],
17	55	CD	NUMBER	55	num	18	SENT_149	[p8l1509t2195r1883b2262],
18	Females	NNS	O	female	dep	14	SENT_149	[p8l9t2279r279b2342],
19	,	,	O	,	_	0	SENT_149	[p8l9t2279r279b2342],
20	n	NN	O	n	appos	14	SENT_149	[p8l303t2296r340b2331],
21	(	CD	PERCENT	(	num	22	SENT_149	[p8l363t2279r472b2344],
22	%	NN	PERCENT	%	dep	20	SENT_149	[p8l363t2279r472b2344],
23	)	CD	NUMBER	)	number	24	SENT_149	[p8l363t2279r472b2344],
24	78	CD	NUMBER	78	num	22	SENT_149	[p8l1471t2279r1542b2332],
25	(	NN	O	(	dep	27	SENT_149	[p8l1569t2279r1770b2344],
26	70.9	CD	NUMBER	70.9	num	25	SENT_149	[p8l1569t2279r1770b2344],
27	)	NN	O	)	dep	35	SENT_149	[p8l1569t2279r1770b2344],
28	''	''	O	''	_	0	SENT_149	[p8l1569t2279r1770b2344],
29	‘‘	CD	NUMBER	‘‘	num	31	SENT_149	[p8l1569t2279r1770b2344],
30	Atopic	JJ	O	atopic	amod	31	SENT_149	[p8l9t2362r215b2432],
31	diseases	NNS	O	disease	dep	27	SENT_149	[p8l238t2362r485b2416],
32	101	CD	NUMBER	101	number	33	SENT_149	[p8l1468t2363r1567b2417],
33	(	CD	NUMBER	(	dep	31	SENT_149	[p8l1598t2363r1777b2429],
34	91.8	CD	NUMBER	91.8	num	35	SENT_149	[p8l1598t2363r1777b2429],
35	)	NN	O	)	dep	36	SENT_149	[p8l1598t2363r1777b2429],
36	Rhinitis	NN	O	rhinitis	dep	39	SENT_149	[p8l9t2446r249b2499],
37	96	CD	NUMBER	96	num	36	SENT_149	[p8l1481t2446r1554b2500],
38	(	CD	NUMBER	(	number	39	SENT_149	[p8l1579t2446r1757b2511],
39	87.3	CD	NUMBER	87.3	dep	57	SENT_149	[p8l1579t2446r1757b2511],
40	)	CD	NUMBER	)	num	41	SENT_149	[p8l1579t2446r1757b2511],
41	Rhinitis	NN	O	rhinitis	dep	39	SENT_149	[p8l9t2529r249b2582],
42	and	CC	O	and	_	0	SENT_149	[p8l273t2529r381b2582],
43	asthma	NN	O	asthma	nn	45	SENT_149	[p8l403t2529r618b2582],
44	23	CD	NUMBER	23	num	45	SENT_149	[p8l1481t2529r1551b2582],
45	(	NN	O	(	conj_and	39	SENT_149	[p8l1579t2529r1757b2594],
46	20.9	CD	NUMBER	20.9	number	47	SENT_149	[p8l1579t2529r1757b2594],
47	)	CD	NUMBER	)	dep	45	SENT_149	[p8l1579t2529r1757b2594],
48	Only	JJ	O	only	amod	56	SENT_149	[p8l11t2612r160b2682],
49	asthma	NN	O	asthma	nn	56	SENT_149	[p8l183t2612r398b2666],
50	2	CD	NUMBER	2	num	56	SENT_149	[p8l1520t2613r1554b2666],
51	(	CD	NUMBER	(	num	56	SENT_149	[p8l1579t2613r1719b2679],
52	1.8	CD	NUMBER	1.8	num	56	SENT_149	[p8l1579t2613r1719b2679],
53	)	CD	NUMBER	)	num	56	SENT_149	[p8l1579t2613r1719b2679],
54	Positive	JJ	O	positive	amod	56	SENT_149	[p8l9t2697r254b2751],
55	skin	NN	O	skin	nn	56	SENT_149	[p8l278t2697r402b2751],
56	test	NN	O	test	nsubj	57	SENT_149	[p8l423t2705r529b2751],
57	results	VBZ	O	result	rcmod	1	SENT_149	[p8l548t2697r745b2751],
58	to	TO	O	to	aux	59	SENT_149	[p8l768t2705r825b2751],
59	inhaled	VBN	O	inhale	xcomp	57	SENT_149	[p8l847t2697r1071b2751],
60	allergens	NNS	O	allergen	dobj	59	SENT_149	[p8l1094t2697r1364b2767],
61	91/92	CD	NUMBER	91/92	number	62	SENT_149	[p8l1432t2697r1603b2752],
62	(	CD	NUMBER	(	num	64	SENT_149	[p8l1628t2697r1806b2763],
63	98.0	CD	NUMBER	98.0	number	64	SENT_149	[p8l1628t2697r1806b2763],
64	)	CD	NUMBER	)	dep	60	SENT_149	[p8l1628t2697r1806b2763],
65	Clinical	JJ	O	clinical	amod	66	SENT_149	[p8l10t2781r250b2835],
66	pattern	NN	O	pattern	dep	64	SENT_149	[p8l271t2789r483b2851],

1	Mixed	JJ	O	mixed	amod	2	SENT_150	[p8l66t2864r266b2918],
2	64	CD	NUMBER	64	dep	36	SENT_150	[p8l1482t2864r1554b2919],
3	(	CD	NUMBER	(	num	14	SENT_150	[p8l1579t2864r1757b2931],
4	58.2	CD	NUMBER	58.2	number	5	SENT_150	[p8l1579t2864r1757b2931],
5	)	CD	NUMBER	)	num	14	SENT_150	[p8l1579t2864r1757b2931],
6	Cutaneous	JJ	O	cutaneous	amod	14	SENT_150	[p8l67t2949r387b3002],
7	46	CD	NUMBER	46	number	8	SENT_150	[p8l1480t2949r1554b3002],
8	(	CD	NUMBER	(	num	10	SENT_150	[p8l1579t2949r1757b3014],
9	41.8	CD	NUMBER	41.8	number	10	SENT_150	[p8l1579t2949r1757b3014],
10	)	CD	NUMBER	)	npadvmod	11	SENT_150	[p8l1579t2949r1757b3014],
11	High	JJ	O	high	amod	14	SENT_150	[p8l9t3033r303b3103],
12	—	NN	O	—	nn	14	SENT_150	[p8l9t3033r303b3103],
13	risk	NN	O	risk	nn	14	SENT_150	[p8l9t3033r303b3103],
14	patients	NNS	O	patient	dep	2	SENT_150	[p8l322t3033r558b3103],
15	50	CD	NUMBER	50	number	16	SENT_150	[p8l1482t3033r1554b3087],
16	(	CD	NUMBER	(	num	14	SENT_150	[p8l1579t3033r1757b3099],
17	45.4	CD	NUMBER	45.4	number	18	SENT_150	[p8l1579t3033r1757b3099],
18	)	CD	NUMBER	)	num	23	SENT_150	[p8l1579t3033r1757b3099],
19	Oral	JJ	O	oral	amod	23	SENT_150	[p8l11t3116r143b3171],
20	mite	JJ	O	mite	amod	23	SENT_150	[p8l165t3116r299b3170],
21	anaphylaxis	NN	O	anaphylaxi	nn	23	SENT_150	[p8l322t3116r683b3186],
22	5	CD	NUMBER	5	num	23	SENT_150	[p8l1520t3116r1551b3171],
23	(	NN	O	(	dep	14	SENT_150	[p8l1579t3116r1719b3183],
24	4.5	CD	NUMBER	4.5	number	25	SENT_150	[p8l1579t3116r1719b3183],
25	)	CD	NUMBER	)	num	27	SENT_150	[p8l1579t3116r1719b3183],
26	Total	JJ	O	total	amod	27	SENT_150	[p8l9t3201r164b3255],
27	IgE	NN	O	ige	dep	14	SENT_150	[p8l185t3202r310b3271],
28	,	,	O	,	_	0	SENT_150	[p8l185t3202r310b3271],
29	IU/mL	NN	O	iu/ml	appos	27	SENT_150	[p8l334t3201r541b3255],
30	305.3	CD	NUMBER	305.3	num	29	SENT_150	[p8l1415t3201r1580b3255],
31	(	CD	NUMBER	(	number	32	SENT_150	[p8l1607t3201r1828b3267],
32	1475	CD	DATE	1475	dep	29	SENT_150	[p8l1607t3201r1828b3267],
33	)	CD	NUMBER	)	num	34	SENT_150	[p8l1607t3201r1828b3267],
34	*	NN	O	*	dep	36	SENT_150	[p8l1607t3201r1828b3267],
35	‘	CD	NUMBER	‘	num	36	SENT_150	[p8l1607t3201r1828b3267],
36	IgE	NN	O	ige	dep	41	SENT_150	[p8l9t3284r118b3353],
37	to	TO	O	to	_	0	SENT_150	[p8l139t3291r196b3337],
38	Blomia	NN	O	blomium	nn	39	SENT_150	[p8l216t3283r437b3337],
39	tropicalisb	NN	O	tropicalisb	prep_to	36	SENT_150	[p8l460t3279r771b3352],
40	0.537	CD	NUMBER	0.537	num	41	SENT_150	[p8l1423t3283r1590b3337],
41	(	CD	NUMBER	(	dep	46	SENT_150	[p8l1617t3283r1819b3349],
42	0.59	CD	NUMBER	0.59	num	43	SENT_150	[p8l1617t3283r1819b3349],
43	)	NN	O	)	dep	41	SENT_150	[p8l1617t3283r1819b3349],
44	*	CD	NUMBER	*	number	45	SENT_150	[p8l1617t3283r1819b3349],
45	‘	CD	NUMBER	‘	num	46	SENT_150	[p8l1617t3283r1819b3349],
46	IgE	NN	O	ige	dep	49	SENT_150	[p8l9t3369r118b3437],
47	to	TO	O	to	_	0	SENT_150	[p8l139t3375r196b3421],
48	Dermatophagoides	NNP	O	Dermatophagoides	prep_to	46	SENT_150	[p8l216t3367r804b3436],
49	pteronyssinusb	NN	O	pteronyssinusb	dep	52	SENT_150	[p8l818t3364r1265b3436],
50	0.482	CD	NUMBER	0.482	num	49	SENT_150	[p8l1423t3368r1592b3422],
51	(	CD	NUMBER	(	num	52	SENT_150	[p8l1617t3367r1819b3434],
52	0.66	CD	NUMBER	0.66	_	0	SENT_150	[p8l1617t3367r1819b3434],
53	)	NN	O	)	dep	52	SENT_150	[p8l1617t3367r1819b3434],
54	a	DT	O	a	dep	53	SENT_150	[p8l1617t3367r1819b3434],

1	Abbreviationszlg	NNP	PERSON	Abbreviationszlg	_	0	SENT_151	[p8l8t3550r475b3627],
2	,	,	O	,	_	0	SENT_151	[p8l8t3550r475b3627],
3	immunoglobulin	NN	O	immunoglobulin	appos	1	SENT_151	[p8l500t3550r962b3627],
4	;	:	O	;	_	0	SENT_151	[p8l500t3550r962b3627],
5	OD	NNP	O	OD	dep	1	SENT_151	[p8l985t3552r1081b3619],
6	,	,	O	,	_	0	SENT_151	[p8l985t3552r1081b3619],
7	optical	JJ	O	optical	amod	8	SENT_151	[p8l1105t3550r1283b3627],
8	density	NN	O	density	appos	5	SENT_151	[p8l1309t3550r1512b3627],
9	.	.	O	.	_	0	SENT_151	[p8l1309t3550r1512b3627],

1	3	CD	NUMBER	3	num	2	SENT_152	[p8l10t3642r25b3668],
2	P	NN	O	p	npadvmod	3	SENT_152	[p8l44t3637r267b3694],
3	<	JJR	O	<	dep	4	SENT_152	[p8l44t3637r267b3694],
4	.0001	CD	NUMBER	.0001	_	0	SENT_152	[p8l44t3637r267b3694],
5	compared	VBN	O	compare	_	0	SENT_152	[p8l303t3634r570b3712],
6	to	TO	O	to	prepc_compared_to	4	SENT_152	[p8l595t3642r647b3694],
7	controls	NNS	O	control	nn	9	SENT_152	[p8l672t3634r887b3694],
8	b	NN	O	b	nn	9	SENT_152	[p8l11t3718r27b3753],
9	Mean	NN	O	mean	pobj	4	SENT_152	[p8l53t3723r201b3780],
10	(	CD	NUMBER	(	num	11	SENT_152	[p8l227t3722r337b3791],
11	SD	NN	O	sd	dep	9	SENT_152	[p8l227t3722r337b3791],
12	)	CD	NUMBER	)	num	13	SENT_152	[p8l227t3722r337b3791],
13	OD	NN	O	od	dep	11	SENT_152	[p8l362t3722r442b3780],

1	Table	NNP	O	Table	_	0	SENT_153	[p9l6t139r154b199],
2	2	CD	NUMBER	2	dep	1	SENT_153	[p9l179t142r226b199],
3	.	.	O	.	_	0	SENT_153	[p9l179t142r226b199],

1	Allele	NN	O	allele	nn	4	SENT_154	[p9l247t139r398b199],
2	and	CC	O	and	_	0	SENT_154	[p9l423t139r520b199],
3	Genotype	NN	O	genotype	conj_and	1	SENT_154	[p9l547t142r808b217],
4	Distribution	NN	O	distribution	nsubjpass	19	SENT_154	[p9l835t139r1147b199],
5	of	IN	O	of	_	0	SENT_154	[p9l1174t139r1228b199],
6	A-444C	NN	O	a-444c	prep_of	4	SENT_154	[p9l1241t142r1471b199],
7	in	IN	O	in	_	0	SENT_154	[p9l1496t141r1538b198],
8	Patients	NNS	O	patient	prep_in	6	SENT_154	[p9l1567t141r1779b199],
9	and	CC	O	and	_	0	SENT_154	[p9l1803t139r1900b199],
10	Controls	NNP	O	Controls	prep_in	6	SENT_154	[p9l1928t139r2154b199],
11	and	CC	O	and	_	0	SENT_154	[p9l9t240r133b301],
12	genotype	NN	O	genotype	nn	13	SENT_154	[p9l168t249r488b319],
13	frequencies	NNS	O	frequency	prep_of	4	SENT_154	[p9l523t240r926b319],
14	of	IN	O	of	_	0	SENT_154	[p9l963t240r1039b301],
15	A	DT	O	a	det	17	SENT_154	[p9l1062t240r1357b301],
16	—	CD	NUMBER	—	num	17	SENT_154	[p9l1062t240r1357b301],
17	444C	NN	O	444c	prep_of	13	SENT_154	[p9l1062t240r1357b301],
18	are	VBP	O	be	auxpass	19	SENT_154	[p9l1396t259r1499b301],
19	given	VBN	O	give	_	0	SENT_154	[p9l1535t240r1728b319],
20	in	IN	O	in	_	0	SENT_154	[p9l1762t240r1829b300],
21	Table	NNP	O	Table	prep_in	19	SENT_154	[p9l1861t240r2053b301],
22	2	CD	NUMBER	2	num	21	SENT_154	[p9l2089t240r2148b301],
23	.	.	O	.	_	0	SENT_154	[p9l2089t240r2148b301],

1	A	DT	O	a	det	3	SENT_155	[p9l8t341r69b401],
2	signiﬁcant	JJ	O	signiﬁcant	amod	3	SENT_155	[p9l98t341r462b420],
3	association	NN	O	association	nsubjpass	5	SENT_155	[p9l493t341r882b402],
4	was	VBD	O	be	auxpass	5	SENT_155	[p9l913t360r1045b402],
5	detected	VBN	O	detect	_	0	SENT_155	[p9l1079t341r1371b402],
6	between	IN	O	between	_	0	SENT_155	[p9l1400t341r1693b402],
7	the	DT	O	the	det	11	SENT_155	[p9l1724t341r1829b402],
8	A	NN	O	a	nn	11	SENT_155	[p9l1855t341r2150b402],
9	—	NN	O	—	nn	11	SENT_155	[p9l1855t341r2150b402],
10	444C	NN	O	444c	nn	11	SENT_155	[p9l1855t341r2150b402],
11	genotypes	NNS	O	genotype	prep_between	5	SENT_155	[p9l9t451r358b521],
12	and	CC	O	and	_	0	SENT_155	[p9l380t441r504b502],
13	AIU	NNP	ORGANIZATION	AIU	nn	14	SENT_155	[p9l516t442r670b503],
14	phenotype	NN	O	phenotype	prep_between	5	SENT_155	[p9l688t441r1051b521],
15	under	IN	O	under	_	0	SENT_155	[p9l1068t441r1268b502],
16	a	DT	O	a	det	21	SENT_155	[p9l1287t461r1323b502],
17	general	JJ	O	general	amod	21	SENT_155	[p9l1341t441r1595b521],
18	model	NN	O	model	nn	21	SENT_155	[p9l1613t441r1830b502],
19	(	CD	NUMBER	(	num	21	SENT_155	[p9l1851t442r2153b517],
20	Pearson	NNP	PERSON	Pearson	nn	21	SENT_155	[p9l1851t442r2153b517],
21	x2	NN	O	x2	prep_under	5	SENT_155	[p9l7t539r300b624],
22	=	JJ	O	=	amod	21	SENT_155	[p9l7t539r300b624],
23	9.57	CD	NUMBER	9.57	tmod	22	SENT_155	[p9l7t539r300b624],
24	,	,	O	,	_	0	SENT_155	[p9l7t539r300b624],
25	P	NN	O	p	appos	21	SENT_155	[p9l320t544r622b620],
26	=	JJ	O	=	amod	28	SENT_155	[p9l320t544r622b620],
27	.008	CD	NUMBER	.008	tmod	26	SENT_155	[p9l320t544r622b620],
28	)	NN	O	)	dep	25	SENT_155	[p9l320t544r622b620],
29	,	,	O	,	_	0	SENT_155	[p9l320t544r622b620],
30	which	WDT	O	which	nsubj	32	SENT_155	[p9l644t543r856b605],
31	remained	VBD	O	remain	cop	32	SENT_155	[p9l873t543r1198b605],
32	signiﬁcant	JJ	O	signiﬁcant	rcmod	21	SENT_155	[p9l1218t543r1578b623],
33	after	IN	O	after	_	0	SENT_155	[p9l1597t543r1754b605],
34	adjustment	NN	O	adjustment	prep_after	32	SENT_155	[p9l1773t543r2153b623],
35	for	IN	O	for	_	0	SENT_155	[p9l8t645r110b706],
36	age	NN	O	age	prep_for	32	SENT_155	[p9l143t664r260b724],
37	and	CC	O	and	_	0	SENT_155	[p9l295t645r419b706],
38	gender	NN	O	gender	prep_for	32	SENT_155	[p9l452t645r690b724],
39	when	WRB	O	when	advmod	40	SENT_155	[p9l720t645r909b706],
40	using	VBG	O	use	advcl	32	SENT_155	[p9l940t645r1129b724],
41	logistic	JJ	O	logistic	amod	42	SENT_155	[p9l1163t645r1418b724],
42	regression	NN	O	regression	nn	50	SENT_155	[p9l1451t645r1813b724],
43	(	CD	NUMBER	(	num	44	SENT_155	[p9l1847t645r2149b721],
44	P	NN	O	p	dep	42	SENT_155	[p9l1847t645r2149b721],
45	=	JJ	O	=	amod	50	SENT_155	[p9l1847t645r2149b721],
46	.001	CD	NUMBER	.001	tmod	45	SENT_155	[p9l1847t645r2149b721],
47	,	,	O	,	_	0	SENT_155	[p9l1847t645r2149b721],
48	Table	NNP	O	Table	appos	46	SENT_155	[p9l8t745r200b806],
49	3	CD	NUMBER	3	num	48	SENT_155	[p9l232t746r318b821],
50	)	NN	O	)	dobj	40	SENT_155	[p9l232t746r318b821],
51	.	.	O	.	_	0	SENT_155	[p9l232t746r318b821],

1	This	DT	O	this	det	2	SENT_156	[p9l350t745r502b806],
2	association	NN	O	association	nsubjpass	4	SENT_156	[p9l535t745r924b806],
3	was	VBD	O	be	auxpass	4	SENT_156	[p9l953t765r1085b807],
4	driven	VBN	O	drive	_	0	SENT_156	[p9l1117t745r1340b806],
5	by	IN	O	by	_	0	SENT_156	[p9l1367t745r1454b825],
6	a	DT	O	a	det	8	SENT_156	[p9l1485t765r1522b806],
7	higher	JJR	O	higher	amod	8	SENT_156	[p9l1549t745r1774b825],
8	frequency	NN	O	frequency	agent	4	SENT_156	[p9l1802t745r2151b825],
9	of	IN	O	of	_	0	SENT_156	[p9l9t847r85b908],
10	homozygotes	NNS	O	homozygote	prep_of	8	SENT_156	[p9l106t847r573b926],
11	to	TO	O	to	_	0	SENT_156	[p9l602t856r668b908],
12	the	DT	O	the	det	17	SENT_156	[p9l697t847r802b908],
13	wild	JJ	O	wild	amod	17	SENT_156	[p9l831t847r1165b926],
14	—	NN	O	—	nn	17	SENT_156	[p9l831t847r1165b926],
15	type	NN	O	type	nn	17	SENT_156	[p9l831t847r1165b926],
16	A	NN	O	a	nn	17	SENT_156	[p9l1189t847r1250b907],
17	allele	NN	O	allele	prep_to	4	SENT_156	[p9l1275t847r1462b908],
18	in	IN	O	in	_	0	SENT_156	[p9l1489t847r1557b907],
19	controls	NNS	O	control	prep_in	17	SENT_156	[p9l1584t847r1864b908],
20	and	CC	O	and	_	0	SENT_156	[p9l1895t847r2019b908],
21	the	DT	O	the	det	22	SENT_156	[p9l2046t847r2151b908],
22	presence	NN	O	presence	prep_to	4	SENT_156	[p9l7t967r314b1027],
23	of	IN	O	of	_	0	SENT_156	[p9l344t948r420b1009],
24	the	DT	O	the	det	28	SENT_156	[p9l442t948r547b1009],
25	AC	NN	O	ac	nn	28	SENT_156	[p9l571t948r690b1009],
26	and	CC	O	and	_	0	SENT_156	[p9l722t948r846b1009],
27	CC	NN	O	cc	nn	28	SENT_156	[p9l875t948r987b1009],
28	genotypes	NNS	O	genotype	prep_of	22	SENT_156	[p9l1019t957r1371b1027],
29	in	IN	O	in	_	0	SENT_156	[p9l1401t948r1468b1008],
30	patients	NNS	O	patient	prep_in	4	SENT_156	[p9l1495t948r1766b1027],
31	with	IN	O	with	_	0	SENT_156	[p9l1797t948r1952b1009],
32	AIU	NNP	ORGANIZATION	AIU	prep_with	30	SENT_156	[p9l1975t948r2147b1009],
33	.	.	O	.	_	0	SENT_156	[p9l1975t948r2147b1009],

1	In	IN	O	in	_	0	SENT_157	[p9l8t1050r79b1109],
2	addition	NN	O	addition	prep_in	10	SENT_157	[p9l109t1048r414b1121],
3	,	,	O	,	_	0	SENT_157	[p9l109t1048r414b1121],
4	when	WRB	O	when	advmod	5	SENT_157	[p9l446t1048r635b1110],
5	analyzing	VBG	O	analyze	advcl	10	SENT_157	[p9l665t1048r1003b1128],
6	allele	NN	O	allele	nn	7	SENT_157	[p9l1035t1048r1221b1109],
7	distribution	NN	O	distribution	dobj	5	SENT_157	[p9l1252t1048r1674b1121],
8	,	,	O	,	_	0	SENT_157	[p9l1252t1048r1674b1121],
9	we	PRP	O	we	nsubj	10	SENT_157	[p9l1707t1068r1806b1110],
10	observed	VBD	O	observe	_	0	SENT_157	[p9l1837t1048r2153b1110],
11	that	IN	O	that	complm	19	SENT_157	[p9l8t1150r138b1211],
12	the	DT	O	the	det	15	SENT_157	[p9l154t1150r259b1211],
13	mutant	JJ	O	mutant	amod	15	SENT_157	[p9l277t1159r520b1211],
14	C	NN	O	c	nn	15	SENT_157	[p9l538t1150r591b1211],
15	allele	NN	O	allele	nsubj	19	SENT_157	[p9l613t1150r797b1211],
16	was	VBD	O	be	cop	19	SENT_157	[p9l816t1169r948b1211],
17	signiﬁcantly	RB	O	signiﬁcantly	advmod	19	SENT_157	[p9l971t1150r1397b1229],
18	more	RBR	O	more	advmod	19	SENT_157	[p9l1416t1169r1593b1211],
19	frequent	JJ	O	frequent	ccomp	10	SENT_157	[p9l1612t1150r1902b1229],
20	in	IN	O	in	_	0	SENT_157	[p9l1919t1150r1986b1210],
21	AIU	NNP	ORGANIZATION	AIU	nn	22	SENT_157	[p9l1998t1150r2152b1211],
22	patients	NNS	O	patient	prep_in	19	SENT_157	[p9l7t1251r278b1330],
23	than	IN	O	than	mark	27	SENT_157	[p9l312t1251r462b1312],
24	in	IN	O	in	_	0	SENT_157	[p9l494t1251r560b1311],
25	healthy	JJ	O	healthy	amod	26	SENT_157	[p9l592t1251r849b1330],
26	controls	NNS	O	control	prep_in	27	SENT_157	[p9l883t1251r1162b1312],
27	(	VBP	O	(	ccomp	19	SENT_157	[p9l1199t1251r1448b1327],
28	24.1	CD	PERCENT	24.1	num	29	SENT_157	[p9l1199t1251r1448b1327],
29	%	NN	PERCENT	%	dobj	27	SENT_157	[p9l1199t1251r1448b1327],
30	vs	CC	O	vs	_	0	SENT_157	[p9l1484t1270r1558b1312],
31	13.9	CD	PERCENT	13.9	num	32	SENT_157	[p9l1600t1251r1836b1323],
32	%	NN	PERCENT	%	conj_vs	29	SENT_157	[p9l1600t1251r1836b1323],
33	,	,	O	,	_	0	SENT_157	[p9l1600t1251r1836b1323],
34	P	NN	O	p	appos	32	SENT_157	[p9l1870t1251r2148b1323],
35	=	JJ	O	=	amod	34	SENT_157	[p9l1870t1251r2148b1323],
36	.002	CD	NUMBER	.002	tmod	35	SENT_157	[p9l1870t1251r2148b1323],
37	;	:	O	;	_	0	SENT_157	[p9l1870t1251r2148b1323],
38	Table	NNP	O	Table	dep	34	SENT_157	[p9l8t1352r200b1414],
39	2	CD	NUMBER	2	number	40	SENT_157	[p9l226t1353r313b1428],
40	)	CD	NUMBER	)	dep	38	SENT_157	[p9l226t1353r313b1428],
41	.	.	O	.	_	0	SENT_157	[p9l226t1353r313b1428],

1	A	DT	O	a	det	3	SENT_158	[p9l139t1454r201b1514],
2	further	JJ	O	further	amod	3	SENT_158	[p9l230t1454r470b1515],
3	evaluation	NN	O	evaluation	nsubj	24	SENT_158	[p9l503t1454r868b1515],
4	of	IN	O	of	_	0	SENT_158	[p9l903t1454r979b1515],
5	the	DT	O	the	det	9	SENT_158	[p9l1008t1454r1113b1515],
6	A	NN	O	a	nn	9	SENT_158	[p9l1143t1454r1439b1515],
7	—	NN	O	—	nn	9	SENT_158	[p9l1143t1454r1439b1515],
8	444C	NN	O	444c	nn	9	SENT_158	[p9l1143t1454r1439b1515],
9	distribution	NN	O	distribution	prep_of	3	SENT_158	[p9l1476t1454r1880b1515],
10	among	IN	O	among	_	0	SENT_158	[p9l1916t1473r2151b1533],
11	patients	NNS	O	patient	prep_among	9	SENT_158	[p9l7t1555r273b1634],
12	according	VBG	O	accord	_	0	SENT_158	[p9l295t1555r632b1634],
13	to	TO	O	to	prepc_according_to	24	SENT_158	[p9l651t1564r715b1616],
14	their	PRP$	O	they	poss	16	SENT_158	[p9l734t1555r893b1616],
15	clinical	JJ	O	clinical	amod	16	SENT_158	[p9l910t1555r1161b1616],
16	pattern	NN	O	pattern	pobj	24	SENT_158	[p9l1178t1564r1418b1634],
17	of	IN	O	of	_	0	SENT_158	[p9l1437t1555r1512b1616],
18	AIU	NNP	O	AIU	dep	20	SENT_158	[p9l1519t1555r1672b1616],
19	(	CD	NUMBER	(	num	18	SENT_158	[p9l1692t1555r2062b1631],
20	cutaneous	JJ	O	cutaneous	amod	23	SENT_158	[p9l1692t1555r2062b1631],
21	or	CC	O	or	_	0	SENT_158	[p9l2083t1574r2153b1616],
22	mixed	JJ	O	mixed	amod	23	SENT_158	[p9l8t1655r247b1731],
23	)	NN	O	)	prep_of	16	SENT_158	[p9l8t1655r247b1731],
24	showed	VBD	O	show	_	0	SENT_158	[p9l268t1655r527b1717],
25	that	IN	O	that	complm	29	SENT_158	[p9l541t1655r669b1716],
26	the	DT	O	the	det	28	SENT_158	[p9l683t1655r786b1716],
27	AA	NNP	O	AA	nn	28	SENT_158	[p9l797t1656r921b1716],
28	genotype	NN	O	genotype	nsubj	29	SENT_158	[p9l933t1665r1244b1735],
29	tended	VBD	O	tend	ccomp	24	SENT_158	[p9l1260t1655r1487b1716],
30	to	TO	O	to	aux	33	SENT_158	[p9l1502t1665r1566b1716],
31	be	VB	O	be	cop	33	SENT_158	[p9l1582t1655r1662b1716],
32	more	RBR	O	more	advmod	33	SENT_158	[p9l1678t1675r1853b1716],
33	frequent	JJ	O	frequent	xcomp	29	SENT_158	[p9l1869t1655r2153b1735],
34	in	IN	O	in	_	0	SENT_158	[p9l8t1757r74b1817],
35	patients	NNS	O	patient	prep_in	33	SENT_158	[p9l97t1757r368b1836],
36	with	IN	O	with	_	0	SENT_158	[p9l395t1757r549b1818],
37	the	DT	O	the	det	41	SENT_158	[p9l573t1757r677b1818],
38	mixed	JJ	O	mixed	amod	41	SENT_158	[p9l702t1757r921b1818],
39	pattern	NN	O	pattern	nn	41	SENT_158	[p9l943t1766r1188b1836],
40	(	NN	O	(	nn	41	SENT_158	[p9l1214t1757r1985b1836],
41	urticaria/angioedema	NN	O	urticaria/angioedema	prep_with	33	SENT_158	[p9l1214t1757r1985b1836],
42	plus	CC	O	plus	prep	41	SENT_158	[p9l2006t1757r2150b1836],
43	respiratory	JJ	O	respiratory	amod	44	SENT_158	[p9l7t1858r387b1937],
44	symptoms	NNS	O	symptom	dep	42	SENT_158	[p9l426t1858r832b1937],
45	)	RB	O	)	advmod	33	SENT_158	[p9l426t1858r832b1937],
46	,	,	O	,	_	0	SENT_158	[p9l426t1858r832b1937],
47	whereas	IN	O	whereas	mark	55	SENT_158	[p9l871t1858r1155b1919],
48	the	DT	O	the	det	52	SENT_158	[p9l1193t1858r1298b1919],
49	AC	NN	O	ac	nn	52	SENT_158	[p9l1329t1858r1448b1919],
50	and	CC	O	and	_	0	SENT_158	[p9l1487t1858r1611b1919],
51	CC	NN	O	cc	nn	52	SENT_158	[p9l1647t1858r1759b1919],
52	genotypes	NNS	O	genotype	nsubj	55	SENT_158	[p9l1797t1867r2150b1937],
53	were	VBD	O	be	cop	55	SENT_158	[p9l8t1978r178b2020],
54	more	RBR	O	more	advmod	55	SENT_158	[p9l215t1978r395b2019],
55	frequent	JJ	O	frequent	advcl	33	SENT_158	[p9l432t1958r728b2038],
56	in	IN	O	in	_	0	SENT_158	[p9l764t1958r831b2019],
57	patients	NNS	O	patient	prep_in	55	SENT_158	[p9l866t1958r1141b2038],
58	with	IN	O	with	_	0	SENT_158	[p9l1180t1958r1336b2020],
59	the	DT	O	the	det	62	SENT_158	[p9l1372t1958r1478b2019],
60	cutaneous	JJ	O	cutaneous	amod	62	SENT_158	[p9l1516t1968r1868b2019],
61	pattern	NN	O	pattern	nn	62	SENT_158	[p9l1905t1967r2152b2038],
62	(	NN	O	(	prep_with	55	SENT_158	[p9l10t2060r230b2136],
63	Table	NNP	O	Table	nn	65	SENT_158	[p9l10t2060r230b2136],
64	3	CD	NUMBER	3	num	65	SENT_158	[p9l268t2060r355b2136],
65	)	NN	O	)	dep	62	SENT_158	[p9l268t2060r355b2136],
66	.	.	O	.	_	0	SENT_158	[p9l268t2060r355b2136],

1	A	DT	O	a	det	2	SENT_159	[p9l390t2060r452b2120],
2	comparison	NN	O	comparison	_	0	SENT_159	[p9l483t2060r894b2139],
3	of	IN	O	of	_	0	SENT_159	[p9l930t2060r1006b2121],
4	allele	NN	O	allele	nn	5	SENT_159	[p9l1038t2060r1225b2121],
5	distribution	NN	O	distribution	prep_of	2	SENT_159	[p9l1262t2060r1667b2121],
6	according	VBG	O	accord	_	0	SENT_159	[p9l1705t2060r2048b2139],
7	to	TO	O	to	prepc_according_to	2	SENT_159	[p9l2085t2069r2151b2121],

1	Genotypes	NNS	O	genotype	nn	2	SENT_160	[p9l216t2270r374b2304],
2	Alglflaltioefts	NNS	O	alglflaltioeft	dep	7	SENT_160	[p9l706t2253r899b2327],
3	Healggliglgtrols	NNPS	O	Healggliglgtrols	dep	2	SENT_160	[p9l1187t2253r1443b2327],
4	OR	NN	O	or	dep	7	SENT_160	[p9l1663t2270r1714b2296],
5	(	CD	PERCENT	(	num	4	SENT_160	[p9l1725t2270r1803b2302],
6	95	CD	PERCENT	95	num	7	SENT_160	[p9l1725t2270r1803b2302],
7	%	NN	PERCENT	%	dep	12	SENT_160	[p9l1725t2270r1803b2302],
8	CI	NN	O	ci	dep	7	SENT_160	[p9l1815t2270r1859b2301],
9	,	,	O	,	_	0	SENT_160	[p9l1815t2270r1859b2301],
10	P	NN	O	p	nn	11	SENT_160	[p9l1870t2271r1893b2296],
11	values	NNS	O	value	appos	8	SENT_160	[p9l1903t2270r2009b2302],
12	)	VBP	O	)	_	0	SENT_160	[p9l1903t2270r2009b2302],

1	AA	NN	O	aa	_	0	SENT_161	[p9l269t2425r322b2451],
2	64	CD	NUMBER	64	dep	23	SENT_161	[p9l735t2424r771b2451],
3	(	CD	NUMBER	(	number	4	SENT_161	[p9l783t2424r870b2457],
4	58.2	CD	NUMBER	58.2	num	5	SENT_161	[p9l783t2424r870b2457],
5	)	NN	O	)	dep	2	SENT_161	[p9l783t2424r870b2457],
6	125	CD	NUMBER	125	number	7	SENT_161	[p9l1242t2424r1292b2451],
7	(	CD	NUMBER	(	num	5	SENT_161	[p9l1305t2424r1392b2457],
8	75.8	CD	NUMBER	75.8	num	9	SENT_161	[p9l1305t2424r1392b2457],
9	)	NN	O	)	dep	5	SENT_161	[p9l1305t2424r1392b2457],
10	1.0	CD	NUMBER	1.0	number	11	SENT_161	[p9l1661t2424r1703b2451],
11	(	CD	NUMBER	(	num	15	SENT_161	[p9l1715t2424r1864b2457],
12	reference	NN	O	reference	nn	15	SENT_161	[p9l1715t2424r1864b2457],
13	category	NN	O	category	nn	15	SENT_161	[p9l1875t2425r2014b2459],
14	)	CD	NUMBER	)	num	15	SENT_161	[p9l1875t2425r2014b2459],
15	AC	NN	ORGANIZATION	ac	dep	9	SENT_161	[p9l269t2470r320b2497],
16	38	CD	NUMBER	38	dep	9	SENT_161	[p9l736t2470r770b2497],
17	(	CD	NUMBER	(	number	18	SENT_161	[p9l783t2470r870b2503],
18	34.5	CD	NUMBER	34.5	dep	16	SENT_161	[p9l783t2470r870b2503],
19	)	NN	O	)	dep	23	SENT_161	[p9l783t2470r870b2503],
20	34	CD	NUMBER	34	num	19	SENT_161	[p9l1248t2470r1284b2497],
21	(	CD	NUMBER	(	num	23	SENT_161	[p9l1295t2470r1383b2503],
22	20.6	CD	NUMBER	20.6	num	23	SENT_161	[p9l1295t2470r1383b2503],
23	)	NN	O	)	dep	32	SENT_161	[p9l1295t2470r1383b2503],
24	3.8	CD	NUMBER	3.8	number	25	SENT_161	[p9l1697t2470r1740b2497],
25	(	CD	NUMBER	(	dep	23	SENT_161	[p9l1753t2470r1879b2503],
26	1.7-8	CD	NUMBER	1.7-8	num	27	SENT_161	[p9l1753t2470r1879b2503],
27	.5	CD	NUMBER	.5	dep	25	SENT_161	[p9l1753t2470r1879b2503],
28	;	:	O	;	_	0	SENT_161	[p9l1753t2470r1879b2503],
29	.001	CD	NUMBER	.001	number	30	SENT_161	[p9l1892t2470r1978b2503],
30	)	CD	NUMBER	)	dep	25	SENT_161	[p9l1892t2470r1978b2503],
31	“	CD	NUMBER	“	dep	30	SENT_161	[p9l1892t2470r1978b2503],
32	CC	NN	O	cc	dep	34	SENT_161	[p9l271t2516r318b2543],
33	8	CD	NUMBER	8	num	32	SENT_161	[p9l755t2516r770b2543],
34	(	NN	O	(	dep	36	SENT_161	[p9l783t2516r852b2549],
35	7.3	CD	NUMBER	7.3	num	34	SENT_161	[p9l783t2516r852b2549],
36	)	NN	O	)	dep	38	SENT_161	[p9l783t2516r852b2549],
37	6	CD	NUMBER	6	num	36	SENT_161	[p9l1267t2516r1283b2543],
38	(	NN	O	(	dep	55	SENT_161	[p9l1295t2516r1364b2549],
39	3.6	CD	NUMBER	3.6	num	38	SENT_161	[p9l1295t2516r1364b2549],
40	)	CD	NUMBER	)	number	41	SENT_161	[p9l1295t2516r1364b2549],
41	4.9	CD	NUMBER	4.9	num	42	SENT_161	[p9l1686t2516r1731b2543],
42	(	NN	O	(	dep	38	SENT_161	[p9l1744t2516r1907b2549],
43	1.06-23	CD	NUMBER	1.06-23	num	44	SENT_161	[p9l1744t2516r1907b2549],
44	.2	NN	NUMBER	.2	dep	42	SENT_161	[p9l1744t2516r1907b2549],
45	;	:	O	;	_	0	SENT_161	[p9l1744t2516r1907b2549],
46	.04	CD	NUMBER	.04	number	47	SENT_161	[p9l1921t2516r1987b2549],
47	)	CD	NUMBER	)	dep	42	SENT_161	[p9l1921t2516r1987b2549],
48	"	``	O	"	punct	49	SENT_161	[p9l1921t2516r1987b2549],
49	AC+CC	NN	O	ac+cc	dep	47	SENT_161	[p9l183t2588r304b2615],
50	vs	CC	O	vs	_	0	SENT_161	[p9l315t2596r347b2615],
51	AA	NN	O	aa	dep	42	SENT_161	[p9l356t2588r409b2615],
52	46/64	CD	NUMBER	46/64	number	53	SENT_161	[p9l761t2588r845b2615],
53	40/125	CD	NUMBER	40/125	dep	51	SENT_161	[p9l1264t2588r1366b2615],
54	4.01	CD	NUMBER	4.01	num	55	SENT_161	[p9l1667t2588r1729b2615],
55	(	CD	NUMBER	(	dep	1	SENT_161	[p9l1744t2588r1888b2621],
56	1.88-8	CD	NUMBER	1.88-8	num	57	SENT_161	[p9l1744t2588r1888b2621],
57	.5	NN	NUMBER	.5	dep	55	SENT_161	[p9l1744t2588r1888b2621],
58	;	:	O	;	_	0	SENT_161	[p9l1744t2588r1888b2621],
59	.0003	CD	NUMBER	.0003	number	60	SENT_161	[p9l1902t2588r2006b2621],
60	)	CD	NUMBER	)	dep	1	SENT_161	[p9l1902t2588r2006b2621],
61	“	NN	O	“	dep	60	SENT_161	[p9l1902t2588r2006b2621],

1	Alleles	NNS	MISC	allele	dep	8	SENT_162	[p9l242t2661r347b2687],
2	A	DT	MISC	a	det	4	SENT_162	[p9l283t2706r309b2733],
3	167	CD	NUMBER	167	num	4	SENT_162	[p9l729t2706r780b2733],
4	(	NN	O	(	dep	1	SENT_162	[p9l792t2706r880b2739],
5	75.9	CD	NUMBER	75.9	num	6	SENT_162	[p9l792t2706r880b2739],
6	)	NN	O	)	dep	8	SENT_162	[p9l792t2706r880b2739],
7	284	CD	NUMBER	284	num	8	SENT_162	[p9l1239t2706r1293b2733],
8	(	NN	O	(	dep	14	SENT_162	[p9l1305t2706r1392b2739],
9	86.1	CD	NUMBER	86.1	number	10	SENT_162	[p9l1305t2706r1392b2739],
10	)	CD	NUMBER	)	dep	8	SENT_162	[p9l1305t2706r1392b2739],
11	1.95	CD	NUMBER	1.95	num	12	SENT_162	[p9l1676t2706r1735b2733],
12	(	NN	O	(	dep	10	SENT_162	[p9l1749t2706r1911b2739],
13	1.26-3	CD	NUMBER	1.26-3	num	14	SENT_162	[p9l1749t2706r1911b2739],
14	.03	CD	NUMBER	.03	_	0	SENT_162	[p9l1749t2706r1911b2739],
15	;	:	O	;	_	0	SENT_162	[p9l1749t2706r1911b2739],
16	.002	CD	NUMBER	.002	dep	20	SENT_162	[p9l1925t2706r1999b2739],
17	)	NN	O	)	dep	16	SENT_162	[p9l1925t2706r1999b2739],
18	C	NN	O	c	dep	20	SENT_162	[p9l283t2752r306b2779],
19	53	CD	NUMBER	53	num	18	SENT_162	[p9l735t2752r770b2779],
20	(	CD	NUMBER	(	dep	26	SENT_162	[p9l783t2752r870b2785],
21	24.1	CD	NUMBER	24.1	num	22	SENT_162	[p9l783t2752r870b2785],
22	)	NN	O	)	dep	20	SENT_162	[p9l783t2752r870b2785],
23	46	CD	NUMBER	46	number	24	SENT_162	[p9l1247t2752r1283b2779],
24	(	CD	NUMBER	(	num	25	SENT_162	[p9l1295t2752r1383b2785],
25	13.9	CD	NUMBER	13.9	dep	22	SENT_162	[p9l1295t2752r1383b2785],
26	)	NN	O	)	dep	14	SENT_162	[p9l1295t2752r1383b2785],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_163	[p9l57t2846r315b2880],
2	:	:	O	:	_	0	SENT_163	[p9l57t2846r315b2880],
3	AIU	NNP	ORGANIZATION	AIU	dep	1	SENT_163	[p9l57t2846r315b2880],
4	,	,	O	,	_	0	SENT_163	[p9l57t2846r315b2880],
5	aspirin-induced	JJ	O	aspirin-induced	amod	6	SENT_163	[p9l326t2846r530b2884],
6	urticaria	NN	O	urticarium	appos	3	SENT_163	[p9l544t2847r660b2880],
7	;	:	O	;	_	0	SENT_163	[p9l544t2847r660b2880],
8	Cl	NNP	O	Cl	dep	1	SENT_163	[p9l672t2847r705b2880],
9	,	,	O	,	_	0	SENT_163	[p9l672t2847r705b2880],
10	conlldence	NN	O	conlldence	nn	11	SENT_163	[p9l716t2846r860b2875],
11	interval	NN	O	interval	appos	8	SENT_163	[p9l873t2846r977b2880],
12	;	:	O	;	_	0	SENT_163	[p9l873t2846r977b2880],
13	OR	NN	O	or	dep	1	SENT_163	[p9l989t2847r1035b2880],
14	,	,	O	,	_	0	SENT_163	[p9l989t2847r1035b2880],
15	odds	NNS	O	odds	nn	16	SENT_163	[p9l1046t2846r1109b2875],
16	ratio	NN	O	ratio	appos	13	SENT_163	[p9l1121t2847r1186b2875],
17	.	.	O	.	_	0	SENT_163	[p9l1121t2847r1186b2875],

1	aAge	NN	O	aage	nsubj	4	SENT_164	[p9l58t2888r127b2925],
2	and	CC	O	and	_	0	SENT_164	[p9l138t2887r186b2916],
3	sex	NN	O	sex	conj_and	1	SENT_164	[p9l199t2895r240b2916],
4	adjusted	VBN	O	adjust	_	0	SENT_164	[p9l252t2887r364b2925],
5	by	IN	O	by	_	0	SENT_164	[p9l377t2887r406b2925],
6	logistic	JJ	O	logistic	amod	7	SENT_164	[p9l418t2887r510b2925],
7	regression	NN	O	regression	prep_by	4	SENT_164	[p9l522t2888r665b2925],
8	.	.	O	.	_	0	SENT_164	[p9l522t2888r665b2925],

1	Table	NNP	O	Table	_	0	SENT_165	[p9l59t3000r131b3030],
2	3	CD	NUMBER	3	dep	1	SENT_165	[p9l143t3001r166b3030],
3	.	.	O	.	_	0	SENT_165	[p9l143t3001r166b3030],

1	Allele	NN	O	allele	_	0	SENT_166	[p9l176t3000r251b3030],
2	and	CC	O	and	_	0	SENT_166	[p9l262t3000r310b3030],
3	Genotype	NN	O	genotype	nn	5	SENT_166	[p9l323t3001r451b3038],
4	Distribution	NN	O	distribution	nn	5	SENT_166	[p9l464t3000r616b3030],
5	ofA-444C	NN	O	ofa-444c	conj_and	1	SENT_166	[p9l629t3000r774b3030],
6	According	VBG	O	accord	_	0	SENT_166	[p9l783t3000r918b3038],
7	to	TO	O	to	prepc_according_to	1	SENT_166	[p9l928t3004r954b3030],
8	the	DT	O	the	det	10	SENT_166	[p9l965t3000r1007b3030],
9	Clinical	JJ	O	clinical	amod	10	SENT_166	[p9l1019t3000r1114b3030],
10	Pattern	NN	O	pattern	pobj	1	SENT_166	[p9l1128t3002r1220b3030],

1	Genotypes	NNS	O	genotype	nsubj	12	SENT_167	[p9l219t3092r375b3126],
2	Mixed	JJ	O	mixed	amod	5	SENT_167	[p9l756t3092r853b3119],
3	Cutaneous	JJ	O	cutaneous	amod	5	SENT_167	[p9l1239t3092r1395b3119],
4	OR	NN	O	or	nn	5	SENT_167	[p9l1664t3092r1715b3119],
5	(	NN	O	(	dep	1	SENT_167	[p9l1726t3092r1804b3125],
6	95	CD	PERCENT	95	number	7	SENT_167	[p9l1726t3092r1804b3125],
7	%	NN	PERCENT	%	amod	8	SENT_167	[p9l1726t3092r1804b3125],
8	CI	NN	O	ci	dep	1	SENT_167	[p9l1816t3092r1860b3123],
9	,	,	O	,	_	0	SENT_167	[p9l1816t3092r1860b3123],
10	P	NN	O	p	nn	11	SENT_167	[p9l1871t3093r1894b3118],
11	values	NNS	O	value	appos	8	SENT_167	[p9l1905t3092r2011b3125],
12	)	VBP	O	)	_	0	SENT_167	[p9l1905t3092r2011b3125],

1	AA	NN	O	aa	_	0	SENT_168	[p9l270t3180r324b3206],
2	42	CD	NUMBER	42	dep	7	SENT_168	[p9l736t3180r772b3206],
3	(	CD	NUMBER	(	number	4	SENT_168	[p9l784t3180r871b3212],
4	65.6	CD	NUMBER	65.6	dep	2	SENT_168	[p9l784t3180r871b3212],
5	)	NN	O	)	dep	4	SENT_168	[p9l784t3180r871b3212],
6	22	CD	NUMBER	22	dep	7	SENT_168	[p9l1249t3180r1285b3206],
7	(	CD	NUMBER	(	dep	16	SENT_168	[p9l1297t3180r1384b3212],
8	47.8	CD	NUMBER	47.8	num	9	SENT_168	[p9l1297t3180r1384b3212],
9	)	NN	O	)	dep	7	SENT_168	[p9l1297t3180r1384b3212],
10	1.0	CD	NUMBER	1.0	number	11	SENT_168	[p9l1662t3180r1704b3206],
11	(	CD	NUMBER	(	num	15	SENT_168	[p9l1716t3180r1866b3212],
12	reference	NN	O	reference	nn	15	SENT_168	[p9l1716t3180r1866b3212],
13	category	NN	O	category	nn	15	SENT_168	[p9l1876t3180r2016b3214],
14	)	CD	NUMBER	)	num	15	SENT_168	[p9l1876t3180r2016b3214],
15	AC	NN	ORGANIZATION	ac	dep	9	SENT_168	[p9l271t3225r321b3251],
16	19	CD	NUMBER	19	dep	27	SENT_168	[p9l740t3225r772b3251],
17	(	CD	NUMBER	(	number	18	SENT_168	[p9l784t3225r871b3257],
18	29.7	CD	NUMBER	29.7	dep	16	SENT_168	[p9l784t3225r871b3257],
19	)	NN	O	)	dep	18	SENT_168	[p9l784t3225r871b3257],
20	19	CD	NUMBER	19	num	19	SENT_168	[p9l1252t3225r1284b3251],
21	(	CD	NUMBER	(	number	22	SENT_168	[p9l1297t3225r1384b3257],
22	41.3	CD	NUMBER	41.3	num	23	SENT_168	[p9l1297t3225r1384b3257],
23	)	NN	O	)	dep	18	SENT_168	[p9l1297t3225r1384b3257],
24	1.9	CD	NUMBER	1.9	number	25	SENT_168	[p9l1700t3225r1742b3251],
25	(	CD	NUMBER	(	num	23	SENT_168	[p9l1754t3225r1899b3257],
26	0.83	CD	NUMBER	0.83	num	27	SENT_168	[p9l1754t3225r1899b3257],
27	—	NN	O	—	dep	56	SENT_168	[p9l1754t3225r1899b3257],
28	4.4	CD	NUMBER	4.4	dep	27	SENT_168	[p9l1754t3225r1899b3257],
29	;	:	O	;	_	0	SENT_168	[p9l1754t3225r1899b3257],
30	.13	CD	NUMBER	.13	number	31	SENT_168	[p9l1912t3225r1979b3257],
31	)	CD	NUMBER	)	dep	28	SENT_168	[p9l1912t3225r1979b3257],
32	“	CD	NUMBER	“	num	33	SENT_168	[p9l1912t3225r1979b3257],
33	CC	NN	O	cc	dep	39	SENT_168	[p9l272t3270r320b3297],
34	3	CD	NUMBER	3	num	35	SENT_168	[p9l756t3270r771b3297],
35	(	NN	O	(	dep	33	SENT_168	[p9l784t3270r853b3303],
36	4.7	CD	NUMBER	4.7	num	37	SENT_168	[p9l784t3270r853b3303],
37	)	NN	O	)	dep	39	SENT_168	[p9l784t3270r853b3303],
38	5	CD	NUMBER	5	num	39	SENT_168	[p9l1259t3270r1274b3297],
39	(	CD	NUMBER	(	dep	45	SENT_168	[p9l1287t3270r1375b3303],
40	10.9	CD	NUMBER	10.9	num	41	SENT_168	[p9l1287t3270r1375b3303],
41	)	NN	O	)	dep	39	SENT_168	[p9l1287t3270r1375b3303],
42	3.1	CD	NUMBER	3.1	number	43	SENT_168	[p9l1689t3270r1730b3297],
43	(	CD	NUMBER	(	dep	41	SENT_168	[p9l1745t3270r1908b3303],
44	0.66-14	CD	NUMBER	0.66-14	num	45	SENT_168	[p9l1745t3270r1908b3303],
45	.1	NN	NUMBER	.1	dep	28	SENT_168	[p9l1745t3270r1908b3303],
46	;	:	O	;	_	0	SENT_168	[p9l1745t3270r1908b3303],
47	.15	CD	NUMBER	.15	number	48	SENT_168	[p9l1922t3270r1988b3303],
48	)	CD	NUMBER	)	num	50	SENT_168	[p9l1922t3270r1988b3303],
49	“	NN	O	“	nn	50	SENT_168	[p9l1922t3270r1988b3303],
50	AC+CC	NN	O	ac+cc	dep	28	SENT_168	[p9l184t3337r305b3364],
51	vs	CC	O	vs	_	0	SENT_168	[p9l317t3346r348b3364],
52	AA	NN	O	aa	conj_vs	28	SENT_168	[p9l357t3338r410b3364],
53	22/42	CD	NUMBER	22/42	num	52	SENT_168	[p9l763t3337r846b3364],
54	24/22	CD	NUMBER	24/22	number	55	SENT_168	[p9l1275t3337r1359b3364],
55	2.1	CD	NUMBER	2.1	dep	52	SENT_168	[p9l1688t3337r1730b3364],
56	(	NN	O	(	dep	58	SENT_168	[p9l1745t3337r1889b3370],
57	0.93-4	CD	NUMBER	0.93-4	num	56	SENT_168	[p9l1745t3337r1889b3370],
58	.5	CD	NUMBER	.5	dep	1	SENT_168	[p9l1745t3337r1889b3370],
59	;	:	O	;	_	0	SENT_168	[p9l1745t3337r1889b3370],
60	.072	CD	NUMBER	.072	number	61	SENT_168	[p9l1903t3337r1988b3370],
61	)	CD	NUMBER	)	dep	1	SENT_168	[p9l1903t3337r1988b3370],
62	“	NN	O	“	dep	61	SENT_168	[p9l1903t3337r1988b3370],

1	Alleles	NNS	MISC	allele	dep	12	SENT_169	[p9l243t3404r346b3430],
2	A	DT	O	a	det	4	SENT_169	[p9l284t3450r310b3475],
3	104	CD	NUMBER	104	num	4	SENT_169	[p9l730t3449r782b3476],
4	(	NN	O	(	dep	1	SENT_169	[p9l794t3449r881b3482],
5	81.3	CD	NUMBER	81.3	number	6	SENT_169	[p9l794t3449r881b3482],
6	)	CD	NUMBER	)	dep	4	SENT_169	[p9l794t3449r881b3482],
7	63	CD	NUMBER	63	num	8	SENT_169	[p9l1249t3449r1283b3476],
8	(	NN	O	(	dep	12	SENT_169	[p9l1297t3449r1384b3482],
9	68.5	CD	NUMBER	68.5	num	12	SENT_169	[p9l1297t3449r1384b3482],
10	)	NN	O	)	nn	12	SENT_169	[p9l1297t3449r1384b3482],
11	b	NN	O	b	nn	12	SENT_169	[p9l1978t3477r1988b3492],
12	C	NN	O	c	dep	17	SENT_169	[p9l284t3496r307b3522],
13	24	CD	NUMBER	24	number	14	SENT_169	[p9l737t3495r772b3522],
14	(	CD	NUMBER	(	dep	12	SENT_169	[p9l784t3496r871b3528],
15	18.8	CD	NUMBER	18.8	num	16	SENT_169	[p9l784t3496r871b3528],
16	)	NN	O	)	dep	14	SENT_169	[p9l784t3496r871b3528],
17	29	CD	NUMBER	29	dep	28	SENT_169	[p9l1249t3496r1284b3522],
18	(	CD	NUMBER	(	number	19	SENT_169	[p9l1297t3495r1384b3528],
19	31.5	CD	NUMBER	31.5	num	21	SENT_169	[p9l1297t3495r1384b3528],
20	)	CD	NUMBER	)	number	21	SENT_169	[p9l1297t3495r1384b3528],
21	1.99	CD	NUMBER	1.99	dep	17	SENT_169	[p9l1691t3479r1751b3505],
22	(	NN	O	(	dep	21	SENT_169	[p9l1763t3479r1907b3511],
23	1.07	CD	NUMBER	1.07	num	22	SENT_169	[p9l1763t3479r1907b3511],
24	—	CD	NUMBER	—	number	25	SENT_169	[p9l1763t3479r1907b3511],
25	3.7	CD	NUMBER	3.7	dep	22	SENT_169	[p9l1763t3479r1907b3511],
26	;	:	O	;	_	0	SENT_169	[p9l1763t3479r1907b3511],
27	.02	CD	NUMBER	.02	num	28	SENT_169	[p9l1921t3479r1976b3511],
28	)	CD	NUMBER	)	_	0	SENT_169	[p9l1921t3479r1976b3511],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_170	[p9l59t3575r252b3605],
2	:	:	O	:	_	0	SENT_170	[p9l59t3575r252b3605],
3	CI	NN	O	ci	dep	1	SENT_170	[p9l264t3576r297b3609],
4	,	,	O	,	_	0	SENT_170	[p9l264t3576r297b3609],
5	conlldence	NN	O	conlldence	nn	6	SENT_170	[p9l309t3575r452b3605],
6	interval	NN	O	interval	appos	3	SENT_170	[p9l465t3575r569b3609],
7	;	:	O	;	_	0	SENT_170	[p9l465t3575r569b3609],
8	OR	NN	O	or	dep	1	SENT_170	[p9l581t3576r627b3609],
9	,	,	O	,	_	0	SENT_170	[p9l581t3576r627b3609],
10	odds	NNS	O	odds	nn	11	SENT_170	[p9l639t3575r701b3605],
11	ratio	NN	O	ratio	appos	8	SENT_170	[p9l713t3576r778b3605],
12	.	.	O	.	_	0	SENT_170	[p9l713t3576r778b3605],

1	aAge	NN	O	aage	nsubj	10	SENT_171	[p9l59t3618r128b3655],
2	and	CC	O	and	_	0	SENT_171	[p9l140t3617r187b3646],
3	sex	NN	O	sex	nsubj	10	SENT_171	[p9l200t3625r242b3646],
4	adjusted	VBN	O	adjust	partmod	1	SENT_171	[p9l253t3617r365b3655],
5	by	IN	O	by	_	0	SENT_171	[p9l379t3617r407b3655],
6	logistic	JJ	O	logistic	amod	9	SENT_171	[p9l419t3617r511b3655],
7	regression	NN	O	regression	nn	9	SENT_171	[p9l523t3618r657b3655],
8	b	NN	O	b	nn	9	SENT_171	[p9l60t3658r68b3675],
9	Risk	NN	PERSON	risk	agent	4	SENT_171	[p9l80t3658r133b3688],
10	conferred	VBD	O	confer	_	0	SENT_171	[p9l144t3658r268b3688],
11	by	IN	O	by	_	0	SENT_171	[p9l282t3658r311b3696],
12	allele	NN	O	allele	nn	13	SENT_171	[p9l321t3658r390b3688],
13	C	NN	O	c	prep_by	10	SENT_171	[p9l402t3660r419b3688],
14	to	TO	O	to	_	0	SENT_171	[p9l430t3662r456b3688],
15	cutaneous	JJ	O	cutaneous	amod	16	SENT_171	[p9l468t3662r605b3688],
16	pattern	NN	O	pattern	prep_to	10	SENT_171	[p9l617t3662r711b3696],

1	©	RB	O	©	dep	2	SENT_172	[p10l60t44r83b68],
2	2009	CD	DATE	2009	dep	9	SENT_172	[p10l93t44r158b68],
3	Esmon	NNP	O	Esmon	nn	9	SENT_172	[p10l167t44r259b68],
4	Publicidad	NNP	O	Publicidad	nn	9	SENT_172	[p10l269t44r411b68],
5	J	NNP	O	J	nn	9	SENT_172	[p10l1309t45r1326b68],
6	Im/estig	NNP	O	Im/estig	nn	9	SENT_172	[p10l1333t45r1438b74],
7	Allergol	NNP	O	Allergol	nn	9	SENT_172	[p10l1444t44r1554b74],
8	Clin	NNP	O	Clin	nn	9	SENT_172	[p10l1565t44r1619b68],
9	Immunol	NNP	O	Immunol	dep	12	SENT_172	[p10l1628t44r1747b68],
10	2009	CD	DATE	2009	dep	9	SENT_172	[p10l1756t44r1829b72],
11	;	:	O	;	_	0	SENT_172	[p10l1756t44r1829b72],
12	Vol	NNP	O	Vol	_	0	SENT_172	[p10l1839t44r1891b68],
13	.	.	O	.	_	0	SENT_172	[p10l1839t44r1891b68],

1	19	CD	NUMBER	19	num	2	SENT_173	[p10l1905t44r1980b73],
2	(	CD	NUMBER	(	_	0	SENT_173	[p10l1905t44r1980b73],
3	5	CD	NUMBER	5	num	4	SENT_173	[p10l1905t44r1980b73],
4	)	NN	O	)	dep	2	SENT_173	[p10l1905t44r1980b73],
5	:	:	O	:	_	0	SENT_173	[p10l1905t44r1980b73],
6	375-382 379	CD	NUMBER	375-382 379	num	8	SENT_173	[p10l58t88r118b116],[p10l1992t44r2101b68],
7	M	NN	O	m	nn	8	SENT_173	[p10l895t90r928b115],
8	Sanchez-Borges	NNS	O	sanchez-borge	dep	4	SENT_173	[p10l939t89r1188b123],
9	,	,	O	,	_	0	SENT_173	[p10l939t89r1188b123],
10	et	FW	O	et	nn	11	SENT_173	[p10l1200t93r1227b115],
11	al	FW	O	al	appos	8	SENT_173	[p10l1237t89r1262b115],

1	Table	NNP	O	Table	_	0	SENT_174	[p10l57t217r130b247],
2	4	CD	NUMBER	4	dep	1	SENT_174	[p10l141t219r165b247],
3	.	.	O	.	_	0	SENT_174	[p10l141t219r165b247],

1	Allele	NN	O	allele	nn	4	SENT_175	[p10l175t217r249b247],
2	and	CC	O	and	_	0	SENT_175	[p10l261t217r309b247],
3	Genotype	NN	O	genotype	nn	4	SENT_175	[p10l322t219r449b255],
4	Distribution	NN	O	distribution	_	0	SENT_175	[p10l462t217r615b247],
5	of	IN	O	of	_	0	SENT_175	[p10l628t217r655b247],
6	A-444C	NN	O	a-444c	prep_of	4	SENT_175	[p10l661t219r773b247],
7	According	VBG	O	accord	_	0	SENT_175	[p10l781t217r917b255],
8	to	TO	O	to	prepc_according_to	4	SENT_175	[p10l927t221r952b247],
9	Skin	NNP	O	Skin	nn	11	SENT_175	[p10l965t217r1018b247],
10	Histamine	NNP	O	Histamine	nn	11	SENT_175	[p10l1032t218r1163b247],
11	Reactivity	NN	O	reactivity	pobj	4	SENT_175	[p10l1176t218r1303b255],

1	Wheal	NNP	O	Wheal	nn	2	SENT_176	[p10l596t312r698b340],
2	Diameter	NNP	O	Diameter	_	0	SENT_176	[p10l709t312r866b340],
3	“	NNP	O	“	nn	5	SENT_176	[p10l709t312r866b340],
4	Histamine	NNP	O	Histamine	nn	5	SENT_176	[p10l1227t312r1388b340],
5	Responsel	NNP	O	Responsel	dep	2	SENT_176	[p10l1399t310r1561b348],
6	’	NN	O	’	dep	2	SENT_176	[p10l1399t310r1561b348],

1	Genotype	NN	O	genotype	nn	4	SENT_177	[p10l156t380r300b414],
2	J	NN	O	j	nn	4	SENT_177	[p10l493t363r495b375],
3	m	NN	O	m	nn	4	SENT_177	[p10l537t388r595b406],
4	P	NN	O	p	_	0	SENT_177	[p10l896t381r919b406],
5	i	FW	O	i	dep	4	SENT_177	[p10l1018t363r1020b375],
6	J	NN	O	j	nn	14	SENT_177	[p10l1125t363r1127b375],
7	High	JJ	O	high	amod	14	SENT_177	[p10l1208t380r1282b414],
8	Low	JJ	O	low	amod	14	SENT_177	[p10l1552t381r1620b406],
9	‘	NN	O	‘	nn	14	SENT_177	[p10l1650t363r1652b375],
10	OR	NN	O	or	nn	14	SENT_177	[p10l1765t380r1816b406],
11	(	CD	PERCENT	(	num	14	SENT_177	[p10l1826t380r1902b412],
12	95	CD	PERCENT	95	num	14	SENT_177	[p10l1826t380r1902b412],
13	%	NN	PERCENT	%	nn	14	SENT_177	[p10l1826t380r1902b412],
14	CI	NN	O	ci	dep	5	SENT_177	[p10l1914t380r1957b411],
15	,	,	O	,	_	0	SENT_177	[p10l1914t380r1957b411],
16	P	NN	O	p	nn	17	SENT_177	[p10l1968t381r1991b406],
17	value	NN	O	value	appos	14	SENT_177	[p10l2000t380r2100b412],
18	)	CD	NUMBER	)	num	19	SENT_177	[p10l2000t380r2100b412],
19	“	NN	O	“	dep	4	SENT_177	[p10l2000t380r2100b412],

1	AA	NN	O	aa	dep	11	SENT_178	[p10l204t485r255b512],
2	6.5	CD	NUMBER	6.5	num	1	SENT_178	[p10l508t485r549b512],
3	(	CD	NUMBER	(	number	4	SENT_178	[p10l560t485r624b518],
4	2.0	CD	NUMBER	2.0	num	5	SENT_178	[p10l560t485r624b518],
5	)	NN	O	)	dep	1	SENT_178	[p10l560t485r624b518],
6	21	CD	NUMBER	21	num	7	SENT_178	[p10l1182t486r1213b512],
7	(	CD	NUMBER	(	dep	5	SENT_178	[p10l1226t485r1308b518],
8	75.0	CD	NUMBER	75.0	num	9	SENT_178	[p10l1226t485r1308b518],
9	)	NN	O	)	dep	11	SENT_178	[p10l1226t485r1308b518],
10	32	CD	NUMBER	32	num	11	SENT_178	[p10l1524t486r1558b512],
11	(	CD	NUMBER	(	dep	23	SENT_178	[p10l1568t485r1650b518],
12	50.0	CD	NUMBER	50.0	num	13	SENT_178	[p10l1568t485r1650b518],
13	)	NN	O	)	dep	11	SENT_178	[p10l1568t485r1650b518],
14	1.0	CD	NUMBER	1.0	number	15	SENT_178	[p10l1770t485r1810b512],
15	(	CD	NUMBER	(	num	19	SENT_178	[p10l1819t485r1958b518],
16	reference	NN	O	reference	nn	19	SENT_178	[p10l1819t485r1958b518],
17	category	NN	O	category	nn	19	SENT_178	[p10l1967t486r2097b520],
18	)	CD	NUMBER	)	num	19	SENT_178	[p10l1967t486r2097b520],
19	AC	NN	ORGANIZATION	ac	dep	13	SENT_178	[p10l203t531r253b558],
20	5.7	CD	NUMBER	5.7	number	21	SENT_178	[p10l503t531r547b558],
21	(	CD	NUMBER	(	num	19	SENT_178	[p10l559t531r628b564],
22	1.0	CD	NUMBER	1.0	num	23	SENT_178	[p10l559t531r628b564],
23	)	NN	O	)	dep	26	SENT_178	[p10l559t531r628b564],
24	.04	CD	NUMBER	.04	number	25	SENT_178	[p10l886t531r930b558],
25	6	CD	NUMBER	6	num	26	SENT_178	[p10l1187t531r1203b558],
26	(	NN	O	(	dep	32	SENT_178	[p10l1215t531r1302b564],
27	21.4	CD	NUMBER	21.4	number	28	SENT_178	[p10l1215t531r1302b564],
28	)	CD	NUMBER	)	num	26	SENT_178	[p10l1215t531r1302b564],
29	26	CD	NUMBER	26	dep	26	SENT_178	[p10l1519t531r1554b558],
30	(	CD	NUMBER	(	num	32	SENT_178	[p10l1566t531r1654b564],
31	40.6	CD	NUMBER	40.6	num	32	SENT_178	[p10l1566t531r1654b564],
32	)	NN	O	)	dep	42	SENT_178	[p10l1566t531r1654b564],
33	2.8	CD	NUMBER	2.8	number	34	SENT_178	[p10l1797t531r1841b558],
34	(	CD	NUMBER	(	dep	32	SENT_178	[p10l1854t531r1998b564],
35	0.99-8	CD	NUMBER	0.99-8	num	36	SENT_178	[p10l1854t531r1998b564],
36	.2	NN	NUMBER	.2	dep	34	SENT_178	[p10l1854t531r1998b564],
37	;	:	O	;	_	0	SENT_178	[p10l1854t531r1998b564],
38	.05	CD	NUMBER	.05	number	39	SENT_178	[p10l2012t531r2067b564],
39	)	CD	NUMBER	)	dep	34	SENT_178	[p10l2012t531r2067b564],
40	CC	NN	O	cc	dep	39	SENT_178	[p10l204t577r252b603],
41	5.7	CD	NUMBER	5.7	num	40	SENT_178	[p10l503t577r547b603],
42	(	NN	O	(	dep	44	SENT_178	[p10l559t577r628b609],
43	1.1	CD	NUMBER	1.1	num	42	SENT_178	[p10l559t577r628b609],
44	)	NN	O	)	dep	46	SENT_178	[p10l559t577r628b609],
45	1	CD	NUMBER	1	num	44	SENT_178	[p10l1199t577r1210b603],
46	(	NN	O	(	dep	48	SENT_178	[p10l1225t577r1293b609],
47	3.6	CD	NUMBER	3.6	num	46	SENT_178	[p10l1225t577r1293b609],
48	)	NN	O	)	dep	50	SENT_178	[p10l1225t577r1293b609],
49	6	CD	NUMBER	6	num	48	SENT_178	[p10l1538t577r1554b603],
50	(	NN	O	(	dep	52	SENT_178	[p10l1566t577r1635b609],
51	9.4	CD	NUMBER	9.4	num	50	SENT_178	[p10l1566t577r1635b609],
52	)	NN	O	)	dep	71	SENT_178	[p10l1566t577r1635b609],
53	3.9	CD	NUMBER	3.9	num	52	SENT_178	[p10l1779t577r1823b604],
54	(	CD	NUMBER	(	number	55	SENT_178	[p10l1835t577r2017b609],
55	0.443	CD	NUMBER	0.443	dep	52	SENT_178	[p10l1835t577r2017b609],
56	—	NN	O	—	dep	55	SENT_178	[p10l1835t577r2017b609],
57	35.4	CD	NUMBER	35.4	num	56	SENT_178	[p10l1835t577r2017b609],
58	;	:	O	;	_	0	SENT_178	[p10l1835t577r2017b609],
59	.21	CD	NUMBER	.21	number	60	SENT_178	[p10l2031t577r2086b609],
60	)	CD	NUMBER	)	num	61	SENT_178	[p10l2031t577r2086b609],
61	AC+CC	NN	O	ac+cc	dep	55	SENT_178	[p10l116t622r237b649],
62	vs	CC	O	vs	_	0	SENT_178	[p10l249t631r280b649],
63	AA	NN	O	aa	dep	55	SENT_178	[p10l289t623r342b649],
64	6.5	CD	NUMBER	6.5	num	63	SENT_178	[p10l494t622r537b649],
65	vs	CC	O	vs	_	0	SENT_178	[p10l550t631r581b649],
66	5.7	CD	NUMBER	5.7	number	67	SENT_178	[p10l593t622r637b649],
67	.03	CD	NUMBER	.03	num	68	SENT_178	[p10l886t622r928b649],
68	7/21	CD	NUMBER	7/21	dep	55	SENT_178	[p10l1212t622r1274b649],
69	32/32	CD	NUMBER	32/32	number	70	SENT_178	[p10l1545t622r1628b649],
70	3.02	CD	NUMBER	3.02	num	68	SENT_178	[p10l1770t622r1833b649],
71	(	NN	O	(	dep	73	SENT_178	[p10l1845t622r2025b655],
72	1.112-8	CD	NUMBER	1.112-8	num	71	SENT_178	[p10l1845t622r2025b655],
73	.16	CD	NUMBER	.16	dep	76	SENT_178	[p10l1845t622r2025b655],
74	;	:	O	;	_	0	SENT_178	[p10l1845t622r2025b655],
75	.02	CD	NUMBER	.02	num	76	SENT_178	[p10l2039t622r2094b655],
76	)	CD	NUMBER	)	_	0	SENT_178	[p10l2039t622r2094b655],

1	Alleles	NNS	MISC	allele	dep	9	SENT_179	[p10l176t699r280b726],
2	A	DT	O	a	det	4	SENT_179	[p10l216t746r242b772],
3	6.3	CD	NUMBER	6.3	num	4	SENT_179	[p10l503t746r546b772],
4	(	NN	O	(	dep	1	SENT_179	[p10l559t746r628b778],
5	2.0	CD	NUMBER	2.0	number	6	SENT_179	[p10l559t746r628b778],
6	)	CD	NUMBER	)	dep	4	SENT_179	[p10l559t746r628b778],
7	.03	CD	NUMBER	.03	dep	9	SENT_179	[p10l886t763r928b789],
8	48	CD	NUMBER	48	num	9	SENT_179	[p10l1176t746r1212b772],
9	(	NN	O	(	dep	15	SENT_179	[p10l1225t746r1312b778],
10	85.7	CD	NUMBER	85.7	number	11	SENT_179	[p10l1225t746r1312b778],
11	)	CD	NUMBER	)	dep	9	SENT_179	[p10l1225t746r1312b778],
12	91	CD	NUMBER	91	num	13	SENT_179	[p10l1519t746r1551b773],
13	(	NN	O	(	dep	11	SENT_179	[p10l1566t746r1654b778],
14	71.1	CD	NUMBER	71.1	num	15	SENT_179	[p10l1566t746r1654b778],
15	)	CD	NUMBER	)	dep	20	SENT_179	[p10l1566t746r1654b778],
16	0.41	CD	NUMBER	0.41	number	17	SENT_179	[p10l1778t763r1838b789],
17	(	CD	NUMBER	(	dep	15	SENT_179	[p10l1854t762r2017b795],
18	0.16	CD	NUMBER	0.16	num	19	SENT_179	[p10l1854t762r2017b795],
19	_	NN	O	_	dep	17	SENT_179	[p10l1854t762r2017b795],
20	1.01	CD	NUMBER	1.01	_	0	SENT_179	[p10l1854t762r2017b795],
21	;	:	O	;	_	0	SENT_179	[p10l1854t762r2017b795],
22	.03	CD	NUMBER	.03	num	24	SENT_179	[p10l2031t763r2086b795],
23	)	NN	O	)	nn	24	SENT_179	[p10l2031t763r2086b795],
24	C	NN	O	c	dep	32	SENT_179	[p10l216t792r239b818],
25	5.7	CD	NUMBER	5.7	number	26	SENT_179	[p10l503t792r547b818],
26	(	CD	NUMBER	(	dep	24	SENT_179	[p10l559t792r628b824],
27	1.0	CD	NUMBER	1.0	num	28	SENT_179	[p10l559t792r628b824],
28	)	NN	O	)	dep	26	SENT_179	[p10l559t792r628b824],
29	8	CD	NUMBER	8	num	30	SENT_179	[p10l1187t792r1202b818],
30	(	NN	O	(	dep	32	SENT_179	[p10l1215t792r1302b824],
31	14.3	CD	NUMBER	14.3	num	32	SENT_179	[p10l1215t792r1302b824],
32	)	NN	O	)	dep	36	SENT_179	[p10l1215t792r1302b824],
33	37	CD	NUMBER	37	num	34	SENT_179	[p10l1519t792r1553b818],
34	(	CD	NUMBER	(	dep	32	SENT_179	[p10l1566t792r1654b824],
35	28.9	CD	NUMBER	28.9	num	36	SENT_179	[p10l1566t792r1654b824],
36	)	NN	O	)	dep	20	SENT_179	[p10l1566t792r1654b824],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_180	[p10l7t899r438b963],
2	:	:	O	:	_	0	SENT_180	[p10l7t899r438b963],
3	CI	NN	O	ci	dep	1	SENT_180	[p10l464t902r538b973],
4	,	,	O	,	_	0	SENT_180	[p10l464t902r538b973],
5	conlldence	NN	O	conlldence	nn	6	SENT_180	[p10l564t899r883b963],
6	interval	NN	O	interval	appos	3	SENT_180	[p10l911t899r1143b973],
7	;	:	O	;	_	0	SENT_180	[p10l911t899r1143b973],
8	OR	NN	O	or	dep	1	SENT_180	[p10l1170t902r1272b973],
9	,	,	O	,	_	0	SENT_180	[p10l1170t902r1272b973],
10	odds	NNS	O	odds	nn	11	SENT_180	[p10l1298t899r1436b963],
11	ratio	NN	O	ratio	appos	8	SENT_180	[p10l1464t901r1608b963],
12	.	.	O	.	_	0	SENT_180	[p10l1464t901r1608b963],

1	a	DT	O	a	det	2	SENT_181	[p10l9t998r26b1026],
2	Mean	NN	O	mean	dep	32	SENT_181	[p10l56t993r236b1064],
3	,	,	O	,	_	0	SENT_181	[p10l56t993r236b1064],
4	SD	NN	O	sd	nn	5	SENT_181	[p10l262t992r336b1054],
5	(	NN	O	(	appos	2	SENT_181	[p10l364t989r634b1074],
6	adjusted	VBN	O	adjust	partmod	5	SENT_181	[p10l364t989r634b1074],
7	linear	JJ	O	linear	amod	8	SENT_181	[p10l665t989r827b1054],
8	regression	NN	O	regression	dep	17	SENT_181	[p10l853t991r1177b1074],
9	)	CD	NUMBER	)	num	10	SENT_181	[p10l853t991r1177b1074],
10	bAccording	NN	O	baccording	dep	8	SENT_181	[p10l10t1080r346b1166],
11	to	TO	O	to	_	0	SENT_181	[p10l369t1090r426b1147],
12	wheal	JJ	O	wheal	dep	13	SENT_181	[p10l451t1082r627b1147],
13	diameter	NN	O	diameter	amod	14	SENT_181	[p10l655t1082r918b1147],
14	>	JJR	O	>	prep_to	10	SENT_181	[p10l944t1085r1026b1146],
15	7	CD	NUMBER	7	num	16	SENT_181	[p10l944t1085r1026b1146],
16	mm	NN	O	mm	dep	17	SENT_181	[p10l1055t1100r1158b1146],
17	(	NN	O	(	dep	23	SENT_181	[p10l1187t1080r1318b1159],
18	75	CD	NUMBER	75	num	17	SENT_181	[p10l1187t1080r1318b1159],
19	‘“	CD	NUMBER	‘“	num	20	SENT_181	[p10l1187t1080r1318b1159],
20	percentile	NN	O	percentile	dep	17	SENT_181	[p10l1347t1082r1655b1166],
21	)	CD	NUMBER	)	number	22	SENT_181	[p10l1347t1082r1655b1166],
22	“	CD	NUMBER	“	num	23	SENT_181	[p10l9t1177r158b1257],
23	Age	NNP	O	Age	dep	6	SENT_181	[p10l9t1177r158b1257],
24	and	CC	O	and	_	0	SENT_181	[p10l185t1174r290b1238],
25	sex	NN	O	sex	dep	6	SENT_181	[p10l318t1192r411b1238],
26	adjusted	VBN	O	adjust	partmod	23	SENT_181	[p10l436t1174r685b1257],
27	by	IN	O	by	_	0	SENT_181	[p10l716t1174r780b1257],
28	logistic	JJ	O	logistic	amod	31	SENT_181	[p10l805t1174r1010b1257],
29	regression	NN	O	regression	nn	31	SENT_181	[p10l1037t1176r1336b1257],
30	clinical	JJ	O	clinical	amod	31	SENT_181	[p10l9t1424r265b1485],
31	pattern	NN	O	pattern	agent	26	SENT_181	[p10l291t1434r534b1504],
32	showed	VBD	O	show	_	0	SENT_181	[p10l564t1424r828b1485],
33	a	DT	O	a	det	35	SENT_181	[p10l856t1444r892b1485],
34	signiﬁcant	JJ	O	signiﬁcant	amod	35	SENT_181	[p10l921t1424r1283b1504],
35	association	NN	O	association	dobj	32	SENT_181	[p10l1310t1424r1698b1485],
36	between	IN	O	between	_	0	SENT_181	[p10l1723t1424r2015b1485],
37	the	DT	O	the	det	39	SENT_181	[p10l2042t1424r2147b1485],
38	C	NN	O	c	nn	39	SENT_181	[p10l10t1525r63b1586],
39	allele	NN	O	allele	prep_between	35	SENT_181	[p10l91t1525r277b1586],
40	and	CC	O	and	_	0	SENT_181	[p10l304t1525r427b1586],
41	the	DT	O	the	det	43	SENT_181	[p10l451t1525r556b1586],
42	cutaneous	JJ	O	cutaneous	amod	43	SENT_181	[p10l582t1534r928b1586],
43	pattern	NN	O	pattern	dobj	32	SENT_181	[p10l954t1534r1197b1604],
44	of	IN	O	of	_	0	SENT_181	[p10l1222t1525r1298b1586],
45	AIU	NNP	O	AIU	nn	47	SENT_181	[p10l1311t1525r1466b1586],
46	(	CD	NUMBER	(	num	47	SENT_181	[p10l1493t1525r1749b1601],
47	P	NN	O	p	prep_of	43	SENT_181	[p10l1493t1525r1749b1601],
48	=	JJ	O	=	amod	49	SENT_181	[p10l1493t1525r1749b1601],
49	.02	CD	NUMBER	.02	nsubj	32	SENT_181	[p10l1493t1525r1749b1601],
50	,	,	O	,	_	0	SENT_181	[p10l1493t1525r1749b1601],
51	Table	NNP	O	Table	appos	49	SENT_181	[p10l1775t1525r1966b1586],
52	3	CD	NUMBER	3	num	53	SENT_181	[p10l1994t1525r2080b1600],
53	)	NN	O	)	dep	51	SENT_181	[p10l1994t1525r2080b1600],
54	.	.	O	.	_	0	SENT_181	[p10l1994t1525r2080b1600],

1	Histamine	NN	O	histamine	nsubj	5	SENT_182	[p10l140t1625r499b1686],
2	is	VBZ	O	be	cop	5	SENT_182	[p10l522t1625r576b1686],
3	an	DT	O	a	det	5	SENT_182	[p10l603t1645r682b1686],
4	important	JJ	O	important	amod	5	SENT_182	[p10l704t1625r1046b1705],
5	mediator	NN	O	mediator	_	0	SENT_182	[p10l1067t1625r1379b1686],
6	of	IN	O	of	_	0	SENT_182	[p10l1401t1625r1477b1686],
7	urticarial	JJ	O	urticarial	amod	8	SENT_182	[p10l1493t1625r1809b1686],
8	reactions	NNS	O	reaction	prep_of	5	SENT_182	[p10l1831t1625r2145b1686],
9	and	CC	O	and	_	0	SENT_182	[p10l10t1727r134b1788],
10	histamine	NN	O	histamine	nn	11	SENT_182	[p10l162t1727r502b1788],
11	levels	NNS	O	level	nsubj	14	SENT_182	[p10l533t1727r733b1788],
12	are	VBP	O	be	cop	14	SENT_182	[p10l767t1747r870b1788],
13	characteristically	RB	O	characteristically	advmod	14	SENT_182	[p10l901t1727r1498b1807],
14	higher	JJR	O	higher	conj_and	5	SENT_182	[p10l1527t1727r1753b1807],
15	in	IN	O	in	_	0	SENT_182	[p10l1780t1727r1847b1787],
16	lesional	JJ	O	lesional	amod	17	SENT_182	[p10l1876t1727r2148b1788],
17	skin	NN	O	skin	prep_in	14	SENT_182	[p10l11t1828r153b1889],
18	than	IN	O	than	prep	14	SENT_182	[p10l181t1828r330b1889],
19	in	IN	O	in	pcomp	18	SENT_182	[p10l358t1828r424b1888],
20	nonlesional	JJ	O	nonlesional	amod	21	SENT_182	[p10l452t1828r855b1889],
21	skin	NN	O	skin	pobj	19	SENT_182	[p10l887t1828r1028b1889],
22	in	IN	O	in	_	0	SENT_182	[p10l1056t1828r1122b1888],
23	all	DT	O	all	det	24	SENT_182	[p10l1152t1828r1235b1889],
24	forms	NNS	O	form	prep_in	21	SENT_182	[p10l1264t1828r1465b1889],
25	of	IN	O	of	_	0	SENT_182	[p10l1496t1828r1572b1889],
26	urticaria	NN	LOCATION	urticarium	prep_of	24	SENT_182	[p10l1593t1828r1903b1900],
27	,	,	O	,	_	0	SENT_182	[p10l1593t1828r1903b1900],
28	where	WRB	O	where	advmod	35	SENT_182	[p10l1935t1828r2147b1889],
29	binding	NN	O	binding	nsubj	35	SENT_182	[p10l8t1928r270b2008],
30	to	TO	O	to	_	0	SENT_182	[p10l288t1938r353b1989],
31	H1	NN	O	h1	nn	34	SENT_182	[p10l372t1930r454b2018],
32	and	CC	O	and	_	0	SENT_182	[p10l477t1928r599b1989],
33	H2	NN	O	h2	nn	34	SENT_182	[p10l616t1930r702b2018],
34	receptors	NNS	O	receptor	prep_to	29	SENT_182	[p10l719t1938r1032b2008],
35	induces	VBZ	O	induce	advcl	14	SENT_182	[p10l1052t1928r1312b1989],
36	erythema	NN	O	erythema	dobj	35	SENT_182	[p10l1333t1928r1654b2008],
37	and	CC	O	and	_	0	SENT_182	[p10l1671t1928r1794b1989],
38	whealing	NN	O	whealing	dobj	35	SENT_182	[p10l1810t1928r2142b2008],
39	.	.	O	.	_	0	SENT_182	[p10l1810t1928r2142b2008],

1	It	PRP	O	it	nsubjpass	4	SENT_183	[p10l9t2032r62b2091],
2	has	VBZ	O	have	aux	4	SENT_183	[p10l98t2030r214b2091],
3	been	VBN	O	be	auxpass	4	SENT_183	[p10l253t2030r421b2091],
4	postulated	VBN	O	postulate	_	0	SENT_183	[p10l457t2030r828b2110],
5	that	IN	O	that	complm	18	SENT_183	[p10l865t2030r999b2091],
6	inhibition	NN	O	inhibition	nsubj	18	SENT_183	[p10l1035t2030r1385b2091],
7	of	IN	O	of	_	0	SENT_183	[p10l1424t2030r1500b2091],
8	prostaglandin	NN	O	prostaglandin	nn	9	SENT_183	[p10l1531t2030r2022b2110],
9	D2	NN	O	d2	prep_of	6	SENT_183	[p10l2059t2032r2147b2120],
10	and	CC	O	and	_	0	SENT_183	[p10l10t2131r134b2192],
11	E2	NN	O	e2	nn	12	SENT_183	[p10l169t2132r246b2220],
12	production	NN	O	production	conj_and	9	SENT_183	[p10l281t2131r663b2210],
13	by	IN	O	by	_	0	SENT_183	[p10l697t2131r783b2210],
14	aspirin	NN	O	aspirin	nn	17	SENT_183	[p10l822t2131r1058b2210],
15	and	CC	O	and	_	0	SENT_183	[p10l1095t2131r1219b2192],
16	other	JJ	O	other	nn	17	SENT_183	[p10l1255t2131r1435b2192],
17	NSAIDS	NN	MISC	nsaid	prep_by	9	SENT_183	[p10l1468t2131r1768b2192],
18	facilitates	VBZ	O	facilitate	ccomp	4	SENT_183	[p10l1806t2131r2145b2192],
19	cutaneous	JJ	O	cutaneous	amod	22	SENT_183	[p10l9t2241r356b2292],
20	mast	NN	O	mast	nn	22	SENT_183	[p10l384t2241r549b2292],
21	cell	NN	O	cell	nn	22	SENT_183	[p10l574t2231r697b2292],
22	degranulation	NN	O	degranulation	dobj	18	SENT_183	[p10l724t2231r1205b2311],
23	in	IN	O	in	_	0	SENT_183	[p10l1229t2231r1296b2292],
24	humans	NNS	O	human	prep_in	22	SENT_183	[p10l1320t2231r1590b2292],
25	[	CD	NUMBER	[	number	26	SENT_183	[p10l1624t2232r1736b2306],
26	4	CD	NUMBER	4	num	27	SENT_183	[p10l1624t2232r1736b2306],
27	]	NN	O	]	dep	24	SENT_183	[p10l1624t2232r1736b2306],
28	,	,	O	,	_	0	SENT_183	[p10l1624t2232r1736b2306],
29	since	IN	O	since	mark	35	SENT_183	[p10l1768t2231r1943b2292],
30	these	DT	O	these	det	32	SENT_183	[p10l1969t2231r2147b2292],
31	lipid	NN	O	lipid	nn	32	SENT_183	[p10l9t2333r168b2413],
32	metabolites	NNS	O	metabolite	nsubj	35	SENT_183	[p10l202t2333r603b2394],
33	are	VBP	O	be	cop	35	SENT_183	[p10l642t2353r744b2394],
34	natural	JJ	O	natural	amod	35	SENT_183	[p10l780t2333r1021b2394],
35	inhibitors	NNS	O	inhibitor	dep	24	SENT_183	[p10l1056t2333r1389b2394],
36	of	IN	O	of	_	0	SENT_183	[p10l1427t2333r1503b2394],
37	histamine	NN	O	histamine	nn	38	SENT_183	[p10l1530t2333r1871b2394],
38	release	NN	O	release	prep_of	35	SENT_183	[p10l1905t2333r2147b2394],
39	in	IN	O	in	_	0	SENT_183	[p10l8t2434r75b2494],
40	rat	NN	O	rat	prep_in	38	SENT_183	[p10l104t2443r196b2495],
41	peritoneal	JJ	O	peritoneal	amod	43	SENT_183	[p10l224t2434r574b2513],
42	mast	NN	O	mast	nn	43	SENT_183	[p10l604t2443r770b2495],
43	cells	NNS	O	cell	nsubj	44	SENT_183	[p10l799t2434r955b2495],
44	[	VBP	O	[	rcmod	35	SENT_183	[p10l993t2434r1149b2508],
45	31	CD	NUMBER	31	num	46	SENT_183	[p10l993t2434r1149b2508],
46	]	CD	NUMBER	]	dobj	44	SENT_183	[p10l993t2434r1149b2508],
47	.	.	O	.	_	0	SENT_183	[p10l993t2434r1149b2508],

1	Here	RB	O	here	advmod	4	SENT_184	[p10l1183t2435r1371b2506],
2	,	,	O	,	_	0	SENT_184	[p10l1183t2435r1371b2506],
3	we	PRP	O	we	nsubj	4	SENT_184	[p10l1405t2453r1504b2495],
4	used	VBD	O	use	_	0	SENT_184	[p10l1533t2434r1694b2495],
5	skin	NN	O	skin	nn	6	SENT_184	[p10l1726t2434r1867b2495],
6	tests	NNS	O	test	dobj	4	SENT_184	[p10l1897t2443r2049b2495],
7	to	TO	O	to	aux	8	SENT_184	[p10l2081t2443r2146b2495],
8	evaluate	VB	O	evaluate	xcomp	4	SENT_184	[p10l9t2534r294b2596],
9	the	DT	O	the	dobj	8	SENT_184	[p10l313t2534r416b2595],
10	in	FW	O	in	nn	11	SENT_184	[p10l434t2534r500b2595],
11	vivo	FW	O	vivo	dep	12	SENT_184	[p10l517t2534r668b2596],
12	response	NN	O	response	dep	9	SENT_184	[p10l686t2554r988b2614],
13	to	TO	O	to	_	0	SENT_184	[p10l1005t2544r1070b2595],
14	histamine	NN	O	histamine	prep_to	8	SENT_184	[p10l1088t2534r1423b2595],
15	in	IN	O	in	_	0	SENT_184	[p10l1441t2534r1507b2595],
16	patients	NNS	O	patient	prep_in	8	SENT_184	[p10l1523t2534r1789b2614],
17	with	IN	O	with	_	0	SENT_184	[p10l1809t2534r1961b2596],
18	AIU	NNP	ORGANIZATION	AIU	prep_with	16	SENT_184	[p10l1973t2535r2143b2596],
19	.	.	O	.	_	0	SENT_184	[p10l1973t2535r2143b2596],

1	The	DT	O	the	det	2	SENT_185	[p10l9t2636r143b2697],
2	results	NNS	O	result	nsubj	3	SENT_185	[p10l174t2636r400b2697],
3	revealed	VBD	O	reveal	dep	27	SENT_185	[p10l433t2636r730b2697],
4	that	IN	O	that	complm	14	SENT_185	[p10l761t2636r892b2697],
5	wheal	NN	O	wheal	nn	6	SENT_185	[p10l923t2636r1130b2697],
6	diameter	NN	O	diameter	nsubj	14	SENT_185	[p10l1163t2636r1469b2697],
7	after	IN	O	after	_	0	SENT_185	[p10l1501t2636r1660b2697],
8	epicutaneous	JJ	O	epicutaneous	amod	9	SENT_185	[p10l1691t2636r2145b2716],
9	application	NN	O	application	prep_after	6	SENT_185	[p10l10t2737r398b2816],
10	of	IN	O	of	_	0	SENT_185	[p10l421t2737r496b2798],
11	histamine	NN	O	histamine	prep_of	9	SENT_185	[p10l512t2737r851b2798],
12	was	VBD	O	be	cop	14	SENT_185	[p10l874t2756r1006b2798],
13	signiﬁcantly	RB	O	signiﬁcantly	advmod	14	SENT_185	[p10l1033t2737r1463b2816],
14	lower	JJR	O	lower	ccomp	3	SENT_185	[p10l1486t2737r1685b2798],
15	in	IN	O	in	_	0	SENT_185	[p10l1705t2737r1771b2797],
16	carriers	NNS	O	carrier	prep_in	14	SENT_185	[p10l1794t2737r2052b2798],
17	of	IN	O	of	_	0	SENT_185	[p10l2077t2737r2153b2798],
18	the	DT	O	the	det	22	SENT_185	[p10l8t2837r113b2898],
19	AC	NN	O	ac	nn	22	SENT_185	[p10l136t2838r254b2899],
20	and	CC	O	and	_	0	SENT_185	[p10l285t2837r409b2898],
21	CC	NN	O	cc	conj_and	19	SENT_185	[p10l436t2838r549b2899],
22	genotypes	NNS	O	genotype	prep_of	16	SENT_185	[p10l578t2847r930b2917],
23	compared	VBN	O	compare	_	0	SENT_185	[p10l960t2837r1305b2917],
24	to	TO	O	to	prepc_compared_to	14	SENT_185	[p10l1331t2847r1396b2898],
25	AA	NN	O	aa	nn	26	SENT_185	[p10l1419t2838r1545b2898],
26	carriers	NNS	O	carrier	pobj	14	SENT_185	[p10l1568t2837r1826b2898],
27	(	VBP	O	(	_	0	SENT_185	[p10l1858t2838r2142b2913],
28	P	NN	O	p	nsubj	29	SENT_185	[p10l1858t2838r2142b2913],
29	=	JJ	O	=	xcomp	27	SENT_185	[p10l1858t2838r2142b2913],
30	.02	CD	NUMBER	.02	num	31	SENT_185	[p10l1858t2838r2142b2913],
31	)	NN	O	)	nsubj	27	SENT_185	[p10l1858t2838r2142b2913],
32	.	.	O	.	_	0	SENT_185	[p10l1858t2838r2142b2913],

1	This	DT	O	this	det	2	SENT_186	[p10l9t2939r161b3000],
2	effect	NN	O	effect	nsubjpass	5	SENT_186	[p10l193t2939r390b3000],
3	was	VBD	O	be	auxpass	5	SENT_186	[p10l418t2959r550b3000],
4	also	RB	O	also	advmod	5	SENT_186	[p10l583t2939r719b3000],
5	observed	VBN	O	observe	_	0	SENT_186	[p10l751t2939r1066b3000],
6	when	WRB	O	when	advmod	7	SENT_186	[p10l1095t2939r1283b3000],
7	analyzing	VBG	O	analyze	advcl	5	SENT_186	[p10l1313t2939r1651b3019],
8	the	DT	O	the	det	9	SENT_186	[p10l1680t2939r1785b3000],
9	degree	NN	O	degree	dobj	7	SENT_186	[p10l1816t2939r2046b3019],
10	of	IN	O	of	_	0	SENT_186	[p10l2077t2939r2153b3000],
11	response	NN	O	response	prep_of	9	SENT_186	[p10l8t3059r314b3119],
12	to	TO	O	to	_	0	SENT_186	[p10l342t3049r407b3101],
13	histamine	NN	O	histamine	prep_to	7	SENT_186	[p10l435t3040r775b3101],
14	according	VBG	O	accord	_	0	SENT_186	[p10l805t3040r1147b3119],
15	to	TO	O	to	prepc_according_to	7	SENT_186	[p10l1176t3049r1241b3101],
16	the	DT	O	the	det	20	SENT_186	[p10l1270t3040r1375b3101],
17	A	NN	O	a	nn	20	SENT_186	[p10l1398t3040r1692b3101],
18	—	NN	O	—	nn	20	SENT_186	[p10l1398t3040r1692b3101],
19	444C	NN	O	444c	nn	20	SENT_186	[p10l1398t3040r1692b3101],
20	distribution	NN	O	distribution	pobj	7	SENT_186	[p10l1723t3040r2144b3112],
21	,	,	O	,	_	0	SENT_186	[p10l1723t3040r2144b3112],
22	considering	VBG	O	consider	dep	7	SENT_186	[p10l9t3140r430b3220],
23	high	JJ	O	high	amod	24	SENT_186	[p10l468t3140r628b3220],
24	reactivity	NN	O	reactivity	dobj	22	SENT_186	[p10l664t3140r1008b3220],
25	a	DT	O	a	det	27	SENT_186	[p10l1048t3160r1085b3201],
26	wheal	NN	O	wheal	nn	27	SENT_186	[p10l1121t3140r1335b3202],
27	diameter	NN	O	diameter	npadvmod	28	SENT_186	[p10l1374t3140r1690b3201],
28	higher	JJR	O	higher	advmod	22	SENT_186	[p10l1726t3140r1957b3220],
29	than	IN	O	than	_	0	SENT_186	[p10l1994t3140r2148b3201],
30	7	CD	NUMBER	7	num	32	SENT_186	[p10l9t3244r47b3303],
31	mm	NN	O	mm	nn	32	SENT_186	[p10l84t3262r221b3302],
32	(	NN	O	(	nn	35	SENT_186	[p10l256t3242r437b3318],
33	75th	JJ	ORDINAL	75th	amod	35	SENT_186	[p10l256t3242r437b3318],
34	percentile	NN	O	percentile	nn	35	SENT_186	[p10l469t3242r862b3322],
35	)	NN	O	)	prep_than	22	SENT_186	[p10l469t3242r862b3322],
36	.	.	O	.	_	0	SENT_186	[p10l469t3242r862b3322],

1	In	IN	O	in	_	0	SENT_187	[p10l901t3244r972b3302],
2	addition	NN	O	addition	prep_in	9	SENT_187	[p10l1008t3242r1311b3314],
3	,	,	O	,	_	0	SENT_187	[p10l1008t3242r1311b3314],
4	the	DT	O	the	det	6	SENT_187	[p10l1348t3242r1453b3303],
5	C	NN	O	c	nn	6	SENT_187	[p10l1488t3243r1542b3304],
6	allele	NN	O	allele	nsubj	9	SENT_187	[p10l1580t3242r1765b3303],
7	was	VBD	O	be	cop	9	SENT_187	[p10l1801t3262r1933b3303],
8	more	RBR	O	more	advmod	9	SENT_187	[p10l1969t3262r2147b3303],
9	frequent	JJ	O	frequent	_	0	SENT_187	[p10l9t3343r300b3422],
10	among	IN	O	among	_	0	SENT_187	[p10l319t3362r553b3422],
11	patients	NNS	O	patient	prep_among	9	SENT_187	[p10l572t3343r841b3422],
12	with	IN	O	with	_	0	SENT_187	[p10l862t3343r1016b3404],
13	a	DT	O	a	det	16	SENT_187	[p10l1036t3362r1072b3404],
14	low	JJ	O	low	amod	16	SENT_187	[p10l1090t3343r1218b3404],
15	skin	NN	O	skin	nn	16	SENT_187	[p10l1241t3343r1382b3404],
16	response	NN	O	response	prep_with	11	SENT_187	[p10l1399t3362r1705b3422],
17	to	TO	O	to	_	0	SENT_187	[p10l1724t3352r1788b3404],
18	histamine	NN	O	histamine	prep_to	9	SENT_187	[p10l1808t3343r2147b3404],
19	compared	VBN	O	compare	_	0	SENT_187	[p10l9t3443r354b3523],
20	to	TO	O	to	prepc_compared_to	9	SENT_187	[p10l388t3453r454b3504],
21	those	DT	O	those	pobj	9	SENT_187	[p10l490t3443r673b3504],
22	with	IN	O	with	_	0	SENT_187	[p10l709t3443r863b3505],
23	a	DT	O	a	det	25	SENT_187	[p10l900t3463r936b3504],
24	high	JJ	O	high	amod	25	SENT_187	[p10l969t3443r1124b3523],
25	response	NN	O	response	prep_with	21	SENT_187	[p10l1158t3463r1464b3523],
26	(	CD	PERCENT	(	number	27	SENT_187	[p10l1502t3444r1750b3519],
27	28.9	CD	PERCENT	28.9	num	28	SENT_187	[p10l1502t3444r1750b3519],
28	%	NN	PERCENT	%	dep	25	SENT_187	[p10l1502t3444r1750b3519],
29	vs	CC	O	vs	_	0	SENT_187	[p10l1789t3463r1863b3504],
30	14.3	CD	PERCENT	14.3	num	31	SENT_187	[p10l1908t3444r2144b3516],
31	%	NN	PERCENT	%	prep_with	21	SENT_187	[p10l1908t3444r2144b3516],
32	,	,	O	,	_	0	SENT_187	[p10l1908t3444r2144b3516],
33	P	NN	O	p	appos	31	SENT_187	[p10l7t3546r238b3617],
34	=	JJ	O	=	amod	33	SENT_187	[p10l7t3546r238b3617],
35	.03	CD	NUMBER	.03	tmod	34	SENT_187	[p10l7t3546r238b3617],
36	,	,	O	,	_	0	SENT_187	[p10l7t3546r238b3617],
37	Table	NNP	O	Table	appos	25	SENT_187	[p10l263t3545r454b3606],
38	4	CD	NUMBER	4	number	39	SENT_187	[p10l477t3545r566b3621],
39	)	CD	NUMBER	)	dep	37	SENT_187	[p10l477t3545r566b3621],
40	.	.	O	.	_	0	SENT_187	[p10l477t3545r566b3621],

1	The	DT	O	the	det	2	SENT_188	[p10l592t3545r726b3606],
2	effects	NNS	O	effect	nsubjpass	13	SENT_188	[p10l750t3545r978b3606],
3	were	VBD	O	be	auxpass	13	SENT_188	[p10l1003t3565r1171b3606],
4	signiﬁcant	JJ	O	signiﬁcant	amod	11	SENT_188	[p10l1198t3545r1560b3625],
5	after	IN	O	after	_	0	SENT_188	[p10l1583t3545r1742b3606],
6	adjustment	NN	O	adjustment	prep_after	4	SENT_188	[p10l1765t3545r2148b3625],
7	for	IN	O	for	_	0	SENT_188	[p10l9t3646r111b3707],
8	clinical	JJ	O	clinical	amod	10	SENT_188	[p10l139t3646r395b3707],
9	pattern	NN	O	pattern	nn	10	SENT_188	[p10l424t3655r667b3725],
10	(	NN	O	(	prep_for	6	SENT_188	[p10l699t3646r871b3722],
11	data	NNS	O	datum	npadvmod	12	SENT_188	[p10l699t3646r871b3722],
12	not	RB	O	not	neg	13	SENT_188	[p10l899t3655r1010b3707],
13	shown	VBN	O	show	_	0	SENT_188	[p10l1042t3646r1293b3721],
14	)	NN	O	)	dobj	13	SENT_188	[p10l1042t3646r1293b3721],
15	and	CC	O	and	_	0	SENT_188	[p10l1327t3646r1450b3707],
16	no	DT	O	no	det	17	SENT_188	[p10l1479t3665r1564b3707],
17	association	NN	O	association	nsubjpass	19	SENT_188	[p10l1596t3646r1984b3707],
18	was	VBD	O	be	auxpass	19	SENT_188	[p10l2013t3665r2145b3707],
19	observed	VBN	O	observe	conj_and	13	SENT_188	[p11l10t17r325b78],
20	with	IN	O	with	_	0	SENT_188	[p11l352t17r506b79],
21	the	DT	O	the	det	23	SENT_188	[p11l534t17r639b78],
22	wheal	NN	O	wheal	nn	23	SENT_188	[p11l667t17r875b79],
23	diameter	NN	O	diameter	prep_with	19	SENT_188	[p11l904t17r1210b78],
24	of	IN	O	of	_	0	SENT_188	[p11l1238t17r1313b78],
25	any	DT	O	any	prep_of	23	SENT_188	[p11l1337t37r1459b97],
26	of	IN	O	of	_	0	SENT_188	[p11l1489t17r1565b78],
27	the	DT	O	the	det	29	SENT_188	[p11l1587t17r1692b78],
28	25	CD	NUMBER	25	num	29	SENT_188	[p11l1721t17r1802b79],
29	allergens	NNS	O	allergen	prep_of	25	SENT_188	[p11l1835t17r2145b97],
30	tested	VBN	O	test	partmod	29	SENT_188	[p11l8t119r229b180],
31	.	.	O	.	_	0	SENT_188	[p11l8t119r229b180],

1	In	IN	O	in	_	0	SENT_189	[p11l140t221r213b280],
2	this	DT	O	this	det	3	SENT_189	[p11l237t220r365b281],
3	population	NN	O	population	prep_in	12	SENT_189	[p11l390t220r802b299],
4	,	,	O	,	_	0	SENT_189	[p11l390t220r802b299],
5	the	DT	O	the	det	9	SENT_189	[p11l830t220r938b281],
6	A	NN	O	a	nn	9	SENT_189	[p11l958t220r1261b281],
7	—	NN	O	—	nn	9	SENT_189	[p11l958t220r1261b281],
8	444C	CD	NUMBER	444c	num	9	SENT_189	[p11l958t220r1261b281],
9	SNP	NN	ORGANIZATION	snp	nsubjpass	12	SENT_189	[p11l1290t220r1450b281],
10	was	VBD	O	be	auxpass	12	SENT_189	[p11l1471t239r1607b281],
11	not	RB	O	not	neg	12	SENT_189	[p11l1634t229r1749b281],
12	associated	VBN	O	associate	_	0	SENT_189	[p11l1774t220r2148b281],
13	with	IN	O	with	_	0	SENT_189	[p11l9t320r168b381],
14	atopy	NN	O	atopy	prep_with	12	SENT_189	[p11l196t330r409b400],
15	,	,	O	,	_	0	SENT_189	[p11l196t330r409b400],
16	total	JJ	O	total	amod	18	SENT_189	[p11l438t320r599b381],
17	IgE	NN	O	ige	nn	18	SENT_189	[p11l625t322r754b400],
18	levels	NNS	O	level	conj_or	14	SENT_189	[p11l780t320r1011b393],
19	,	,	O	,	_	0	SENT_189	[p11l780t320r1011b393],
20	or	CC	O	or	_	0	SENT_189	[p11l1042t340r1115b381],
21	speciﬁc	JJ	O	speciﬁc	amod	23	SENT_189	[p11l1143t320r1415b400],
22	IgE	NN	O	ige	nn	23	SENT_189	[p11l1442t322r1571b400],
23	levels	NNS	O	level	conj_or	14	SENT_189	[p11l1597t320r1806b382],
24	to	TO	O	to	_	0	SENT_189	[p11l1834t330r1901b381],
25	mites	NNS	O	mite	prep_to	12	SENT_189	[p11l1928t320r2143b381],
26	.	.	O	.	_	0	SENT_189	[p11l1928t320r2143b381],

1	We	PRP	O	we	nsubj	2	SENT_190	[p11l8t424r123b483],
2	found	VBD	O	find	_	0	SENT_190	[p11l164t422r376b483],
3	no	DT	O	no	det	4	SENT_190	[p11l416t442r503b483],
4	association	NN	O	association	dobj	2	SENT_190	[p11l545t422r956b483],
5	when	WRB	O	when	advmod	6	SENT_190	[p11l996t422r1191b483],
6	analyzing	VBG	O	analyze	advcl	2	SENT_190	[p11l1232t422r1587b502],
7	the	DT	O	the	det	11	SENT_190	[p11l1628t422r1738b483],
8	allele	NN	O	allele	nn	11	SENT_190	[p11l1780t422r1977b483],
9	and	CC	O	and	_	0	SENT_190	[p11l2020t422r2148b483],
10	genotype	NN	O	genotype	nn	11	SENT_190	[p11l10t532r338b602],
11	distribution	NN	O	distribution	dobj	6	SENT_190	[p11l362t523r780b584],
12	of	IN	O	of	_	0	SENT_190	[p11l803t523r880b584],
13	A	DT	O	a	det	15	SENT_190	[p11l891t523r1192b584],
14	—	CD	NUMBER	—	num	15	SENT_190	[p11l891t523r1192b584],
15	444C	NN	O	444c	prep_of	11	SENT_190	[p11l891t523r1192b584],
16	as	IN	O	as	_	0	SENT_190	[p11l1217t542r1286b584],
17	a	DT	O	a	det	19	SENT_190	[p11l1311t542r1348b584],
18	dichotomous	JJ	O	dichotomous	amod	19	SENT_190	[p11l1369t523r1833b584],
19	variable	NN	O	variable	prep_as	6	SENT_190	[p11l1857t523r2147b584],
20	or	CC	O	or	_	0	SENT_190	[p11l10t643r83b684],
21	stratiﬁed	VBN	O	stratiﬁed	advcl	2	SENT_190	[p11l108t623r425b684],
22	by	IN	O	by	_	0	SENT_190	[p11l447t623r535b703],
23	the	DT	O	the	det	27	SENT_190	[p11l559t623r667b684],
24	sensitization	NN	O	sensitization	nn	27	SENT_190	[p11l694t623r1150b684],
25	pattern	NN	O	pattern	nn	27	SENT_190	[p11l1173t633r1427b703],
26	(	NN	O	(	nn	27	SENT_190	[p11l1453t623r2148b699],
27	monosensitization	NN	O	monosensitization	prep_by	21	SENT_190	[p11l1453t623r2148b699],
28	or	CC	O	or	_	0	SENT_190	[p11l10t745r83b786],
29	dual	JJ	O	dual	amod	31	SENT_190	[p11l114t725r267b786],
30	sensitization	NN	O	sensitization	nn	31	SENT_190	[p11l303t725r787b801],
31	)	NN	O	)	conj_or	27	SENT_190	[p11l303t725r787b801],
32	according	VBG	O	accord	_	0	SENT_190	[p11l823t725r1179b805],
33	to	TO	O	to	prepc_according_to	21	SENT_190	[p11l1212t735r1279b786],
34	the	DT	O	the	det	37	SENT_190	[p11l1312t725r1420b786],
35	speciﬁc	JJ	O	speciﬁc	amod	37	SENT_190	[p11l1456t725r1728b805],
36	IgE	NN	O	ige	nn	37	SENT_190	[p11l1761t727r1890b805],
37	result	NN	O	result	pobj	21	SENT_190	[p11l1920t725r2142b786],
38	.	.	O	.	_	0	SENT_190	[p11l1920t725r2142b786],

1	The	DT	O	the	det	3	SENT_191	[p11l9t826r146b887],
2	C	NN	O	c	nn	3	SENT_191	[p11l184t826r237b887],
3	allele	NN	O	allele	nsubj	4	SENT_191	[p11l276t826r471b887],
4	tended	VBD	O	tend	_	0	SENT_191	[p11l507t826r749b887],
5	to	TO	O	to	aux	8	SENT_191	[p11l784t835r851b887],
6	be	VB	O	be	cop	8	SENT_191	[p11l887t826r970b887],
7	more	RBR	O	more	advmod	8	SENT_191	[p11l1006t845r1189b887],
8	frequent	JJ	O	frequent	xcomp	4	SENT_191	[p11l1226t826r1530b905],
9	in	IN	O	in	_	0	SENT_191	[p11l1565t826r1633b886],
10	patients	NNS	O	patient	prep_in	8	SENT_191	[p11l1667t826r1950b905],
11	with	IN	O	with	_	0	SENT_191	[p11l1988t826r2148b887],
12	AIU	NNP	ORGANIZATION	AIU	prep_with	10	SENT_191	[p11l8t927r166b988],
13	who	WP	O	who	nsubj	14	SENT_191	[p11l204t926r355b988],
14	had	VBD	O	have	rcmod	10	SENT_191	[p11l393t926r523b987],
15	allergic	JJ	O	allergic	amod	16	SENT_191	[p11l562t926r831b1006],
16	rhinitis	NN	O	rhinitis	dobj	14	SENT_191	[p11l869t926r1127b987],
17	than	IN	O	than	advmod	8	SENT_191	[p11l1167t926r1321b987],
18	in	IN	O	in	_	0	SENT_191	[p11l1359t926r1427b987],
19	those	DT	O	those	prep_in	17	SENT_191	[p11l1464t926r1654b987],
20	who	WP	O	who	nsubj	21	SENT_191	[p11l1693t926r1844b988],
21	did	VBD	O	do	rcmod	19	SENT_191	[p11l1884t926r1997b987],
22	not	RB	O	not	neg	25	SENT_191	[p11l2034t936r2149b987],
23	(	CD	PERCENT	(	num	25	SENT_191	[p11l11t1028r203b1104],
24	26	CD	PERCENT	26	num	25	SENT_191	[p11l11t1028r203b1104],
25	%	NN	PERCENT	%	dobj	21	SENT_191	[p11l11t1028r203b1104],
26	vs	CC	O	vs	_	0	SENT_191	[p11l250t1048r326b1089],
27	10.7	CD	PERCENT	10.7	num	28	SENT_191	[p11l379t1028r632b1101],
28	%	NN	PERCENT	%	dobj	21	SENT_191	[p11l379t1028r632b1101],
29	,	,	O	,	_	0	SENT_191	[p11l379t1028r632b1101],
30	respectively	RB	O	respectively	advmod	31	SENT_191	[p11l676t1028r1192b1108],
31	)	CD	NUMBER	)	appos	28	SENT_191	[p11l676t1028r1192b1108],
32	,	,	O	,	_	0	SENT_191	[p11l676t1028r1192b1108],
33	although	IN	O	although	mark	41	SENT_191	[p11l1240t1028r1568b1108],
34	the	DT	O	the	det	35	SENT_191	[p11l1609t1028r1721b1089],
35	difference	NN	O	difference	nsubj	41	SENT_191	[p11l1765t1028r2147b1089],
36	was	VBD	O	be	cop	41	SENT_191	[p11l9t1148r145b1190],
37	not	RB	O	not	neg	41	SENT_191	[p11l174t1138r288b1190],
38	statistically	RB	O	statistically	advmod	39	SENT_191	[p11l317t1129r733b1208],
39	signiﬁcant	JJ	O	signiﬁcant	amod	41	SENT_191	[p11l763t1129r1141b1208],
40	(	NN	O	(	nn	41	SENT_191	[p11l1170t1129r1466b1205],
41	P	NN	O	p	dep	28	SENT_191	[p11l1170t1129r1466b1205],
42	=	JJ	O	=	amod	41	SENT_191	[p11l1170t1129r1466b1205],
43	.07	CD	NUMBER	.07	num	44	SENT_191	[p11l1170t1129r1466b1205],
44	)	NN	O	)	dep	42	SENT_191	[p11l1170t1129r1466b1205],
45	.	.	O	.	_	0	SENT_191	[p11l1170t1129r1466b1205],

1	The	DT	O	the	det	5	SENT_192	[p11l1497t1129r1634b1190],
2	A	NN	O	a	nn	5	SENT_192	[p11l1656t1129r1959b1190],
3	—	NN	O	—	nn	5	SENT_192	[p11l1656t1129r1959b1190],
4	444C	CD	NUMBER	444c	num	5	SENT_192	[p11l1656t1129r1959b1190],
5	SNP	NN	O	snp	nsubjpass	8	SENT_192	[p11l1990t1129r2151b1190],
6	was	VBD	O	be	auxpass	8	SENT_192	[p11l9t1249r145b1290],
7	not	RB	O	not	neg	8	SENT_192	[p11l178t1239r293b1290],
8	associated	VBN	O	associate	_	0	SENT_192	[p11l325t1229r699b1290],
9	with	IN	O	with	_	0	SENT_192	[p11l730t1229r889b1291],
10	any	DT	O	any	det	12	SENT_192	[p11l922t1249r1048b1309],
11	particular	JJ	O	particular	amod	12	SENT_192	[p11l1079t1229r1432b1309],
12	hypersensitivity	NN	O	hypersensitivity	prep_with	8	SENT_192	[p11l1461t1229r2048b1309],
13	to	TO	O	to	_	0	SENT_192	[p11l2079t1239r2146b1290],
14	NSAIDS	NNPS	MISC	NSAIDS	prep_to	8	SENT_192	[p11l8t1332r339b1403],
15	,	,	O	,	_	0	SENT_192	[p11l8t1332r339b1403],
16	and	CC	O	and	_	0	SENT_192	[p11l373t1331r500b1392],
17	we	PRP	O	we	nsubj	20	SENT_192	[p11l529t1351r630b1392],
18	did	VBD	O	do	aux	20	SENT_192	[p11l661t1331r774b1392],
19	not	RB	O	not	neg	20	SENT_192	[p11l803t1341r918b1392],
20	observe	VB	O	observe	conj_and	8	SENT_192	[p11l947t1331r1227b1392],
21	any	DT	O	any	det	22	SENT_192	[p11l1259t1351r1384b1411],
22	association	NN	O	association	dobj	20	SENT_192	[p11l1416t1331r1821b1392],
23	with	IN	O	with	_	0	SENT_192	[p11l1850t1331r2010b1392],
24	the	DT	O	the	det	25	SENT_192	[p11l2038t1331r2146b1392],
25	responsiveness	NN	O	responsiveness	prep_with	22	SENT_192	[p11l8t1432r555b1511],
26	to	TO	O	to	_	0	SENT_192	[p11l592t1441r658b1493],
27	weak	JJ	O	weak	amod	28	SENT_192	[p11l694t1432r884b1493],
28	inhibitors	NNS	O	inhibitor	prep_to	20	SENT_192	[p11l916t1432r1265b1493],
29	of	IN	O	of	_	0	SENT_192	[p11l1302t1432r1379b1493],
30	COX-1	NN	O	cox-1	nn	34	SENT_192	[p11l1409t1432r1664b1493],
31	(	CD	NUMBER	(	num	34	SENT_192	[p11l1709t1432r2042b1507],
32	low	JJ	O	low	amod	34	SENT_192	[p11l1709t1432r2042b1507],
33	—	NN	O	—	nn	34	SENT_192	[p11l1709t1432r2042b1507],
34	risk	NN	O	risk	prep_of	28	SENT_192	[p11l1709t1432r2042b1507],
35	or	CC	O	or	_	0	SENT_192	[p11l2075t1451r2149b1493],
36	high	JJ	O	high	amod	39	SENT_192	[p11l8t1532r340b1612],
37	—	NN	O	—	nn	39	SENT_192	[p11l8t1532r340b1612],
38	risk	NN	O	risk	nn	39	SENT_192	[p11l8t1532r340b1612],
39	patients	NNS	O	patient	prep_to	20	SENT_192	[p11l365t1532r700b1612],
40	)	CD	NUMBER	)	dep	39	SENT_192	[p11l365t1532r700b1612],
41	.	.	O	.	_	0	SENT_192	[p11l365t1532r700b1612],

1	J	NNP	O	J	nn	5	SENT_193	[p11l7t1781r44b1832],
2	Investig	NNP	O	Investig	nn	5	SENT_193	[p11l58t1781r292b1845],
3	Allergol	NNP	O	Allergol	nn	5	SENT_193	[p11l307t1779r551b1845],
4	Clin	NNP	O	Clin	nn	5	SENT_193	[p11l574t1779r695b1832],
5	Immunol	NNP	O	Immunol	_	0	SENT_193	[p11l715t1779r980b1831],
6	2009	CD	DATE	2009	num	5	SENT_193	[p11l1000t1779r1163b1840],
7	;	:	O	;	_	0	SENT_193	[p11l1000t1779r1163b1840],
8	Vol	NNP	O	Vol	dep	5	SENT_193	[p11l1185t1779r1299b1831],
9	.	.	O	.	_	0	SENT_193	[p11l1185t1779r1299b1831],

1	19	CD	NUMBER	19	num	2	SENT_194	[p11l1331t1779r1498b1843],
2	(	CD	NUMBER	(	_	0	SENT_194	[p11l1331t1779r1498b1843],
3	5	CD	NUMBER	5	num	4	SENT_194	[p11l1331t1779r1498b1843],
4	)	NN	O	)	dep	2	SENT_194	[p11l1331t1779r1498b1843],
5	:	:	O	:	_	0	SENT_194	[p11l1331t1779r1498b1843],
6	375-382	CD	NUMBER	375-382	dep	4	SENT_194	[p11l1525t1779r1767b1831],

1	Discussion	NN	O	discussion	_	0	SENT_195	[p11l16t2012r541b2098],

1	We	PRP	O	we	nsubj	2	SENT_196	[p11l137t2241r251b2300],
2	evaluated	VBD	O	evaluate	_	0	SENT_196	[p11l271t2239r605b2300],
3	the	DT	O	the	det	4	SENT_196	[p11l623t2239r728b2300],
4	frequency	NN	O	frequency	dobj	2	SENT_196	[p11l747t2239r1096b2319],
5	of	IN	O	of	_	0	SENT_196	[p11l1116t2239r1192b2300],
6	the	DT	O	the	det	10	SENT_196	[p11l1204t2239r1309b2300],
7	A	NN	O	a	nn	10	SENT_196	[p11l1323t2239r1618b2301],
8	—	NN	O	—	nn	10	SENT_196	[p11l1323t2239r1618b2301],
9	444C	NN	O	444c	nn	10	SENT_196	[p11l1323t2239r1618b2301],
10	polymorphism	NN	O	polymorphism	prep_of	4	SENT_196	[p11l1637t2239r2150b2319],
11	of	IN	O	of	_	0	SENT_196	[p11l8t2340r84b2401],
12	LTC4S	NN	O	ltc4	prep_of	10	SENT_196	[p11l98t2340r344b2402],
13	in	IN	O	in	_	0	SENT_196	[p11l363t2340r430b2400],
14	a	DT	O	a	det	16	SENT_196	[p11l454t2359r490b2401],
15	Venezuelan	JJ	LOCATION	venezuelan	amod	16	SENT_196	[p11l509t2340r914b2401],
16	population	NN	O	population	prep_in	2	SENT_196	[p11l934t2340r1311b2419],
17	and	CC	O	and	_	0	SENT_196	[p11l1334t2340r1458b2401],
18	its	PRP$	O	its	poss	19	SENT_196	[p11l1480t2340r1558b2401],
19	association	NN	O	association	conj_and	16	SENT_196	[p11l1585t2340r1973b2401],
20	with	IN	O	with	_	0	SENT_196	[p11l1995t2340r2149b2401],
21	AIU	NNP	ORGANIZATION	AIU	prep_with	19	SENT_196	[p11l7t2441r163b2502],
22	in	IN	O	in	_	0	SENT_196	[p11l201t2440r268b2501],
23	a	DT	O	a	det	25	SENT_196	[p11l308t2460r344b2502],
24	well-characterized	JJ	O	well-characterized	amod	25	SENT_196	[p11l380t2440r1047b2502],
25	population	NN	O	population	prep_in	21	SENT_196	[p11l1083t2440r1468b2520],
26	of	IN	O	of	_	0	SENT_196	[p11l1507t2440r1584b2502],
27	NSAID	NN	O	nsaid	nn	30	SENT_196	[p11l1615t2441r2146b2502],
28	—	CD	NUMBER	—	num	30	SENT_196	[p11l1615t2441r2146b2502],
29	cross	NN	O	cross	nn	30	SENT_196	[p11l1615t2441r2146b2502],
30	—	NN	O	—	prep_of	25	SENT_196	[p11l1615t2441r2146b2502],
31	reactive	JJ	O	reactive	amod	32	SENT_196	[p11l6t2542r291b2603],
32	patients	NNS	O	patient	dep	19	SENT_196	[p11l329t2542r629b2622],
33	.	.	O	.	_	0	SENT_196	[p11l329t2542r629b2622],

1	Based	VBN	O	base	_	0	SENT_197	[p11l672t2542r890b2603],
2	on	IN	O	on	prepc_based_on	18	SENT_197	[p11l929t2562r1015b2603],
3	one	CD	NUMBER	one	pobj	18	SENT_197	[p11l1054t2562r1179b2603],
4	of	IN	O	of	_	0	SENT_197	[p11l1219t2542r1296b2603],
5	the	DT	O	the	det	7	SENT_197	[p11l1328t2542r1435b2603],
6	largest	JJS	O	largest	amod	7	SENT_197	[p11l1474t2542r1713b2622],
7	samples	NNS	O	sample	prep_of	3	SENT_197	[p11l1753t2542r2036b2622],
8	of	IN	O	of	_	0	SENT_197	[p11l2078t2542r2154b2603],
9	patients	NNS	O	patient	prep_of	7	SENT_197	[p11l6t2643r286b2722],
10	for	IN	O	for	_	0	SENT_197	[p11l326t2643r431b2704],
11	genetic	JJ	O	genetic	amod	12	SENT_197	[p11l468t2643r726b2722],
12	studies	NNS	O	study	prep_for	9	SENT_197	[p11l768t2643r1013b2704],
13	of	IN	O	of	_	0	SENT_197	[p11l1055t2643r1132b2704],
14	this	DT	O	this	det	15	SENT_197	[p11l1164t2643r1290b2704],
15	disease	NN	O	disease	prep_of	12	SENT_197	[p11l1332t2643r1611b2715],
16	,	,	O	,	_	0	SENT_197	[p11l1332t2643r1611b2715],
17	we	PRP	O	we	nsubj	18	SENT_197	[p11l1653t2662r1753b2704],
18	replicated	VBD	O	replicate	_	0	SENT_197	[p11l1791t2643r2150b2722],
19	previous	JJ	O	previous	amod	20	SENT_197	[p11l6t2743r309b2823],
20	ﬁndings	NNS	O	ﬁndings	nsubj	21	SENT_197	[p11l349t2743r630b2823],
21	[	VBP	O	[	ccomp	18	SENT_197	[p11l674t2743r900b2818],
22	5,17	CD	NUMBER	5,17	num	23	SENT_197	[p11l674t2743r900b2818],
23	]	CD	NUMBER	]	dobj	21	SENT_197	[p11l674t2743r900b2818],
24	,	,	O	,	_	0	SENT_197	[p11l674t2743r900b2818],
25	suggesting	VBG	O	suggest	partmod	21	SENT_197	[p11l942t2743r1317b2823],
26	that	IN	O	that	complm	33	SENT_197	[p11l1354t2743r1486b2805],
27	A	DT	O	a	det	29	SENT_197	[p11l1516t2744r1813b2805],
28	—	CD	NUMBER	—	num	29	SENT_197	[p11l1516t2744r1813b2805],
29	444C	NN	O	444c	nsubj	33	SENT_197	[p11l1516t2744r1813b2805],
30	is	VBZ	O	be	cop	33	SENT_197	[p11l1851t2743r1906b2805],
31	a	DT	O	a	det	33	SENT_197	[p11l1946t2763r1982b2805],
32	risk	NN	O	risk	nn	33	SENT_197	[p11l2016t2743r2150b2805],
33	factor	NN	O	factor	ccomp	25	SENT_197	[p11l7t2845r212b2906],
34	for	IN	O	for	_	0	SENT_197	[p11l246t2845r348b2906],
35	AIU	NNP	O	AIU	prep_for	33	SENT_197	[p11l377t2846r549b2906],
36	.	.	O	.	_	0	SENT_197	[p11l377t2846r549b2906],

1	In	IN	O	in	_	0	SENT_198	[p11l589t2847r661b2905],
2	addition	NN	O	addition	prep_in	5	SENT_198	[p11l697t2845r1001b2917],
3	,	,	O	,	_	0	SENT_198	[p11l697t2845r1001b2917],
4	we	PRP	O	we	nsubj	5	SENT_198	[p11l1040t2865r1140b2906],
5	described	VBD	O	describe	_	0	SENT_198	[p11l1177t2845r1512b2906],
6	for	IN	O	for	_	0	SENT_198	[p11l1547t2845r1649b2906],
7	the	DT	O	the	det	9	SENT_198	[p11l1683t2845r1788b2906],
8	ﬁrst	JJ	O	ﬁrst	amod	9	SENT_198	[p11l1825t2845r1960b2906],
9	time	NN	O	time	prep_for	5	SENT_198	[p11l1994t2845r2148b2906],
10	that	WDT	O	that	dobj	15	SENT_198	[p11l7t2946r138b3007],
11	A	DT	O	a	det	13	SENT_198	[p11l164t2946r459b3007],
12	—	CD	NUMBER	—	num	13	SENT_198	[p11l164t2946r459b3007],
13	444C	NN	O	444c	nsubjpass	15	SENT_198	[p11l164t2946r459b3007],
14	is	VBZ	O	be	auxpass	15	SENT_198	[p11l493t2946r547b3007],
15	associated	VBN	O	associate	ccomp	5	SENT_198	[p11l583t2946r941b3007],
16	with	IN	O	with	_	0	SENT_198	[p11l973t2946r1127b3007],
17	a	DT	O	a	det	20	SENT_198	[p11l1161t2965r1197b3007],
18	particular	JJ	O	particular	amod	20	SENT_198	[p11l1227t2946r1565b3025],
19	clinical	JJ	O	clinical	amod	20	SENT_198	[p11l1596t2946r1852b3007],
20	pattern	NN	O	pattern	prep_with	15	SENT_198	[p11l1883t2955r2145b3025],
21	,	,	O	,	_	0	SENT_198	[p11l1883t2955r2145b3025],
22	that	WDT	O	that	nsubj	23	SENT_198	[p11l7t3046r138b3108],
23	is	VBZ	O	be	rcmod	20	SENT_198	[p11l166t3046r241b3119],
24	,	,	O	,	_	0	SENT_198	[p11l166t3046r241b3119],
25	the	DT	O	the	det	28	SENT_198	[p11l274t3046r379b3108],
26	variant	JJ	O	variant	amod	28	SENT_198	[p11l409t3046r652b3108],
27	C	NN	O	c	nn	28	SENT_198	[p11l681t3047r735b3108],
28	allele	NN	O	allele	nsubj	31	SENT_198	[p11l768t3046r954b3108],
29	is	VBZ	O	be	cop	31	SENT_198	[p11l984t3046r1038b3108],
30	more	RBR	O	more	advmod	31	SENT_198	[p11l1069t3066r1248b3108],
31	frequent	JJ	O	frequent	ccomp	23	SENT_198	[p11l1278t3046r1570b3126],
32	in	IN	O	in	_	0	SENT_198	[p11l1598t3046r1664b3107],
33	patients	NNS	O	patient	prep_in	31	SENT_198	[p11l1693t3046r1964b3126],
34	with	IN	O	with	_	0	SENT_198	[p11l1995t3046r2149b3108],
35	cutaneous	JJ	O	cutaneous	amod	37	SENT_198	[p11l8t3157r355b3209],
36	adverse	JJ	O	adverse	amod	37	SENT_198	[p11l389t3148r654b3209],
37	reactions	NNS	O	reaction	prep_with	33	SENT_198	[p11l683t3148r998b3209],
38	to	TO	O	to	_	0	SENT_198	[p11l1030t3157r1095b3209],
39	aspirin	NN	O	aspirin	nn	42	SENT_198	[p11l1129t3148r1365b3228],
40	and	CC	O	and	_	0	SENT_198	[p11l1397t3148r1520b3209],
41	other	JJ	O	other	conj_and	39	SENT_198	[p11l1551t3148r1730b3209],
42	NSAIDS	NNS	MISC	nsaid	prep_to	31	SENT_198	[p11l1758t3148r2078b3220],
43	,	,	O	,	_	0	SENT_198	[p11l1758t3148r2078b3220],
44	a	DT	O	a	det	46	SENT_198	[p11l2114t3168r2150b3209],
45	clinical	JJ	O	clinical	amod	46	SENT_198	[p11l8t3249r264b3310],
46	picture	NN	O	picture	attr	31	SENT_198	[p11l284t3249r527b3328],
47	restricted	JJ	O	restricted	amod	46	SENT_198	[p11l547t3249r875b3310],
48	to	TO	O	to	_	0	SENT_198	[p11l895t3258r960b3310],
49	the	DT	O	the	det	50	SENT_198	[p11l982t3249r1087b3310],
50	skin	NN	O	skin	prep_to	47	SENT_198	[p11l1111t3249r1253b3310],
51	and	CC	O	and	_	0	SENT_198	[p11l1275t3249r1399b3310],
52	devoid	JJ	O	devoid	amod	46	SENT_198	[p11l1420t3249r1657b3310],
53	of	IN	O	of	_	0	SENT_198	[p11l1679t3249r1754b3310],
54	respiratory	JJ	O	respiratory	amod	57	SENT_198	[p11l1769t3249r2148b3328],
55	or	CC	O	or	_	0	SENT_198	[p11l8t3369r80b3411],
56	ocular	JJ	O	ocular	amod	57	SENT_198	[p11l104t3350r322b3411],
57	manifestations	NNS	O	manifestation	prep_of	46	SENT_198	[p11l345t3349r874b3411],
58	.	.	O	.	_	0	SENT_198	[p11l345t3349r874b3411],

1	An	DT	O	a	det	2	SENT_199	[p11l138t3452r244b3511],
2	association	NN	O	association	nsubj	12	SENT_199	[p11l275t3451r663b3512],
3	between	IN	O	between	_	0	SENT_199	[p11l692t3451r985b3512],
4	A	DT	O	a	det	6	SENT_199	[p11l1009t3451r1304b3513],
5	—	CD	NUMBER	—	num	6	SENT_199	[p11l1009t3451r1304b3513],
6	444C	NN	O	444c	prep_between	2	SENT_199	[p11l1009t3451r1304b3513],
7	and	CC	O	and	_	0	SENT_199	[p11l1338t3451r1461b3512],
8	aspirin	NN	O	aspirin	nn	11	SENT_199	[p11l1492t3451r2148b3531],
9	—	NN	O	—	nn	11	SENT_199	[p11l1492t3451r2148b3531],
10	intolerance	NN	O	intolerance	nn	11	SENT_199	[p11l1492t3451r2148b3531],
11	phenotypes	NNS	O	phenotype	prep_between	2	SENT_199	[p11l6t3552r407b3631],
12	(	VBP	O	(	_	0	SENT_199	[p11l448t3552r630b3627],
13	AIU	NNP	ORGANIZATION	AIU	nsubj	26	SENT_199	[p11l448t3552r630b3627],
14	and	CC	O	and	_	0	SENT_199	[p11l667t3552r791b3613],
15	AIA	NNP	ORGANIZATION	AIA	nsubj	26	SENT_199	[p11l822t3552r1004b3627],
16	)	NN	O	)	nsubj	18	SENT_199	[p11l822t3552r1004b3627],
17	was	VBD	O	be	cop	18	SENT_199	[p11l1043t3571r1175b3613],
18	ﬁrst	CD	NUMBER	ﬁrst	rcmod	13	SENT_199	[p11l1215t3552r1350b3613],
19	reported	VBN	O	report	partmod	18	SENT_199	[p11l1384t3552r1680b3631],
20	by	IN	O	by	_	0	SENT_199	[p11l1714t3552r1800b3631],
21	Sanak	NNP	PERSON	Sanak	agent	19	SENT_199	[p11l1839t3552r2053b3613],
22	et	FW	O	et	nn	24	SENT_199	[p11l2088t3561r2150b3613],
23	al	FW	O	al	nn	24	SENT_199	[p11l9t3653r67b3714],
24	[	FW	O	[	dobj	19	SENT_199	[p11l91t3653r246b3727],
25	32	CD	NUMBER	32	num	26	SENT_199	[p11l91t3653r246b3727],
26	]	NN	O	]	xcomp	12	SENT_199	[p11l91t3653r246b3727],
27	;	:	O	;	_	0	SENT_199	[p11l91t3653r246b3727],
28	however	RB	O	however	advmod	37	SENT_199	[p11l266t3653r576b3725],
29	,	,	O	,	_	0	SENT_199	[p11l266t3653r576b3725],
30	studies	NNS	O	study	nsubj	37	SENT_199	[p11l600t3652r831b3714],
31	including	VBG	O	include	_	0	SENT_199	[p11l851t3652r1173b3732],
32	white	JJ	O	white	amod	35	SENT_199	[p11l1191t3652r1380b3714],
33	and	CC	O	and	_	0	SENT_199	[p11l1400t3653r1522b3714],
34	Asian	JJ	LOCATION	asian	conj_and	32	SENT_199	[p11l1533t3652r1732b3714],
35	populations	NNS	O	population	prep_including	30	SENT_199	[p11l1748t3652r2147b3732],
36	have	VBP	O	have	aux	37	SENT_199	[p12l6t18r174b79],
37	failed	VBN	O	fail	parataxis	12	SENT_199	[p12l212t18r416b79],
38	to	TO	O	to	aux	39	SENT_199	[p12l453t27r519b79],
39	replicate	VB	O	replicate	xcomp	37	SENT_199	[p12l557t18r867b98],
40	this	DT	O	this	det	42	SENT_199	[p12l905t18r1031b79],
41	ﬁnding	JJ	O	ﬁnding	amod	42	SENT_199	[p12l1072t18r1322b98],
42	[	NN	O	[	iobj	39	SENT_199	[p12l1368t18r1595b92],
43	8,14	CD	NUMBER	8,14	num	44	SENT_199	[p12l1368t18r1595b92],
44	]	NN	O	]	dobj	39	SENT_199	[p12l1368t18r1595b92],
45	.	.	O	.	_	0	SENT_199	[p12l1368t18r1595b92],

1	This	DT	O	this	nsubjpass	4	SENT_200	[p12l1636t18r1792b79],
2	could	MD	O	could	aux	4	SENT_200	[p12l1832t18r2030b79],
3	be	VB	O	be	auxpass	4	SENT_200	[p12l2066t18r2148b79],
4	explained	VBN	O	explain	_	0	SENT_200	[p12l8t119r348b198],
5	by	IN	O	by	_	0	SENT_200	[p12l378t119r464b198],
6	differences	NNS	O	difference	agent	4	SENT_200	[p12l497t119r882b180],
7	in	IN	O	in	_	0	SENT_200	[p12l916t119r982b179],
8	ethnic	JJ	O	ethnic	amod	9	SENT_200	[p12l1014t119r1225b180],
9	characteristics	NNS	O	characteristic	prep_in	6	SENT_200	[p12l1259t119r1779b191],
10	,	,	O	,	_	0	SENT_200	[p12l1259t119r1779b191],
11	deﬁnition	NN	O	deﬁnition	appos	9	SENT_200	[p12l1814t119r2149b180],
12	of	IN	O	of	_	0	SENT_200	[p12l8t219r84b281],
13	outcomes	NNS	O	outcome	prep_of	11	SENT_200	[p12l109t229r463b292],
14	,	,	O	,	_	0	SENT_200	[p12l109t229r463b292],
15	criteria	NNS	O	criterion	appos	13	SENT_200	[p12l497t219r744b281],
16	for	IN	O	for	_	0	SENT_200	[p12l773t219r875b281],
17	deﬁning	VBG	O	deﬁning	amod	19	SENT_200	[p12l905t219r1189b299],
18	hypersensitivity	NN	O	hypersensitivity	nn	19	SENT_200	[p12l1220t219r1780b299],
19	reactions	NNS	O	reaction	prep_for	15	SENT_200	[p12l1810t219r2145b292],
20	,	,	O	,	_	0	SENT_200	[p12l1810t219r2145b292],
21	and	CC	O	and	_	0	SENT_200	[p12l9t321r133b382],
22	different	JJ	O	different	amod	23	SENT_200	[p12l162t321r462b382],
23	environmental	JJ	O	environmental	appos	13	SENT_200	[p12l490t321r996b382],
24	and	CC	O	and	_	0	SENT_200	[p12l1027t321r1150b382],
25	genetic	JJ	O	genetic	amod	26	SENT_200	[p12l1180t321r1429b401],
26	backgrounds	NNS	O	background	conj_and	15	SENT_200	[p12l1458t321r1925b401],
27	.	.	O	.	_	0	SENT_200	[p12l1458t321r1925b401],

1	Here	RB	O	here	advmod	4	SENT_201	[p12l1958t323r2145b394],
2	,	,	O	,	_	0	SENT_201	[p12l1958t323r2145b394],
3	we	PRP	O	we	nsubj	24	SENT_201	[p12l7t441r109b483],
4	found	VBD	O	find	_	0	SENT_201	[p12l148t422r359b483],
5	a	DT	O	a	det	7	SENT_201	[p12l399t441r435b483],
6	significant	JJ	O	significant	amod	7	SENT_201	[p12l475t422r860b501],
7	association	NN	O	association	dobj	4	SENT_201	[p12l899t422r1303b483],
8	between	IN	O	between	_	0	SENT_201	[p12l1341t422r1643b483],
9	A	DT	O	a	det	11	SENT_201	[p12l1677t422r1980b483],
10	—	CD	NUMBER	—	num	11	SENT_201	[p12l1677t422r1980b483],
11	444C	NN	O	444c	prep_between	7	SENT_201	[p12l1677t422r1980b483],
12	and	CC	O	and	_	0	SENT_201	[p12l2022t422r2150b483],
13	AIU	NNP	ORGANIZATION	AIU	conj_and	7	SENT_201	[p12l7t523r166b584],
14	in	IN	O	in	_	0	SENT_201	[p12l206t522r274b583],
15	a	DT	O	a	det	16	SENT_201	[p12l316t542r352b584],
16	group	NN	O	group	prep_in	13	SENT_201	[p12l392t542r602b602],
17	of	IN	O	of	_	0	SENT_201	[p12l644t522r722b584],
18	cross	JJ	O	cross	amod	19	SENT_201	[p12l756t522r1271b584],
19	—	NN	O	—	prep_of	16	SENT_201	[p12l756t522r1271b584],
20	reactive	JJ	O	reactive	amod	22	SENT_201	[p12l756t522r1271b584],
21	nonwhite	JJ	O	nonwhite	amod	22	SENT_201	[p12l1311t522r1652b584],
22	patients	NNS	O	patient	dep	13	SENT_201	[p12l1691t522r1977b602],
23	and	CC	O	and	_	0	SENT_201	[p12l2021t522r2150b584],
24	showed	VBD	O	show	conj_and	4	SENT_201	[p12l10t624r274b685],
25	that	IN	O	that	complm	33	SENT_201	[p12l308t624r439b685],
26	A	DT	O	a	det	28	SENT_201	[p12l467t624r761b686],
27	—	CD	NUMBER	—	num	28	SENT_201	[p12l467t624r761b686],
28	444C	NN	O	444c	nsubj	33	SENT_201	[p12l467t624r761b686],
29	is	VBZ	O	be	cop	33	SENT_201	[p12l797t624r851b685],
30	an	DT	O	a	det	33	SENT_201	[p12l889t644r968b685],
31	important	JJ	O	important	amod	33	SENT_201	[p12l1002t624r1344b704],
32	risk	NN	O	risk	nn	33	SENT_201	[p12l1375t624r1508b685],
33	factor	NN	O	factor	ccomp	24	SENT_201	[p12l1540t624r1745b685],
34	for	IN	O	for	_	0	SENT_201	[p12l1777t624r1879b685],
35	aspirin	NN	O	aspirin	nn	36	SENT_201	[p12l1913t624r2149b704],
36	hypersensitivity	NN	O	hypersensitivity	prep_for	33	SENT_201	[p12l7t725r580b804],
37	.	.	O	.	_	0	SENT_201	[p12l7t725r580b804],

1	In	IN	O	in	_	0	SENT_202	[p12l138t827r210b886],
2	contrast	NN	O	contrast	prep_in	10	SENT_202	[p12l229t835r506b887],
3	to	TO	O	to	_	0	SENT_202	[p12l524t835r589b887],
4	our	PRP$	O	we	poss	5	SENT_202	[p12l610t845r726b887],
5	results	NNS	O	result	prep_to	2	SENT_202	[p12l742t826r989b898],
6	,	,	O	,	_	0	SENT_202	[p12l742t826r989b898],
7	Kim	NNP	PERSON	Kim	nn	9	SENT_202	[p12l1013t825r1167b886],
8	et	NNP	O	et	nn	9	SENT_202	[p12l1185t835r1247b887],
9	al	NNP	O	al	nsubj	10	SENT_202	[p12l1266t825r1326b887],
10	reported	VBD	O	report	_	0	SENT_202	[p12l1344t826r1637b905],
11	no	DT	O	no	det	12	SENT_202	[p12l1655t845r1740b887],
12	association	NN	O	association	nsubj	21	SENT_202	[p12l1762t825r2149b887],
13	between	IN	O	between	_	0	SENT_202	[p12l6t927r299b988],
14	A	DT	O	a	det	16	SENT_202	[p12l321t927r615b989],
15	—	CD	NUMBER	—	num	16	SENT_202	[p12l321t927r615b989],
16	444C	NN	O	444c	prep_between	12	SENT_202	[p12l321t927r615b989],
17	and	CC	O	and	_	0	SENT_202	[p12l646t927r770b988],
18	AIU	NNP	ORGANIZATION	AIU	conj_and	12	SENT_202	[p12l792t928r946b989],
19	in	IN	O	in	_	0	SENT_202	[p12l973t927r1040b987],
20	Koreans	NNPS	O	Koreans	prep_in	18	SENT_202	[p12l1068t929r1356b988],
21	[	VBP	O	[	ccomp	10	SENT_202	[p12l1391t927r1657b1001],
22	16,33	CD	NUMBER	16,33	number	23	SENT_202	[p12l1391t927r1657b1001],
23	]	CD	NUMBER	]	dobj	21	SENT_202	[p12l1391t927r1657b1001],
24	.	.	O	.	_	0	SENT_202	[p12l1391t927r1657b1001],

1	Interestingly	RB	O	interestingly	advmod	4	SENT_203	[p12l1689t927r2145b1007],
2	,	,	O	,	_	0	SENT_203	[p12l1689t927r2145b1007],
3	there	EX	O	there	expl	4	SENT_203	[p12l7t1028r187b1089],
4	is	VBZ	O	be	_	0	SENT_203	[p12l226t1028r282b1089],
5	no	DT	O	no	det	7	SENT_203	[p12l323t1047r409b1089],
6	signiﬁcant	NN	O	signiﬁcant	nn	7	SENT_203	[p12l452t1028r829b1107],
7	difference	NN	O	difference	nsubj	4	SENT_203	[p12l868t1028r1234b1089],
8	in	IN	O	in	_	0	SENT_203	[p12l1273t1028r1341b1088],
9	the	DT	O	the	det	10	SENT_203	[p12l1380t1028r1488b1089],
10	frequency	NN	O	frequency	prep_in	7	SENT_203	[p12l1528t1028r1889b1107],
11	of	IN	O	of	_	0	SENT_203	[p12l1930t1028r2007b1089],
12	the	DT	O	the	det	14	SENT_203	[p12l2040t1028r2148b1089],
13	minor	JJ	O	minor	amod	14	SENT_203	[p12l7t1128r217b1190],
14	allele	NN	O	allele	prep_of	10	SENT_203	[p12l253t1128r439b1190],
15	between	IN	O	between	_	0	SENT_203	[p12l475t1128r767b1190],
16	Koreans	NNPS	LOCATION	Koreans	prep_between	14	SENT_203	[p12l804t1130r1092b1190],
17	and	CC	O	and	_	0	SENT_203	[p12l1132t1129r1256b1190],
18	our	PRP$	O	we	poss	21	SENT_203	[p12l1291t1148r1407b1190],
19	population	NN	O	population	nn	21	SENT_203	[p12l1440t1128r1816b1208],
20	(	CD	NUMBER	(	num	21	SENT_203	[p12l1854t1129r2145b1208],
21	q	NN	O	q	prep_of	10	SENT_203	[p12l1854t1129r2145b1208],
22	=	JJ	O	=	amod	28	SENT_203	[p12l1854t1129r2145b1208],
23	0.13	CD	NUMBER	0.13	tmod	22	SENT_203	[p12l1854t1129r2145b1208],
24	,	,	O	,	_	0	SENT_203	[p12l1854t1129r2145b1208],
25	P	NN	O	p	nn	27	SENT_203	[p12l6t1231r221b1306],
26	=	JJ	O	=	amod	27	SENT_203	[p12l6t1231r221b1306],
27	.2	NN	NUMBER	.2	appos	23	SENT_203	[p12l6t1231r221b1306],
28	)	NN	O	)	dep	21	SENT_203	[p12l6t1231r221b1306],
29	.	.	O	.	_	0	SENT_203	[p12l6t1231r221b1306],

1	In	IN	O	in	_	0	SENT_204	[p12l248t1232r319b1290],
2	this	DT	O	this	det	3	SENT_204	[p12l340t1230r463b1291],
3	case	NN	O	case	prep_in	12	SENT_204	[p12l488t1250r655b1302],
4	,	,	O	,	_	0	SENT_204	[p12l488t1250r655b1302],
5	a	DT	O	a	det	8	SENT_204	[p12l682t1250r719b1291],
6	different	JJ	O	different	amod	8	SENT_204	[p12l740t1230r1040b1291],
7	genetic	JJ	O	genetic	amod	8	SENT_204	[p12l1061t1230r1311b1310],
8	background	NN	O	background	nsubj	12	SENT_204	[p12l1333t1230r1749b1310],
9	could	MD	O	could	aux	12	SENT_204	[p12l1771t1230r1964b1291],
10	have	VB	O	have	aux	12	SENT_204	[p12l1984t1230r2148b1291],
11	been	VBN	O	be	cop	12	SENT_204	[p12l6t1331r172b1392],
12	responsible	JJ	O	responsible	_	0	SENT_204	[p12l194t1331r594b1410],
13	for	IN	O	for	_	0	SENT_204	[p12l618t1331r720b1392],
14	variations	NNS	O	variation	prep_for	12	SENT_204	[p12l743t1331r1085b1392],
15	in	IN	O	in	_	0	SENT_204	[p12l1112t1331r1178b1391],
16	the	DT	O	the	det	20	SENT_204	[p12l1202t1331r1307b1392],
17	A	NN	O	a	nn	20	SENT_204	[p12l1326t1331r1621b1392],
18	—	NN	O	—	nn	20	SENT_204	[p12l1326t1331r1621b1392],
19	444C	NN	O	444c	nn	20	SENT_204	[p12l1326t1331r1621b1392],
20	effect	NN	O	effect	prep_in	14	SENT_204	[p12l1647t1331r1861b1392],
21	.	.	O	.	_	0	SENT_204	[p12l1647t1331r1861b1392],

1	Indeed	RB	O	indeed	advmod	8	SENT_205	[p12l1889t1331r2145b1403],
2	,	,	O	,	_	0	SENT_205	[p12l1889t1331r2145b1403],
3	A	DT	O	a	det	5	SENT_205	[p12l7t1432r298b1493],
4	—	JJ	O	—	amod	5	SENT_205	[p12l7t1432r298b1493],
5	444C	NN	O	444c	nsubjpass	8	SENT_205	[p12l7t1432r298b1493],
6	was	VBD	O	be	auxpass	8	SENT_205	[p12l318t1451r449b1493],
7	only	RB	O	only	advmod	8	SENT_205	[p12l470t1432r620b1511],
8	associated	VBN	O	associate	_	0	SENT_205	[p12l641t1431r993b1493],
9	with	IN	O	with	_	0	SENT_205	[p12l1010t1431r1162b1493],
10	intolerance	NN	O	intolerance	prep_with	8	SENT_205	[p12l1180t1431r1562b1493],
11	to	TO	O	to	_	0	SENT_205	[p12l1580t1441r1644b1493],
12	aspirin	NN	O	aspirin	prep_to	8	SENT_205	[p12l1665t1431r1897b1511],
13	among	IN	O	among	_	0	SENT_205	[p12l1916t1451r2148b1511],
14	Koreans	NNPS	O	Koreans	prep_among	12	SENT_205	[p12l9t1535r296b1594],
15	in	IN	O	in	_	0	SENT_205	[p12l318t1533r384b1593],
16	the	DT	O	the	det	17	SENT_205	[p12l403t1533r508b1594],
17	setting	NN	O	setting	prep_in	12	SENT_205	[p12l531t1533r759b1613],
18	of	IN	O	of	_	0	SENT_205	[p12l781t1533r856b1594],
19	a	DT	O	a	det	23	SENT_205	[p12l872t1553r908b1594],
20	gene	NN	O	gene	nn	23	SENT_205	[p12l927t1553r1116b1613],
21	—	NN	O	—	nn	23	SENT_205	[p12l927t1553r1116b1613],
22	gene	NN	O	gene	nn	23	SENT_205	[p12l1123t1553r1285b1613],
23	interaction	NN	O	interaction	prep_of	17	SENT_205	[p12l1305t1533r1680b1594],
24	with	IN	O	with	_	0	SENT_205	[p12l1699t1533r1854b1594],
25	variants	NNS	O	variant	prep_with	12	SENT_205	[p12l1872t1533r2147b1594],
26	in	IN	O	in	_	0	SENT_205	[p12l7t1634r74b1694],
27	CysLTR2	NN	O	cysltr2	nn	31	SENT_205	[p12l100t1634r436b1713],
28	(	CD	NUMBER	(	num	31	SENT_205	[p12l465t1634r807b1713],
29	cysteinyl	NN	O	cysteinyl	nn	31	SENT_205	[p12l465t1634r807b1713],
30	leukotriene	NN	O	leukotriene	nn	31	SENT_205	[p12l834t1634r1227b1695],
31	receptor	NN	O	receptor	prep_in	25	SENT_205	[p12l1253t1643r1542b1713],
32	2	CD	NUMBER	2	number	33	SENT_205	[p12l1567t1634r1634b1710],
33	)	CD	NUMBER	)	num	34	SENT_205	[p12l1567t1634r1634b1710],
34	[	NN	O	[	dep	12	SENT_205	[p12l1669t1634r1825b1708],
35	34	CD	NUMBER	34	num	36	SENT_205	[p12l1669t1634r1825b1708],
36	]	NN	O	]	dep	34	SENT_205	[p12l1669t1634r1825b1708],
37	.	.	O	.	_	0	SENT_205	[p12l1669t1634r1825b1708],

1	The	DT	O	the	det	2	SENT_206	[p12l1854t1634r1988b1695],
2	role	NN	O	role	nsubj	14	SENT_206	[p12l2013t1634r2148b1695],
3	of	IN	O	of	_	0	SENT_206	[p12l8t1734r84b1796],
4	the	DT	O	the	det	6	SENT_206	[p12l109t1734r214b1796],
5	genetic	JJ	O	genetic	amod	6	SENT_206	[p12l247t1734r496b1814],
6	component	NN	O	component	prep_of	2	SENT_206	[p12l530t1744r920b1814],
7	in	IN	O	in	_	0	SENT_206	[p12l950t1734r1016b1795],
8	the	DT	O	the	det	9	SENT_206	[p12l1047t1735r1152b1796],
9	pathogenesis	NN	O	pathogenesis	prep_in	6	SENT_206	[p12l1183t1734r1635b1814],
10	of	IN	O	of	_	0	SENT_206	[p12l1669t1734r1745b1796],
11	AIU	NNP	ORGANIZATION	AIU	prep_of	9	SENT_206	[p12l1765t1735r1920b1796],
12	is	VBZ	O	be	cop	14	SENT_206	[p12l1951t1734r2005b1796],
13	not	RB	O	not	neg	14	SENT_206	[p12l2039t1744r2150b1796],
14	clear	JJ	O	clear	_	0	SENT_206	[p12l8t1836r189b1897],
15	.	.	O	.	_	0	SENT_206	[p12l8t1836r189b1897],

1	Genes	NNS	O	gene	nsubj	8	SENT_207	[p12l227t1836r442b1898],
2	conferring	VBG	O	confer	partmod	1	SENT_207	[p12l477t1836r840b1916],
3	speciﬁc	NN	O	speciﬁc	nn	4	SENT_207	[p12l877t1836r1139b1916],
4	susceptibility	NN	O	susceptibility	dobj	2	SENT_207	[p12l1177t1836r1641b1916],
5	to	TO	O	to	_	0	SENT_207	[p12l1674t1845r1739b1897],
6	AIU	NNP	ORGANIZATION	AIU	prep_to	2	SENT_207	[p12l1768t1837r1923b1898],
7	could	MD	O	could	aux	8	SENT_207	[p12l1956t1836r2149b1897],
8	exist	VB	O	exist	_	0	SENT_207	[p12l8t1937r172b1998],
9	while	IN	O	while	mark	12	SENT_207	[p12l194t1937r387b1998],
10	others	NNS	O	other	nsubj	12	SENT_207	[p12l411t1937r621b1998],
11	could	MD	O	could	aux	12	SENT_207	[p12l646t1937r840b1998],
12	inﬂuence	VB	O	inﬂuence	advcl	8	SENT_207	[p12l861t1937r1182b1998],
13	the	DT	O	the	det	15	SENT_207	[p12l1205t1937r1309b1998],
14	AERD	NN	O	aerd	nn	15	SENT_207	[p12l1328t1937r1564b1997],
15	phenotype	NN	O	phenotype	dobj	12	SENT_207	[p12l1587t1937r1970b2016],
16	.	.	O	.	_	0	SENT_207	[p12l1587t1937r1970b2016],

1	Two	CD	NUMBER	two	num	4	SENT_208	[p12l1996t1938r2147b1998],
2	strong	JJ	O	strong	amod	4	SENT_208	[p12l10t2047r224b2117],
3	positive	JJ	O	positive	amod	4	SENT_208	[p12l260t2037r537b2117],
4	associations	NNS	O	association	nsubjpass	7	SENT_208	[p12l574t2037r994b2099],
5	have	VBP	O	have	aux	7	SENT_208	[p12l1031t2037r1195b2099],
6	been	VBN	O	be	auxpass	7	SENT_208	[p12l1230t2037r1395b2099],
7	reported	VBN	O	report	_	0	SENT_208	[p12l1429t2037r1722b2117],
8	in	IN	O	in	_	0	SENT_208	[p12l1756t2037r1822b2098],
9	Koreans	NNPS	O	Koreans	prep_in	7	SENT_208	[p12l1859t2039r2146b2099],
10	between	IN	O	between	_	0	SENT_208	[p12l6t2139r302b2201],
11	HLA	NN	O	hlum	prep_between	9	SENT_208	[p12l339t2135r980b2201],
12	.	.	O	.	_	0	SENT_208	[p12l339t2135r980b2201],

1	—	NN	O	—	_	0	SENT_209	[p12l339t2135r980b2201],
2	.	.	O	.	_	0	SENT_209	[p12l339t2135r980b2201],

1	DRB1	NN	O	drb1	_	0	SENT_210	[p12l339t2135r980b2201],
2	*	CD	NUMBER	*	num	3	SENT_210	[p12l339t2135r980b2201],
3	l302	NN	O	l302	dep	1	SENT_210	[p12l339t2135r980b2201],
4	and	CC	O	and	_	0	SENT_210	[p12l1019t2139r1144b2201],
5	HLA	NN	O	hlum	dep	1	SENT_210	[p12l1181t2136r1825b2215],
6	.	.	O	.	_	0	SENT_210	[p12l1181t2136r1825b2215],

1	—	NN	O	—	_	0	SENT_211	[p12l1181t2136r1825b2215],
2	.	.	O	.	_	0	SENT_211	[p12l1181t2136r1825b2215],

1	DQBl	NN	O	dqbl	_	0	SENT_212	[p12l1181t2136r1825b2215],
2	*	CD	NUMBER	*	number	3	SENT_212	[p12l1181t2136r1825b2215],
3	0609	CD	DATE	0609	dep	1	SENT_212	[p12l1181t2136r1825b2215],
4	markers	NNS	O	marker	dep	3	SENT_212	[p12l1863t2139r2146b2201],

1	©	RB	O	©	dep	2	SENT_213	[p12l1368t2382r1419b2433],
2	2009	CD	DATE	2009	dep	4	SENT_213	[p12l1443t2382r1586b2434],
3	Esmon	NNP	O	Esmon	nn	4	SENT_213	[p12l1608t2383r1813b2433],
4	Publicidad	NNP	O	Publicidad	_	0	SENT_213	[p12l1833t2382r2149b2433],

1	The	DT	O	the	det	3	SENT_214	[p12l746t2510r803b2536],
2	A	NN	O	a	nn	3	SENT_214	[p12l811t2510r937b2536],
3	—	NN	O	—	_	0	SENT_214	[p12l811t2510r937b2536],
4	444C	CD	NUMBER	444c	num	5	SENT_214	[p12l811t2510r937b2536],
5	SNP	NN	O	snp	dep	3	SENT_214	[p12l949t2510r1016b2536],
6	and	CC	O	and	_	0	SENT_214	[p12l1025t2510r1078b2536],
7	Aspirin	NN	O	aspirin	dep	3	SENT_214	[p12l1086t2509r1331b2544],
8	.	.	O	.	_	0	SENT_214	[p12l1086t2509r1331b2544],

1	—	NN	O	—	_	0	SENT_215	[p12l1086t2509r1331b2544],
2	.	.	O	.	_	0	SENT_215	[p12l1086t2509r1331b2544],

1	Induced	VBN	O	induce	_	0	SENT_216	[p12l1086t2509r1331b2544],
2	Urticaria	NN	O	urticarium	dobj	1	SENT_216	[p12l1341t2509r1474b2536],
3	380	CD	NUMBER	380	num	2	SENT_216	[p12l2041t2509r2100b2537],

1	and	CC	O	and	dep	2	SENT_217	[p12l10t2728r133b2789],
2	AIU	NNP	ORGANIZATION	AIU	_	0	SENT_217	[p12l146t2728r318b2800],
3	,	,	O	,	_	0	SENT_217	[p12l146t2728r318b2800],
4	although	IN	O	although	mark	9	SENT_217	[p12l342t2728r644b2807],
5	this	DT	O	this	det	6	SENT_217	[p12l662t2728r784b2789],
6	association	NN	O	association	nsubjpass	9	SENT_217	[p12l806t2728r1191b2789],
7	was	VBD	O	be	auxpass	9	SENT_217	[p12l1210t2747r1341b2789],
8	not	RB	O	not	neg	9	SENT_217	[p12l1362t2737r1473b2789],
9	found	VBN	O	find	dep	2	SENT_217	[p12l1490t2728r1693b2789],
10	with	IN	O	with	_	0	SENT_217	[p12l1711t2728r1864b2789],
11	aspirininduced	JJ	O	aspirininduced	amod	15	SENT_217	[p12l1884t2728r2144b2807, p12l8t2829r285b2890],
12	asthma	NN	O	asthma	nn	15	SENT_217	[p12l308t2829r554b2890],
13	[	NN	O	[	nn	15	SENT_217	[p12l581t2828r737b2903],
14	35	CD	NUMBER	35	num	15	SENT_217	[p12l581t2828r737b2903],
15	]	NN	O	]	prep_with	9	SENT_217	[p12l581t2828r737b2903],
16	.	.	O	.	_	0	SENT_217	[p12l581t2828r737b2903],

1	The	DT	O	the	det	2	SENT_218	[p12l762t2829r896b2890],
2	ﬁndings	NNS	O	ﬁndings	nsubj	16	SENT_218	[p12l919t2829r1197b2908],
3	of	IN	O	of	_	0	SENT_218	[p12l1221t2829r1297b2890],
4	speciﬁc	NN	O	speciﬁc	nn	5	SENT_218	[p12l1316t2829r1578b2908],
5	polymorphisms	NNS	O	polymorphism	prep_of	2	SENT_218	[p12l1600t2829r2144b2908],
6	associated	VBN	O	associate	partmod	5	SENT_218	[p12l10t2929r365b2990],
7	with	IN	O	with	_	0	SENT_218	[p12l383t2929r535b2991],
8	AIU	NNP	ORGANIZATION	AIU	prep_with	6	SENT_218	[p12l548t2930r702b2991],
9	but	CC	O	but	_	0	SENT_218	[p12l719t2929r830b2990],
10	not	RB	O	not	_	0	SENT_218	[p12l847t2939r958b2990],
11	with	IN	O	with	_	0	SENT_218	[p12l975t2929r1128b2991],
12	other	JJ	O	other	amod	15	SENT_218	[p12l1147t2929r1324b2990],
13	aspirin	NN	O	aspirin	nn	15	SENT_218	[p12l1342t2929r1575b3009],
14	hypersensitivity	NN	O	hypersensitivity	nn	15	SENT_218	[p12l1592t2929r2146b3009],
15	phenotypes	NNS	O	phenotype	prep_with	6	SENT_218	[p12l7t3031r403b3110],
16	suggest	VBP	O	suggest	_	0	SENT_218	[p12l426t3040r685b3110],
17	different	JJ	O	different	amod	19	SENT_218	[p12l703t3031r1000b3092],
18	underlying	VBG	O	underlie	amod	19	SENT_218	[p12l1017t3031r1394b3110],
19	alterations	NNS	O	alteration	dobj	16	SENT_218	[p12l1415t3031r1773b3092],
20	[	CD	NUMBER	[	number	21	SENT_218	[p12l1800t3031r1911b3105],
21	9	CD	NUMBER	9	num	22	SENT_218	[p12l1800t3031r1911b3105],
22	]	NN	O	]	dobj	16	SENT_218	[p12l1800t3031r1911b3105],
23	.	.	O	.	_	0	SENT_218	[p12l1800t3031r1911b3105],

1	In	IN	O	in	_	0	SENT_219	[p12l1934t3032r2004b3091],
2	this	DT	O	this	det	3	SENT_219	[p12l2023t3031r2145b3092],
3	regard	NN	O	regard	prep_in	7	SENT_219	[p12l7t3132r250b3211],
4	,	,	O	,	_	0	SENT_219	[p12l7t3132r250b3211],
5	our	PRP$	O	we	poss	6	SENT_219	[p12l281t3151r396b3193],
6	results	NNS	O	result	nsubj	7	SENT_219	[p12l421t3132r648b3193],
7	support	VBP	O	support	_	0	SENT_219	[p12l680t3141r940b3211],
8	the	DT	O	the	det	9	SENT_219	[p12l966t3132r1070b3193],
9	idea	NN	O	idea	dobj	7	SENT_219	[p12l1098t3132r1244b3193],
10	that	IN	O	that	dep	12	SENT_219	[p12l1270t3132r1400b3193],
11	there	EX	O	there	expl	12	SENT_219	[p12l1427t3132r1600b3193],
12	are	VBP	O	be	dep	9	SENT_219	[p12l1629t3151r1732b3193],
13	differences	NNS	O	difference	nsubj	12	SENT_219	[p12l1761t3132r2145b3193],
14	in	IN	O	in	_	0	SENT_219	[p12l8t3232r75b3293],
15	the	DT	O	the	det	16	SENT_219	[p12l97t3232r202b3293],
16	pathogenesis	NN	O	pathogenesis	prep_in	13	SENT_219	[p12l224t3232r675b3312],
17	of	IN	O	of	_	0	SENT_219	[p12l701t3232r777b3293],
18	these	DT	O	these	det	22	SENT_219	[p12l794t3232r972b3293],
19	aspirin	NN	O	aspirin	nn	22	SENT_219	[p12l997t3232r2148b3312],
20	—	NN	O	—	nn	22	SENT_219	[p12l997t3232r2148b3312],
21	hypersensitivity	NN	O	hypersensitivity	nn	22	SENT_219	[p12l997t3232r2148b3312],
22	—	NN	O	—	prep_of	16	SENT_219	[p12l997t3232r2148b3312],
23	induced	VBD	O	induce	partmod	22	SENT_219	[p12l997t3232r2148b3312],
24	syndromes	NNS	O	syndrome	dobj	23	SENT_219	[p12l11t3334r406b3413],
25	,	,	O	,	_	0	SENT_219	[p12l11t3334r406b3413],
26	and	CC	O	and	_	0	SENT_219	[p12l439t3334r563b3395],
27	that	IN	O	that	dep	33	SENT_219	[p12l590t3334r721b3395],
28	A	DT	O	a	det	30	SENT_219	[p12l743t3334r1037b3395],
29	—	CD	NUMBER	—	num	30	SENT_219	[p12l743t3334r1037b3395],
30	444C	NN	O	444c	nsubj	33	SENT_219	[p12l743t3334r1037b3395],
31	could	MD	O	could	aux	33	SENT_219	[p12l1068t3334r1260b3395],
32	be	VB	O	be	cop	33	SENT_219	[p12l1287t3334r1368b3395],
33	useful	JJ	O	useful	dep	9	SENT_219	[p12l1396t3334r1609b3395],
34	as	IN	O	as	_	0	SENT_219	[p12l1639t3353r1706b3395],
35	a	DT	O	a	det	36	SENT_219	[p12l1738t3353r1774b3395],
36	marker	NN	O	marker	prep_as	33	SENT_219	[p12l1801t3334r2050b3395],
37	of	IN	O	of	_	0	SENT_219	[p12l2077t3334r2153b3395],
38	the	DT	O	the	det	40	SENT_219	[p12l8t3435r112b3496],
39	AIU	NNP	ORGANIZATION	AIU	nn	40	SENT_219	[p12l125t3435r277b3496],
40	phenotype	NN	O	phenotype	prep_of	36	SENT_219	[p12l293t3435r670b3514],
41	,	,	O	,	_	0	SENT_219	[p12l293t3435r670b3514],
42	especially	RB	O	especially	advmod	33	SENT_219	[p12l692t3435r1033b3514],
43	of	IN	O	of	_	0	SENT_219	[p12l1052t3435r1127b3496],
44	the	DT	O	the	det	47	SENT_219	[p12l1138t3435r1241b3496],
45	clinical	JJ	O	clinical	amod	47	SENT_219	[p12l1260t3435r1510b3496],
46	cutaneous	JJ	O	cutaneous	amod	47	SENT_219	[p12l1528t3444r1869b3496],
47	pattem	NN	O	pattem	prep_of	9	SENT_219	[p12l1887t3444r2142b3514],
48	.	.	O	.	_	0	SENT_219	[p12l1887t3444r2142b3514],

1	Our	PRP$	O	we	poss	2	SENT_220	[p12l10t3536r144b3597],
2	ﬁndings	NNS	O	ﬁndings	nsubj	4	SENT_220	[p12l173t3535r451b3615],
3	also	RB	O	also	advmod	4	SENT_220	[p12l484t3535r620b3596],
4	suggest	VBP	O	suggest	_	0	SENT_220	[p12l653t3545r912b3615],
5	the	DT	O	the	det	7	SENT_220	[p12l940t3535r1045b3596],
6	possible	JJ	O	possible	amod	7	SENT_220	[p12l1073t3535r1359b3615],
7	inﬂuence	NN	O	inﬂuence	dobj	4	SENT_220	[p12l1389t3535r1708b3596],
8	of	IN	O	of	_	0	SENT_220	[p12l1739t3535r1814b3596],
9	this	DT	O	this	det	10	SENT_220	[p12l1837t3535r1960b3596],
10	SNP	NN	O	snp	prep_of	7	SENT_220	[p12l1993t3536r2150b3597],
11	on	IN	O	on	_	0	SENT_220	[p12l9t3656r95b3698],
12	other	JJ	O	other	amod	13	SENT_220	[p12l134t3637r317b3698],
13	phenotypes	NNS	O	phenotype	prep_on	10	SENT_220	[p12l352t3637r782b3716],
14	,	,	O	,	_	0	SENT_220	[p12l352t3637r782b3716],
15	because	IN	O	because	_	0	SENT_220	[p12l822t3637r1105b3698],
16	the	DT	O	the	det	20	SENT_220	[p12l1143t3637r1250b3698],
17	AC	NN	O	ac	nn	20	SENT_220	[p12l1283t3637r1402b3698],
18	and	CC	O	and	_	0	SENT_220	[p12l1444t3637r1569b3698],
19	CC	NN	O	cc	nn	20	SENT_220	[p12l1607t3637r1721b3698],
20	genotypes	NNS	O	genotype	prep_because	4	SENT_220	[p12l1761t3646r2143b3716],
21	,	,	O	,	_	0	SENT_220	[p12l1761t3646r2143b3716],

1	as	RB	O	as	advmod	2	SENT_221	[p13l10t37r78b79],
2	well	RB	O	well	advmod	11	SENT_221	[p13l119t18r272b79],
3	as	IN	O	as	_	0	SENT_221	[p13l312t37r380b79],
4	the	DT	O	the	det	6	SENT_221	[p13l421t18r528b79],
5	C	NN	O	c	nn	6	SENT_221	[p13l567t18r621b79],
6	allele	NN	O	allele	prep_as	11	SENT_221	[p13l663t18r876b90],
7	,	,	O	,	_	0	SENT_221	[p13l663t18r876b90],
8	were	VBD	O	be	cop	11	SENT_221	[p13l918t37r1089b79],
9	signiﬁcantly	RB	O	signiﬁcantly	advmod	11	SENT_221	[p13l1131t18r1575b97],
10	more	RBR	O	more	advmod	11	SENT_221	[p13l1614t37r1796b79],
11	common	JJ	O	common	_	0	SENT_221	[p13l1835t37r2147b79],
12	in	IN	O	in	_	0	SENT_221	[p13l8t118r75b179],
13	patients	NNS	O	patient	prep_in	11	SENT_221	[p13l111t118r387b198],
14	with	IN	O	with	_	0	SENT_221	[p13l427t118r583b180],
15	a	DT	O	a	det	18	SENT_221	[p13l622t138r658b179],
16	lower	JJR	O	lower	dep	17	SENT_221	[p13l694t118r897b180],
17	cutaneous	JJ	O	cutaneous	amod	18	SENT_221	[p13l933t128r1286b179],
18	response	NN	O	response	prep_with	13	SENT_221	[p13l1324t138r1636b198],
19	to	TO	O	to	_	0	SENT_221	[p13l1674t128r1740b179],
20	histamine	NN	O	histamine	prep_to	18	SENT_221	[p13l1777t118r2142b179],
21	.	.	O	.	_	0	SENT_221	[p13l1777t118r2142b179],

1	Logistic	JJ	O	logistic	amod	3	SENT_222	[p13l8t220r293b299],
2	regression	NN	O	regression	nn	3	SENT_222	[p13l312t220r673b299],
3	analysis	NN	O	analysis	nsubj	4	SENT_222	[p13l694t220r971b299],
4	showed	VBD	O	show	_	0	SENT_222	[p13l995t220r1259b281],
5	that	IN	O	that	complm	24	SENT_222	[p13l1278t220r1408b281],
6	the	DT	O	the	det	7	SENT_222	[p13l1426t220r1531b281],
7	effect	NN	O	effect	nsubjpass	24	SENT_222	[p13l1551t220r1748b281],
8	of	IN	O	of	_	0	SENT_222	[p13l1767t220r1843b281],
9	A	DT	O	a	det	11	SENT_222	[p13l1850t220r2145b281],
10	—	CD	NUMBER	—	num	11	SENT_222	[p13l1850t220r2145b281],
11	444C	NN	O	444c	prep_of	7	SENT_222	[p13l1850t220r2145b281],
12	on	IN	O	on	_	0	SENT_222	[p13l9t340r94b382],
13	histamine	NN	O	histamine	nn	14	SENT_222	[p13l121t321r461b382],
14	reactivity	NN	O	reactivity	prep_on	11	SENT_222	[p13l489t321r819b400],
15	is	VBZ	O	be	auxpass	24	SENT_222	[p13l848t321r902b382],
16	independent	JJ	O	independent	amod	22	SENT_222	[p13l932t321r1361b400],
17	of	IN	O	of	_	0	SENT_222	[p13l1389t321r1465b382],
18	the	DT	O	the	det	21	SENT_222	[p13l1487t321r1592b382],
19	clinical	JJ	O	clinical	amod	21	SENT_222	[p13l1621t321r1877b382],
20	pattern	NN	O	pattern	nn	21	SENT_222	[p13l1904t330r2147b400],
21	(	NN	O	(	prep_of	16	SENT_222	[p13l11t422r183b498],
22	data	NNS	O	datum	npadvmod	23	SENT_222	[p13l11t422r183b498],
23	not	RB	O	not	neg	24	SENT_222	[p13l206t432r318b484],
24	shown	VBN	O	show	ccomp	4	SENT_222	[p13l344t422r615b498],
25	)	NN	O	)	dobj	24	SENT_222	[p13l344t422r615b498],
26	.	.	O	.	_	0	SENT_222	[p13l344t422r615b498],

1	AIU	NNP	ORGANIZATION	AIU	nsubj	2	SENT_223	[p13l139t524r294b585],
2	responds	VBZ	O	respond	_	0	SENT_223	[p13l325t524r635b603],
3	to	TO	O	to	_	0	SENT_223	[p13l669t533r734b585],
4	antihistamines	NNS	O	antihistamine	prep_to	2	SENT_223	[p13l771t524r1293b596],
5	,	,	O	,	_	0	SENT_223	[p13l771t524r1293b596],
6	which	WDT	O	which	nsubj	12	SENT_223	[p13l1330t524r1543b585],
7	are	VBP	O	be	cop	12	SENT_223	[p13l1577t543r1679b585],
8	the	DT	O	the	det	12	SENT_223	[p13l1713t524r1817b585],
9	ﬁrst	JJ	O	ﬁrst	amod	12	SENT_223	[p13l1852t524r2146b585],
10	—	NN	O	—	nn	12	SENT_223	[p13l1852t524r2146b585],
11	line	NN	O	line	nn	12	SENT_223	[p13l1852t524r2146b585],
12	medication	NN	O	medication	rcmod	4	SENT_223	[p13l8t625r391b686],
13	for	IN	O	for	_	0	SENT_223	[p13l408t625r509b686],
14	this	DT	O	this	det	18	SENT_223	[p13l524t625r645b686],
15	condition	NN	O	condition	nn	18	SENT_223	[p13l666t625r990b686],
16	[	NN	O	[	nn	18	SENT_223	[p13l1013t625r1122b699],
17	4	CD	NUMBER	4	num	18	SENT_223	[p13l1013t625r1122b699],
18	]	NN	O	]	prep_for	12	SENT_223	[p13l1013t625r1122b699],
19	.	.	O	.	_	0	SENT_223	[p13l1013t625r1122b699],

1	Our	PRP$	O	we	poss	2	SENT_224	[p13l1146t625r1279b686],
2	results	NNS	O	result	nsubj	3	SENT_224	[p13l1294t625r1516b686],
3	show	VBP	O	show	_	0	SENT_224	[p13l1539t625r1716b686],
4	a	DT	O	a	det	6	SENT_224	[p13l1736t644r1773b686],
5	signiﬁcant	JJ	O	signiﬁcant	amod	6	SENT_224	[p13l1792t625r2148b704],
6	association	NN	O	association	dobj	3	SENT_224	[p13l10t725r397b786],
7	between	IN	O	between	_	0	SENT_224	[p13l432t725r723b787],
8	A	DT	O	a	det	10	SENT_224	[p13l754t726r1048b787],
9	—	CD	NUMBER	—	num	10	SENT_224	[p13l754t726r1048b787],
10	444C	NN	O	444c	prep_between	6	SENT_224	[p13l754t726r1048b787],
11	and	CC	O	and	_	0	SENT_224	[p13l1087t725r1210b786],
12	a	DT	O	a	det	14	SENT_224	[p13l1247t745r1283b786],
13	differential	JJ	O	differential	amod	14	SENT_224	[p13l1318t725r1704b786],
14	response	NN	O	response	conj_and	6	SENT_224	[p13l1739t745r2045b805],
15	to	TO	O	to	_	0	SENT_224	[p13l2081t735r2146b786],
16	exogenous	JJ	O	exogenous	amod	17	SENT_224	[p13l9t846r380b906],
17	histamine	NN	O	histamine	prep_to	14	SENT_224	[p13l413t827r753b888],
18	in	IN	O	in	_	0	SENT_224	[p13l785t827r852b887],
19	patients	NNS	O	patient	prep_in	3	SENT_224	[p13l882t827r1152b906],
20	with	IN	O	with	_	0	SENT_224	[p13l1187t827r1340b888],
21	AIU	NNP	ORGANIZATION	AIU	prep_with	19	SENT_224	[p13l1367t827r1538b888],
22	.	.	O	.	_	0	SENT_224	[p13l1367t827r1538b888],

1	This	DT	O	this	nsubj	3	SENT_225	[p13l1573t827r1725b888],
2	could	MD	O	could	aux	3	SENT_225	[p13l1759t827r1952b888],
3	have	VB	O	have	_	0	SENT_225	[p13l1983t827r2146b888],
4	implications	NNS	O	implication	dobj	3	SENT_225	[p13l8t928r439b1007],
5	for	IN	O	for	_	0	SENT_225	[p13l464t928r565b989],
6	therapy	NN	O	therapy	prep_for	4	SENT_225	[p13l586t928r859b1007],
7	.	.	O	.	_	0	SENT_225	[p13l586t928r859b1007],

1	We	PRP	O	we	nsubj	4	SENT_226	[p13l883t929r996b989],
2	do	VBP	O	do	aux	4	SENT_226	[p13l1020t928r1103b989],
3	not	RB	O	not	neg	4	SENT_226	[p13l1127t937r1238b989],
4	know	VB	O	know	_	0	SENT_226	[p13l1258t928r1451b989],
5	the	DT	O	the	det	7	SENT_226	[p13l1474t928r1579b989],
6	biological	JJ	O	biological	amod	7	SENT_226	[p13l1600t928r1951b1007],
7	basis	NN	O	basis	dobj	4	SENT_226	[p13l1972t928r2145b989],
8	of	IN	O	of	_	0	SENT_226	[p13l9t1028r85b1089],
9	the	DT	O	the	det	10	SENT_226	[p13l108t1028r213b1089],
10	association	NN	O	association	prep_of	7	SENT_226	[p13l243t1028r631b1089],
11	between	IN	O	between	_	0	SENT_226	[p13l657t1028r950b1090],
12	A	DT	O	a	det	14	SENT_226	[p13l973t1029r1267b1090],
13	—	CD	NUMBER	—	num	14	SENT_226	[p13l973t1029r1267b1090],
14	444C	NN	O	444c	prep_between	10	SENT_226	[p13l973t1029r1267b1090],
15	and	CC	O	and	_	0	SENT_226	[p13l1299t1028r1423b1089],
16	histamine	NN	O	histamine	nn	17	SENT_226	[p13l1450t1028r1790b1089],
17	response	NN	O	response	prep_between	10	SENT_226	[p13l1818t1048r2142b1108],
18	.	.	O	.	_	0	SENT_226	[p13l1818t1048r2142b1108],

1	Although	IN	O	although	mark	3	SENT_227	[p13l8t1130r339b1209],
2	patients	NNS	O	patient	nsubj	3	SENT_227	[p13l357t1130r627b1209],
3	were	VBD	O	be	advcl	23	SENT_227	[p13l650t1149r817b1191],
4	not	RB	O	not	neg	3	SENT_227	[p13l837t1139r949b1191],
5	under	IN	O	under	_	0	SENT_227	[p13l967t1130r1167b1191],
6	the	DT	O	the	det	7	SENT_227	[p13l1185t1130r1289b1191],
7	effects	NNS	O	effect	prep_under	3	SENT_227	[p13l1310t1130r1538b1191],
8	of	IN	O	of	_	0	SENT_227	[p13l1561t1130r1637b1191],
9	antihistaminic	JJ	O	antihistaminic	amod	10	SENT_227	[p13l1652t1130r2145b1191],
10	treatment	NN	O	treatment	prep_of	7	SENT_227	[p13l8t1240r340b1292],
11	by	IN	O	by	_	0	SENT_227	[p13l362t1231r448b1310],
12	the	DT	O	the	det	13	SENT_227	[p13l474t1231r579b1292],
13	time	NN	O	time	prep_by	3	SENT_227	[p13l604t1231r758b1292],
14	we	PRP	O	we	nsubj	15	SENT_227	[p13l783t1250r882b1292],
15	performed	VBD	O	perform	rcmod	13	SENT_227	[p13l907t1231r1273b1310],
16	the	DT	O	the	det	19	SENT_227	[p13l1297t1231r1402b1292],
17	cutaneous	JJ	O	cutaneous	amod	19	SENT_227	[p13l1428t1240r1775b1292],
18	skin	NN	O	skin	nn	19	SENT_227	[p13l1805t1231r1946b1292],
19	tests	NNS	O	test	dobj	15	SENT_227	[p13l1971t1240r2143b1303],
20	,	,	O	,	_	0	SENT_227	[p13l1971t1240r2143b1303],
21	it	PRP	O	it	nsubj	23	SENT_227	[p13l8t1331r56b1392],
22	is	VBZ	O	be	cop	23	SENT_227	[p13l85t1331r139b1392],
23	possible	JJ	O	possible	_	0	SENT_227	[p13l170t1331r457b1411],
24	that	IN	O	that	complm	29	SENT_227	[p13l487t1331r618b1392],
25	different	JJ	O	different	amod	26	SENT_227	[p13l648t1331r948b1392],
26	treatments	NNS	O	treatment	nsubj	29	SENT_227	[p13l976t1341r1338b1392],
27	could	MD	O	could	aux	29	SENT_227	[p13l1371t1331r1565b1392],
28	be	VB	O	be	aux	29	SENT_227	[p13l1593t1331r1674b1392],
29	confounding	VBG	O	confound	ccomp	23	SENT_227	[p13l1705t1331r2146b1411],
30	this	DT	O	this	det	31	SENT_227	[p13l8t1433r130b1494],
31	result	NN	O	result	dobj	29	SENT_227	[p13l149t1433r358b1494],
32	.	.	O	.	_	0	SENT_227	[p13l149t1433r358b1494],

1	Nevertheless	RB	O	nevertheless	advmod	4	SENT_228	[p13l380t1433r847b1505],
2	,	,	O	,	_	0	SENT_228	[p13l380t1433r847b1505],
3	we	PRP	O	we	nsubj	4	SENT_228	[p13l869t1452r968b1494],
4	found	VBD	O	find	_	0	SENT_228	[p13l986t1433r1188b1494],
5	no	DT	O	no	det	6	SENT_228	[p13l1206t1452r1290b1494],
6	association	NN	O	association	dobj	4	SENT_228	[p13l1311t1433r1694b1494],
7	between	IN	O	between	_	0	SENT_228	[p13l1711t1433r2001b1494],
8	low	JJ	O	low	amod	9	SENT_228	[p13l2018t1433r2146b1494],
9	response	NN	O	response	prep_between	6	SENT_228	[p13l7t1553r313b1613],
10	to	TO	O	to	_	0	SENT_228	[p13l346t1543r411b1595],
11	histamine	NN	O	histamine	nn	14	SENT_228	[p13l444t1534r784b1595],
12	and	CC	O	and	_	0	SENT_228	[p13l818t1534r942b1595],
13	low	JJ	O	low	conj_and	11	SENT_228	[p13l974t1534r1102b1595],
14	response	NN	O	response	prep_to	4	SENT_228	[p13l1134t1553r1440b1613],
15	to	TO	O	to	_	0	SENT_228	[p13l1473t1543r1538b1595],
16	any	DT	O	any	prep_to	14	SENT_228	[p13l1573t1553r1695b1613],
17	of	IN	O	of	_	0	SENT_228	[p13l1729t1534r1805b1595],
18	the	DT	O	the	det	20	SENT_228	[p13l1831t1534r1936b1595],
19	other	JJ	O	other	amod	20	SENT_228	[p13l1969t1534r2149b1595],
20	allergens	NNS	O	allergen	prep_of	16	SENT_228	[p13l10t1634r323b1714],
21	tested	VBN	O	test	partmod	20	SENT_228	[p13l362t1634r568b1695],
22	simultaneously	RB	O	simultaneously	advmod	21	SENT_228	[p13l606t1634r1151b1714],
23	.	.	O	.	_	0	SENT_228	[p13l606t1634r1151b1714],

1	We	PRP	O	we	nsubj	2	SENT_229	[p13l1190t1636r1304b1695],
2	speculate	VBP	O	speculate	_	0	SENT_229	[p13l1343t1634r1668b1714],
3	that	IN	O	that	complm	10	SENT_229	[p13l1705t1634r1837b1695],
4	patients	NNS	O	patient	nsubj	10	SENT_229	[p13l1871t1634r2144b1714],
5	carrying	VBG	O	carry	partmod	4	SENT_229	[p13l9t1736r308b1815],
6	the	DT	O	the	det	8	SENT_229	[p13l347t1736r454b1797],
7	C	NN	O	c	nn	8	SENT_229	[p13l494t1736r548b1797],
8	allele	NN	O	allele	dobj	5	SENT_229	[p13l590t1736r782b1797],
9	could	MD	O	could	aux	10	SENT_229	[p13l822t1736r1021b1797],
10	produce	VB	O	produce	ccomp	2	SENT_229	[p13l1057t1736r1347b1815],
11	more	JJR	O	more	amod	12	SENT_229	[p13l1386t1755r1568b1797],
12	histamine	NN	O	histamine	dobj	10	SENT_229	[p13l1606t1736r1957b1797],
13	and	CC	O	and	cc	2	SENT_229	[p13l1998t1736r2143b1809],
14	,	,	O	,	_	0	SENT_229	[p13l1998t1736r2143b1809],
15	consequently	RB	O	consequently	advmod	19	SENT_229	[p13l9t1837r483b1916],
16	,	,	O	,	_	0	SENT_229	[p13l9t1837r483b1916],
17	are	VBP	O	be	cop	19	SENT_229	[p13l524t1856r627b1898],
18	more	RBR	O	more	advmod	19	SENT_229	[p13l662t1856r840b1898],
19	resistant	JJ	O	resistant	ccomp	2	SENT_229	[p13l875t1837r1168b1898],
20	to	TO	O	to	_	0	SENT_229	[p13l1202t1846r1267b1898],
21	the	DT	O	the	det	23	SENT_229	[p13l1303t1837r1408b1898],
22	physiological	JJ	O	physiological	amod	23	SENT_229	[p13l1442t1837r1915b1916],
23	effect	NN	O	effect	prep_to	19	SENT_229	[p13l1952t1837r2148b1898],
24	of	IN	O	of	_	0	SENT_229	[p13l9t1937r85b1998],
25	exogenous	JJ	O	exogenous	amod	26	SENT_229	[p13l117t1957r491b2017],
26	histamine	NN	O	histamine	prep_of	23	SENT_229	[p13l528t1937r871b1998],
27	in	IN	O	in	_	0	SENT_229	[p13l908t1937r974b1998],
28	the	DT	O	the	det	29	SENT_229	[p13l1010t1937r1116b1998],
29	skin	NN	O	skin	prep_in	26	SENT_229	[p13l1155t1937r1315b1998],
30	.	.	O	.	_	0	SENT_229	[p13l1155t1937r1315b1998],

1	Indeed	RB	O	indeed	advmod	9	SENT_230	[p13l1356t1937r1614b2010],
2	,	,	O	,	_	0	SENT_230	[p13l1356t1937r1614b2010],
3	differences	NNS	O	difference	nsubjpass	9	SENT_230	[p13l1654t1937r2042b1998],
4	in	IN	O	in	_	0	SENT_230	[p13l2080t1937r2147b1998],
5	histamine	NN	O	histamine	nn	6	SENT_230	[p13l8t2039r347b2100],
6	levels	NNS	O	level	prep_in	3	SENT_230	[p13l374t2039r575b2100],
7	have	VBP	O	have	aux	9	SENT_230	[p13l602t2039r765b2100],
8	been	VBN	O	be	auxpass	9	SENT_230	[p13l791t2039r956b2100],
9	described	VBN	O	describe	_	0	SENT_230	[p13l982t2039r1317b2100],
10	in	IN	O	in	_	0	SENT_230	[p13l1341t2039r1408b2099],
11	patients	NNS	O	patient	prep_in	9	SENT_230	[p13l1432t2039r1703b2118],
12	with	IN	O	with	_	0	SENT_230	[p13l1730t2039r1885b2100],
13	aspirin	NN	O	aspirin	nn	14	SENT_230	[p13l1912t2039r2148b2118],
14	hypersensitivity	NN	O	hypersensitivity	prep_with	9	SENT_230	[p13l8t2140r568b2219],
15	[	CD	NUMBER	[	number	16	SENT_230	[p13l599t2140r754b2214],
16	36	CD	NUMBER	36	num	17	SENT_230	[p13l599t2140r754b2214],
17	]	NN	O	]	dep	9	SENT_230	[p13l599t2140r754b2214],
18	.	.	O	.	_	0	SENT_230	[p13l599t2140r754b2214],

1	Previous	JJ	O	previous	amod	2	SENT_231	[p13l139t2240r443b2301],
2	studies	NNS	O	study	nsubj	3	SENT_231	[p13l480t2240r717b2301],
3	described	VBD	O	describe	_	0	SENT_231	[p13l752t2240r1086b2301],
4	an	DT	O	a	det	5	SENT_231	[p13l1120t2260r1198b2301],
5	increase	NN	O	increase	dobj	3	SENT_231	[p13l1230t2240r1515b2301],
6	in	IN	O	in	_	0	SENT_231	[p13l1548t2240r1614b2301],
7	the	DT	O	the	det	8	SENT_231	[p13l1646t2240r1750b2301],
8	wheal	NN	O	wheal	prep_in	5	SENT_231	[p13l1783t2240r1990b2302],
9	and	CC	O	and	cc	5	SENT_231	[p13l2024t2240r2148b2301],

1	ﬂare	NN	O	ﬂare	nn	2	SENT_232	[p13l10t2342r160b2403],
2	response	NN	O	response	nsubj	15	SENT_232	[p13l177t2361r480b2421],
3	to	TO	O	to	_	0	SENT_232	[p13l498t2351r562b2403],
4	intradermal	JJ	O	intradermal	amod	5	SENT_232	[p13l581t2342r979b2403],
5	histamine	NN	O	histamine	prep_to	2	SENT_232	[p13l996t2342r1332b2403],
6	in	IN	O	in	_	0	SENT_232	[p13l1350t2342r1416b2402],
7	patients	NNS	O	patient	prep_in	5	SENT_232	[p13l1432t2342r1698b2421],
8	with	IN	O	with	_	0	SENT_232	[p13l1719t2342r1872b2403],
9	chronic	JJ	O	chronic	amod	11	SENT_232	[p13l1889t2342r2145b2403],
10	idiopathic	JJ	O	idiopathic	amod	11	SENT_232	[p13l8t2443r356b2522],
11	urticaria	NN	O	urticarium	prep_with	7	SENT_232	[p13l387t2443r680b2504],
12	compared	VBN	O	compare	_	0	SENT_232	[p13l710t2443r1054b2522],
13	to	TO	O	to	prepc_compared_to	11	SENT_232	[p13l1083t2452r1148b2504],
14	controls	NNS	O	control	pobj	11	SENT_232	[p13l1180t2443r1458b2504],
15	[	VBP	O	[	_	0	SENT_232	[p13l1497t2443r1652b2517],
16	37	CD	NUMBER	37	number	17	SENT_232	[p13l1497t2443r1652b2517],
17	]	CD	NUMBER	]	dobj	15	SENT_232	[p13l1497t2443r1652b2517],
18	.	.	O	.	_	0	SENT_232	[p13l1497t2443r1652b2517],

1	More	JJR	O	more	amod	2	SENT_233	[p13l1686t2444r1874b2504],
2	studies	NNS	O	study	nsubjpass	4	SENT_233	[p13l1908t2443r2145b2504],
3	are	VBP	O	be	auxpass	4	SENT_233	[p13l10t2563r114b2604],
4	needed	VBN	O	need	_	0	SENT_233	[p13l151t2543r401b2604],
5	to	TO	O	to	aux	6	SENT_233	[p13l436t2553r502b2604],
6	evaluate	VB	O	evaluate	xcomp	4	SENT_233	[p13l540t2543r833b2605],
7	the	DT	O	the	det	10	SENT_233	[p13l870t2543r976b2604],
8	possible	JJ	O	possible	amod	10	SENT_233	[p13l1011t2543r1301b2623],
9	biological	JJ	O	biological	amod	10	SENT_233	[p13l1337t2543r1692b2623],
10	relationship	NN	O	relationship	dobj	6	SENT_233	[p13l1727t2543r2146b2623],
11	between	IN	O	between	_	0	SENT_233	[p13l7t2645r297b2706],
12	A	DT	O	a	det	14	SENT_233	[p13l310t2645r602b2706],
13	—	CD	NUMBER	—	num	14	SENT_233	[p13l310t2645r602b2706],
14	444C	NN	O	444c	prep_between	10	SENT_233	[p13l310t2645r602b2706],
15	and	CC	O	and	_	0	SENT_233	[p13l624t2645r746b2706],
16	the	DT	O	the	det	19	SENT_233	[p13l764t2645r868b2706],
17	less	RBR	O	less	advmod	18	SENT_233	[p13l887t2645r1013b2706],
18	intense	JJ	O	intense	amod	19	SENT_233	[p13l1033t2645r1277b2706],
19	response	NN	O	response	conj_and	10	SENT_233	[p13l1294t2664r1598b2724],
20	to	TO	O	to	_	0	SENT_233	[p13l1616t2654r1681b2706],
21	histamine	NN	O	histamine	prep_to	6	SENT_233	[p13l1699t2645r2055b2717],
22	,	,	O	,	_	0	SENT_233	[p13l1699t2645r2055b2717],
23	as	IN	O	as	mark	27	SENT_233	[p13l2078t2664r2145b2706],
24	our	PRP$	O	we	poss	25	SENT_233	[p13l9t2765r125b2807],
25	results	NNS	O	result	nsubj	27	SENT_233	[p13l144t2746r371b2807],
26	may	MD	O	may	aux	27	SENT_233	[p13l394t2765r543b2825],
27	reveal	VB	O	reveal	advcl	6	SENT_233	[p13l565t2746r778b2807],
28	a	DT	O	a	det	30	SENT_233	[p13l802t2765r838b2807],
29	particular	JJ	O	particular	amod	30	SENT_233	[p13l857t2746r1195b2825],
30	feature	NN	O	feature	dobj	27	SENT_233	[p13l1216t2746r1457b2807],
31	in	IN	O	in	_	0	SENT_233	[p13l1479t2746r1546b2806],
32	the	DT	O	the	det	33	SENT_233	[p13l1567t2746r1672b2807],
33	pathogenesis	NN	O	pathogenesis	prep_in	27	SENT_233	[p13l1694t2746r2145b2825],
34	of	IN	O	of	_	0	SENT_233	[p13l9t2846r85b2907],
35	AIU	NNP	ORGANIZATION	AIU	prep_of	33	SENT_233	[p13l99t2847r270b2908],
36	.	.	O	.	_	0	SENT_233	[p13l99t2847r270b2908],

1	The	DT	O	the	det	3	SENT_234	[p13l170t2948r304b3009],
2	cutaneous	JJ	O	cutaneous	amod	3	SENT_234	[p13l339t2957r686b3009],
3	phenotype	NN	O	phenotype	nsubjpass	8	SENT_234	[p13l721t2948r1086b3027],
4	of	IN	O	of	_	0	SENT_234	[p13l1121t2948r1197b3009],
5	AIU	NNP	ORGANIZATION	AIU	prep_of	3	SENT_234	[p13l1220t2948r1375b3009],
6	has	VBZ	O	have	aux	8	SENT_234	[p13l1408t2948r1522b3009],
7	been	VBN	O	be	auxpass	8	SENT_234	[p13l1557t2948r1722b3009],
8	reported	VBN	O	report	_	0	SENT_234	[p13l1755t2948r2047b3027],
9	to	TO	O	to	aux	10	SENT_234	[p13l2081t2957r2146b3009],
10	occur	VB	O	occur	xcomp	8	SENT_234	[p13l9t3068r210b3110],
11	more	RBR	O	more	advmod	12	SENT_234	[p13l247t3068r430b3110],
12	frequently	RB	O	frequently	advmod	10	SENT_234	[p13l469t3049r842b3128],
13	in	IN	O	in	mark	16	SENT_234	[p13l882t3049r950b3109],
14	atopic	JJ	O	atopic	amod	15	SENT_234	[p13l990t3049r1208b3128],
15	individuals	NNS	O	individual	nsubj	16	SENT_234	[p13l1248t3049r1652b3110],
16	[	VBP	O	[	dep	12	SENT_234	[p13l1698t3049r1977b3123],
17	38,39	CD	NUMBER	38,39	number	18	SENT_234	[p13l1698t3049r1977b3123],
18	]	CD	NUMBER	]	dobj	16	SENT_234	[p13l1698t3049r1977b3123],
19	,	,	O	,	_	0	SENT_234	[p13l1698t3049r1977b3123],
20	and	CC	O	and	_	0	SENT_234	[p13l2021t3049r2148b3110],
21	we	PRP	O	we	nsubj	23	SENT_234	[p13l9t3169r109b3211],
22	previously	RB	DATE	previously	advmod	23	SENT_234	[p13l147t3149r527b3229],
23	showed	VBD	O	show	conj_and	8	SENT_234	[p13l568t3149r839b3211],
24	that	IN	O	that	complm	31	SENT_234	[p13l875t3149r1010b3210],
25	the	DT	O	the	det	29	SENT_234	[p13l1047t3149r1154b3210],
26	A	NN	O	a	nn	29	SENT_234	[p13l1187t3150r1487b3211],
27	—	NN	O	—	nn	29	SENT_234	[p13l1187t3150r1487b3211],
28	444C	NN	O	444c	nn	29	SENT_234	[p13l1187t3150r1487b3211],
29	polymorphism	NN	O	polymorphism	nsubjpass	31	SENT_234	[p13l1526t3149r2053b3229],
30	is	VBZ	O	be	auxpass	31	SENT_234	[p13l2089t3149r2144b3210],
31	associated	VBN	O	associate	ccomp	23	SENT_234	[p13l10t3251r382b3312],
32	with	IN	O	with	_	0	SENT_234	[p13l421t3251r580b3312],
33	the	DT	O	the	det	36	SENT_234	[p13l617t3251r725b3312],
34	speciﬁc	JJ	O	speciﬁc	amod	36	SENT_234	[p13l767t3251r1039b3330],
35	IgE	NN	O	ige	nn	36	SENT_234	[p13l1079t3252r1206b3330],
36	response	NN	O	response	prep_with	31	SENT_234	[p13l1243t3270r1561b3330],
37	to	TO	O	to	_	0	SENT_234	[p13l1600t3260r1666b3312],
38	mite	JJ	O	mite	amod	45	SENT_234	[p13l1706t3251r1864b3312],
39	among	IN	O	among	_	0	SENT_234	[p13l1905t3270r2146b3330],
40	Colombian	JJ	MISC	colombian	amod	42	SENT_234	[p13l9t3352r395b3413],
41	asthmatic	JJ	O	asthmatic	amod	42	SENT_234	[p13l415t3352r744b3413],
42	patients	NNS	O	patient	prep_among	38	SENT_234	[p13l763t3352r1031b3431],
43	[	IN	O	[	_	0	SENT_234	[p13l1058t3352r1212b3426],
44	40	CD	NUMBER	40	prep_[	42	SENT_234	[p13l1058t3352r1212b3426],
45	]	NN	O	]	prep_to	31	SENT_234	[p13l1058t3352r1212b3426],
46	.	.	O	.	_	0	SENT_234	[p13l1058t3352r1212b3426],

1	Whether	IN	O	whether	complm	15	SENT_235	[p13l1232t3352r1534b3413],
2	the	DT	O	the	det	3	SENT_235	[p13l1550t3352r1654b3413],
3	association	NN	O	association	nsubjpass	15	SENT_235	[p13l1675t3352r2059b3413],
4	of	IN	O	of	_	0	SENT_235	[p13l2078t3352r2153b3413],
5	A	DT	O	a	det	7	SENT_235	[p13l8t3453r300b3514],
6	—	CD	NUMBER	—	num	7	SENT_235	[p13l8t3453r300b3514],
7	444C	NN	O	444c	prep_of	3	SENT_235	[p13l8t3453r300b3514],
8	with	IN	O	with	_	0	SENT_235	[p13l320t3452r473b3513],
9	the	DT	O	the	det	11	SENT_235	[p13l491t3452r594b3513],
10	cutaneous	JJ	O	cutaneous	amod	11	SENT_235	[p13l614t3462r957b3513],
11	manifestations	NNS	O	manifestation	prep_with	7	SENT_235	[p13l977t3452r1480b3513],
12	of	IN	O	of	_	0	SENT_235	[p13l1501t3452r1577b3513],
13	AIU	NNP	ORGANIZATION	AIU	prep_of	11	SENT_235	[p13l1584t3453r1737b3514],
14	is	VBZ	O	be	auxpass	15	SENT_235	[p13l1755t3452r1809b3513],
15	related	VBN	O	relate	csubj	18	SENT_235	[p13l1828t3452r2064b3513],
16	to	TO	O	to	_	0	SENT_235	[p13l2081t3462r2146b3513],
17	atopy	NN	O	atopy	prep_to	15	SENT_235	[p13l10t3563r201b3633],
18	deserves	VBZ	O	deserve	_	0	SENT_235	[p13l229t3554r527b3615],
19	further	JJ	O	further	amod	20	SENT_235	[p13l556t3554r795b3615],
20	investigation	NN	O	investigation	dobj	18	SENT_235	[p13l820t3554r1293b3633],
21	;	:	O	;	_	0	SENT_235	[p13l820t3554r1293b3633],
22	however	RB	O	however	advmod	30	SENT_235	[p13l1323t3554r1640b3626],
23	,	,	O	,	_	0	SENT_235	[p13l1323t3554r1640b3626],
24	in	IN	O	in	_	0	SENT_235	[p13l1670t3554r1736b3614],
25	the	DT	O	the	det	27	SENT_235	[p13l1763t3554r1868b3615],
26	present	JJ	DATE	present	amod	27	SENT_235	[p13l1894t3563r2148b3633],
27	study	NN	O	study	prep_in	30	SENT_235	[p13l11t3655r210b3734],
28	,	,	O	,	_	0	SENT_235	[p13l11t3655r210b3734],
29	we	PRP	O	we	nsubj	30	SENT_235	[p13l244t3674r343b3716],
30	found	VBD	O	find	parataxis	18	SENT_235	[p13l374t3655r577b3716],
31	no	DT	O	no	det	32	SENT_235	[p13l606t3674r691b3716],
32	association	NN	O	association	dobj	30	SENT_235	[p13l724t3655r1111b3716],
33	between	IN	O	between	_	0	SENT_235	[p13l1140t3655r1432b3716],
34	A	DT	O	a	det	36	SENT_235	[p13l1457t3655r1751b3716],
35	—	CD	NUMBER	—	num	36	SENT_235	[p13l1457t3655r1751b3716],
36	444C	NN	O	444c	prep_between	32	SENT_235	[p13l1457t3655r1751b3716],
37	and	CC	O	and	_	0	SENT_235	[p13l1785t3655r1908b3716],
38	atopy	NN	O	atopy	prep_between	32	SENT_235	[p13l1939t3664r2143b3734],
39	,	,	O	,	_	0	SENT_235	[p13l1939t3664r2143b3734],

1	or	CC	O	or	_	0	SENT_236	[p14l9t37r81b78],
2	total	JJ	O	total	amod	3	SENT_236	[p14l114t17r267b78],
3	IgE	NN	O	ige	nsubj	11	SENT_236	[p14l302t19r427b97],
4	or	CC	O	or	_	0	SENT_236	[p14l462t37r534b78],
5	speciﬁc	JJ	O	speciﬁc	amod	7	SENT_236	[p14l569t17r831b97],
6	IgE	NN	O	ige	nn	7	SENT_236	[p14l867t19r992b97],
7	levels	NNS	O	level	conj_or	3	SENT_236	[p14l1027t17r1227b79],
8	to	TO	O	to	dep	3	SENT_236	[p14l1263t27r1328b78],
9	mites	NNS	O	mite	dep	3	SENT_236	[p14l1364t17r1571b90],
10	,	,	O	,	_	0	SENT_236	[p14l1364t17r1571b90],
11	suggesting	VBG	O	suggest	_	0	SENT_236	[p14l1612t17r1982b97],
12	that	IN	O	that	complm	16	SENT_236	[p14l2017t17r2148b78],
13	A	DT	O	a	det	15	SENT_236	[p14l8t119r300b180],
14	—	CD	NUMBER	—	num	15	SENT_236	[p14l8t119r300b180],
15	444C	NN	O	444c	nsubj	16	SENT_236	[p14l8t119r300b180],
16	has	VBZ	O	have	ccomp	11	SENT_236	[p14l318t119r431b180],
17	an	DT	O	a	det	19	SENT_236	[p14l453t138r531b180],
18	independent	JJ	O	independent	amod	19	SENT_236	[p14l548t119r972b198],
19	effect	NN	O	effect	dobj	16	SENT_236	[p14l989t119r1183b180],
20	on	IN	O	on	_	0	SENT_236	[p14l1201t138r1285b180],
21	the	DT	O	the	det	23	SENT_236	[p14l1302t119r1406b180],
22	cutaneous	JJ	O	cutaneous	amod	23	SENT_236	[p14l1425t128r1767b180],
23	phenotype	NN	O	phenotype	prep_on	19	SENT_236	[p14l1786t119r2146b198],
24	and	CC	O	and	_	0	SENT_236	[p14l10t220r135b281],
25	that	IN	O	that	complm	28	SENT_236	[p14l170t220r303b281],
26	this	DT	O	this	det	27	SENT_236	[p14l338t220r463b281],
27	effect	NN	O	effect	nsubj	28	SENT_236	[p14l502t220r701b281],
28	involves	VBZ	O	involve	conj_and	16	SENT_236	[p14l736t220r1034b281],
29	mechanisms	NNS	O	mechanism	nsubj	30	SENT_236	[p14l1073t220r1508b281],
30	other	JJ	O	other	xcomp	28	SENT_236	[p14l1548t220r1729b281],
31	than	IN	O	than	_	0	SENT_236	[p14l1764t220r1915b281],
32	atopy	NN	O	atopy	nn	33	SENT_236	[p14l1954t229r2146b299],
33	pathways	NNS	O	pathway	prep_than	30	SENT_236	[p14l7t320r356b400],
34	.	.	O	.	_	0	SENT_236	[p14l7t320r356b400],

1	Nevertheless	RB	O	nevertheless	advmod	11	SENT_237	[p14l382t320r853b393],
2	,	,	O	,	_	0	SENT_237	[p14l382t320r853b393],
3	in	IN	O	in	_	0	SENT_237	[p14l879t320r946b381],
4	speciﬁc	JJ	O	speciﬁc	amod	6	SENT_237	[p14l971t320r1232b400],
5	genetic	JJ	O	genetic	amod	6	SENT_237	[p14l1257t320r1506b400],
6	backgrounds	NNS	O	background	prep_in	11	SENT_237	[p14l1529t320r1996b400],
7	,	,	O	,	_	0	SENT_237	[p14l1529t320r1996b400],
8	this	DT	O	this	det	9	SENT_237	[p14l2022t320r2145b381],
9	SNP	NN	O	snp	nsubj	11	SENT_237	[p14l11t422r168b483],
10	could	MD	O	could	aux	11	SENT_237	[p14l197t422r390b483],
11	co	VB	O	co	_	0	SENT_237	[p14l423t431r863b501],
12	—	RB	O	—	advmod	11	SENT_237	[p14l423t431r863b501],
13	segregate	VB	O	segregate	ccomp	11	SENT_237	[p14l423t431r863b501],
14	with	IN	O	with	_	0	SENT_237	[p14l896t422r1050b483],
15	other	JJ	O	other	amod	16	SENT_237	[p14l1083t422r1262b483],
16	variants	NNS	O	variant	prep_with	13	SENT_237	[p14l1293t422r1567b483],
17	predisposing	VBG	O	predispose	partmod	16	SENT_237	[p14l1600t422r2048b501],
18	to	TO	O	to	_	0	SENT_237	[p14l2081t431r2146b483],
19	AIU	NNP	ORGANIZATION	AIU	prep_to	17	SENT_237	[p14l8t523r181b595],
20	,	,	O	,	_	0	SENT_237	[p14l8t523r181b595],
21	atopy	NN	O	atopy	conj_or	19	SENT_237	[p14l216t532r421b602],
22	,	,	O	,	_	0	SENT_237	[p14l216t532r421b602],
23	or	CC	O	or	_	0	SENT_237	[p14l455t542r526b584],
24	high	JJ	O	high	amod	27	SENT_237	[p14l554t523r709b602],
25	total	JJ	O	total	amod	27	SENT_237	[p14l739t523r893b584],
26	IgE	NN	O	ige	nn	27	SENT_237	[p14l923t524r1048b602],
27	levels	NNS	O	level	conj_or	19	SENT_237	[p14l1079t523r1299b595],
28	,	,	O	,	_	0	SENT_237	[p14l1079t523r1299b595],
29	as	IN	O	as	mark	30	SENT_237	[p14l1335t542r1402b584],
30	found	VBN	O	find	advcl	11	SENT_237	[p14l1434t523r1637b584],
31	elsewhere	RB	O	elsewhere	advmod	30	SENT_237	[p14l1668t523r2016b584],
32	for	IN	O	for	_	0	SENT_237	[p14l2047t523r2149b584],
33	2	CD	NUMBER	2	num	35	SENT_237	[p14l9t624r49b684],
34	promoter	NN	O	promoter	nn	35	SENT_237	[p14l74t633r396b703],
35	polymorphisms	NNS	O	polymorphism	prep_for	30	SENT_237	[p14l418t623r962b703],
36	in	IN	O	in	_	0	SENT_237	[p14l989t623r1055b684],
37	the	DT	O	the	det	40	SENT_237	[p14l1079t623r1184b684],
38	F	NN	O	f	nn	40	SENT_237	[p14l1208t626r1265b684],
39	CERIB	NN	O	cerib	nn	40	SENT_237	[p14l1267t625r1509b685],
40	gene	NN	O	gene	prep_in	35	SENT_237	[p14l1535t643r1697b703],
41	[	CD	NUMBER	[	number	42	SENT_237	[p14l1728t624r1884b698],
42	41	CD	NUMBER	41	num	43	SENT_237	[p14l1728t624r1884b698],
43	]	NN	O	]	dobj	30	SENT_237	[p14l1728t624r1884b698],
44	.	.	O	.	_	0	SENT_237	[p14l1728t624r1884b698],

1	Although	IN	O	although	mark	4	SENT_238	[p14l139t725r470b804],
2	we	PRP	O	we	nsubj	4	SENT_238	[p14l499t744r598b786],
3	are	VBP	O	be	cop	4	SENT_238	[p14l629t744r732b786],
4	aware	JJ	O	aware	advcl	26	SENT_238	[p14l763t744r968b786],
5	that	IN	O	that	complm	9	SENT_238	[p14l998t725r1128b786],
6	patients	NNS	O	patient	nsubj	9	SENT_238	[p14l1155t725r1425b804],
7	and	CC	O	and	_	0	SENT_238	[p14l1458t725r1582b786],
8	controls	NNS	O	control	nsubj	9	SENT_238	[p14l1610t725r1889b786],
9	shared	VBN	O	share	ccomp	4	SENT_238	[p14l1923t725r2147b786],
10	common	JJ	O	common	amod	12	SENT_238	[p14l9t845r314b887],
11	demographic	JJ	O	demographic	amod	12	SENT_238	[p14l335t826r790b905],
12	characteristics	NNS	O	characteristic	dobj	9	SENT_238	[p14l813t826r1332b898],
13	,	,	O	,	_	0	SENT_238	[p14l813t826r1332b898],
14	especially	RB	O	especially	advmod	17	SENT_238	[p14l1357t826r1705b905],
15	having	VBG	O	have	aux	17	SENT_238	[p14l1725t826r1962b905],
16	been	VBN	O	be	auxpass	17	SENT_238	[p14l1982t826r2147b887],
17	born	VBN	O	bear	xcomp	9	SENT_238	[p14l7t926r167b987],
18	in	IN	O	in	_	0	SENT_238	[p14l186t926r252b987],
19	Caracas	NNP	LOCATION	Caracas	prep_in	17	SENT_238	[p14l271t927r564b999],
20	,	,	O	,	_	0	SENT_238	[p14l271t927r564b999],
21	there	EX	O	there	expl	26	SENT_238	[p14l587t926r760b987],
22	may	MD	O	may	aux	26	SENT_238	[p14l779t946r927b1006],
23	still	RB	O	still	advmod	26	SENT_238	[p14l950t926r1076b987],
24	be	VB	O	be	cop	26	SENT_238	[p14l1093t926r1175b987],
25	a	DT	O	a	det	26	SENT_238	[p14l1196t946r1232b987],
26	bias	NN	O	bias	_	0	SENT_238	[p14l1248t926r1386b987],
27	in	IN	O	in	_	0	SENT_238	[p14l1407t926r1474b987],
28	our	PRP$	O	we	poss	29	SENT_238	[p14l1493t946r1608b987],
29	results	NNS	O	result	prep_in	26	SENT_238	[p14l1624t926r1850b987],
30	because	IN	O	because	_	0	SENT_238	[p14l1870t926r2146b987],
31	of	IN	O	of	_	0	SENT_238	[p14l9t1028r85b1089],
32	genetic	JJ	O	genetic	amod	33	SENT_238	[p14l106t1028r355b1108],
33	stratiﬁcation	NN	O	stratiﬁcation	prep_because_of	26	SENT_238	[p14l386t1028r821b1089],
34	of	IN	O	of	_	0	SENT_238	[p14l848t1028r923b1089],
35	the	DT	O	the	det	36	SENT_238	[p14l943t1028r1048b1089],
36	population	NN	O	population	prep_of	33	SENT_238	[p14l1073t1028r1466b1108],
37	.	.	O	.	_	0	SENT_238	[p14l1073t1028r1466b1108],

1	However	RB	O	however	advmod	5	SENT_239	[p14l1497t1030r1832b1100],
2	,	,	O	,	_	0	SENT_239	[p14l1497t1030r1832b1100],
3	it	PRP	O	it	nsubj	5	SENT_239	[p14l1861t1028r1909b1089],
4	seems	VBZ	O	seem	cop	5	SENT_239	[p14l1937t1048r2145b1089],
5	unlikely	JJ	O	unlikely	_	0	SENT_239	[p14l8t1129r294b1208],
6	that	IN	O	that	complm	8	SENT_239	[p14l327t1129r458b1190],
7	stratiﬁcation	NN	O	stratiﬁcation	nsubj	8	SENT_239	[p14l493t1129r927b1190],
8	acts	VBZ	O	act	ccomp	5	SENT_239	[p14l962t1138r1092b1190],
9	as	IN	O	as	quantmod	10	SENT_239	[p14l1129t1148r1196b1190],
10	a	DT	O	a	num	11	SENT_239	[p14l1232t1148r1269b1190],
11	confounder	NN	O	confounder	dobj	8	SENT_239	[p14l1301t1129r1714b1201],
12	,	,	O	,	_	0	SENT_239	[p14l1301t1129r1714b1201],
13	because	RB	O	because	advmod	11	SENT_239	[p14l1749t1129r2045b1201],
14	,	,	O	,	_	0	SENT_239	[p14l1749t1129r2045b1201],
15	in	IN	O	in	prep	11	SENT_239	[p14l2081t1129r2147b1189],

1	©	RB	O	©	advmod	5	SENT_240	[p14l10t1375r61b1426],
2	2009	CD	DATE	2009	num	5	SENT_240	[p14l84t1375r227b1427],
3	Esmon	NNP	O	Esmon	nn	5	SENT_240	[p14l249t1376r454b1426],
4	Publicidad	NNP	O	Publicidad	nn	5	SENT_240	[p14l474t1375r790b1426],
5	addition	NN	O	addition	ccomp	16	SENT_240	[p14l12t1467r299b1528],
6	to	TO	O	to	_	0	SENT_240	[p14l335t1476r400b1528],
7	the	DT	O	the	det	8	SENT_240	[p14l438t1467r543b1528],
8	associations	NNS	O	association	prep_to	5	SENT_240	[p14l581t1467r1005b1528],
9	between	IN	O	between	_	0	SENT_240	[p14l1042t1467r1336b1528],
10	patients	NNS	O	patient	prep_between	8	SENT_240	[p14l1371t1467r1644b1546],
11	and	CC	O	and	_	0	SENT_240	[p14l1684t1467r1809b1528],
12	controls	NNS	O	control	conj_and	10	SENT_240	[p14l1845t1467r2147b1539],
13	,	,	O	,	_	0	SENT_240	[p14l1845t1467r2147b1539],
14	we	PRP	O	we	nsubj	16	SENT_240	[p14l10t1587r111b1629],
15	also	RB	O	also	advmod	16	SENT_240	[p14l151t1568r290b1629],
16	found	VBD	O	find	_	0	SENT_240	[p14l329t1568r537b1629],
17	associations	NNS	O	association	dobj	16	SENT_240	[p14l575t1568r1006b1629],
18	between	IN	O	between	_	0	SENT_240	[p14l1044t1568r1343b1629],
19	A	DT	O	a	det	21	SENT_240	[p14l1375t1568r1675b1629],
20	—	CD	NUMBER	—	num	21	SENT_240	[p14l1375t1568r1675b1629],
21	444C	NN	O	444c	prep_between	17	SENT_240	[p14l1375t1568r1675b1629],
22	and	CC	O	and	_	0	SENT_240	[p14l1716t1568r1841b1629],
23	speciﬁc	NN	O	speciﬁc	nn	24	SENT_240	[p14l1881t1568r2149b1647],
24	phenotypes	NNS	O	phenotype	dobj	16	SENT_240	[p14l9t1668r401b1748],
25	of	IN	O	of	_	0	SENT_240	[p14l422t1668r497b1729],
26	AIU	NNP	ORGANIZATION	AIU	prep_of	24	SENT_240	[p14l504t1669r657b1730],
27	within	IN	O	within	_	0	SENT_240	[p14l675t1668r894b1730],
28	subgroups	NNS	O	subgroup	prep_within	16	SENT_240	[p14l915t1668r1264b1748],
29	of	IN	O	of	_	0	SENT_240	[p14l1285t1668r1360b1729],
30	patients	NNS	O	patient	prep_of	28	SENT_240	[p14l1371t1668r1637b1748],
31	by	IN	O	by	_	0	SENT_240	[p14l1656t1668r1741b1748],
32	statistically	RB	O	statistically	advmod	33	SENT_240	[p14l1762t1668r2150b1748],
33	independent	JJ	O	independent	amod	34	SENT_240	[p14l10t1770r439b1849],
34	effects	NNS	O	effect	prep_by	16	SENT_240	[p14l463t1770r711b1831],
35	.	.	O	.	_	0	SENT_240	[p14l463t1770r711b1831],

1	In	IN	O	in	_	0	SENT_241	[p14l142t1872r213b1931],
2	summary	NN	O	summary	prep_in	6	SENT_241	[p14l253t1890r594b1950],
3	,	,	O	,	_	0	SENT_241	[p14l253t1890r594b1950],
4	our	PRP$	O	we	poss	5	SENT_241	[p14l636t1890r753b1932],
5	data	NNS	O	datum	nsubj	6	SENT_241	[p14l789t1871r937b1932],
6	support	VBP	O	support	_	0	SENT_241	[p14l975t1880r1241b1950],
7	the	DT	O	the	det	8	SENT_241	[p14l1276t1871r1383b1932],
8	association	NN	O	association	dobj	6	SENT_241	[p14l1422t1871r1818b1932],
9	between	IN	O	between	_	0	SENT_241	[p14l1854t1871r2151b1932],
10	A	DT	O	a	det	12	SENT_241	[p14l10t1972r304b2033],
11	—	CD	NUMBER	—	num	12	SENT_241	[p14l10t1972r304b2033],
12	444C	NN	O	444c	prep_between	8	SENT_241	[p14l10t1972r304b2033],
13	and	CC	O	and	_	0	SENT_241	[p14l343t1971r467b2032],
14	AIU	NNP	O	AIU	conj_and	12	SENT_241	[p14l496t1972r668b2033],
15	.	.	O	.	_	0	SENT_241	[p14l496t1972r668b2033],

1	This	DT	O	this	nsubj	5	SENT_242	[p14l706t1971r858b2032],
2	is	VBZ	O	be	cop	5	SENT_242	[p14l895t1971r950b2032],
3	the	DT	O	the	det	5	SENT_242	[p14l986t1971r1091b2032],
4	ﬁrst	NN	O	ﬁrst	nn	5	SENT_242	[p14l1128t1971r1263b2032],
5	report	NN	O	report	_	0	SENT_242	[p14l1296t1981r1506b2051],
6	of	IN	O	of	_	0	SENT_242	[p14l1541t1971r1617b2032],
7	an	DT	O	a	det	8	SENT_242	[p14l1648t1991r1727b2032],
8	association	NN	O	association	prep_of	5	SENT_242	[p14l1763t1971r2151b2032],
9	between	IN	O	between	_	0	SENT_242	[p14l9t2073r301b2134],
10	A	DT	O	a	det	12	SENT_242	[p14l332t2073r626b2134],
11	—	CD	NUMBER	—	num	12	SENT_242	[p14l332t2073r626b2134],
12	444C	NN	O	444c	prep_between	8	SENT_242	[p14l332t2073r626b2134],
13	and	CC	O	and	_	0	SENT_242	[p14l665t2073r789b2134],
14	the	DT	O	the	det	17	SENT_242	[p14l824t2073r928b2134],
15	cutaneous	JJ	O	cutaneous	amod	17	SENT_242	[p14l965t2082r1312b2134],
16	clinical	JJ	O	clinical	amod	17	SENT_242	[p14l1350t2073r1607b2134],
17	pattern	NN	O	pattern	prep_of	5	SENT_242	[p14l1641t2082r1885b2152],
18	of	IN	O	of	_	0	SENT_242	[p14l1921t2073r1996b2134],
19	this	DT	O	this	det	20	SENT_242	[p14l2026t2073r2149b2134],
20	phenotype	NN	O	phenotype	prep_of	17	SENT_242	[p14l9t2174r388b2253],
21	,	,	O	,	_	0	SENT_242	[p14l9t2174r388b2253],
22	thus	RB	O	thus	advmod	23	SENT_242	[p14l409t2174r550b2235],
23	stressing	VBG	O	stress	partmod	5	SENT_242	[p14l572t2174r870b2253],
24	the	DT	O	the	det	25	SENT_242	[p14l888t2174r992b2235],
25	importance	NN	O	importance	dobj	23	SENT_242	[p14l1010t2174r1398b2253],
26	of	IN	O	of	_	0	SENT_242	[p14l1418t2174r1493b2235],
27	this	DT	O	this	det	28	SENT_242	[p14l1505t2174r1626b2235],
28	polymorphism	NN	O	polymorphism	prep_of	25	SENT_242	[p14l1645t2174r2152b2253],
29	as	IN	O	as	_	0	SENT_242	[p14l12t2294r79b2335],
30	a	DT	O	a	det	32	SENT_242	[p14l119t2294r155b2335],
31	genetic	JJ	O	genetic	amod	32	SENT_242	[p14l192t2274r443b2354],
32	marker	NN	O	marker	prep_as	23	SENT_242	[p14l480t2274r731b2335],
33	of	IN	O	of	_	0	SENT_242	[p14l767t2274r843b2335],
34	AIU	NNP	ORGANIZATION	AIU	prep_of	32	SENT_242	[p14l868t2275r1041b2336],
35	.	.	O	.	_	0	SENT_242	[p14l868t2275r1041b2336],

1	Further	JJ	O	further	amod	2	SENT_243	[p14l1081t2274r1342b2335],
2	studies	NNS	O	study	nsubjpass	4	SENT_243	[p14l1380t2274r1619b2335],
3	are	VBP	O	be	auxpass	4	SENT_243	[p14l1659t2294r1763b2335],
4	needed	VBN	O	need	_	0	SENT_243	[p14l1799t2274r2049b2335],
5	to	TO	O	to	aux	6	SENT_243	[p14l2084t2284r2150b2335],
6	evaluate	VB	O	evaluate	xcomp	4	SENT_243	[p14l11t2376r313b2437],
7	the	DT	O	the	det	9	SENT_243	[p14l352t2376r460b2437],
8	functional	JJ	O	functional	amod	9	SENT_243	[p14l500t2376r870b2437],
9	basis	NN	O	basis	dobj	6	SENT_243	[p14l908t2376r1088b2437],
10	of	IN	O	of	_	0	SENT_243	[p14l1130t2376r1207b2437],
11	the	DT	O	the	det	12	SENT_243	[p14l1240t2376r1349b2437],
12	effect	NN	O	effect	prep_of	9	SENT_243	[p14l1389t2376r1595b2437],
13	of	IN	O	of	_	0	SENT_243	[p14l1633t2376r1711b2437],
14	A	DT	O	a	det	16	SENT_243	[p14l1739t2376r2042b2437],
15	—	CD	NUMBER	—	num	16	SENT_243	[p14l1739t2376r2042b2437],
16	444C	NN	O	444c	prep_of	12	SENT_243	[p14l1739t2376r2042b2437],
17	in	IN	O	in	_	0	SENT_243	[p14l2083t2376r2151b2436],
18	AIU	NNP	ORGANIZATION	AIU	prep_in	16	SENT_243	[p14l10t2477r164b2538],
19	and	CC	O	and	_	0	SENT_243	[p14l202t2477r326b2538],
20	the	DT	O	the	det	22	SENT_243	[p14l361t2477r466b2538],
21	cutaneous	JJ	O	cutaneous	amod	22	SENT_243	[p14l503t2486r852b2538],
22	manifestations	NNS	O	manifestation	prep_of	12	SENT_243	[p14l890t2477r1401b2538],
23	of	IN	O	of	_	0	SENT_243	[p14l1440t2477r1516b2538],
24	this	DT	O	this	det	25	SENT_243	[p14l1545t2477r1669b2538],
25	disease	NN	O	disease	prep_of	22	SENT_243	[p14l1708t2477r1977b2538],
26	.	.	O	.	_	0	SENT_243	[p14l1708t2477r1977b2538],

1	The	DT	O	the	det	3	SENT_244	[p14l2016t2477r2151b2538],
2	biological	JJ	O	biological	amod	3	SENT_244	[p14l9t2577r378b2657],
3	pathways	NNS	O	pathway	nsubj	25	SENT_244	[p14l417t2577r761b2657],
4	underlying	VBG	O	underlie	partmod	3	SENT_244	[p14l802t2577r1199b2657],
5	differences	NNS	O	difference	dobj	4	SENT_244	[p14l1240t2577r1645b2638],
6	in	IN	O	in	_	0	SENT_244	[p14l1687t2577r1755b2638],
7	histamine	NN	O	histamine	nn	8	SENT_244	[p14l1794t2577r2151b2638],
8	reactivity	NN	O	reactivity	prep_in	5	SENT_244	[p14l9t2679r340b2758],
9	according	VBG	O	accord	_	0	SENT_244	[p14l369t2679r711b2758],
10	to	TO	O	to	prepc_according_to	4	SENT_244	[p14l738t2688r803b2740],
11	the	DT	O	the	det	15	SENT_244	[p14l830t2679r934b2740],
12	A	NN	O	a	nn	15	SENT_244	[p14l956t2679r1251b2740],
13	—	NN	O	—	nn	15	SENT_244	[p14l956t2679r1251b2740],
14	444C	CD	NUMBER	444c	num	15	SENT_244	[p14l956t2679r1251b2740],
15	SNP	NN	O	snp	pobj	4	SENT_244	[p14l1281t2679r1438b2740],
16	and	CC	O	and	_	0	SENT_244	[p14l1463t2679r1586b2740],
17	its	PRP$	O	its	poss	18	SENT_244	[p14l1611t2679r1690b2740],
18	inﬂuence	NN	O	inﬂuence	pobj	4	SENT_244	[p14l1718t2679r2038b2740],
19	on	IN	O	on	_	0	SENT_244	[p14l2066t2698r2151b2740],
20	antihistamine	NN	O	antihistamine	nn	21	SENT_244	[p14l12t2780r482b2841],
21	responsiveness	NN	O	responsiveness	prep_on	18	SENT_244	[p14l507t2780r1032b2859],
22	in	IN	O	in	_	0	SENT_244	[p14l1059t2780r1125b2840],
23	AIU	NNP	ORGANIZATION	AIU	nn	24	SENT_244	[p14l1146t2780r1300b2841],
24	patients	NNS	O	patient	prep_in	21	SENT_244	[p14l1324t2780r1594b2859],
25	deserve	VBP	O	deserve	_	0	SENT_244	[p14l1623t2780r1888b2841],
26	further	JJ	O	further	amod	27	SENT_244	[p14l1914t2780r2152b2841],
27	investigation	NN	O	investigation	dobj	25	SENT_244	[p14l10t2880r480b2960],
28	.	.	O	.	_	0	SENT_244	[p14l10t2880r480b2960],

1	Acknowledgments	NNS	O	acknowledgment	_	0	SENT_245	[p14l7t3127r981b3241],

1	We	PRP	O	we	nsubj	2	SENT_246	[p14l140t3357r252b3417],
2	thank	VBP	O	thank	_	0	SENT_246	[p14l268t3356r459b3417],
3	all	PDT	O	all	predet	5	SENT_246	[p14l474t3356r555b3417],
4	the	DT	O	the	det	5	SENT_246	[p14l571t3356r673b3417],
5	participants	NNS	O	participant	dobj	2	SENT_246	[p14l688t3356r1082b3435],
6	for	IN	O	for	_	0	SENT_246	[p14l1100t3356r1199b3417],
7	their	PRP$	O	they	poss	9	SENT_246	[p14l1213t3356r1369b3417],
8	voluntary	JJ	O	voluntary	amod	9	SENT_246	[p14l1383t3356r1707b3435],
9	participation	NN	O	participation	prep_for	5	SENT_246	[p14l1722t3356r2151b3435],
10	in	IN	O	in	_	0	SENT_246	[p14l10t3457r76b3517],
11	the	DT	O	the	det	12	SENT_246	[p14l94t3457r198b3518],
12	study	NN	O	study	prep_in	9	SENT_246	[p14l219t3457r415b3536],
13	.	.	O	.	_	0	SENT_246	[p14l219t3457r415b3536],

1	This	DT	O	this	det	2	SENT_247	[p14l436t3457r587b3518],
2	work	NN	O	work	nsubjpass	5	SENT_247	[p14l608t3457r787b3518],
3	was	VBD	O	be	auxpass	5	SENT_247	[p14l803t3476r934b3518],
4	partially	RB	O	partially	advmod	5	SENT_247	[p14l954t3457r1243b3536],
5	supported	VBN	O	support	_	0	SENT_247	[p14l1265t3457r1604b3536],
6	by	IN	O	by	_	0	SENT_247	[p14l1621t3457r1706b3536],
7	Colciencias	NNP	O	Colciencias	nn	10	SENT_247	[p14l1726t3457r2148b3529],
8	,	,	O	,	_	0	SENT_247	[p14l1726t3457r2148b3529],
9	Grant	NNP	O	Grant	appos	10	SENT_247	[p14l11t3558r219b3619],
10	number	NN	O	number	agent	5	SENT_247	[p14l258t3557r538b3618],
11	331-2004	CD	NUMBER	331-2004	num	10	SENT_247	[p14l579t3558r948b3619],
12	.	.	O	.	_	0	SENT_247	[p14l579t3558r948b3619],

1	N.	NNP	PERSON	N.	nn	2	SENT_248	[p14l992t3559r1074b3618],
2	Acevedo	NNP	PERSON	Acevedo	nsubjpass	4	SENT_248	[p14l1114t3557r1438b3619],
3	was	VBD	O	be	auxpass	4	SENT_248	[p14l1479t3577r1616b3619],
4	supported	VBN	O	support	_	0	SENT_248	[p14l1662t3557r2023b3637],
5	by	IN	O	by	_	0	SENT_248	[p14l2062t3557r2150b3637],
6	Fundemeb	NN	PERSON	fundemeb	agent	4	SENT_248	[p14l9t3658r397b3719],
7	.	.	O	.	_	0	SENT_248	[p14l9t3658r397b3719],

1	References	NNS	O	reference	_	0	SENT_249	[p15l18t116r571b205],

1	Sanchez-Borges	NNP	O	Sanchez-Borges	nn	2	SENT_250	[p15l157t340r656b429],
2	M	NNP	O	M	_	0	SENT_250	[p15l715t344r788b419],
3	,	,	O	,	_	0	SENT_250	[p15l715t344r788b419],
4	Capriles-Hulett	NNP	O	Capriles-Hulett	nn	5	SENT_250	[p15l844t340r1314b429],
5	A	NNP	O	A	appos	2	SENT_250	[p15l1360t344r1424b419],
6	,	,	O	,	_	0	SENT_250	[p15l1360t344r1424b419],
7	Caballero-Fonseca	NNP	O	Caballero-Fonseca	nn	11	SENT_250	[p15l1479t340r2055b408],
8	F.	NNP	O	F.	nn	11	SENT_250	[p15l2116t344r2149b409],
9	The	NNP	O	The	nn	11	SENT_250	[p15l154t442r262b510],
10	multiple	JJ	O	multiple	amod	11	SENT_250	[p15l324t442r572b530],
11	faces	NNS	O	face	appos	2	SENT_250	[p15l629t441r788b510],
12	of	IN	O	of	_	0	SENT_250	[p15l847t441r910b510],
13	nonsteroidal	JJ	O	nonsteroidal	amod	18	SENT_250	[p15l965t442r1351b510],
14	antiinl	JJ	O	antiinl	amod	18	SENT_250	[p15l1412t444r1952b530],
15	]	NN	O	]	nn	18	SENT_250	[p15l1412t444r1952b530],
16	ammatory	JJ	O	ammatory	amod	18	SENT_250	[p15l1412t444r1952b530],
17	drug	NN	O	drug	nn	18	SENT_250	[p15l2008t442r2150b530],
18	hypersensitivity	NN	O	hypersensitivity	prep_of	11	SENT_250	[p15l159t542r690b631],
19	]	CD	NUMBER	]	dep	2	SENT_250	[p15l159t542r690b631],
20	Investig	NNP	PERSON	Investig	nn	23	SENT_250	[p15l719t544r962b631],
21	Allergol	NNP	PERSON	Allergol	nn	23	SENT_250	[p15l978t542r1218b631],
22	Clin	NNP	PERSON	Clin	nn	23	SENT_250	[p15l1247t542r1361b611],
23	Immunol	NNP	PERSON	Immunol	dep	19	SENT_250	[p15l1387t542r1682b611],
24	.	.	O	.	_	0	SENT_250	[p15l1387t542r1682b611],

1	2004	CD	DATE	2004	_	0	SENT_251	[p15l1706t545r2149b621, p15l156t647r253b713],
2	;	:	O	;	_	0	SENT_251	[p15l1706t545r2149b621, p15l156t647r253b713],
3	14:32934	CD	NUMBER	14:32934	dep	1	SENT_251	[p15l1706t545r2149b621, p15l156t647r253b713],
4	.	.	O	.	_	0	SENT_251	[p15l1706t545r2149b621, p15l156t647r253b713],

1	2	LS	NUMBER	2	_	0	SENT_252	[p15l54t749r109b814],
2	.	.	O	.	_	0	SENT_252	[p15l54t749r109b814],

1	jenneck	NN	O	jenneck	nn	2	SENT_253	[p15l145t746r406b830],
2	C	NN	O	c	_	0	SENT_253	[p15l441t749r804b834],
3	,	,	O	,	_	0	SENT_253	[p15l441t749r804b834],
4	Juergens	NNP	PERSON	Juergens	nn	5	SENT_253	[p15l441t749r804b834],
5	U	NNP	PERSON	U	appos	2	SENT_253	[p15l843t749r900b824],
6	,	,	O	,	_	0	SENT_253	[p15l843t749r900b824],
7	Buecheler	NNP	O	Buecheler	nn	8	SENT_253	[p15l939t746r1244b814],
8	M	NNP	O	M	appos	2	SENT_253	[p15l1282t749r1356b824],
9	,	,	O	,	_	0	SENT_253	[p15l1282t749r1356b824],
10	Novak	NNP	PERSON	Novak	nn	12	SENT_253	[p15l1395t746r1590b814],
11	N.	NNP	PERSON	N.	nn	12	SENT_253	[p15l1628t749r1685b814],
12	Pathogenesis	NNP	PERSON	Pathogenesis	appos	8	SENT_253	[p15l1724t746r2149b834],
13	,	,	O	,	_	0	SENT_253	[p15l1724t746r2149b834],

1	diagnosis	NN	O	diagnosis	_	0	SENT_254	[p15l157t846r466b935],
2	,	,	O	,	_	0	SENT_254	[p15l157t846r466b935],
3	and	CC	O	and	dep	1	SENT_254	[p15l509t846r621b915],
4	treatment	NN	O	treatment	dep	1	SENT_254	[p15l666t855r977b915],
5	of	IN	O	of	dep	4	SENT_254	[p15l1020t846r1082b915],
6	aspirin	NN	O	aspirin	nn	7	SENT_254	[p15l1121t848r1324b935],
7	intolerance	NN	O	intolerance	pobj	5	SENT_254	[p15l1373t846r1732b915],
8	.	.	O	.	_	0	SENT_254	[p15l1373t846r1732b915],

1	Ann	NNP	PERSON	Ann	nn	4	SENT_255	[p15l1768t850r1893b914],
2	Allergy	NNP	PERSON	Allergy	nn	4	SENT_255	[p15l1932t846r2151b935],
3	Asthma	NNP	PERSON	Asthma	nn	4	SENT_255	[p15l154t947r392b1015],
4	Immunol	NNP	PERSON	Immunol	_	0	SENT_255	[p15l421t947r716b1016],
5	.	.	O	.	_	0	SENT_255	[p15l421t947r716b1016],

1	2007	CD	DATE	2007	_	0	SENT_256	[p15l743t950r1246b1026],
2	;	:	O	;	_	0	SENT_256	[p15l743t950r1246b1026],
3	99:13	CD	NUMBER	99:13	number	4	SENT_256	[p15l743t950r1246b1026],
4	-21	CD	NUMBER	-21	dep	1	SENT_256	[p15l743t950r1246b1026],
5	.	.	O	.	_	0	SENT_256	[p15l743t950r1246b1026],

1	.	.	O	.	_	0	SENT_257	[p15l99t1105r109b1117],

1	Gollapudi	NNP	O	Gollapudi	nn	2	SENT_258	[p15l158t1049r457b1137],
2	RR	NNP	O	RR	_	0	SENT_258	[p15l502t1052r599b1127],
3	,	,	O	,	_	0	SENT_258	[p15l502t1052r599b1127],
4	Teirstein	NNP	PERSON	Teirstein	nn	5	SENT_258	[p15l630t1051r889b1117],
5	PS	NNP	O	PS	appos	2	SENT_258	[p15l935t1052r1019b1127],
6	,	,	O	,	_	0	SENT_258	[p15l935t1052r1019b1127],
7	Stevenson	NNP	PERSON	Stevenson	nn	8	SENT_258	[p15l1058t1052r1374b1117],
8	DD	NNP	O	DD	appos	2	SENT_258	[p15l1419t1052r1523b1127],
9	,	,	O	,	_	0	SENT_258	[p15l1419t1052r1523b1127],
10	Simon	NNP	PERSON	Simon	nn	11	SENT_258	[p15l1562t1051r1751b1117],
11	RA	NN	O	ra	appos	2	SENT_258	[p15l1797t1052r1898b1117],
12	.	.	O	.	_	0	SENT_258	[p15l1797t1052r1898b1117],

1	Aspirin	NN	O	aspirin	nn	2	SENT_259	[p15l1930t1051r2146b1137],
2	sensitivity	NN	O	sensitivity	_	0	SENT_259	[p15l156t1151r479b1238],
3	:	:	O	:	_	0	SENT_259	[p15l156t1151r479b1238],
4	implications	NNS	O	implication	dep	2	SENT_259	[p15l544t1149r918b1238],
5	for	IN	O	for	_	0	SENT_259	[p15l980t1149r1066b1218],
6	patients	NNS	O	patient	prep_for	4	SENT_259	[p15l1130t1151r1377b1238],
7	with	IN	O	with	_	0	SENT_259	[p15l1439t1149r1572b1218],
8	coronary	JJ	O	coronary	amod	10	SENT_259	[p15l1640t1168r1911b1238],
9	artery	NN	O	artery	nn	10	SENT_259	[p15l1972t1158r2151b1238],
10	disease	NN	O	disease	prep_with	6	SENT_259	[p15l157t1251r629b1336],
11	.	.	O	.	_	0	SENT_259	[p15l157t1251r629b1336],

1	JAMA	NN	O	jama	_	0	SENT_260	[p15l157t1251r629b1336],
2	.	.	O	.	_	0	SENT_260	[p15l157t1251r629b1336],

1	2004	CD	DATE	2004	_	0	SENT_261	[p15l656t1254r1286b1330],
2	;	:	O	;	_	0	SENT_261	[p15l656t1254r1286b1330],
3	292:3017	CD	NUMBER	292:3017	number	4	SENT_261	[p15l656t1254r1286b1330],
4	-23	CD	NUMBER	-23	dep	1	SENT_261	[p15l656t1254r1286b1330],
5	.	.	O	.	_	0	SENT_261	[p15l656t1254r1286b1330],

1	.	.	O	.	_	0	SENT_262	[p15l99t1409r109b1421],

1	Grattan	NNP	PERSON	Grattan	nn	2	SENT_263	[p15l158t1356r391b1421],
2	CE	NNP	O	CE	_	0	SENT_263	[p15l423t1355r756b1441],
3	.	.	O	.	_	0	SENT_263	[p15l423t1355r756b1441],

1	Aspirin	NN	O	aspirin	_	0	SENT_264	[p15l423t1355r756b1441],
2	sensitivity	NN	O	sensitivity	dep	1	SENT_264	[p15l786t1355r1093b1441],
3	and	CC	O	and	_	0	SENT_264	[p15l1119t1353r1230b1421],
4	urticaria	NN	O	urticarium	dep	1	SENT_264	[p15l1263t1355r1534b1421],
5	.	.	O	.	_	0	SENT_264	[p15l1263t1355r1534b1421],

1	Clin	NNP	PERSON	Clin	nn	3	SENT_265	[p15l1563t1353r1677b1421],
2	Exp	NNP	PERSON	Exp	nn	3	SENT_265	[p15l1711t1356r1814b1441],
3	Dermatol	NNP	PERSON	Dermatol	_	0	SENT_265	[p15l1847t1353r2149b1421],
4	.	.	O	.	_	0	SENT_265	[p15l1847t1353r2149b1421],

1	.	.	O	.	_	0	SENT_266	[p15l98t1611r109b1624],

1	Mastalerz	NNP	PERSON	Mastalerz	nn	2	SENT_267	[p15l160t1555r461b1623],
2	L	NNP	PERSON	L	_	0	SENT_267	[p15l486t1559r529b1634],
3	,	,	O	,	_	0	SENT_267	[p15l486t1559r529b1634],
4	Setkowicz	NNP	O	Setkowicz	nn	5	SENT_267	[p15l550t1555r860b1623],
5	M	NNP	O	M	appos	2	SENT_267	[p15l884t1559r958b1634],
6	,	,	O	,	_	0	SENT_267	[p15l884t1559r958b1634],
7	Sanak	NNP	O	Sanak	nn	8	SENT_267	[p15l979t1555r1168b1623],
8	M	NNP	O	M	appos	2	SENT_267	[p15l1191t1559r1265b1634],
9	,	,	O	,	_	0	SENT_267	[p15l1191t1559r1265b1634],
10	SzczeklikA	NNP	O	SzczeklikA	appos	2	SENT_267	[p15l1285t1555r1640b1624],
11	.	.	O	.	_	0	SENT_267	[p15l1285t1555r1640b1624],

1	Hypersensitivity	NN	O	hypersensitivity	_	0	SENT_268	[p15l1663t1557r2151b1644],
2	to	TO	O	to	_	0	SENT_268	[p15l154t1666r214b1725],
3	aspirin	NN	O	aspirin	prep_to	1	SENT_268	[p15l266t1659r491b1745],
4	:	:	O	:	_	0	SENT_268	[p15l266t1659r491b1745],
5	common	JJ	O	common	amod	7	SENT_268	[p15l541t1676r808b1725],
6	eicosanoid	NN	O	eicosanoid	nn	7	SENT_268	[p15l862t1657r1191b1725],
7	alterations	NNS	O	alteration	dep	1	SENT_268	[p15l1245t1657r1575b1725],
8	in	IN	O	in	_	0	SENT_268	[p15l1628t1659r1676b1724],
9	urticaria	NN	O	urticarium	prep_in	7	SENT_268	[p15l1731t1659r1981b1725],
10	and	CC	O	and	_	0	SENT_268	[p15l2034t1657r2146b1725],
11	asthma	NN	O	asthma	nn	15	SENT_268	[p15l156t1757r445b1842],
12	]	CD	NUMBER	]	num	15	SENT_268	[p15l156t1757r445b1842],
13	Allergy	NNP	O	Allergy	nn	15	SENT_268	[p15l470t1757r689b1846],
14	Clin	NNP	O	Clin	nn	15	SENT_268	[p15l716t1757r830b1826],
15	Immunol	NNP	O	Immunol	prep_in	7	SENT_268	[p15l859t1757r1153b1826],
16	.	.	O	.	_	0	SENT_268	[p15l859t1757r1153b1826],

1	2004	CD	DATE	2004	_	0	SENT_269	[p15l1180t1760r1726b1836],
2	;	:	O	;	_	0	SENT_269	[p15l1180t1760r1726b1836],
3	113:771	CD	NUMBER	113:771	number	4	SENT_269	[p15l1180t1760r1726b1836],
4	-5	CD	NUMBER	-5	dep	1	SENT_269	[p15l1180t1760r1726b1836],
5	.	.	O	.	_	0	SENT_269	[p15l1180t1760r1726b1836],

1	.	.	O	.	_	0	SENT_270	[p15l99t1858r509b1927],

1	Zembowicz	NNP	MISC	Zembowicz	nn	2	SENT_271	[p15l99t1858r509b1927],
2	A	NNP	MISC	A	_	0	SENT_271	[p15l574t1862r638b1937],
3	,	,	O	,	_	0	SENT_271	[p15l574t1862r638b1937],
4	Mastalerz	NNP	PERSON	Mastalerz	nn	5	SENT_271	[p15l713t1858r1014b1926],
5	L	NNP	PERSON	L	appos	2	SENT_271	[p15l1090t1862r1134b1937],
6	,	,	O	,	_	0	SENT_271	[p15l1090t1862r1134b1937],
7	Setkowicz	NNP	O	Setkowicz	nn	8	SENT_271	[p15l1205t1858r1514b1926],
8	M	NNP	O	M	appos	2	SENT_271	[p15l1591t1862r1664b1937],
9	,	,	O	,	_	0	SENT_271	[p15l1591t1862r1664b1937],
10	Radziszewski	NNP	PERSON	Radziszewski	nn	11	SENT_271	[p15l1739t1858r2147b1926],
11	W	NNP	O	W	appos	2	SENT_271	[p15l154t1964r231b2038],
12	,	,	O	,	_	0	SENT_271	[p15l154t1964r231b2038],
13	Szczeklik	NNP	O	Szczeklik	nn	15	SENT_271	[p15l282t1960r562b2028],
14	A.	NNP	O	A.	nn	15	SENT_271	[p15l603t1963r668b2028],
15	Safety	NNP	O	Safety	appos	2	SENT_271	[p15l719t1959r909b2048],
16	of	IN	O	of	_	0	SENT_271	[p15l959t1959r1021b2028],
17	cyclooxygenase	NN	O	cyclooxygenase	prep_of	15	SENT_271	[p15l1068t1960r1551b2048],
18	2	CD	NUMBER	2	num	19	SENT_271	[p15l1604t1963r1638b2027],
19	inhibitors	NNS	O	inhibitor	dep	15	SENT_271	[p15l1693t1960r1982b2028],
20	and	CC	O	and	_	0	SENT_271	[p15l2034t1960r2145b2028],
21	increased	VBD	O	increase	conj_and	19	SENT_271	[p15l158t2060r449b2129],
22	leukotriene	NN	O	leukotriene	nn	23	SENT_271	[p15l493t2060r839b2129],
23	synthesis	NN	O	synthesis	dobj	21	SENT_271	[p15l877t2060r1158b2149],
24	in	IN	O	in	_	0	SENT_271	[p15l1198t2062r1246b2128],
25	chronic	JJ	O	chronic	amod	27	SENT_271	[p15l1287t2060r1511b2129],
26	idiopathic	JJ	O	idiopathic	amod	27	SENT_271	[p15l1551t2060r1856b2149],
27	urticaria	NN	O	urticarium	prep_in	21	SENT_271	[p15l1896t2062r2145b2129],
28	with	IN	O	with	_	0	SENT_271	[p15l154t2161r288b2229],
29	sensitivity	NN	O	sensitivity	prep_with	27	SENT_271	[p15l327t2163r634b2250],
30	to	TO	O	to	_	0	SENT_271	[p15l666t2170r725b2229],
31	nonsteroidal	JJ	O	nonsteroidal	amod	33	SENT_271	[p15l766t2161r1151b2229],
32	anti-inﬂammatory	JJ	O	anti-inﬂammatory	amod	33	SENT_271	[p15l1190t2163r1756b2250],
33	drugs	NNS	O	drug	prep_to	21	SENT_271	[p15l1790t2161r1977b2250],
34	.	.	O	.	_	0	SENT_271	[p15l1790t2161r1977b2250],

1	Arch	NNP	O	Arch	nn	2	SENT_272	[p15l2005t2161r2146b2229],
2	Dermatol	NNP	O	Dermatol	_	0	SENT_272	[p15l160t2264r463b2332],
3	.	.	O	.	_	0	SENT_272	[p15l160t2264r463b2332],

1	2003	CD	DATE	2003	_	0	SENT_273	[p15l490t2267r1120b2342],
2	;	:	O	;	_	0	SENT_273	[p15l490t2267r1120b2342],
3	139:1577	CD	NUMBER	139:1577	number	4	SENT_273	[p15l490t2267r1120b2342],
4	-82	CD	NUMBER	-82	dep	1	SENT_273	[p15l490t2267r1120b2342],
5	.	.	O	.	_	0	SENT_273	[p15l490t2267r1120b2342],

1	.	.	O	.	_	0	SENT_274	[p15l99t2421r109b2433],

1	Szczeklik	NNP	O	Szczeklik	nn	5	SENT_275	[p15l157t2364r436b2433],
2	A.	NNP	O	A.	nn	5	SENT_275	[p15l482t2368r547b2433],
3	The	NNP	O	The	nn	5	SENT_275	[p15l595t2364r703b2433],
4	cyclooxygenase	NN	O	cyclooxygenase	nn	5	SENT_275	[p15l761t2364r1244b2453],
5	theory	NN	O	theory	_	0	SENT_275	[p15l1299t2364r1498b2453],
6	of	IN	O	of	_	0	SENT_275	[p15l1552t2364r1614b2433],
7	aspirin-induced	JJ	O	aspirin-induced	amod	8	SENT_275	[p15l1665t2364r2145b2453],
8	asthma	NN	O	asthma	prep_of	5	SENT_275	[p15l156t2465r404b2534],
9	.	.	O	.	_	0	SENT_275	[p15l156t2465r404b2534],

1	Eur	NNP	MISC	Eur	nn	2	SENT_276	[p15l434t2469r530b2533],
2	RespirJ	NNP	O	RespirJ	_	0	SENT_276	[p15l560t2467r1339b2554],
3	.1990	CD	NUMBER	.1990	num	2	SENT_276	[p15l560t2467r1339b2554],
4	;	:	O	;	_	0	SENT_276	[p15l560t2467r1339b2554],
5	3:588	CD	NUMBER	3:588	number	6	SENT_276	[p15l560t2467r1339b2554],
6	-93	CD	NUMBER	-93	dep	2	SENT_276	[p15l560t2467r1339b2554],
7	.	.	O	.	_	0	SENT_276	[p15l560t2467r1339b2554],

1	.	.	O	.	_	0	SENT_277	[p15l99t2623r109b2635],

1	Kim	NNP	PERSON	Kim	nn	2	SENT_278	[p15l160t2569r270b2634],
2	SH	NNP	O	SH	_	0	SENT_278	[p15l300t2570r488b2645],
3	,	,	O	,	_	0	SENT_278	[p15l300t2570r488b2645],
4	Ye	NNP	PERSON	Ye	nn	5	SENT_278	[p15l300t2570r488b2645],
5	YM	NNP	PERSON	YM	appos	2	SENT_278	[p15l507t2570r632b2645],
6	,	,	O	,	_	0	SENT_278	[p15l507t2570r632b2645],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_278	[p15l661t2571r760b2635],
8	SK	NNP	O	SK	appos	2	SENT_278	[p15l787t2570r881b2645],
9	,	,	O	,	_	0	SENT_278	[p15l787t2570r881b2645],
10	Park	NNP	O	Park	nn	11	SENT_278	[p15l911t2567r1041b2635],
11	HS	NN	O	h	appos	2	SENT_278	[p15l1070t2570r1162b2635],
12	.	.	O	.	_	0	SENT_278	[p15l1070t2570r1162b2635],

1	Genetic	JJ	O	genetic	amod	2	SENT_279	[p15l1189t2569r1425b2635],
2	mechanism	NN	O	mechanism	_	0	SENT_279	[p15l1454t2567r1803b2635],
3	of	IN	O	of	_	0	SENT_279	[p15l1833t2566r1895b2635],
4	aspirininduced	JJ	O	aspirininduced	amod	5	SENT_279	[p15l1917t2569r2148b2655, p15l158t2667r399b2736],
5	urticaria/angioedema	NN	O	urticaria/angioedema	prep_of	2	SENT_279	[p15l430t2667r1119b2756],
6	.	.	O	.	_	0	SENT_279	[p15l430t2667r1119b2756],

1	Curr	NNP	PERSON	Curr	nn	5	SENT_280	[p15l1147t2670r1278b2736],
2	Opin	NNP	PERSON	Opin	nn	5	SENT_280	[p15l1304t2669r1446b2756],
3	Allergy	NNP	PERSON	Allergy	nn	5	SENT_280	[p15l1468t2667r1687b2756],
4	Clin	NNP	PERSON	Clin	nn	5	SENT_280	[p15l1713t2667r1826b2736],
5	Immunol	NNP	PERSON	Immunol	_	0	SENT_280	[p15l1855t2667r2150b2736],
6	.	.	O	.	_	0	SENT_280	[p15l1855t2667r2150b2736],

1	2006	CD	DATE	2006	_	0	SENT_281	[p15l157t2772r660b2848],
2	;	:	O	;	_	0	SENT_281	[p15l157t2772r660b2848],
3	6:266	CD	NUMBER	6:266	number	4	SENT_281	[p15l157t2772r660b2848],
4	—	CD	NUMBER	—	dep	1	SENT_281	[p15l157t2772r660b2848],
5	70	CD	NUMBER	70	dep	4	SENT_281	[p15l157t2772r660b2848],
6	.	.	O	.	_	0	SENT_281	[p15l157t2772r660b2848],

1	.	.	O	.	_	0	SENT_282	[p15l99t2927r109b2939],

1	Kim	NNP	PERSON	Kim	nn	2	SENT_283	[p15l160t2873r270b2938],
2	SH	NNP	O	SH	_	0	SENT_283	[p15l312t2874r410b2949],
3	,	,	O	,	_	0	SENT_283	[p15l312t2874r410b2949],
4	Park	NNP	O	Park	nn	5	SENT_283	[p15l452t2871r583b2939],
5	HS	NN	O	h	appos	2	SENT_283	[p15l623t2874r715b2939],
6	.	.	O	.	_	0	SENT_283	[p15l623t2874r715b2939],

1	Genetic	JJ	O	genetic	amod	2	SENT_284	[p15l755t2873r991b2939],
2	markers	NNS	O	marker	_	0	SENT_284	[p15l1031t2871r1274b2939],
3	for	IN	O	for	_	0	SENT_284	[p15l1311t2870r1397b2939],
4	differentiating	VBG	O	differentiate	prepc_for	2	SENT_284	[p15l1434t2870r1879b2959],
5	aspirinhypersensitivity	NN	O	aspirinhypersensitivity	dobj	4	SENT_284	[p15l1917t2873r2148b2959, p15l159t2971r652b3060],
6	.	.	O	.	_	0	SENT_284	[p15l1917t2873r2148b2959, p15l159t2971r652b3060],

1	Yonsei	NNP	ORGANIZATION	Yonsei	nn	3	SENT_285	[p15l670t2973r871b3040],
2	Med	NNP	ORGANIZATION	Med	nn	3	SENT_285	[p15l904t2971r1034b3040],
3	J.	NNP	O	J.	_	0	SENT_285	[p15l1053t2975r1100b3056],
4	2006	CD	DATE	2006	num	3	SENT_285	[p15l1127t2974r1630b3050],
5	;	:	O	;	_	0	SENT_285	[p15l1127t2974r1630b3050],
6	47:15	CD	NUMBER	47:15	number	7	SENT_285	[p15l1127t2974r1630b3050],
7	-21	CD	NUMBER	-21	dep	3	SENT_285	[p15l1127t2974r1630b3050],
8	.	.	O	.	_	0	SENT_285	[p15l1127t2974r1630b3050],

1	Kim	NNP	PERSON	Kim	nn	2	SENT_286	[p15l160t3074r270b3140],
2	SH	NNP	O	SH	_	0	SENT_286	[p15l302t3075r577b3161],
3	,	,	O	,	_	0	SENT_286	[p15l302t3075r577b3161],
4	Yang	NNP	ORGANIZATION	Yang	nn	5	SENT_286	[p15l302t3075r577b3161],
5	EM	NNP	ORGANIZATION	EM	appos	2	SENT_286	[p15l609t3076r722b3151],
6	,	,	O	,	_	0	SENT_286	[p15l609t3076r722b3151],
7	Park	NNP	O	Park	nn	9	SENT_286	[p15l754t3072r884b3140],
8	H	NNP	O	H	nn	9	SENT_286	[p15l915t3076r996b3156],
9	]	NN	O	]	appos	5	SENT_286	[p15l915t3076r996b3156],
10	,	,	O	,	_	0	SENT_286	[p15l915t3076r996b3156],
11	Ye	NNP	PERSON	Ye	nn	12	SENT_286	[p15l1016t3076r1088b3140],
12	YM	NNP	PERSON	YM	appos	5	SENT_286	[p15l1110t3076r1234b3151],
13	,	,	O	,	_	0	SENT_286	[p15l1110t3076r1234b3151],
14	Lee	NNP	PERSON	Lee	nn	15	SENT_286	[p15l1266t3076r1365b3140],
15	HY	NNP	PERSON	HY	appos	5	SENT_286	[p15l1398t3076r1489b3151],
16	,	,	O	,	_	0	SENT_286	[p15l1398t3076r1489b3151],
17	Park	NNP	O	Park	nn	18	SENT_286	[p15l1521t3072r1651b3140],
18	HS	NN	O	h	appos	5	SENT_286	[p15l1682t3075r1774b3141],
19	.	.	O	.	_	0	SENT_286	[p15l1682t3075r1774b3141],

1	Differential	JJ	O	differential	amod	2	SENT_287	[p15l1806t3072r2146b3140],
2	contribution	NN	O	contribution	_	0	SENT_287	[p15l157t3174r535b3242],
3	of	IN	O	of	_	0	SENT_287	[p15l589t3173r651b3242],
4	the	DT	O	the	det	5	SENT_287	[p15l695t3174r793b3242],
5	CysLTR1	NN	O	cysltr1	prep_of	2	SENT_287	[p15l846t3177r1087b3262],
6	gene	NN	O	gene	dep	5	SENT_287	[p15l1149t3193r1301b3262],
7	in	IN	O	in	prep	6	SENT_287	[p15l1355t3176r1402b3241],
8	patients	NNS	O	patient	dep	7	SENT_287	[p15l1458t3176r1706b3262],
9	with	IN	O	with	_	0	SENT_287	[p15l1755t3174r1889b3242],
10	aspirin	NN	O	aspirin	nn	11	SENT_287	[p15l1943t3176r2146b3262],
11	hypersensitivity	NN	O	hypersensitivity	prep_with	8	SENT_287	[p15l159t3274r693b3363],
12	.	.	O	.	_	0	SENT_287	[p15l159t3274r693b3363],
13	)	SYM	O	)	dep	6	SENT_287	[p15l159t3274r693b3363],

1	Clin	NNP	PERSON	Clin	nn	2	SENT_288	[p15l727t3274r841b3343],
2	Immunol	NNP	PERSON	Immunol	_	0	SENT_288	[p15l870t3274r1164b3343],
3	.	.	O	.	_	0	SENT_288	[p15l870t3274r1164b3343],

1	2007	CD	DATE	2007	_	0	SENT_289	[p15l1191t3277r1694b3353],
2	;	:	O	;	_	0	SENT_289	[p15l1191t3277r1694b3353],
3	27:613	CD	NUMBER	27:613	number	4	SENT_289	[p15l1191t3277r1694b3353],
4	-9	CD	NUMBER	-9	dep	1	SENT_289	[p15l1191t3277r1694b3353],
5	.	.	O	.	_	0	SENT_289	[p15l1191t3277r1694b3353],

1	Cowburn	NNP	PERSON	Cowburn	nn	2	SENT_290	[p15l158t3375r440b3443],
2	AS	NNP	O	AS	_	0	SENT_290	[p15l482t3378r580b3454],
3	,	,	O	,	_	0	SENT_290	[p15l482t3378r580b3454],
4	Sladek	NNP	PERSON	Sladek	nn	5	SENT_290	[p15l627t3375r833b3443],
5	K	NNP	PERSON	K	appos	2	SENT_290	[p15l882t3379r935b3454],
6	,	,	O	,	_	0	SENT_290	[p15l882t3379r935b3454],
7	Soja	NNP	PERSON	Soja	nn	8	SENT_290	[p15l982t3377r1108b3464],
8	J	NNP	PERSON	J	appos	2	SENT_290	[p15l1146t3379r1193b3459],
9	,	,	O	,	_	0	SENT_290	[p15l1146t3379r1193b3459],
10	Adamek	NNP	PERSON	Adamek	nn	11	SENT_290	[p15l1232t3375r1494b3443],
11	L	NNP	O	L	appos	2	SENT_290	[p15l1543t3379r1587b3454],
12	,	,	O	,	_	0	SENT_290	[p15l1543t3379r1587b3454],
13	Nizankowska	NNP	O	Nizankowska	nn	14	SENT_290	[p15l1637t3375r2048b3443],
14	E	NNP	O	E	appos	2	SENT_290	[p15l2102t3379r2149b3454],
15	,	,	O	,	_	0	SENT_290	[p15l2102t3379r2149b3454],
16	SzczeklikA	NNP	O	SzczeklikA	appos	2	SENT_290	[p15l157t3477r512b3555],
17	,	,	O	,	_	0	SENT_290	[p15l157t3477r512b3555],
18	Lam	NNP	LOCATION	Lam	nn	19	SENT_290	[p15l537t3480r657b3545],
19	BK	NNP	LOCATION	BK	appos	2	SENT_290	[p15l686t3480r783b3555],
20	,	,	O	,	_	0	SENT_290	[p15l686t3480r783b3555],
21	PenroseJF	NNP	O	PenroseJF	appos	2	SENT_290	[p15l807t3480r1363b3561],
22	,	,	O	,	_	0	SENT_290	[p15l807t3480r1363b3561],
23	Austen	NNP	PERSON	Austen	nn	24	SENT_290	[p15l807t3480r1363b3561],
24	FK	NN	O	fk	appos	2	SENT_290	[p15l1391t3480r1480b3555],
25	,	,	O	,	_	0	SENT_290	[p15l1391t3480r1480b3555],
26	Holgate	NNP	ORGANIZATION	Holgate	appos	2	SENT_290	[p15l1504t3477r1744b3565],
27	ST	JJ	ORGANIZATION	st	dep	26	SENT_290	[p15l1766t3480r1844b3555],
28	,	,	O	,	_	0	SENT_290	[p15l1766t3480r1844b3555],
29	Sampson	NNP	PERSON	Sampson	appos	2	SENT_290	[p15l1865t3480r2146b3565],

1	J	NNP	O	J	nn	5	SENT_291	[p15l388t3734r425b3784],
2	Investig	NNP	O	Investig	nn	5	SENT_291	[p15l439t3734r673b3798],
3	Allergol	NNP	O	Allergol	nn	5	SENT_291	[p15l688t3732r933b3798],
4	Clin	NNP	O	Clin	nn	5	SENT_291	[p15l955t3732r1077b3785],
5	Immunol	NNP	O	Immunol	_	0	SENT_291	[p15l1097t3732r1362b3784],
6	2009	CD	DATE	2009	num	5	SENT_291	[p15l1382t3732r1544b3793],
7	;	:	O	;	_	0	SENT_291	[p15l1382t3732r1544b3793],
8	Vol	NNP	O	Vol	dep	5	SENT_291	[p15l1567t3732r1681b3784],
9	.	.	O	.	_	0	SENT_291	[p15l1567t3732r1681b3784],

1	19	CD	NUMBER	19	num	2	SENT_292	[p15l1713t3732r1880b3796],
2	(	CD	NUMBER	(	_	0	SENT_292	[p15l1713t3732r1880b3796],
3	5	CD	NUMBER	5	num	4	SENT_292	[p15l1713t3732r1880b3796],
4	)	NN	O	)	dep	2	SENT_292	[p15l1713t3732r1880b3796],
5	:	:	O	:	_	0	SENT_292	[p15l1713t3732r1880b3796],
6	375-382	CD	NUMBER	375-382	dep	4	SENT_292	[p15l1908t3732r2150b3784],

1	381	CD	NUMBER	381	num	3	SENT_293	[p16l59t64r113b92],
2	M	NN	O	m	nn	3	SENT_293	[p16l896t65r929b90],
3	Sanchez-Borges	NNS	O	sanchez-borge	_	0	SENT_293	[p16l940t64r1189b98],
4	,	,	O	,	_	0	SENT_293	[p16l940t64r1189b98],
5	et	FW	O	et	nn	6	SENT_293	[p16l1201t68r1228b90],
6	a1	FW	O	a1	appos	3	SENT_293	[p16l1238t64r1263b90],

1	AP	NN	O	ap	_	0	SENT_294	[p16l152t288r247b353],
2	.	.	O	.	_	0	SENT_294	[p16l152t288r247b353],

1	Overexpression	NN	O	overexpression	_	0	SENT_295	[p16l292t287r769b373],
2	of	IN	O	of	_	0	SENT_295	[p16l817t284r880b353],
3	leukotriene	NN	O	leukotriene	prep_of	1	SENT_295	[p16l923t285r1269b353],
4	C4	NN	O	c4	dep	1	SENT_295	[p16l1317t288r1401b353],
5	synthase	NN	O	synthase	dep	4	SENT_295	[p16l1445t285r1716b373],
6	in	IN	O	in	_	0	SENT_295	[p16l1765t287r1812b352],
7	bronchial	JJ	O	bronchial	amod	8	SENT_295	[p16l1863t285r2148b353],
8	biopsies	NNS	O	biopsy	prep_in	5	SENT_295	[p16l158t385r407b474],
9	from	IN	O	from	_	0	SENT_295	[p16l447t385r589b454],
10	patients	NNS	O	patient	prep_from	8	SENT_295	[p16l636t387r883b474],
11	with	IN	O	with	mark	13	SENT_295	[p16l923t385r1056b454],
12	aspirin-intolerant	JJ	O	aspirin-intolerant	amod	13	SENT_295	[p16l1101t385r1643b474],
13	asthma	NN	O	asthma	dep	8	SENT_295	[p16l1683t385r1986b470],
14	.	.	O	.	_	0	SENT_295	[p16l1683t385r1986b470],
15	)	SYM	O	)	dep	5	SENT_295	[p16l1683t385r1986b470],

1	Clin	NNP	O	Clin	nn	2	SENT_296	[p16l2034t385r2148b454],
2	Invest	NNP	O	Invest	_	0	SENT_296	[p16l154t491r356b556],
3	.	.	O	.	_	0	SENT_296	[p16l154t491r356b556],

1	1998	CD	DATE	1998	_	0	SENT_297	[p16l386t490r972b566],
2	;	:	O	;	_	0	SENT_297	[p16l386t490r972b566],
3	101:834	CD	NUMBER	101:834	number	4	SENT_297	[p16l386t490r972b566],
4	—	CD	NUMBER	—	dep	1	SENT_297	[p16l386t490r972b566],
5	46	CD	NUMBER	46	dep	4	SENT_297	[p16l386t490r972b566],
6	.	.	O	.	_	0	SENT_297	[p16l386t490r972b566],

1	12	CD	NUMBER	12	_	0	SENT_298	[p16l14t593r107b658],
2	.	.	O	.	_	0	SENT_298	[p16l14t593r107b658],

1	Sanak	NNP	O	Sanak	nn	2	SENT_299	[p16l155t590r346b658],
2	M	NNP	O	M	_	0	SENT_299	[p16l369t593r443b668],
3	,	,	O	,	_	0	SENT_299	[p16l369t593r443b668],
4	Pierzchalska	NNP	LOCATION	Pierzchalska	nn	5	SENT_299	[p16l467t590r847b658],
5	M	NNP	O	M	appos	2	SENT_299	[p16l876t593r949b668],
6	,	,	O	,	_	0	SENT_299	[p16l876t593r949b668],
7	Bazan-Socha	NNP	O	Bazan-Socha	nn	8	SENT_299	[p16l974t590r1375b658],
8	S	NNP	O	S	appos	2	SENT_299	[p16l1400t593r1446b668],
9	,	,	O	,	_	0	SENT_299	[p16l1400t593r1446b668],
10	SzczeklikA	NNP	O	SzczeklikA	appos	2	SENT_299	[p16l1467t590r1823b658],
11	.	.	O	.	_	0	SENT_299	[p16l1467t590r1823b658],

1	Enhanced	VBN	O	enhance	csubj	19	SENT_300	[p16l1849t590r2148b658],
2	expression	NN	O	expression	nsubj	11	SENT_300	[p16l156t692r483b779],
3	of	IN	O	of	_	0	SENT_300	[p16l521t690r583b759],
4	the	DT	O	the	det	6	SENT_300	[p16l609t690r707b759],
5	leukotriene	NN	O	leukotriene	nn	6	SENT_300	[p16l745t690r1091b759],
6	C	NN	O	c	prep_of	2	SENT_300	[p16l1127t693r1255b772],
7	(	CD	NUMBER	(	number	8	SENT_300	[p16l1127t693r1255b772],
8	4	CD	NUMBER	4	num	10	SENT_300	[p16l1127t693r1255b772],
9	)	NN	O	)	nn	10	SENT_300	[p16l1127t693r1255b772],
10	synthase	NN	O	synthase	npadvmod	11	SENT_300	[p16l1289t690r1560b779],
11	due	JJ	O	due	xcomp	1	SENT_300	[p16l1595t690r1707b759],
12	to	TO	O	to	_	0	SENT_300	[p16l1739t699r1799b759],
13	overactive	JJ	O	overactive	amod	14	SENT_300	[p16l1835t692r2150b759],
14	transcription	NN	O	transcription	prep_to	11	SENT_300	[p16l153t793r546b880],
15	of	IN	O	of	_	0	SENT_300	[p16l604t791r667b859],
16	an	DT	O	a	det	18	SENT_300	[p16l717t810r787b859],
17	allelic	JJ	O	allelic	amod	18	SENT_300	[p16l846t791r1021b859],
18	variant	NN	O	variant	prep_of	14	SENT_300	[p16l1073t793r1291b859],
19	associated	VBN	O	associate	_	0	SENT_300	[p16l1345t791r1670b859],
20	with	IN	O	with	_	0	SENT_300	[p16l1726t791r1860b859],
21	aspirinintolerant	JJ	O	aspirinintolerant	amod	22	SENT_300	[p16l1919t793r2151b880, p16l157t893r458b961],
22	asthma	NN	O	asthma	prep_with	19	SENT_300	[p16l484t893r899b977],
23	.	.	O	.	_	0	SENT_300	[p16l484t893r899b977],

1	AmJ	NN	O	amj	_	0	SENT_301	[p16l484t893r899b977],
2	Respir	NNP	O	Respir	nn	5	SENT_301	[p16l936t895r1124b981],
3	Cell	NNP	O	Cell	nn	5	SENT_301	[p16l1151t893r1261b961],
4	Mol	NNP	O	Mol	nn	5	SENT_301	[p16l1295t893r1407b961],
5	Biol	NNP	O	Biol	dep	1	SENT_301	[p16l1440t893r1570b961],
6	.	.	O	.	_	0	SENT_301	[p16l1440t893r1570b961],

1	2000	CD	DATE	2000	_	0	SENT_302	[p16l1597t896r2102b971],
2	;	:	O	;	_	0	SENT_302	[p16l1597t896r2102b971],
3	23:290	CD	NUMBER	23:290	number	4	SENT_302	[p16l1597t896r2102b971],
4	-6	CD	NUMBER	-6	dep	1	SENT_302	[p16l1597t896r2102b971],
5	.	.	O	.	_	0	SENT_302	[p16l1597t896r2102b971],

1	13	CD	NUMBER	13	_	0	SENT_303	[p16l14t996r107b1062],
2	.	.	O	.	_	0	SENT_303	[p16l14t996r107b1062],

1	Asano	NNP	PERSON	Asano	nn	2	SENT_304	[p16l152t997r349b1062],
2	K	NNP	PERSON	K	_	0	SENT_304	[p16l373t997r425b1072],
3	,	,	O	,	_	0	SENT_304	[p16l373t997r425b1072],
4	ShiomiT	NNP	O	ShiomiT	appos	2	SENT_304	[p16l444t993r707b1072],
5	,	,	O	,	_	0	SENT_304	[p16l444t993r707b1072],
6	Hasegawa	NNP	PERSON	Hasegawa	nn	7	SENT_304	[p16l729t997r1048b1082],
7	N	NNP	O	N	appos	2	SENT_304	[p16l1073t997r1131b1072],
8	,	,	O	,	_	0	SENT_304	[p16l1073t997r1131b1072],
9	Nakamura	NNP	PERSON	Nakamura	nn	10	SENT_304	[p16l1153t993r1472b1062],
10	H	NNP	O	H	appos	7	SENT_304	[p16l1497t997r1555b1072],
11	,	,	O	,	_	0	SENT_304	[p16l1497t997r1555b1072],
12	Kudo	NNP	PERSON	Kudo	nn	13	SENT_304	[p16l1577t993r1729b1062],
13	H	NNP	PERSON	H	appos	7	SENT_304	[p16l1752t997r1811b1072],
14	,	,	O	,	_	0	SENT_304	[p16l1752t997r1811b1072],
15	Matsuzaki	NNP	PERSON	Matsuzaki	nn	16	SENT_304	[p16l1832t993r2149b1062],
16	T	NN	O	t	appos	7	SENT_304	[p16l153t1098r196b1173],
17	,	,	O	,	_	0	SENT_304	[p16l153t1098r196b1173],
18	Hakuno	NNP	PERSON	Hakuno	nn	19	SENT_304	[p16l232t1094r470b1162],
19	H	NNP	PERSON	H	appos	7	SENT_304	[p16l509t1098r567b1173],
20	,	,	O	,	_	0	SENT_304	[p16l509t1098r567b1173],
21	Fukunaga	NNP	PERSON	Fukunaga	nn	22	SENT_304	[p16l604t1094r907b1183],
22	K	NNP	PERSON	K	appos	7	SENT_304	[p16l948t1098r1000b1173],
23	,	,	O	,	_	0	SENT_304	[p16l948t1098r1000b1173],
24	Suzuki	NNP	PERSON	Suzuki	nn	25	SENT_304	[p16l1034t1094r1233b1162],
25	Y	NN	PERSON	y	appos	7	SENT_304	[p16l1261t1098r1309b1173],
26	,	,	O	,	_	0	SENT_304	[p16l1261t1098r1309b1173],
27	Kanazawa	NNP	PERSON	Kanazawa	nn	28	SENT_304	[p16l1347t1098r1664b1162],
28	M	NNP	O	M	appos	7	SENT_304	[p16l1705t1098r1779b1173],
29	,	,	O	,	_	0	SENT_304	[p16l1705t1098r1779b1173],
30	Yamaguchi	NNP	PERSON	Yamaguchi	nn	31	SENT_304	[p16l1804t1094r2149b1183],
31	K.	NNP	PERSON	K.	appos	7	SENT_304	[p16l159t1199r212b1264],
32	Leukotriene	NN	PERSON	leukotriene	nn	36	SENT_304	[p16l247t1196r609b1264],
33	C4	NN	O	c4	nn	36	SENT_304	[p16l643t1199r726b1264],
34	synthase	NN	O	synthase	nn	36	SENT_304	[p16l757t1196r1028b1284],
35	gene	NN	O	gene	nn	36	SENT_304	[p16l1059t1215r1211b1284],
36	A	NN	O	a	dep	2	SENT_304	[p16l1236t1199r1528b1277],
37	(	CD	NUMBER	(	num	38	SENT_304	[p16l1236t1199r1528b1277],
38	-444	CD	NUMBER	-444	dep	36	SENT_304	[p16l1236t1199r1528b1277],
39	)	NN	O	)	nn	41	SENT_304	[p16l1236t1199r1528b1277],
40	C	NN	O	c	nn	41	SENT_304	[p16l1236t1199r1528b1277],
41	polymorphism	NN	O	polymorphism	dep	2	SENT_304	[p16l1563t1196r2000b1284],
42	and	CC	O	and	_	0	SENT_304	[p16l2036t1196r2148b1264],
43	clinical	JJ	O	clinical	amod	44	SENT_304	[p16l156t1296r364b1365],
44	response	NN	O	response	conj_and	41	SENT_304	[p16l420t1315r696b1385],
45	to	TO	O	to	_	0	SENT_304	[p16l747t1305r807b1365],
46	a	DT	O	a	det	48	SENT_304	[p16l861t1315r891b1365],
47	CYS-LT	NN	O	cys-lt	nn	48	SENT_304	[p16l947t1299r1243b1378],
48	(	NN	O	(	prep_to	41	SENT_304	[p16l947t1299r1243b1378],
49	1	CD	NUMBER	1	num	51	SENT_304	[p16l947t1299r1243b1378],
50	)	NN	O	)	nn	51	SENT_304	[p16l947t1299r1243b1378],
51	antagonist	NN	O	antagonist	dep	2	SENT_304	[p16l1295t1298r1648b1385],
52	,	,	O	,	_	0	SENT_304	[p16l1295t1298r1648b1385],
53	pranlukast	NN	O	pranlukast	appos	51	SENT_304	[p16l1701t1296r2046b1385],
54	,	,	O	,	_	0	SENT_304	[p16l1701t1296r2046b1385],
55	in	IN	O	in	_	0	SENT_304	[p16l2100t1298r2148b1364],
56	Japanese	JJ	MISC	japanese	amod	57	SENT_304	[p16l144t1401r440b1486],
57	patients	NNS	O	patient	prep_in	2	SENT_304	[p16l481t1399r729b1486],
58	with	IN	O	with	_	0	SENT_304	[p16l765t1397r899b1465],
59	moderate	JJ	O	moderate	amod	60	SENT_304	[p16l941t1397r1237b1465],
60	asthma	NN	O	asthma	prep_with	57	SENT_304	[p16l1275t1397r1523b1466],
61	.	.	O	.	_	0	SENT_304	[p16l1275t1397r1523b1466],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_305	[p16l1564t1397r2151b1486],
2	.	.	O	.	_	0	SENT_305	[p16l1564t1397r2151b1486],

1	2002	CD	DATE	2002	_	0	SENT_306	[p16l155t1502r703b1578],
2	;	:	O	;	_	0	SENT_306	[p16l155t1502r703b1578],
3	12:565	CD	NUMBER	12:565	number	4	SENT_306	[p16l155t1502r703b1578],
4	-70	CD	NUMBER	-70	dep	1	SENT_306	[p16l155t1502r703b1578],
5	.	.	O	.	_	0	SENT_306	[p16l155t1502r703b1578],

1	14	CD	NUMBER	14	_	0	SENT_307	[p16l14t1605r107b1670],
2	.	.	O	.	_	0	SENT_307	[p16l14t1605r107b1670],

1	Van	NNP	PERSON	Van	nn	3	SENT_308	[p16l152t1605r268b1670],
2	Sambeek	NNP	PERSON	Sambeek	nn	3	SENT_308	[p16l302t1601r589b1670],
3	R	NNP	PERSON	R	_	0	SENT_308	[p16l621t1605r674b1681],
4	,	,	O	,	_	0	SENT_308	[p16l621t1605r674b1681],
5	Stevenson	NNP	PERSON	Stevenson	nn	6	SENT_308	[p16l705t1604r1021b1670],
6	DD	NNP	O	DD	appos	3	SENT_308	[p16l1058t1605r1162b1681],
7	,	,	O	,	_	0	SENT_308	[p16l1058t1605r1162b1681],
8	Baldasaro	NNP	PERSON	Baldasaro	nn	9	SENT_308	[p16l1195t1601r1502b1670],
9	M	NNP	O	M	appos	6	SENT_308	[p16l1538t1605r1611b1681],
10	,	,	O	,	_	0	SENT_308	[p16l1538t1605r1611b1681],
11	Lam	NNP	LOCATION	Lam	nn	12	SENT_308	[p16l1645t1605r1766b1670],
12	BK	NNP	LOCATION	BK	appos	6	SENT_308	[p16l1804t1605r1901b1681],
13	,	,	O	,	_	0	SENT_308	[p16l1804t1605r1901b1681],
14	Zhao	NNP	PERSON	Zhao	nn	15	SENT_308	[p16l1931t1601r2084b1670],
15	J	NNP	PERSON	J	appos	6	SENT_308	[p16l2104t1605r2151b1686],
16	,	,	O	,	_	0	SENT_308	[p16l2104t1605r2151b1686],
17	Yoshida	NNP	PERSON	Yoshida	nn	18	SENT_308	[p16l153t1702r395b1770],
18	S	NNP	O	S	appos	6	SENT_308	[p16l425t1705r472b1781],
19	,	,	O	,	_	0	SENT_308	[p16l425t1705r472b1781],
20	Yandora	NNP	O	Yandora	nn	21	SENT_308	[p16l490t1702r745b1770],
21	C	NNP	O	C	appos	6	SENT_308	[p16l776t1705r832b1781],
22	,	,	O	,	_	0	SENT_308	[p16l776t1705r832b1781],
23	DrazenJM	NNP	O	DrazenJM	appos	6	SENT_308	[p16l861t1706r1204b1786],
24	,	,	O	,	_	0	SENT_308	[p16l861t1706r1204b1786],
25	PenrosejF	NNP	O	PenrosejF	appos	6	SENT_308	[p16l1234t1706r1565b1786],
26	.	.	O	.	_	0	SENT_308	[p16l1234t1706r1565b1786],

1	5	CD	NUMBER	5	number	2	SENT_309	[p16l1592t1706r1649b1770],
2	’	CD	NUMBER	’	num	4	SENT_309	[p16l1592t1706r1649b1770],
3	Danking	NN	O	danking	nn	4	SENT_309	[p16l1678t1702r1928b1791],
4	region	NN	O	region	nn	5	SENT_309	[p16l1956t1704r2148b1791],
5	polymorphism	NN	O	polymorphism	nsubj	15	SENT_309	[p16l158t1804r596b1892],
6	of	IN	O	of	_	0	SENT_309	[p16l636t1803r698b1872],
7	the	DT	O	the	det	8	SENT_309	[p16l727t1804r825b1872],
8	gene	NN	O	gene	prep_of	5	SENT_309	[p16l861t1823r1013b1892],
9	encoding	VBG	O	encode	partmod	8	SENT_309	[p16l1050t1804r1337b1892],
10	leukotriene	NN	O	leukotriene	nn	12	SENT_309	[p16l1375t1804r1722b1872],
11	C4	NN	O	c4	nn	12	SENT_309	[p16l1760t1807r1843b1872],
12	synthase	NN	O	synthase	dobj	9	SENT_309	[p16l1879t1804r2150b1892],
13	does	VBZ	O	do	aux	15	SENT_309	[p16l156t1904r299b1973],
14	not	RB	O	not	neg	15	SENT_309	[p16l323t1913r422b1973],
15	correlate	VB	O	correlate	_	0	SENT_309	[p16l442t1904r714b1973],
16	with	IN	O	with	_	0	SENT_309	[p16l734t1904r868b1973],
17	the	DT	O	the	det	20	SENT_309	[p16l889t1904r987b1973],
18	aspirin-intolerant	JJ	O	aspirin-intolerant	amod	20	SENT_309	[p16l1009t1904r1551b1993],
19	asthma	NN	O	asthma	nn	20	SENT_309	[p16l1570t1904r1796b1973],
20	phenotype	NN	O	phenotype	prep_with	15	SENT_309	[p16l1823t1904r2150b1993],
21	in	IN	O	in	_	0	SENT_309	[p16l157t2007r205b2073],
22	the	DT	O	the	det	24	SENT_309	[p16l233t2005r332b2073],
23	United	NNP	LOCATION	United	nn	24	SENT_309	[p16l363t2005r562b2073],
24	States	NNPS	LOCATION	States	prep_in	20	SENT_309	[p16l593t2008r838b2089],
25	]	CD	NUMBER	]	tmod	15	SENT_309	[p16l593t2008r838b2089],
26	Allergy	NNP	O	Allergy	nn	28	SENT_309	[p16l863t2005r1083b2094],
27	Clin	NNP	O	Clin	nn	28	SENT_309	[p16l1109t2005r1223b2073],
28	Immunol	NNP	O	Immunol	dep	25	SENT_309	[p16l1252t2005r1547b2074],
29	.	.	O	.	_	0	SENT_309	[p16l1252t2005r1547b2074],

1	2000	CD	DATE	2000	_	0	SENT_310	[p16l1574t2008r2078b2084],
2	;	:	O	;	_	0	SENT_310	[p16l1574t2008r2078b2084],
3	106:72	CD	NUMBER	106:72	number	4	SENT_310	[p16l1574t2008r2078b2084],
4	-6	CD	NUMBER	-6	dep	1	SENT_310	[p16l1574t2008r2078b2084],
5	.	.	O	.	_	0	SENT_310	[p16l1574t2008r2078b2084],

1	15	CD	NUMBER	15	_	0	SENT_311	[p16l14t2110r107b2175],
2	.	.	O	.	_	0	SENT_311	[p16l14t2110r107b2175],

1	KawagishiY	NNP	O	KawagishiY	_	0	SENT_312	[p16l159t2107r523b2195],
2	,	,	O	,	_	0	SENT_312	[p16l159t2107r523b2195],
3	Mita	NNP	PERSON	Mita	nn	4	SENT_312	[p16l550t2109r678b2175],
4	H	NNP	PERSON	H	appos	1	SENT_312	[p16l707t2107r1061b2195],
5	,	,	O	,	_	0	SENT_312	[p16l707t2107r1061b2195],
6	Taniguchi	NNP	PERSON	Taniguchi	nn	7	SENT_312	[p16l707t2107r1061b2195],
7	M	NNP	O	M	appos	1	SENT_312	[p16l1090t2110r1162b2185],
8	,	,	O	,	_	0	SENT_312	[p16l1090t2110r1162b2185],
9	Maruyama	NNP	PERSON	Maruyama	nn	10	SENT_312	[p16l1188t2110r1502b2195],
10	M	NNP	O	M	appos	1	SENT_312	[p16l1532t2110r1604b2185],
11	,	,	O	,	_	0	SENT_312	[p16l1532t2110r1604b2185],
12	Oosaki	NNP	PERSON	Oosaki	nn	13	SENT_312	[p16l1628t2107r1829b2175],
13	R	NNP	PERSON	R	appos	1	SENT_312	[p16l1857t2110r1908b2185],
14	,	,	O	,	_	0	SENT_312	[p16l1857t2110r1908b2185],
15	Higashi	NNP	PERSON	Higashi	nn	16	SENT_312	[p16l1934t2107r2149b2195],
16	N	NNP	O	N	appos	1	SENT_312	[p16l159t2211r215b2286],
17	,	,	O	,	_	0	SENT_312	[p16l159t2211r215b2286],
18	Kashii	NNP	ORGANIZATION	Kashii	nn	19	SENT_312	[p16l258t2207r428b2276],
19	T	NN	ORGANIZATION	t	appos	1	SENT_312	[p16l462t2211r503b2286],
20	,	,	O	,	_	0	SENT_312	[p16l462t2211r503b2286],
21	Kobayashi	NNP	LOCATION	Kobayashi	nn	22	SENT_312	[p16l545t2207r841b2296],
22	M	NNP	LOCATION	M	appos	1	SENT_312	[p16l886t2211r958b2286],
23	,	,	O	,	_	0	SENT_312	[p16l886t2211r958b2286],
24	Akiyama	NNP	PERSON	Akiyama	nn	25	SENT_312	[p16l989t2207r1247b2296],
25	K.	NNP	PERSON	K.	appos	1	SENT_312	[p16l1293t2211r1344b2276],
26	Leukotriene	NN	PERSON	leukotriene	nn	28	SENT_312	[p16l1386t2207r1730b2276],
27	C4	NN	O	c4	nn	28	SENT_312	[p16l1772t2210r1853b2276],
28	synthase	NN	O	synthase	dep	1	SENT_312	[p16l1891t2207r2150b2296],
29	promoter	NN	O	promoter	nn	32	SENT_312	[p16l158t2317r433b2397],
30	polymorphism	NN	O	polymorphism	nn	32	SENT_312	[p16l458t2308r877b2397],
31	injapanese	NN	O	injapanese	nn	32	SENT_312	[p16l906t2310r1251b2397],
32	patients	NNS	O	patient	dep	28	SENT_312	[p16l1279t2310r1513b2397],
33	with	IN	O	with	prep	32	SENT_312	[p16l1535t2308r1664b2376],
34	aspirin-induced	JJ	O	aspirin-induced	amod	35	SENT_312	[p16l1691t2308r2148b2397],
35	asthma	NN	O	asthma	dep	33	SENT_312	[p16l155t2410r430b2494],
36	.	.	O	.	_	0	SENT_312	[p16l155t2410r430b2494],
37	)	SYM	O	)	dep	32	SENT_312	[p16l155t2410r430b2494],

1	Allergy	NN	O	allergy	nn	2	SENT_313	[p16l452t2410r661b2498],
2	Clin	NN	O	clin	_	0	SENT_313	[p16l684t2410r792b2478],
3	Immunol	NNP	O	Immunol	dep	2	SENT_313	[p16l818t2410r1101b2478],
4	.	.	O	.	_	0	SENT_313	[p16l818t2410r1101b2478],

1	2002	CD	DATE	2002	_	0	SENT_314	[p16l1124t2413r1686b2488],
2	;	:	O	;	_	0	SENT_314	[p16l1124t2413r1686b2488],
3	109:936	CD	NUMBER	109:936	number	4	SENT_314	[p16l1124t2413r1686b2488],
4	-42	CD	NUMBER	-42	dep	1	SENT_314	[p16l1124t2413r1686b2488],
5	.	.	O	.	_	0	SENT_314	[p16l1124t2413r1686b2488],

1	16	CD	NUMBER	16	_	0	SENT_315	[p16l14t2514r107b2580],
2	.	.	O	.	_	0	SENT_315	[p16l14t2514r107b2580],

1	Choi	NNP	O	Choi	nn	2	SENT_316	[p16l157t2511r294b2580],
2	JH	NNP	O	JH	_	0	SENT_316	[p16l320t2515r419b2596],
3	,	,	O	,	_	0	SENT_316	[p16l320t2515r419b2596],
4	Kim	NNP	PERSON	Kim	nn	5	SENT_316	[p16l457t2513r567b2579],
5	SH	NNP	O	SH	appos	2	SENT_316	[p16l605t2514r704b2591],
6	,	,	O	,	_	0	SENT_316	[p16l605t2514r704b2591],
7	Bae	NNP	ORGANIZATION	Bae	nn	8	SENT_316	[p16l742t2515r852b2580],
8	JS	NNP	O	JS	appos	5	SENT_316	[p16l876t2514r961b2596],
9	,	,	O	,	_	0	SENT_316	[p16l876t2514r961b2596],
10	Yu	NNP	O	Yu	nn	11	SENT_316	[p16l988t2515r1061b2580],
11	HL	NNS	O	hl	appos	5	SENT_316	[p16l1103t2515r1195b2591],
12	,	,	O	,	_	0	SENT_316	[p16l1103t2515r1195b2591],
13	Suh	NNP	PERSON	Suh	nn	14	SENT_316	[p16l1230t2511r1340b2580],
14	CH	NN	O	ch	appos	5	SENT_316	[p16l1379t2514r1487b2591],
15	,	,	O	,	_	0	SENT_316	[p16l1379t2514r1487b2591],
16	Nahm	NNP	ORGANIZATION	Nahm	nn	17	SENT_316	[p16l1524t2511r1705b2580],
17	DH	NNP	O	DH	appos	5	SENT_316	[p16l1746t2515r1853b2591],
18	,	,	O	,	_	0	SENT_316	[p16l1746t2515r1853b2591],
19	Park	NNP	O	Park	nn	20	SENT_316	[p16l1891t2511r2023b2580],
20	HS	NN	O	h	appos	5	SENT_316	[p16l2059t2514r2151b2580],
21	.	.	O	.	_	0	SENT_316	[p16l2059t2514r2151b2580],

1	Lack	NN	O	lack	_	0	SENT_317	[p16l159t2612r295b2680],
2	of	IN	O	of	_	0	SENT_317	[p16l332t2612r395b2680],
3	an	DT	O	a	det	4	SENT_317	[p16l428t2631r500b2680],
4	association	NN	O	association	prep_of	1	SENT_317	[p16l541t2614r889b2680],
5	between	IN	O	between	_	0	SENT_317	[p16l933t2612r1198b2680],
6	a	DT	O	a	det	11	SENT_317	[p16l1240t2631r1269b2680],
7	newly	RB	O	newly	advmod	8	SENT_317	[p16l1314t2612r1494b2701],
8	identiDed	JJ	O	identided	amod	11	SENT_317	[p16l1532t2612r1820b2680],
9	promoter	NN	O	promoter	nn	11	SENT_317	[p16l1865t2621r2152b2701],
10	polymorphism	NN	O	polymorphism	nn	11	SENT_317	[p16l158t2714r596b2802],
11	(	NN	O	(	prep_between	4	SENT_317	[p16l639t2717r900b2795],
12	-1702	CD	NUMBER	-1702	num	13	SENT_317	[p16l639t2717r900b2795],
13	G	NN	O	g	npadvmod	14	SENT_317	[p16l639t2717r900b2795],
14	>	JJR	O	>	amod	11	SENT_317	[p16l945t2727r988b2771],
15	A	DT	O	a	det	16	SENT_317	[p16l1022t2717r1091b2795],
16	)	NN	O	)	dep	1	SENT_317	[p16l1022t2717r1091b2795],
17	of	IN	O	of	_	0	SENT_317	[p16l1132t2713r1194b2782],
18	the	DT	O	the	det	22	SENT_317	[p16l1227t2714r1325b2782],
19	leukotriene	NN	O	leukotriene	nn	22	SENT_317	[p16l1368t2714r1715b2782],
20	C4	NN	O	c4	nn	22	SENT_317	[p16l1757t2717r1840b2782],
21	synthase	NN	O	synthase	nn	22	SENT_317	[p16l1879t2714r2150b2802],
22	gene	NN	O	gene	prep_of	16	SENT_317	[p16l154t2833r306b2903],
23	and	CC	O	and	_	0	SENT_317	[p16l349t2814r461b2883],
24	aspirin-intolerant	JJ	O	aspirin-intolerant	amod	25	SENT_317	[p16l507t2814r1048b2903],
25	asthma	NN	O	asthma	prep_of	16	SENT_317	[p16l1089t2814r1316b2883],
26	in	IN	O	in	_	0	SENT_317	[p16l1364t2816r1412b2882],
27	a	DT	O	a	det	29	SENT_317	[p16l1457t2833r1487b2883],
28	Korean	JJ	LOCATION	korean	amod	29	SENT_317	[p16l1537t2818r1748b2883],
29	population	NN	O	population	prep_in	22	SENT_317	[p16l1796t2814r2151b2903],
30	.	.	O	.	_	0	SENT_317	[p16l1796t2814r2151b2903],

1	Tohokuj	NNP	O	Tohokuj	nn	3	SENT_318	[p16l153t2915r426b2999],
2	Exp	NNP	O	Exp	nn	3	SENT_318	[p16l463t2919r567b3004],
3	Med	NNP	O	Med	_	0	SENT_318	[p16l599t2915r751b2984],
4	.	.	O	.	_	0	SENT_318	[p16l599t2915r751b2984],

1	2006	CD	DATE	2006	_	0	SENT_319	[p16l778t2918r1325b2994],
2	;	:	O	;	_	0	SENT_319	[p16l778t2918r1325b2994],
3	208:49	CD	NUMBER	208:49	number	4	SENT_319	[p16l778t2918r1325b2994],
4	-56	CD	NUMBER	-56	dep	1	SENT_319	[p16l778t2918r1325b2994],
5	.	.	O	.	_	0	SENT_319	[p16l778t2918r1325b2994],

1	17	CD	NUMBER	17	_	0	SENT_320	[p16l14t3020r107b3085],
2	.	.	O	.	_	0	SENT_320	[p16l14t3020r107b3085],

1	Mastalerz	NNP	PERSON	Mastalerz	nn	2	SENT_321	[p16l159t3017r461b3085],
2	L	NNP	PERSON	L	_	0	SENT_321	[p16l496t3020r540b3095],
3	,	,	O	,	_	0	SENT_321	[p16l496t3020r540b3095],
4	Setkowicz	NNP	O	Setkowicz	nn	5	SENT_321	[p16l571t3017r881b3085],
5	M	NNP	O	M	appos	2	SENT_321	[p16l917t3020r990b3095],
6	,	,	O	,	_	0	SENT_321	[p16l917t3020r990b3095],
7	Sanak	NNP	O	Sanak	nn	8	SENT_321	[p16l1021t3017r1212b3085],
8	M	NN	O	m	appos	2	SENT_321	[p16l1245t3020r1319b3095],
9	,	,	O	,	_	0	SENT_321	[p16l1245t3020r1319b3095],
10	Rybarczyk	NN	PERSON	rybarczyk	nn	11	SENT_321	[p16l1354t3017r1663b3105],
11	H	NN	PERSON	h	appos	2	SENT_321	[p16l1696t3020r1754b3095],
12	,	,	O	,	_	0	SENT_321	[p16l1696t3020r1754b3095],
13	SzczeklikA	NN	O	szczeklika	appos	2	SENT_321	[p16l1785t3017r2151b3085],
14	.	.	O	.	_	0	SENT_321	[p16l1785t3017r2151b3085],

1	Familial	JJ	O	familial	amod	2	SENT_322	[p16l159t3117r390b3186],
2	aggregation	NN	O	aggregation	_	0	SENT_322	[p16l412t3119r791b3206],
3	of	IN	O	of	_	0	SENT_322	[p16l813t3117r875b3186],
4	aspirin-induced	JJ	O	aspirin-induced	amod	5	SENT_322	[p16l889t3117r1370b3206],
5	urticaria	NN	O	urticarium	prep_of	2	SENT_322	[p16l1395t3119r1645b3186],
6	and	CC	O	and	_	0	SENT_322	[p16l1667t3117r1779b3186],
7	leukotriene	NN	O	leukotriene	nn	11	SENT_322	[p16l1804t3117r2150b3186],
8	C	NN	O	c	nn	11	SENT_322	[p16l157t3221r197b3286],
9	synthase	NN	O	synthase	nn	11	SENT_322	[p16l224t3218r495b3307],
10	allelic	JJ	O	allelic	amod	11	SENT_322	[p16l523t3218r698b3286],
11	variant	NN	O	variant	conj_and	5	SENT_322	[p16l723t3220r957b3287],
12	.	.	O	.	_	0	SENT_322	[p16l723t3220r957b3287],

1	Br	NN	O	br	_	0	SENT_323	[p16l987t3222r1088b3302],
2	]	CD	NUMBER	]	num	3	SENT_323	[p16l987t3222r1088b3302],
3	Dermatol	NN	O	dermatol	dep	1	SENT_323	[p16l1124t3218r1428b3287],
4	.	.	O	.	_	0	SENT_323	[p16l1124t3218r1428b3287],

1	2006	CD	DATE	2006	_	0	SENT_324	[p16l1455t3221r2044b3297],
2	;	:	O	;	_	0	SENT_324	[p16l1455t3221r2044b3297],
3	154:256	CD	NUMBER	154:256	number	4	SENT_324	[p16l1455t3221r2044b3297],
4	-60	CD	NUMBER	-60	dep	1	SENT_324	[p16l1455t3221r2044b3297],
5	.	.	O	.	_	0	SENT_324	[p16l1455t3221r2044b3297],

1	18	CD	NUMBER	18	_	0	SENT_325	[p16l14t3323r107b3388],
2	.	.	O	.	_	0	SENT_325	[p16l14t3323r107b3388],

1	Kim	NNP	PERSON	Kim	nn	2	SENT_326	[p16l159t3322r269b3387],
2	SH	NNP	O	SH	_	0	SENT_326	[p16l315t3323r413b3398],
3	,	,	O	,	_	0	SENT_326	[p16l315t3323r413b3398],
4	Choi	NNP	O	Choi	nn	5	SENT_326	[p16l456t3320r594b3388],
5	JH	NNP	O	JH	appos	2	SENT_326	[p16l626t3323r726b3404],
6	,	,	O	,	_	0	SENT_326	[p16l626t3323r726b3404],
7	Holloway	NNP	PERSON	Holloway	nn	8	SENT_326	[p16l771t3320r1057b3408],
8	JW	NNP	O	JW	appos	5	SENT_326	[p16l1086t3323r1198b3404],
9	,	,	O	,	_	0	SENT_326	[p16l1086t3323r1198b3404],
10	Suh	NNP	PERSON	Suh	nn	11	SENT_326	[p16l1240t3320r1350b3388],
11	CH	NN	O	ch	appos	5	SENT_326	[p16l1396t3323r1504b3398],
12	,	,	O	,	_	0	SENT_326	[p16l1396t3323r1504b3398],
13	Nahm	NNP	ORGANIZATION	Nahm	nn	14	SENT_326	[p16l1549t3320r1729b3388],
14	DH	NNP	O	DH	appos	5	SENT_326	[p16l1778t3323r1885b3398],
15	,	,	O	,	_	0	SENT_326	[p16l1778t3323r1885b3398],
16	Ha	NNP	O	Ha	nn	17	SENT_326	[p16l1930t3323r2005b3388],
17	EH	NNP	O	EH	appos	5	SENT_326	[p16l2055t3323r2151b3398],
18	,	,	O	,	_	0	SENT_326	[p16l2055t3323r2151b3398],
19	Park	NNP	O	Park	nn	20	SENT_326	[p16l159t3420r290b3489],
20	CS	NNP	O	CS	appos	5	SENT_326	[p16l325t3423r418b3499],
21	,	,	O	,	_	0	SENT_326	[p16l325t3423r418b3499],
22	Park	NNP	O	Park	nn	23	SENT_326	[p16l456t3420r588b3489],
23	HS	NN	O	h	appos	5	SENT_326	[p16l624t3423r716b3489],
24	.	.	O	.	_	0	SENT_326	[p16l624t3423r716b3489],

1	Leukotriene-related	JJ	O	leukotriene-related	amod	3	SENT_327	[p16l755t3420r1363b3489],
2	gene	NN	O	gene	nn	3	SENT_327	[p16l1399t3439r1551b3509],
3	polymorphisms	NNS	O	polymorphism	_	0	SENT_327	[p16l1590t3420r2062b3509],
4	in	IN	O	in	_	0	SENT_327	[p16l2100t3422r2148b3488],
5	patients	NNS	O	patient	prep_in	3	SENT_327	[p16l158t3523r405b3610],
6	with	IN	O	with	_	0	SENT_327	[p16l436t3521r569b3589],
7	aspirin-intolerant	JJ	O	aspirin-intolerant	amod	8	SENT_327	[p16l604t3521r1146b3610],
8	urticaria	NN	O	urticarium	prep_with	5	SENT_327	[p16l1179t3523r1429b3589],
9	and	CC	O	and	_	0	SENT_327	[p16l1464t3521r1576b3589],
10	aspirin-intolerant	JJ	O	aspirin-intolerant	amod	11	SENT_327	[p16l1611t3521r2152b3610],
11	asthma	NN	O	asthma	prep_with	5	SENT_327	[p16l155t3623r403b3691],
12	:	:	O	:	_	0	SENT_327	[p16l155t3623r403b3691],
13	differing	VBG	O	differ	amod	14	SENT_327	[p16l454t3622r715b3711],
14	contributions	NNS	O	contribution	dep	3	SENT_327	[p16l766t3623r1178b3691],
15	of	IN	O	of	_	0	SENT_327	[p16l1230t3622r1292b3691],
16	ALOX5	NN	O	alox5	nn	17	SENT_327	[p16l1330t3626r1550b3691],
17	polymorphism	NN	O	polymorphism	prep_of	14	SENT_327	[p16l1605t3623r2044b3711],
18	in	IN	O	in	_	0	SENT_327	[p16l2100t3625r2148b3690],
19	Korean	JJ	LOCATION	korean	amod	22	SENT_327	[p16l159t3727r370b3792],
20	popu	NN	O	popu	nn	22	SENT_327	[p16l403t3723r799b3812],
21	|	NN	O	|	nn	22	SENT_327	[p16l403t3723r799b3812],
22	ation	NN	O	ation	prep_in	14	SENT_327	[p16l403t3723r799b3812],
23	.	.	O	.	_	0	SENT_327	[p16l403t3723r799b3812],

1	J	NN	MISC	j	_	0	SENT_328	[p16l403t3723r799b3812],
2	Korean	JJ	MISC	korean	amod	4	SENT_328	[p16l836t3727r1047b3792],
3	Med	JJ	MISC	med	amod	4	SENT_328	[p16l1081t3723r1212b3792],
4	Sci	NNP	MISC	Sci	dep	1	SENT_328	[p16l1242t3725r1343b3792],
5	.	.	O	.	_	0	SENT_328	[p16l1242t3725r1343b3792],

1	2005	CD	DATE	2005	_	0	SENT_329	[p16l1370t3726r1917b3802],
2	;	:	O	;	_	0	SENT_329	[p16l1370t3726r1917b3802],
3	20:926	CD	NUMBER	20:926	number	4	SENT_329	[p16l1370t3726r1917b3802],
4	-31	CD	NUMBER	-31	dep	1	SENT_329	[p16l1370t3726r1917b3802],
5	.	.	O	.	_	0	SENT_329	[p16l1370t3726r1917b3802],

1	19	CD	NUMBER	19	_	0	SENT_330	[p17l14t16r107b82],
2	.	.	O	.	_	0	SENT_330	[p17l14t16r107b82],

1	Torres-Galvan	JJ	O	torres-galvan	amod	3	SENT_331	[p17l153t13r588b81],
2	M	NN	O	m	nn	3	SENT_331	[p17l651t17r748b97],
3	]	NN	O	]	_	0	SENT_331	[p17l651t17r748b97],
4	,	,	O	,	_	0	SENT_331	[p17l651t17r748b97],
5	Ortega	NNP	PERSON	Ortega	nn	6	SENT_331	[p17l805t16r1014b102],
6	N	NNP	O	N	appos	3	SENT_331	[p17l1077t17r1135b92],
7	,	,	O	,	_	0	SENT_331	[p17l1077t17r1135b92],
8	Sanchez-Garcia	NNP	PERSON	Sanchez-Garcia	nn	9	SENT_331	[p17l1192t13r1675b81],
9	F	NN	O	f	appos	3	SENT_331	[p17l1739t17r1773b92],
10	,	,	O	,	_	0	SENT_331	[p17l1739t17r1773b92],
11	Blanco	NNP	PERSON	Blanco	nn	12	SENT_331	[p17l1832t13r2037b81],
12	C	NNP	O	C	appos	3	SENT_331	[p17l2096t16r2151b92],
13	,	,	O	,	_	0	SENT_331	[p17l2096t16r2151b92],
14	Carrillo	NNP	PERSON	Carrillo	nn	15	SENT_331	[p17l157t115r378b183],
15	T	NN	O	t	appos	3	SENT_331	[p17l423t118r465b193],
16	,	,	O	,	_	0	SENT_331	[p17l423t118r465b193],
17	Quiralte	NNP	O	Quiralte	nn	18	SENT_331	[p17l516t115r762b197],
18	J.	NNP	O	J.	appos	3	SENT_331	[p17l801t118r849b199],
19	LTC4-synthase	NN	O	ltc4-synthase	nn	21	SENT_331	[p17l902t115r1349b203],
20	A-444C	NN	O	a-444c	nn	21	SENT_331	[p17l1392t118r1638b183],
21	polymorphism	NN	O	polymorphism	dep	18	SENT_331	[p17l1691t115r2151b203],
22	:	:	O	:	_	0	SENT_331	[p17l1691t115r2151b203],
23	lack	NN	O	lack	dep	3	SENT_331	[p17l158t215r279b284],
24	of	IN	O	of	_	0	SENT_331	[p17l325t215r387b284],
25	association	NN	O	association	prep_of	23	SENT_331	[p17l430t217r777b284],
26	with	IN	O	with	_	0	SENT_331	[p17l826t215r960b284],
27	NSAID-induced	JJ	MISC	nsaid-induced	amod	30	SENT_331	[p17l1014t215r1487b284],
28	isolated	VBN	O	isolate	amod	30	SENT_331	[p17l1540t215r1779b284],
29	periorbital	JJ	O	periorbital	amod	30	SENT_331	[p17l1832t215r2148b304],
30	angioedema	NN	O	angioedema	prep_with	25	SENT_331	[p17l155t316r542b405],
31	in	IN	O	in	_	0	SENT_331	[p17l598t318r646b384],
32	a	DT	O	a	det	34	SENT_331	[p17l700t335r729b384],
33	Spanish	JJ	LOCATION	spanish	amod	34	SENT_331	[p17l784t316r1023b405],
34	population	NN	O	population	prep_in	30	SENT_331	[p17l1079t316r1434b405],
35	.	.	O	.	_	0	SENT_331	[p17l1079t316r1434b405],

1	Ann	NNP	PERSON	Ann	nn	4	SENT_332	[p17l1477t320r1602b384],
2	Allergy	NNP	PERSON	Allergy	nn	4	SENT_332	[p17l1648t316r1868b405],
3	Asthma	NNP	PERSON	Asthma	nn	4	SENT_332	[p17l1909t316r2148b384],
4	Immunol	NNP	PERSON	Immunol	_	0	SENT_332	[p17l154t419r449b487],
5	.	.	O	.	_	0	SENT_332	[p17l154t419r449b487],

1	2001	CD	DATE	2001	_	0	SENT_333	[p17l476t422r1023b497],
2	;	:	O	;	_	0	SENT_333	[p17l476t422r1023b497],
3	87:506	CD	NUMBER	87:506	number	4	SENT_333	[p17l476t422r1023b497],
4	-10	CD	NUMBER	-10	dep	1	SENT_333	[p17l476t422r1023b497],
5	.	.	O	.	_	0	SENT_333	[p17l476t422r1023b497],

1	20	CD	NUMBER	20	_	0	SENT_334	[p17l11t522r107b588],
2	.	.	O	.	_	0	SENT_334	[p17l11t522r107b588],

1	Sanchez-Borges	NNP	O	Sanchez-Borges	nn	2	SENT_335	[p17l156t519r656b608],
2	M	NNP	O	M	_	0	SENT_335	[p17l715t523r788b598],
3	,	,	O	,	_	0	SENT_335	[p17l715t523r788b598],
4	Caballero-Fonseca	NNP	O	Caballero-Fonseca	nn	5	SENT_335	[p17l844t519r1420b588],
5	F	NN	O	f	appos	2	SENT_335	[p17l1482t523r1515b598],
6	,	,	O	,	_	0	SENT_335	[p17l1482t523r1515b598],
7	Capriles-Hulett	NNP	O	Capriles-Hulett	nn	9	SENT_335	[p17l1570t519r2042b608],
8	A.	NNP	O	A.	nn	9	SENT_335	[p17l2087t523r2151b588],
9	Safety	NNP	O	Safety	appos	2	SENT_335	[p17l155t620r346b709],
10	of	IN	O	of	_	0	SENT_335	[p17l363t620r426b688],
11	etoricoxib	NN	O	etoricoxib	prep_of	9	SENT_335	[p17l440t620r761b699],
12	,	,	O	,	_	0	SENT_335	[p17l440t620r761b699],
13	a	DT	O	a	det	15	SENT_335	[p17l779t639r809b688],
14	new	JJ	O	new	amod	15	SENT_335	[p17l833t639r962b688],
15	cyclooxygenase	NN	O	cyclooxygenase	appos	2	SENT_335	[p17l980t620r1464b709],
16	2	CD	NUMBER	2	num	17	SENT_335	[p17l1484t623r1518b688],
17	inhibitor	NN	O	inhibitor	dep	15	SENT_335	[p17l1541t620r1810b699],
18	,	,	O	,	_	0	SENT_335	[p17l1541t620r1810b699],
19	in	IN	O	in	_	0	SENT_335	[p17l1831t622r1878b688],
20	patients	NNS	O	patient	prep_in	2	SENT_335	[p17l1903t622r2151b709],
21	with	IN	O	with	_	0	SENT_335	[p17l153t722r287b790],
22	nonsteroidal	JJ	O	nonsteroidal	amod	25	SENT_335	[p17l316t722r702b790],
23	anti-inﬂammatory	JJ	O	anti-inﬂammatory	amod	25	SENT_335	[p17l728t724r1294b810],
24	drug-induced	JJ	O	drug-induced	amod	25	SENT_335	[p17l1316t722r1731b810],
25	urticaria	NN	O	urticarium	prep_with	20	SENT_335	[p17l1759t724r2009b790],
26	and	CC	O	and	_	0	SENT_335	[p17l2036t722r2148b790],
27	angioedema	NN	O	angioedema	conj_and	25	SENT_335	[p17l155t822r707b911],
28	.	.	O	.	_	0	SENT_335	[p17l155t822r707b911],

1	Ann	NNP	PERSON	Ann	nn	4	SENT_336	[p17l155t822r707b911],
2	Allergy	NNP	PERSON	Allergy	nn	4	SENT_336	[p17l729t822r949b911],
3	Asthma	NNP	PERSON	Asthma	nn	4	SENT_336	[p17l967t822r1206b891],
4	Immunol	NNP	PERSON	Immunol	_	0	SENT_336	[p17l1235t822r1530b891],
5	.	.	O	.	_	0	SENT_336	[p17l1235t822r1530b891],

1	2005	CD	DATE	2005	_	0	SENT_337	[p17l1557t825r1876b901],
2	;	:	O	;	_	0	SENT_337	[p17l1557t825r1876b901],
3	95:1	CD	NUMBER	95:1	number	4	SENT_337	[p17l1557t825r1876b901],
4	54-8	CD	NUMBER	54-8	dep	1	SENT_337	[p17l1897t825r2061b891],
5	.	.	O	.	_	0	SENT_337	[p17l1897t825r2061b891],

1	21	CD	NUMBER	21	_	0	SENT_338	[p17l11t926r107b992],
2	.	.	O	.	_	0	SENT_338	[p17l11t926r107b992],

1	Sanchez-Borges	NNP	O	Sanchez-Borges	nn	2	SENT_339	[p17l155t923r656b1012],
2	M	NNP	O	M	_	0	SENT_339	[p17l715t927r788b1002],
3	,	,	O	,	_	0	SENT_339	[p17l715t927r788b1002],
4	Capriles-Hulett	NNP	O	Capriles-Hulett	nn	5	SENT_339	[p17l844t923r1315b1012],
5	A	NNP	O	A	appos	2	SENT_339	[p17l1360t927r1425b1002],
6	,	,	O	,	_	0	SENT_339	[p17l1360t927r1425b1002],
7	Caballero-Fonseca	NNP	PERSON	Caballero-Fonseca	nn	10	SENT_339	[p17l1480t923r2056b991],
8	F.	NNP	PERSON	F.	nn	10	SENT_339	[p17l2118t927r2151b992],
9	Cutaneousreactionstoaspirinandnonsteroidalantiinllammatory	NNP	PERSON	Cutaneousreactionstoaspirinandnonsteroidalantiinllammatory	nn	10	SENT_339	[p17l157t1025r2153b1113],
10	drugs	NNS	O	drug	appos	5	SENT_339	[p17l156t1125r343b1214],
11	.	.	O	.	_	0	SENT_339	[p17l156t1125r343b1214],

1	Clin	NNP	O	Clin	nn	2	SENT_340	[p17l371t1125r484b1194],
2	Rev	NN	O	rev	_	0	SENT_340	[p17l519t1129r627b1194],
3	Allergy	NNP	O	Allergy	nn	4	SENT_340	[p17l645t1125r864b1214],
4	Immunol	NNP	O	Immunol	dep	2	SENT_340	[p17l888t1125r1183b1194],
5	.	.	O	.	_	0	SENT_340	[p17l888t1125r1183b1194],

1	2003	CD	DATE	2003	_	0	SENT_341	[p17l1210t1128r1530b1204],
2	;	:	O	;	_	0	SENT_341	[p17l1210t1128r1530b1204],
3	24:1	CD	NUMBER	24:1	number	4	SENT_341	[p17l1210t1128r1530b1204],
4	25-36	CD	NUMBER	25-36	dep	1	SENT_341	[p17l1549t1128r1756b1194],
5	.	.	O	.	_	0	SENT_341	[p17l1549t1128r1756b1194],

1	22	CD	NUMBER	22	_	0	SENT_342	[p17l11t1229r107b1295],
2	.	.	O	.	_	0	SENT_342	[p17l11t1229r107b1295],

1	Matucci	NNP	MISC	Matucci	nn	2	SENT_343	[p17l159t1228r395b1294],
2	A	NNP	MISC	A	_	0	SENT_343	[p17l413t1230r476b1305],
3	,	,	O	,	_	0	SENT_343	[p17l413t1230r476b1305],
4	Parronchi	NNP	PERSON	Parronchi	nn	5	SENT_343	[p17l502t1226r783b1294],
5	P	NN	PERSON	p	appos	2	SENT_343	[p17l812t1226r1158b1315],
6	,	,	O	,	_	0	SENT_343	[p17l812t1226r1158b1315],
7	Vultaggio	NNP	O	Vultaggio	nn	8	SENT_343	[p17l812t1226r1158b1315],
8	A	NNP	O	A	appos	5	SENT_343	[p17l1175t1230r1238b1305],
9	,	,	O	,	_	0	SENT_343	[p17l1175t1230r1238b1305],
10	Rossi	NNP	PERSON	Rossi	nn	11	SENT_343	[p17l1264t1228r1414b1294],
11	o	NN	O	o	appos	5	SENT_343	[p17l1441t1229r1500b1305],
12	,	,	O	,	_	0	SENT_343	[p17l1441t1229r1500b1305],
13	Brugnolo	NNP	O	Brugnolo	nn	14	SENT_343	[p17l1525t1226r1800b1315],
14	F	NN	O	f	appos	5	SENT_343	[p17l1828t1230r1860b1305],
15	,	,	O	,	_	0	SENT_343	[p17l1828t1230r1860b1305],
16	Maggi	NNP	PERSON	Maggi	nn	17	SENT_343	[p17l1887t1228r2075b1315],
17	E	NNP	O	E	appos	5	SENT_343	[p17l2105t1230r2152b1305],
18	,	,	O	,	_	0	SENT_343	[p17l2105t1230r2152b1305],
19	Romagnani	NNP	O	Romagnani	appos	5	SENT_343	[p17l159t1330r504b1416],
20	5	CD	NUMBER	5	num	19	SENT_343	[p17l531t1331r577b1396],
21	.	.	O	.	_	0	SENT_343	[p17l531t1331r577b1396],

1	Partial	JJ	O	partial	amod	2	SENT_344	[p17l603t1328r787b1396],
2	safety	NN	O	safety	_	0	SENT_344	[p17l813t1327r993b1416],
3	of	IN	O	of	_	0	SENT_344	[p17l1016t1327r1077b1396],
4	the	DT	O	the	det	8	SENT_344	[p17l1094t1328r1190b1396],
5	new	JJ	O	new	amod	8	SENT_344	[p17l1217t1347r1344b1396],
6	COX-2	NN	MISC	cox-2	nn	8	SENT_344	[p17l1368t1331r1569b1396],
7	inhibitor	NN	O	inhibitor	nn	8	SENT_344	[p17l1597t1328r1850b1396],
8	rofecoxib	NN	O	rofecoxib	prep_of	2	SENT_344	[p17l1874t1327r2150b1396],
9	in	IN	O	in	_	0	SENT_344	[p17l157t1430r204b1496],
10	NSAIDs	NNS	MISC	nsaid	prep_in	2	SENT_344	[p17l237t1431r461b1497],
11	high	JJ	O	high	amod	13	SENT_344	[p17l489t1428r616b1517],
12	sensitive	JJ	O	sensitive	amod	13	SENT_344	[p17l643t1430r903b1497],
13	patients	NNS	O	patient	dep	10	SENT_344	[p17l932t1430r1188b1517],
14	.	.	O	.	_	0	SENT_344	[p17l932t1430r1188b1517],

1	Allergy	NN	O	allergy	_	0	SENT_345	[p17l1205t1428r1431b1517],
2	.	.	O	.	_	0	SENT_345	[p17l1205t1428r1431b1517],

1	2004	CD	DATE	2004	_	0	SENT_346	[p17l1456t1431r1769b1507],
2	;	:	O	;	_	0	SENT_346	[p17l1456t1431r1769b1507],
3	59:1	CD	NUMBER	59:1	number	4	SENT_346	[p17l1456t1431r1769b1507],
4	133-4	CD	NUMBER	133-4	dep	1	SENT_346	[p17l1791t1431r1990b1497],
5	.	.	O	.	_	0	SENT_346	[p17l1791t1431r1990b1497],

1	23	CD	NUMBER	23	_	0	SENT_347	[p17l11t1532r107b1598],
2	.	.	O	.	_	0	SENT_347	[p17l11t1532r107b1598],

1	Miller	NNP	ORGANIZATION	Miller	nn	2	SENT_348	[p17l159t1529r332b1597],
2	SA	NNP	ORGANIZATION	SA	_	0	SENT_348	[p17l357t1532r456b1608],
3	,	,	O	,	_	0	SENT_348	[p17l357t1532r456b1608],
4	Dykes	NNP	PERSON	Dykes	nn	5	SENT_348	[p17l485t1529r660b1618],
5	DD	NNP	O	DD	appos	2	SENT_348	[p17l690t1533r794b1608],
6	,	,	O	,	_	0	SENT_348	[p17l690t1533r794b1608],
7	Polesky	NNP	O	Polesky	nn	8	SENT_348	[p17l823t1529r1051b1618],
8	HF	NN	O	hf	appos	5	SENT_348	[p17l1078t1533r1227b1598],
9	.	.	O	.	_	0	SENT_348	[p17l1078t1533r1227b1598],

1	A	DT	O	a	det	2	SENT_349	[p17l1078t1533r1227b1598],
2	simple	JJ	O	simple	_	0	SENT_349	[p17l1251t1529r1450b1618],
3	salting	VBG	O	salt	partmod	2	SENT_349	[p17l1477t1529r1685b1618],
4	out	RP	O	out	prt	3	SENT_349	[p17l1710t1538r1812b1597],
5	procedure	NN	O	procedure	dobj	3	SENT_349	[p17l1839t1529r2150b1618],
6	for	IN	O	for	_	0	SENT_349	[p17l153t1630r239b1699],
7	extracting	VBG	O	extract	prepc_for	3	SENT_349	[p17l271t1633r581b1719],
8	DNA	NN	O	dna	dobj	7	SENT_349	[p17l616t1634r759b1698],
9	from	IN	O	from	_	0	SENT_349	[p17l787t1630r929b1699],
10	human	JJ	O	human	amod	12	SENT_349	[p17l968t1631r1179b1699],
11	nucleated	JJ	O	nucleated	amod	12	SENT_349	[p17l1216t1631r1517b1699],
12	cells	NNS	O	cell	prep_from	7	SENT_349	[p17l1553t1631r1699b1699],
13	.	.	O	.	_	0	SENT_349	[p17l1553t1631r1699b1699],

1	Nucleic	JJ	O	nucleic	amod	2	SENT_350	[p17l1735t1631r1958b1699],
2	Acids	NNS	O	acid	_	0	SENT_350	[p17l1982t1631r2151b1699],
3	Res	NNP	O	Res	dep	2	SENT_350	[p17l159t1736r277b1801],
4	.	.	O	.	_	0	SENT_350	[p17l159t1736r277b1801],

1	1988	CD	DATE	1988	_	0	SENT_351	[p17l308t1735r782b1811],
2	;	:	O	;	_	0	SENT_351	[p17l308t1735r782b1811],
3	16:1215	CD	NUMBER	16:1215	dep	1	SENT_351	[p17l308t1735r782b1811],
4	.	.	O	.	_	0	SENT_351	[p17l308t1735r782b1811],

1	24	CD	NUMBER	24	_	0	SENT_352	[p17l11t1836r107b1902],
2	.	.	O	.	_	0	SENT_352	[p17l11t1836r107b1902],

1	Livak	NNP	O	Livak	nn	2	SENT_353	[p17l159t1833r313b1901],
2	KJ	NNP	O	KJ	_	0	SENT_353	[p17l340t1833r620b1917],
3	.	.	O	.	_	0	SENT_353	[p17l340t1833r620b1917],

1	A	DT	O	a	det	5	SENT_354	[p17l340t1833r620b1917],
2	|	JJ	O	|	amod	5	SENT_354	[p17l340t1833r620b1917],
3	|	NN	O	|	nn	5	SENT_354	[p17l340t1833r620b1917],
4	elic	JJ	O	elic	amod	5	SENT_354	[p17l340t1833r620b1917],
5	discrimination	NN	O	discrimination	_	0	SENT_354	[p17l646t1833r1084b1901],
6	using	VBG	O	use	partmod	5	SENT_354	[p17l1114t1835r1279b1922],
7	Duorogenic	JJ	MISC	duorogenic	amod	8	SENT_354	[p17l1306t1835r1655b1922],
8	probes	NNS	O	probe	dobj	6	SENT_354	[p17l1682t1833r1889b1922],
9	and	CC	O	and	_	0	SENT_354	[p17l1914t1833r2026b1901],
10	the	DT	O	the	dobj	6	SENT_354	[p17l2052t1833r2150b1901],

1	5	CD	NUMBER	5	num	2	SENT_355	[p17l157t1939r214b2003],
2	’	NN	O	’	_	0	SENT_355	[p17l157t1939r214b2003],
3	nuclease	NN	O	nuclease	nn	4	SENT_355	[p17l242t1935r511b2003],
4	assay	NN	O	assay	dep	2	SENT_355	[p17l539t1954r721b2023],
5	.	.	O	.	_	0	SENT_355	[p17l539t1954r721b2023],

1	Genet	NNP	O	Genet	nn	2	SENT_356	[p17l749t1938r936b2003],
2	Anal	NNP	O	Anal	_	0	SENT_356	[p17l953t1935r1116b2003],
3	.	.	O	.	_	0	SENT_356	[p17l953t1935r1116b2003],

1	1999	CD	DATE	1999	_	0	SENT_357	[p17l1146t1938r1647b2014],
2	;	:	O	;	_	0	SENT_357	[p17l1146t1938r1647b2014],
3	14:143	CD	NUMBER	14:143	number	4	SENT_357	[p17l1146t1938r1647b2014],
4	—	CD	NUMBER	—	dep	1	SENT_357	[p17l1146t1938r1647b2014],
5	9	CD	NUMBER	9	dep	4	SENT_357	[p17l1146t1938r1647b2014],
6	.	.	O	.	_	0	SENT_357	[p17l1146t1938r1647b2014],

1	25	CD	NUMBER	25	_	0	SENT_358	[p17l11t2038r107b2104],
2	.	.	O	.	_	0	SENT_358	[p17l11t2038r107b2104],

1	Puerta	NNP	PERSON	Puerta	nn	3	SENT_359	[p17l159t2039r354b2104],
2	Llerena	NNP	PERSON	Llerena	nn	3	SENT_359	[p17l406t2035r625b2104],
3	L	NNP	O	L	_	0	SENT_359	[p17l678t2039r721b2114],
4	,	,	O	,	_	0	SENT_359	[p17l678t2039r721b2114],
5	Fernandez-Caldas	NNP	O	Fernandez-Caldas	nn	6	SENT_359	[p17l770t2035r1328b2104],
6	E	NNP	O	E	appos	3	SENT_359	[p17l1378t2039r1426b2114],
7	,	,	O	,	_	0	SENT_359	[p17l1378t2039r1426b2114],
8	Caraballo	NNP	PERSON	Caraballo	nn	10	SENT_359	[p17l1473t2035r1770b2104],
9	Gracia	NNP	PERSON	Gracia	nn	10	SENT_359	[p17l1817t2037r2012b2104],
10	LR	NNP	O	LR	appos	3	SENT_359	[p17l2064t2039r2151b2114],
11	,	,	O	,	_	0	SENT_359	[p17l2064t2039r2151b2114],
12	Lockey	NNP	PERSON	Lockey	nn	13	SENT_359	[p17l159t2136r364b2225],
13	RF	NNP	O	RF	appos	3	SENT_359	[p17l393t2140r470b2205],
14	.	.	O	.	_	0	SENT_359	[p17l393t2140r470b2205],

1	Sensitization	NN	O	sensitization	_	0	SENT_360	[p17l496t2138r891b2204],
2	to	TO	O	to	_	0	SENT_360	[p17l919t2145r979b2204],
3	Blomia	NN	LOCATION	blomium	nn	4	SENT_360	[p17l1010t2136r1219b2204],
4	tropicalis	NN	O	tropicali	prep_to	1	SENT_360	[p17l1247t2136r1530b2225],
5	and	CC	O	and	_	0	SENT_360	[p17l1558t2136r1669b2204],
6	Lepidoglyphus	NN	O	lepidoglyphus	nn	7	SENT_360	[p17l1702t2136r2151b2225],
7	destructor	NN	O	destructor	prep_to	1	SENT_360	[p17l156t2238r473b2306],
8	in	IN	O	in	prep	7	SENT_360	[p17l533t2240r580b2305],
9	Dermatophagoides	NNP	LOCATION	Dermatophagoides	dep	11	SENT_360	[p17l646t2238r1242b2326],
10	spp	NN	O	spp	dep	9	SENT_360	[p17l1302t2238r1664b2326],
11	—	CD	NUMBER	—	dep	8	SENT_360	[p17l1302t2238r1664b2326],
12	allergic	JJ	O	allergic	amod	13	SENT_360	[p17l1302t2238r1664b2326],
13	individuals	NNS	O	individual	dep	11	SENT_360	[p17l1725t2238r2145b2322],
14	.	.	O	.	_	0	SENT_360	[p17l1725t2238r2145b2322],
15	)	SYM	O	)	dep	7	SENT_360	[p17l1725t2238r2145b2322],

1	Allergy	NN	O	allergy	nn	2	SENT_361	[p17l152t2338r372b2427],
2	Clin	NN	O	clin	_	0	SENT_361	[p17l399t2338r512b2407],
3	Immunol	NNP	O	Immunol	dep	2	SENT_361	[p17l542t2338r837b2407],
4	.	.	O	.	_	0	SENT_361	[p17l542t2338r837b2407],

1	1991	CD	DATE	1991	_	0	SENT_362	[p17l867t2341r1410b2417],
2	;	:	O	;	_	0	SENT_362	[p17l867t2341r1410b2417],
3	88:943	CD	NUMBER	88:943	number	4	SENT_362	[p17l867t2341r1410b2417],
4	-50	CD	NUMBER	-50	dep	1	SENT_362	[p17l867t2341r1410b2417],
5	.	.	O	.	_	0	SENT_362	[p17l867t2341r1410b2417],

1	J	NNP	O	J	nn	5	SENT_363	[p17l7t2596r44b2647],
2	Investig	NNP	O	Investig	nn	5	SENT_363	[p17l58t2596r293b2660],
3	Allergol	NNP	O	Allergol	nn	5	SENT_363	[p17l308t2594r553b2660],
4	Clin	NNP	O	Clin	nn	5	SENT_363	[p17l576t2594r697b2647],
5	Immunol	NNP	O	Immunol	_	0	SENT_363	[p17l717t2594r982b2646],
6	2009	CD	DATE	2009	num	5	SENT_363	[p17l1003t2594r1166b2655],
7	;	:	O	;	_	0	SENT_363	[p17l1003t2594r1166b2655],
8	Vol	NNP	O	Vol	dep	5	SENT_363	[p17l1188t2594r1303b2646],
9	.	.	O	.	_	0	SENT_363	[p17l1188t2594r1303b2646],

1	19	CD	NUMBER	19	number	2	SENT_364	[p17l1334t2594r1502b2658],
2	(	CD	NUMBER	(	_	0	SENT_364	[p17l1334t2594r1502b2658],
3	5	CD	NUMBER	5	num	4	SENT_364	[p17l1334t2594r1502b2658],
4	)	NN	O	)	dep	2	SENT_364	[p17l1334t2594r1502b2658],
5	:	:	O	:	_	0	SENT_364	[p17l1334t2594r1502b2658],
6	375-382	CD	NUMBER	375-382	dep	2	SENT_364	[p17l1529t2594r1772b2646],
7	26	CD	NUMBER	26	dep	6	SENT_364	[p17l8t2682r107b2747],
8	.	.	O	.	_	0	SENT_364	[p17l8t2682r107b2747],

1	Ferrandiz	NN	PERSON	ferrandiz	nn	2	SENT_365	[p17l156t2678r444b2747],
2	R	NN	PERSON	r	_	0	SENT_365	[p17l539t2682r592b2757],
3	,	,	O	,	_	0	SENT_365	[p17l539t2682r592b2757],
4	Casas	NNP	ORGANIZATION	Casas	nn	5	SENT_365	[p17l683t2682r867b2747],
5	R	NNP	ORGANIZATION	R	conj_and	2	SENT_365	[p17l961t2683r1015b2757],
6	,	,	O	,	_	0	SENT_365	[p17l961t2683r1015b2757],
7	Dreborg	NNP	O	Dreborg	nn	9	SENT_365	[p17l1108t2679r1363b2767],
8	S.	NNP	O	S.	nn	9	SENT_365	[p17l1453t2682r1500b2747],
9	Sensitization	NN	O	sensitization	conj_and	2	SENT_365	[p17l1590t2681r1995b2747],
10	to	TO	O	to	_	0	SENT_365	[p17l2086t2688r2146b2747],
11	Dermatophagoides	NNP	LOCATION	Dermatophagoides	nn	12	SENT_365	[p17l156t2779r766b2868],
12	siboney	NN	O	siboney	prep_to	9	SENT_365	[p17l830t2779r1087b2868],
13	,	,	O	,	_	0	SENT_365	[p17l830t2779r1087b2868],
14	Blomia	NN	O	blomium	nn	15	SENT_365	[p17l1153t2779r1366b2848],
15	tropicalis	NN	O	tropicali	conj_and	2	SENT_365	[p17l1431t2779r1739b2868],
16	,	,	O	,	_	0	SENT_365	[p17l1431t2779r1739b2868],
17	and	CC	O	and	_	0	SENT_365	[p17l1802t2779r1915b2848],
18	other	JJ	O	other	amod	20	SENT_365	[p17l1982t2779r2150b2848],
19	domestic	JJ	O	domestic	amod	20	SENT_365	[p17l153t2880r439b2948],
20	mites	NNS	O	mite	conj_and	2	SENT_365	[p17l478t2882r645b2948],
21	in	IN	O	in	_	0	SENT_365	[p17l683t2882r732b2948],
22	asthmatic	JJ	O	asthmatic	amod	23	SENT_365	[p17l772t2880r1083b2948],
23	patients	NNS	O	patient	prep_in	20	SENT_365	[p17l1122t2882r1392b2969],
24	.	.	O	.	_	0	SENT_365	[p17l1122t2882r1392b2969],

1	Allergy	NN	O	allergy	_	0	SENT_366	[p17l1420t2880r1658b2969],
2	.	.	O	.	_	0	SENT_366	[p17l1420t2880r1658b2969],

1	1996	CD	DATE	1996	_	0	SENT_367	[p17l1698t2883r2148b2959, p17l154t2986r208b3051],
2	;	:	O	;	_	0	SENT_367	[p17l1698t2883r2148b2959, p17l154t2986r208b3051],
3	51:5015	CD	NUMBER	51:5015	dep	1	SENT_367	[p17l1698t2883r2148b2959, p17l154t2986r208b3051],
4	.	.	O	.	_	0	SENT_367	[p17l1698t2883r2148b2959, p17l154t2986r208b3051],

1	27	CD	NUMBER	27	_	0	SENT_368	[p17l8t3086r107b3152],
2	.	.	O	.	_	0	SENT_368	[p17l8t3086r107b3152],

1	Chew	VB	O	chew	_	0	SENT_369	[p17l154t3083r333b3152],
2	FT	NNP	O	FT	dobj	1	SENT_369	[p17l364t3087r439b3162],
3	,	,	O	,	_	0	SENT_369	[p17l364t3087r439b3162],
4	Lim	NNP	PERSON	Lim	nn	5	SENT_369	[p17l469t3085r571b3151],
5	SH	NNP	O	SH	appos	2	SENT_369	[p17l602t3086r703b3162],
6	,	,	O	,	_	0	SENT_369	[p17l602t3086r703b3162],
7	Goh	NNP	PERSON	Goh	nn	8	SENT_369	[p17l732t3083r857b3152],
8	DY	NNP	PERSON	DY	appos	2	SENT_369	[p17l892t3087r980b3162],
9	,	,	O	,	_	0	SENT_369	[p17l892t3087r980b3162],
10	Lee	NNP	PERSON	Lee	nn	11	SENT_369	[p17l1011t3087r1112b3152],
11	BW	NN	O	bw	appos	2	SENT_369	[p17l1144t3087r1261b3152],
12	.	.	O	.	_	0	SENT_369	[p17l1144t3087r1261b3152],

1	Sensitization	NN	O	sensitization	_	0	SENT_370	[p17l1289t3085r1694b3152],
2	to	TO	O	to	_	0	SENT_370	[p17l1723t3092r1784b3152],
3	local	JJ	O	local	amod	4	SENT_370	[p17l1815t3083r1957b3152],
4	dustmite	NN	O	dustmite	prep_to	1	SENT_370	[p17l1988t3083r2148b3152, p18l155t20r289b86],

1	fauna	NNS	O	fauna	_	0	SENT_371	[p18l317t18r496b86],
2	in	IN	O	in	_	0	SENT_371	[p18l531t20r579b86],
3	Singapore	NNP	LOCATION	Singapore	prep_in	1	SENT_371	[p18l611t20r948b107],
4	.	.	O	.	_	0	SENT_371	[p18l611t20r948b107],

1	Allergy	NN	O	allergy	_	0	SENT_372	[p18l969t18r1208b107],
2	.	.	O	.	_	0	SENT_372	[p18l969t18r1208b107],

1	1999	CD	DATE	1999	_	0	SENT_373	[p18l1240t21r1795b97],
2	;	:	O	;	_	0	SENT_373	[p18l1240t21r1795b97],
3	54:1150	CD	NUMBER	54:1150	number	4	SENT_373	[p18l1240t21r1795b97],
4	-9	CD	NUMBER	-9	dep	1	SENT_373	[p18l1240t21r1795b97],
5	.	.	O	.	_	0	SENT_373	[p18l1240t21r1795b97],

1	Puccio	NNP	ORGANIZATION	Puccio	nn	2	SENT_374	[p18l156t122r356b188],
2	FA	NNP	ORGANIZATION	FA	_	0	SENT_374	[p18l407t123r499b198],
3	,	,	O	,	_	0	SENT_374	[p18l407t123r499b198],
4	Lynch	NNP	ORGANIZATION	Lynch	nn	5	SENT_374	[p18l548t120r717b208],
5	NR	NNP	ORGANIZATION	NR	appos	2	SENT_374	[p18l771t123r878b198],
6	,	,	O	,	_	0	SENT_374	[p18l771t123r878b198],
7	Noya	NNP	PERSON	Noya	nn	8	SENT_374	[p18l927t123r1081b208],
8	o	NN	O	o	appos	5	SENT_374	[p18l1131t123r1192b198],
9	,	,	O	,	_	0	SENT_374	[p18l1131t123r1192b198],
10	Noda	NNP	PERSON	Noda	nn	11	SENT_374	[p18l1242t120r1405b188],
11	A	NNP	O	A	appos	5	SENT_374	[p18l1446t123r1512b198],
12	,	,	O	,	_	0	SENT_374	[p18l1446t123r1512b198],
13	Hagel	NNP	PERSON	Hagel	nn	17	SENT_374	[p18l1561t120r1737b208],
14	I	PRP	O	I	dep	17	SENT_374	[p18l1786t123r1820b198],
15	,	,	O	,	_	0	SENT_374	[p18l1786t123r1820b198],
16	Lopez	NNP	PERSON	Lopez	dep	17	SENT_374	[p18l1869t123r2049b208],
17	E	NNP	O	E	appos	5	SENT_374	[p18l2100t123r2149b198],
18	,	,	O	,	_	0	SENT_374	[p18l2100t123r2149b198],
19	Lopez	NNP	PERSON	Lopez	nn	20	SENT_374	[p18l156t224r336b309],
20	R	NNP	PERSON	R	appos	5	SENT_374	[p18l380t224r434b299],
21	,	,	O	,	_	0	SENT_374	[p18l380t224r434b299],
22	Caraballo	NNP	PERSON	Caraballo	nn	23	SENT_374	[p18l475t220r779b289],
23	L	NNP	PERSON	L	appos	5	SENT_374	[p18l824t224r868b299],
24	,	,	O	,	_	0	SENT_374	[p18l824t224r868b299],
25	Mercado	NNP	ORGANIZATION	Mercado	nn	26	SENT_374	[p18l911t220r1187b289],
26	D	NNP	ORGANIZATION	D	appos	5	SENT_374	[p18l1231t224r1287b299],
27	,	,	O	,	_	0	SENT_374	[p18l1231t224r1287b299],
28	DiPrisco	NNP	PERSON	DiPrisco	nn	29	SENT_374	[p18l1330t222r1580b289],
29	MC	NNP	O	MC	appos	5	SENT_374	[p18l1626t223r1745b289],
30	.	.	O	.	_	0	SENT_374	[p18l1626t223r1745b289],

1	Importance	NN	O	importance	_	0	SENT_375	[p18l1784t224r2147b309],
2	of	IN	O	of	_	0	SENT_375	[p18l153t321r217b389],
3	including	VBG	O	include	prepc_of	1	SENT_375	[p18l263t321r554b410],
4	Blomia	NN	O	blomium	nn	5	SENT_375	[p18l606t321r818b389],
5	tropicalis	NN	O	tropicali	dobj	3	SENT_375	[p18l869t321r1160b410],
6	in	IN	O	in	_	0	SENT_375	[p18l1212t323r1261b389],
7	the	DT	O	the	det	9	SENT_375	[p18l1311t321r1412b389],
8	routine	JJ	O	routine	amod	9	SENT_375	[p18l1464t323r1687b389],
9	diagnosis	NN	O	diagnosis	prep_in	3	SENT_375	[p18l1738t321r2039b410],
10	of	IN	O	of	_	0	SENT_375	[p18l2090t321r2153b389],
11	Venezuelan	JJ	MISC	venezuelan	amod	12	SENT_375	[p18l150t423r519b491],
12	patients	NNS	O	patient	prep_of	9	SENT_375	[p18l595t425r849b511],
13	with	IN	O	with	_	0	SENT_375	[p18l918t423r1054b491],
14	persistent	JJ	O	persistent	amod	16	SENT_375	[p18l1130t425r1442b511],
15	allergic	JJ	O	allergic	amod	16	SENT_375	[p18l1511t423r1740b511],
16	symptoms	NNS	O	symptom	prep_with	3	SENT_375	[p18l1810t432r2149b511],
17	.	.	O	.	_	0	SENT_375	[p18l1810t432r2149b511],

1	Allergy	NN	O	allergy	_	0	SENT_376	[p18l150t523r388b612],
2	.	.	O	.	_	0	SENT_376	[p18l150t523r388b612],

1	2004	CD	DATE	2004	_	0	SENT_377	[p18l417t526r932b602],
2	;	:	O	;	_	0	SENT_377	[p18l417t526r932b602],
3	59:753	CD	NUMBER	59:753	number	4	SENT_377	[p18l417t526r932b602],
4	-7	CD	NUMBER	-7	dep	1	SENT_377	[p18l417t526r932b602],
5	.	.	O	.	_	0	SENT_377	[p18l417t526r932b602],

1	Sanchez-Borges	NNP	O	Sanchez-Borges	nn	2	SENT_378	[p18l153t624r665b713],
2	M	NNP	O	M	_	0	SENT_378	[p18l736t628r811b703],
3	,	,	O	,	_	0	SENT_378	[p18l736t628r811b703],
4	Capriles-Hulett	NNP	O	Capriles-Hulett	nn	5	SENT_378	[p18l879t624r1363b713],
5	A	NNP	O	A	conj_and	2	SENT_378	[p18l1421t628r1486b703],
6	,	,	O	,	_	0	SENT_378	[p18l1421t628r1486b703],
7	Caballero-Fonseca	NNP	O	Caballero-Fonseca	nn	8	SENT_378	[p18l1554t624r2145b692],
8	F	NN	O	f	conj_and	2	SENT_378	[p18l156t730r190b805],
9	,	,	O	,	_	0	SENT_378	[p18l156t730r190b805],
10	Fernandez-Caldas	NNP	PERSON	Fernandez-Caldas	nn	12	SENT_378	[p18l236t725r808b794],
11	E.	NNP	PERSON	E.	nn	12	SENT_378	[p18l853t730r902b794],
12	Mite	NNP	PERSON	Mite	conj_and	2	SENT_378	[p18l947t728r1084b794],
13	and	CC	O	and	_	0	SENT_378	[p18l1127t726r1240b794],
14	cockroach	NN	O	cockroach	nn	15	SENT_378	[p18l1287t726r1606b794],
15	sensitization	NN	O	sensitization	conj_and	2	SENT_378	[p18l1650t728r2049b794],
16	in	IN	O	in	_	0	SENT_378	[p18l2096t728r2145b793],
17	allergic	JJ	O	allergic	amod	18	SENT_378	[p18l153t826r382b915],
18	patients	NNS	O	patient	prep_in	15	SENT_378	[p18l410t828r664b915],
19	from	IN	O	from	_	0	SENT_378	[p18l688t826r832b895],
20	Caracas	NNP	LOCATION	Caracas	nn	22	SENT_378	[p18l863t829r1128b905],
21	,	,	O	,	_	0	SENT_378	[p18l863t829r1128b905],
22	Venezuela	NNP	LOCATION	Venezuela	prep_from	18	SENT_378	[p18l1145t826r1639b895],
23	.	.	O	.	_	0	SENT_378	[p18l1145t826r1639b895],

1	Ann	NNP	PERSON	Ann	nn	3	SENT_379	[p18l1145t826r1639b895],
2	AllergyAsthma	NNP	PERSON	AllergyAsthma	nn	3	SENT_379	[p18l1660t826r2145b915],
3	Immunol	NNP	PERSON	Immunol	_	0	SENT_379	[p18l152t927r453b996],
4	.	.	O	.	_	0	SENT_379	[p18l152t927r453b996],

1	2003	CD	DATE	2003	_	0	SENT_380	[p18l482t930r997b1006],
2	;	:	O	;	_	0	SENT_380	[p18l482t930r997b1006],
3	90:664	CD	NUMBER	90:664	number	4	SENT_380	[p18l482t930r997b1006],
4	-8	CD	NUMBER	-8	dep	1	SENT_380	[p18l482t930r997b1006],
5	.	.	O	.	_	0	SENT_380	[p18l482t930r997b1006],

1	Martinez	NNP	PERSON	Martinez	nn	2	SENT_381	[p18l156t1028r435b1097],
2	B	NNP	PERSON	B	nsubj	24	SENT_381	[p18l489t1033r539b1108],
3	,	,	O	,	_	0	SENT_381	[p18l489t1033r539b1108],
4	Barrios	NNP	O	Barrios	nn	5	SENT_381	[p18l591t1031r809b1097],
5	K	NNP	O	K	appos	2	SENT_381	[p18l863t1033r916b1108],
6	,	,	O	,	_	0	SENT_381	[p18l863t1033r916b1108],
7	Vergara	NNP	PERSON	Vergara	nn	8	SENT_381	[p18l957t1033r1203b1117],
8	C	NNP	O	C	appos	2	SENT_381	[p18l1257t1032r1313b1108],
9	,	,	O	,	_	0	SENT_381	[p18l1257t1032r1313b1108],
10	Mercado	NNP	ORGANIZATION	Mercado	nn	11	SENT_381	[p18l1366t1029r1640b1097],
11	D	NNP	ORGANIZATION	D	appos	2	SENT_381	[p18l1695t1033r1750b1108],
12	,	,	O	,	_	0	SENT_381	[p18l1695t1033r1750b1108],
13	Jiménez	NNP	PERSON	Jiménez	nn	14	SENT_381	[p18l1787t1028r2052b1113],
14	S	NNP	PERSON	S	appos	2	SENT_381	[p18l2101t1032r2149b1108],
15	,	,	O	,	_	0	SENT_381	[p18l2101t1032r2149b1108],
16	Gusmao	NNP	PERSON	Gusmao	nn	17	SENT_381	[p18l154t1132r414b1198],
17	L	NNP	O	L	appos	2	SENT_381	[p18l441t1133r485b1208],
18	,	,	O	,	_	0	SENT_381	[p18l441t1133r485b1208],
19	Caraballo	NNP	PERSON	Caraballo	nn	20	SENT_381	[p18l506t1129r810b1198],
20	L.A	NNP	LOCATION	L.A	appos	2	SENT_381	[p18l836t1133r941b1198],
21	N051	NN	O	n051	nn	23	SENT_381	[p18l963t1132r1129b1198],
22	gene	NN	O	gene	nn	23	SENT_381	[p18l1161t1148r1315b1218],
23	polymorphism	NN	O	polymorphism	dep	20	SENT_381	[p18l1339t1129r1787b1218],
24	associated	VBN	O	associate	_	0	SENT_381	[p18l1811t1129r2144b1198],
25	with	IN	O	with	_	0	SENT_381	[p18l150t1230r287b1298],
26	asthma	NN	O	asthma	prep_with	24	SENT_381	[p18l343t1230r573b1298],
27	and	CC	O	and	_	0	SENT_381	[p18l630t1230r743b1298],
28	speciﬁc	NN	O	speciﬁc	nn	31	SENT_381	[p18l799t1232r1033b1319],
29	immunoglobulin	NN	O	immunoglobulin	nn	31	SENT_381	[p18l1087t1230r1608b1319],
30	E	NN	O	e	nn	31	SENT_381	[p18l1668t1234r1695b1298],
31	response	NN	O	response	conj_and	26	SENT_381	[p18l1752t1249r2034b1319],
32	to	TO	O	to	_	0	SENT_381	[p18l2086t1239r2147b1298],
33	mite	JJ	O	mite	amod	34	SENT_381	[p18l155t1334r289b1400],
34	allergens	NNS	O	allergen	prep_to	24	SENT_381	[p18l332t1332r620b1420],
35	in	IN	O	in	_	0	SENT_381	[p18l665t1334r713b1399],
36	a	DT	O	a	det	38	SENT_381	[p18l758t1351r788b1400],
37	Colombian	JJ	LOCATION	colombian	amod	38	SENT_381	[p18l834t1332r1178b1400],
38	population	NN	O	population	prep_in	24	SENT_381	[p18l1225t1332r1588b1420],
39	.	.	O	.	_	0	SENT_381	[p18l1225t1332r1588b1420],

1	Int	NNP	O	Int	nn	4	SENT_382	[p18l1629t1336r1712b1400],
2	Arch	NNP	O	Arch	nn	4	SENT_382	[p18l1745t1332r1888b1400],
3	Allergy	NNP	O	Allergy	nn	4	SENT_382	[p18l1925t1332r2150b1420],
4	Immunol	NNP	O	Immunol	_	0	SENT_382	[p18l152t1432r453b1501],
5	.	.	O	.	_	0	SENT_382	[p18l152t1432r453b1501],

1	2007	CD	DATE	2007	_	0	SENT_383	[p18l482t1435r1084b1511],
2	;	:	O	;	_	0	SENT_383	[p18l482t1435r1084b1511],
3	144:105	CD	NUMBER	144:105	number	4	SENT_383	[p18l482t1435r1084b1511],
4	-13	CD	NUMBER	-13	dep	1	SENT_383	[p18l482t1435r1084b1511],
5	.	.	O	.	_	0	SENT_383	[p18l482t1435r1084b1511],

1	.	.	O	.	_	0	SENT_384	[p18l97t1589r107b1602],

1	Chan	NNP	ORGANIZATION	Chan	nn	2	SENT_385	[p18l154t1533r315b1601],
2	CL	NN	ORGANIZATION	cl	_	0	SENT_385	[p18l360t1536r455b1612],
3	,	,	O	,	_	0	SENT_385	[p18l360t1536r455b1612],
4	Jones	NNP	PERSON	Jones	nn	5	SENT_385	[p18l484t1537r669b1617],
5	RL	NNP	O	RL	appos	2	SENT_385	[p18l715t1537r804b1612],
6	,	,	O	,	_	0	SENT_385	[p18l715t1537r804b1612],
7	Lau	NNP	PERSON	Lau	nn	8	SENT_385	[p18l848t1537r951b1601],
8	HY	NNP	O	HY	appos	5	SENT_385	[p18l999t1537r1092b1602],
9	.	.	O	.	_	0	SENT_385	[p18l999t1537r1092b1602],

1	Characterization	NN	O	characterization	_	0	SENT_386	[p18l1134t1533r1660b1601],
2	of	IN	O	of	_	0	SENT_386	[p18l1705t1533r1768b1601],
3	prostanoid	NN	O	prostanoid	nn	4	SENT_386	[p18l1807t1533r2144b1622],
4	receptors	NNS	O	receptor	prep_of	1	SENT_386	[p18l154t1644r448b1723],
5	mediating	VBG	O	mediate	partmod	1	SENT_386	[p18l506t1635r826b1723],
6	inhibition	NN	O	inhibition	dobj	5	SENT_386	[p18l883t1635r1181b1703],
7	of	IN	O	of	_	0	SENT_386	[p18l1240t1634r1304b1703],
8	histamine	NN	O	histamine	nn	9	SENT_386	[p18l1357t1635r1665b1703],
9	release	NN	O	release	prep_of	6	SENT_386	[p18l1724t1635r1946b1703],
10	from	IN	O	from	_	0	SENT_386	[p18l2000t1634r2144b1703],
11	anti-IgE-activated	JJ	O	anti-ige-activated	amod	15	SENT_386	[p18l153t1735r722b1824],
12	rat	NN	O	rat	nn	15	SENT_386	[p18l766t1744r849b1804],
13	peritoneal	NN	O	peritoneal	nn	15	SENT_386	[p18l889t1735r1207b1824],
14	mast	NN	O	mast	nn	15	SENT_386	[p18l1251t1744r1403b1804],
15	cells	NNS	O	cell	prep_from	5	SENT_386	[p18l1441t1735r1591b1804],
16	.	.	O	.	_	0	SENT_386	[p18l1441t1735r1591b1804],

1	Br	NN	O	br	_	0	SENT_387	[p18l1633t1739r1747b1820],
2	]	CD	NUMBER	]	num	3	SENT_387	[p18l1633t1739r1747b1820],
3	Pharmacol	NN	O	pharmacol	dep	1	SENT_387	[p18l1795t1735r2149b1804],
4	.	.	O	.	_	0	SENT_387	[p18l1795t1735r2149b1804],

1	2000	CD	DATE	2000	_	0	SENT_388	[p18l153t1840r755b1916],
2	;	:	O	;	_	0	SENT_388	[p18l153t1840r755b1916],
3	129:589	CD	NUMBER	129:589	number	4	SENT_388	[p18l153t1840r755b1916],
4	—	CD	NUMBER	—	dep	1	SENT_388	[p18l153t1840r755b1916],
5	97	CD	NUMBER	97	dep	4	SENT_388	[p18l153t1840r755b1916],
6	.	.	O	.	_	0	SENT_388	[p18l153t1840r755b1916],

1	Sanak	NNP	O	Sanak	nn	2	SENT_389	[p18l153t1939r346b2007],
2	M	NNP	O	M	_	0	SENT_389	[p18l391t1943r466b2018],
3	,	,	O	,	_	0	SENT_389	[p18l391t1943r466b2018],
4	Simon	NNP	PERSON	Simon	nn	5	SENT_389	[p18l508t1941r700b2007],
5	HU	NNP	PERSON	HU	appos	2	SENT_389	[p18l749t1943r856b2018],
6	,	,	O	,	_	0	SENT_389	[p18l749t1943r856b2018],
7	Szczeklik	NNP	O	Szczeklik	nn	8	SENT_389	[p18l899t1939r1185b2007],
8	A.	NNP	O	A.	appos	2	SENT_389	[p18l1218t1942r1284b2007],
9	Leukotriene	NN	O	leukotriene	nn	11	SENT_389	[p18l1329t1939r1699b2007],
10	C4	NN	O	c4	nn	11	SENT_389	[p18l1745t1942r1829b2007],
11	synthase	NN	O	synthase	dep	8	SENT_389	[p18l1870t1939r2147b2027],
12	promoter	NN	O	promoter	nn	13	SENT_389	[p18l155t2048r449b2128],
13	polymorphism	NN	O	polymorphism	dep	2	SENT_389	[p18l486t2039r934b2128],
14	and	CC	O	and	_	0	SENT_389	[p18l972t2039r1086b2108],
15	risk	NN	O	risk	dep	2	SENT_389	[p18l1127t2039r1235b2108],
16	of	IN	O	of	_	0	SENT_389	[p18l1269t2039r1332b2108],
17	aspirin-induced	JJ	O	aspirin-induced	amod	18	SENT_389	[p18l1363t2039r1856b2128],
18	asthma	NN	O	asthma	prep_of	13	SENT_389	[p18l1896t2039r2149b2108],
19	.	.	O	.	_	0	SENT_389	[p18l1896t2039r2149b2108],

1	Lancet	NNP	O	Lancet	_	0	SENT_390	[p18l156t2145r380b2210],
2	.	.	O	.	_	0	SENT_390	[p18l156t2145r380b2210],

1	1997	CD	DATE	1997	_	0	SENT_391	[p18l412t2144r1097b2220],
2	;	:	O	;	_	0	SENT_391	[p18l412t2144r1097b2220],
3	350:1599	CD	NUMBER	350:1599	num	4	SENT_391	[p18l412t2144r1097b2220],
4	—	NN	O	—	dep	1	SENT_391	[p18l412t2144r1097b2220],
5	600	CD	NUMBER	600	dep	4	SENT_391	[p18l412t2144r1097b2220],
6	.	.	O	.	_	0	SENT_391	[p18l412t2144r1097b2220],

1	Choi	NNP	O	Choi	nn	2	SENT_392	[p18l154t2244r294b2312],
2	JH	NNP	O	JH	_	0	SENT_392	[p18l322t2248r423b2328],
3	,	,	O	,	_	0	SENT_392	[p18l322t2248r423b2328],
4	Park	NNP	O	Park	prep	8	SENT_392	[p18l463t2244r597b2312],
5	HS	NN	O	h	dep	4	SENT_392	[p18l635t2247r729b2323],
6	,	,	O	,	_	0	SENT_392	[p18l635t2247r729b2323],
7	oh	UH	O	oh	dep	8	SENT_392	[p18l766t2244r851b2312],
8	HB	NN	O	hb	dep	2	SENT_392	[p18l894t2248r995b2323],
9	,	,	O	,	_	0	SENT_392	[p18l894t2248r995b2323],
10	Lee	NNP	PERSON	Lee	nn	11	SENT_392	[p18l1035t2248r1135b2312],
11	JH	NNP	O	JH	appos	2	SENT_392	[p18l1162t2248r1263b2328],
12	,	,	O	,	_	0	SENT_392	[p18l1162t2248r1263b2328],
13	Suh	NNP	O	Suh	nn	14	SENT_392	[p18l1299t2244r1411b2312],
14	Y	NN	O	y	appos	11	SENT_392	[p18l1444t2248r1528b2328],
15	]	CD	NUMBER	]	num	14	SENT_392	[p18l1444t2248r1528b2328],
16	,	,	O	,	_	0	SENT_392	[p18l1444t2248r1528b2328],
17	Park	NNP	O	Park	nn	18	SENT_392	[p18l1567t2244r1701b2312],
18	CS	NNP	O	CS	appos	11	SENT_392	[p18l1738t2247r1832b2323],
19	,	,	O	,	_	0	SENT_392	[p18l1738t2247r1832b2323],
20	Shin	NNP	PERSON	Shin	nn	21	SENT_392	[p18l1869t2244r1999b2312],
21	HD	NNP	O	HD	appos	11	SENT_392	[p18l2043t2248r2149b2313],
22	.	.	O	.	_	0	SENT_392	[p18l2043t2248r2149b2313],

1	Leukotriene-related	JJ	O	leukotriene-related	amod	3	SENT_393	[p18l156t2344r780b2413],
2	gene	NN	O	gene	nn	3	SENT_393	[p18l832t2363r986b2433],
3	polymorphisms	NNS	O	polymorphism	_	0	SENT_393	[p18l1040t2344r1523b2433],
4	in	IN	O	in	_	0	SENT_393	[p18l1576t2346r1625b2412],
5	ASA-intolerant	JJ	O	asa-intolerant	amod	6	SENT_393	[p18l1670t2344r2150b2413],
6	asthma	NN	O	asthma	prep_in	3	SENT_393	[p18l153t2445r406b2514],
7	:	:	O	:	_	0	SENT_393	[p18l153t2445r406b2514],
8	an	DT	O	a	det	9	SENT_393	[p18l443t2464r515b2513],
9	association	NN	O	association	dep	3	SENT_393	[p18l555t2447r911b2513],
10	with	IN	O	with	_	0	SENT_393	[p18l949t2445r1086b2513],
11	a	DT	O	a	det	12	SENT_393	[p18l1127t2464r1156b2513],
12	haplotype	NN	O	haplotype	prep_with	9	SENT_393	[p18l1200t2445r1513b2534],
13	of	IN	O	of	_	0	SENT_393	[p18l1552t2445r1615b2513],
14	5-lipoxygenase	NN	O	5-lipoxygenase	prep_of	12	SENT_393	[p18l1649t2445r2149b2534],
15	.	.	O	.	_	0	SENT_393	[p18l1649t2445r2149b2534],

1	Hum	NNP	PERSON	Hum	nn	2	SENT_394	[p18l156t2551r296b2616],
2	Genet	NNP	PERSON	Genet	_	0	SENT_394	[p18l329t2551r538b2616],
3	.	.	O	.	_	0	SENT_394	[p18l329t2551r538b2616],

1	2004	CD	DATE	2004	_	0	SENT_395	[p18l567t2551r1169b2627],
2	;	:	O	;	_	0	SENT_395	[p18l567t2551r1169b2627],
3	114:337	CD	NUMBER	114:337	number	4	SENT_395	[p18l567t2551r1169b2627],
4	-44	CD	NUMBER	-44	dep	1	SENT_395	[p18l567t2551r1169b2627],
5	.	.	O	.	_	0	SENT_395	[p18l567t2551r1169b2627],

1	Park	NNP	O	Park	nn	2	SENT_396	[p18l156t2648r290b2717],
2	JS	NNP	O	JS	_	0	SENT_396	[p18l316t2651r402b2733],
3	,	,	O	,	_	0	SENT_396	[p18l316t2651r402b2733],
4	Chang	NNP	PERSON	Chang	nn	5	SENT_396	[p18l442t2648r647b2737],
5	HS	NN	O	h	appos	2	SENT_396	[p18l689t2651r783b2727],
6	,	,	O	,	_	0	SENT_396	[p18l689t2651r783b2727],
7	Park	NNP	ORGANIZATION	Park	nn	8	SENT_396	[p18l825t2648r958b2717],
8	CS	NNP	ORGANIZATION	CS	appos	5	SENT_396	[p18l997t2651r1091b2727],
9	,	,	O	,	_	0	SENT_396	[p18l997t2651r1091b2727],
10	Lee	NNP	PERSON	Lee	nn	11	SENT_396	[p18l1133t2652r1234b2717],
11	JH	NNP	O	JH	appos	5	SENT_396	[p18l1262t2652r1363b2733],
12	,	,	O	,	_	0	SENT_396	[p18l1262t2652r1363b2733],
13	Lee	NNP	PERSON	Lee	nn	14	SENT_396	[p18l1405t2652r1505b2717],
14	YM	NNP	PERSON	YM	appos	5	SENT_396	[p18l1538t2652r1664b2727],
15	,	,	O	,	_	0	SENT_396	[p18l1538t2652r1664b2727],
16	Choi	NNP	O	Choi	nn	17	SENT_396	[p18l1704t2648r1844b2717],
17	JH	NNP	O	JH	appos	5	SENT_396	[p18l1873t2652r1974b2733],
18	,	,	O	,	_	0	SENT_396	[p18l1873t2652r1974b2733],
19	Park	NNP	O	Park	nn	20	SENT_396	[p18l2016t2648r2150b2717],
20	HS	NN	O	h	appos	5	SENT_396	[p18l156t2752r250b2828],
21	,	,	O	,	_	0	SENT_396	[p18l156t2752r250b2828],
22	Kim	NNP	PERSON	Kim	nn	23	SENT_396	[p18l289t2751r400b2817],
23	LH	NNP	O	LH	appos	5	SENT_396	[p18l442t2753r537b2828],
24	,	,	O	,	_	0	SENT_396	[p18l442t2753r537b2828],
25	Park	NNP	O	Park	nn	26	SENT_396	[p18l574t2749r708b2817],
26	BL	NN	O	bl	appos	5	SENT_396	[p18l745t2753r834b2828],
27	,	,	O	,	_	0	SENT_396	[p18l745t2753r834b2828],
28	Choi	NNP	PERSON	Choi	nn	29	SENT_396	[p18l871t2749r1011b2817],
29	YH	NNP	O	YH	appos	5	SENT_396	[p18l1040t2753r1151b2828],
30	,	,	O	,	_	0	SENT_396	[p18l1040t2753r1151b2828],
31	Shin	NNP	PERSON	Shin	nn	32	SENT_396	[p18l1186t2749r1316b2817],
32	HD	NNP	O	HD	appos	5	SENT_396	[p18l1358t2753r1463b2818],
33	.	.	O	.	_	0	SENT_396	[p18l1358t2753r1463b2818],

1	Association	NN	O	association	nn	2	SENT_397	[p18l1491t2751r1860b2817],
2	analysis	NN	O	analysis	nsubj	10	SENT_397	[p18l1898t2749r2148b2838],
3	of	IN	O	of	_	0	SENT_397	[p18l153t2850r217b2919],
4	cysteinyl	NN	O	cysteinyl	nn	7	SENT_397	[p18l245t2851r906b2939],
5	—	NN	O	—	nn	7	SENT_397	[p18l245t2851r906b2939],
6	leukotriene	NN	O	leukotriene	nn	7	SENT_397	[p18l245t2851r906b2939],
7	receptor	NN	O	receptor	prep_of	2	SENT_397	[p18l942t2860r1205b2939],
8	2	CD	NUMBER	2	num	10	SENT_397	[p18l1237t2854r1271b2918],
9	(	CD	NUMBER	(	num	10	SENT_397	[p18l1307t2854r1629b2932],
10	CYSLTR2	NN	O	cysltr2	_	0	SENT_397	[p18l1307t2854r1629b2932],
11	)	CD	NUMBER	)	num	12	SENT_397	[p18l1307t2854r1629b2932],
12	polymorphisms	NNS	O	polymorphism	dobj	10	SENT_397	[p18l1665t2851r2148b2939],
13	with	IN	O	with	_	0	SENT_397	[p18l151t2951r287b3020],
14	aspirin	NN	O	aspirin	nn	15	SENT_397	[p18l365t2953r573b3040],
15	intolerance	NN	O	intolerance	prep_with	12	SENT_397	[p18l653t2951r1006b3020],
16	in	IN	O	in	_	0	SENT_397	[p18l1084t2953r1132b3019],
17	asthmatics	NNS	O	asthmatic	prep_in	10	SENT_397	[p18l1210t2951r1569b3020],
18	.	.	O	.	_	0	SENT_397	[p18l1210t2951r1569b3020],

1	Pharmacogenet	NNP	O	Pharmacogenet	nn	2	SENT_398	[p18l1647t2951r2150b3040],
2	Genomics	NNPS	O	Genomics	_	0	SENT_398	[p18l154t3055r483b3122],
3	.	.	O	.	_	0	SENT_398	[p18l154t3055r483b3122],

1	2005	CD	DATE	2005	_	0	SENT_399	[p18l512t3056r1071b3132],
2	;	:	O	;	_	0	SENT_399	[p18l512t3056r1071b3132],
3	15:483	CD	NUMBER	15:483	number	4	SENT_399	[p18l512t3056r1071b3132],
4	-92	CD	NUMBER	-92	dep	1	SENT_399	[p18l512t3056r1071b3132],
5	.	.	O	.	_	0	SENT_399	[p18l512t3056r1071b3132],

1	Kim	NNP	PERSON	Kim	nn	2	SENT_400	[p19l157t21r268b87],
2	SH	NNP	O	SH	_	0	SENT_400	[p19l319t22r420b98],
3	,	,	O	,	_	0	SENT_400	[p19l319t22r420b98],
4	Choi	NNP	PERSON	Choi	nn	5	SENT_400	[p19l468t19r608b87],
5	JH	NNP	O	JH	appos	2	SENT_400	[p19l647t23r748b103],
6	,	,	O	,	_	0	SENT_400	[p19l647t23r748b103],
7	Lee	NNP	O	Lee	nn	8	SENT_400	[p19l798t23r899b87],
8	KW	NNP	O	KW	appos	5	SENT_400	[p19l952t23r1068b98],
9	,	,	O	,	_	0	SENT_400	[p19l952t23r1068b98],
10	Kim	NNP	PERSON	Kim	nn	11	SENT_400	[p19l1119t21r1230b87],
11	SH	NNP	O	SH	nsubj	17	SENT_400	[p19l1282t22r1382b98],
12	,	,	O	,	_	0	SENT_400	[p19l1282t22r1382b98],
13	Shin	NNP	PERSON	Shin	nn	14	SENT_400	[p19l1430t19r1560b87],
14	ES	NN	PERSON	e	dep	11	SENT_400	[p19l1615t22r1699b98],
15	,	,	O	,	_	0	SENT_400	[p19l1615t22r1699b98],
16	Oh	UH	O	oh	dep	17	SENT_400	[p19l1747t19r1831b87],
17	HB	NN	O	hb	rcmod	5	SENT_400	[p19l1885t23r1986b98],
18	,	,	O	,	_	0	SENT_400	[p19l1885t23r1986b98],
19	Suh	NNP	PERSON	Suh	nn	20	SENT_400	[p19l2034t19r2145b87],
20	CH	NN	O	ch	appos	2	SENT_400	[p19l154t122r264b198],
21	,	,	O	,	_	0	SENT_400	[p19l154t122r264b198],
22	Nahm	NNP	ORGANIZATION	Nahm	nn	23	SENT_400	[p19l324t119r507b188],
23	DH	NNP	O	DH	appos	2	SENT_400	[p19l571t123r680b198],
24	,	,	O	,	_	0	SENT_400	[p19l571t123r680b198],
25	Park	NNP	O	Park	nn	26	SENT_400	[p19l741t119r874b188],
26	HS	NN	O	h	appos	2	SENT_400	[p19l933t122r1028b188],
27	.	.	O	.	_	0	SENT_400	[p19l933t122r1028b188],

1	The	DT	O	the	det	11	SENT_401	[p19l1078t119r1188b188],
2	human	JJ	O	human	amod	11	SENT_401	[p19l1249t119r1463b188],
3	leucocyte	NN	O	leucocyte	nn	11	SENT_401	[p19l1526t119r1821b208],
4	antigenDRB1	NN	O	antigendrb1	nn	11	SENT_401	[p19l1880t121r2148b208, p19l156t220r1391b302],
5	*	CD	NUMBER	*	num	11	SENT_401	[p19l1880t121r2148b208, p19l156t220r1391b302],
6	1302-DQB1	NN	O	1302-dqb1	nn	11	SENT_401	[p19l1880t121r2148b208, p19l156t220r1391b302],
7	*	CD	NUMBER	*	num	11	SENT_401	[p19l1880t121r2148b208, p19l156t220r1391b302],
8	0609-DPBl	NN	O	0609-dpbl	nn	11	SENT_401	[p19l1880t121r2148b208, p19l156t220r1391b302],
9	*	CD	NUMBER	*	num	11	SENT_401	[p19l1880t121r2148b208, p19l156t220r1391b302],
10	O201	NN	O	o201	nn	11	SENT_401	[p19l1880t121r2148b208, p19l156t220r1391b302],
11	haplotype	NN	O	haplotype	nsubj	17	SENT_401	[p19l1454t220r1767b309],
12	may	MD	O	may	aux	17	SENT_401	[p19l1819t239r1947b309],
13	be	VB	O	be	cop	17	SENT_401	[p19l1996t220r2065b288],
14	a	DT	O	a	det	17	SENT_401	[p19l2115t239r2145b288],
15	strong	JJ	O	strong	amod	17	SENT_401	[p19l152t331r355b410],
16	genetic	JJ	O	genetic	amod	17	SENT_401	[p19l388t324r621b410],
17	marker	NN	O	marker	_	0	SENT_401	[p19l659t322r878b390],
18	for	IN	O	for	mark	21	SENT_401	[p19l910t321r997b390],
19	aspirin	NN	O	aspirin	nn	20	SENT_401	[p19l1032t322r1525b410],
20	—	NN	O	—	nsubj	21	SENT_401	[p19l1032t322r1525b410],
21	induced	VBD	O	induce	advcl	17	SENT_401	[p19l1032t322r1525b410],
22	urticaria	NN	O	urticarium	dobj	21	SENT_401	[p19l1566t324r1846b390],
23	.	.	O	.	_	0	SENT_401	[p19l1566t324r1846b390],

1	Clin	NNP	O	Clin	nn	3	SENT_402	[p19l1883t322r1999b390],
2	Exp	NNP	O	Exp	nn	3	SENT_402	[p19l2042t326r2146b410],
3	Allergy	NNP	O	Allergy	_	0	SENT_402	[p19l150t422r388b511],
4	.	.	O	.	_	0	SENT_402	[p19l150t422r388b511],

1	2005	CD	DATE	2005	_	0	SENT_403	[p19l417t425r976b501],
2	;	:	O	;	_	0	SENT_403	[p19l417t425r976b501],
3	35:339	CD	NUMBER	35:339	number	4	SENT_403	[p19l417t425r976b501],
4	-44	CD	NUMBER	-44	dep	1	SENT_403	[p19l417t425r976b501],
5	.	.	O	.	_	0	SENT_403	[p19l417t425r976b501],

1	Asad	NNP	PERSON	Asad	nn	2	SENT_404	[p19l150t524r306b592],
2	SI	NNP	PERSON	SI	_	0	SENT_404	[p19l357t527r428b603],
3	,	,	O	,	_	0	SENT_404	[p19l357t527r428b603],
4	Murdoch	NNP	PERSON	Murdoch	nn	5	SENT_404	[p19l479t524r757b592],
5	R	NNP	PERSON	R	appos	2	SENT_404	[p19l811t528r865b603],
6	,	,	O	,	_	0	SENT_404	[p19l811t528r865b603],
7	Youlten	NNP	ORGANIZATION	Youlten	nn	8	SENT_404	[p19l904t524r1143b592],
8	LJ	NNP	ORGANIZATION	LJ	appos	2	SENT_404	[p19l1197t528r1265b609],
9	,	,	O	,	_	0	SENT_404	[p19l1197t528r1265b609],
10	Lessof	NNP	O	Lessof	nn	11	SENT_404	[p19l1315t524r1513b593],
11	MH	NNP	O	MH	appos	2	SENT_404	[p19l1559t528r1684b593],
12	.	.	O	.	_	0	SENT_404	[p19l1559t528r1684b593],

1	Plasma	NN	O	plasma	nn	2	SENT_405	[p19l1734t524r1955b593],
2	level	NN	O	level	_	0	SENT_405	[p19l2008t524r2145b592],
3	of	IN	O	of	_	0	SENT_405	[p19l153t625r217b694],
4	histamine	NN	O	histamine	prep_of	2	SENT_405	[p19l284t626r592b694],
5	in	IN	O	in	_	0	SENT_405	[p19l665t628r713b693],
6	aspirin	NN	O	aspirin	npadvmod	8	SENT_405	[p19l786t628r1305b714],
7	—	CD	NUMBER	—	num	6	SENT_405	[p19l786t628r1305b714],
8	sensitive	JJ	O	sensitive	amod	9	SENT_405	[p19l786t628r1305b714],
9	urticaria	NN	O	urticarium	prep_in	2	SENT_405	[p19l1378t628r1657b694],
10	.	.	O	.	_	0	SENT_405	[p19l1378t628r1657b694],

1	Ann	NNP	PERSON	Ann	nn	2	SENT_406	[p19l1719t629r1845b693],
2	Allergy	NNP	PERSON	Allergy	_	0	SENT_406	[p19l1910t626r2149b714],
3	.	.	O	.	_	0	SENT_406	[p19l1910t626r2149b714],

1	1987	CD	DATE	1987	_	0	SENT_407	[p19l156t730r712b806],
2	;	:	O	;	_	0	SENT_407	[p19l156t730r712b806],
3	59:219	CD	NUMBER	59:219	number	4	SENT_407	[p19l156t730r712b806],
4	-22	CD	NUMBER	-22	dep	1	SENT_407	[p19l156t730r712b806],
5	.	.	O	.	_	0	SENT_407	[p19l156t730r712b806],

1	Krause	NNP	PERSON	Krause	nn	2	SENT_408	[p19l157t832r366b896],
2	LB	NNP	O	LB	nsubj	6	SENT_408	[p19l409t832r495b907],
3	,	,	O	,	_	0	SENT_408	[p19l409t832r495b907],
4	Shuster	NNP	PERSON	Shuster	nn	5	SENT_408	[p19l533t828r771b896],
5	S.	NNP	O	S.	nsubj	6	SENT_408	[p19l808t831r856b897],
6	Enhanced	VBD	O	enhance	_	0	SENT_408	[p19l898t828r1202b896],
7	weal	NN	O	weal	nn	10	SENT_408	[p19l1242t828r1391b896],
8	and	CC	O	and	_	0	SENT_408	[p19l1432t828r1545b896],
9	Dare	NN	O	dare	nn	10	SENT_408	[p19l1590t832r1725b896],
10	response	NN	O	response	dobj	6	SENT_408	[p19l1766t847r2048b917],
11	to	TO	O	to	_	0	SENT_408	[p19l2086t837r2146b896],
12	histamine	NN	O	histamine	prep_to	6	SENT_408	[p19l155t930r463b998],
13	in	IN	O	in	_	0	SENT_408	[p19l497t932r545b997],
14	chronic	JJ	O	chronic	amod	16	SENT_408	[p19l579t930r809b998],
15	idiopathic	JJ	O	idiopathic	amod	16	SENT_408	[p19l841t930r1155b1018],
16	urticaria	NN	O	urticarium	prep_in	6	SENT_408	[p19l1187t932r1466b998],
17	.	.	O	.	_	0	SENT_408	[p19l1187t932r1466b998],

1	Br	NN	O	br	_	0	SENT_409	[p19l1500t934r1605b1014],
2	]	CD	NUMBER	]	num	1	SENT_409	[p19l1500t934r1605b1014],
3	Clin	NNP	PERSON	Clin	nn	4	SENT_409	[p19l1642t930r1758b998],
4	Pharmacol	NNP	PERSON	Pharmacol	dep	1	SENT_409	[p19l1795t930r2149b998],
5	.	.	O	.	_	0	SENT_409	[p19l1795t930r2149b998],

1	1985	CD	DATE	1985	_	0	SENT_410	[p19l156t1034r669b1110],
2	;	:	O	;	_	0	SENT_410	[p19l156t1034r669b1110],
3	20:486	CD	NUMBER	20:486	number	4	SENT_410	[p19l156t1034r669b1110],
4	-8	CD	NUMBER	-8	dep	1	SENT_410	[p19l156t1034r669b1110],
5	.	.	O	.	_	0	SENT_410	[p19l156t1034r669b1110],

1	Sanchez-Borges	NNP	O	Sanchez-Borges	nn	2	SENT_411	[p19l153t1132r665b1221],
2	M	NNP	O	M	_	0	SENT_411	[p19l722t1136r797b1211],
3	,	,	O	,	_	0	SENT_411	[p19l722t1136r797b1211],
4	Capriles-Hulett	NNP	O	Capriles-Hulett	nn	5	SENT_411	[p19l851t1132r1335b1221],
5	A	NNP	O	A	appos	2	SENT_411	[p19l1378t1136r1444b1211],
6	,	,	O	,	_	0	SENT_411	[p19l1378t1136r1444b1211],
7	Capriles-Behrens	NNP	O	Capriles-Behrens	nn	8	SENT_411	[p19l1498t1132r2043b1221],
8	E	NNP	O	E	appos	2	SENT_411	[p19l2100t1136r2149b1211],
9	,	,	O	,	_	0	SENT_411	[p19l2100t1136r2149b1211],
10	Fernandez	NNP	PERSON	Fernandez	appos	2	SENT_411	[p19l156t1234r728b1302],
11	.	.	O	.	_	0	SENT_411	[p19l156t1234r728b1302],

1	—	NN	O	—	_	0	SENT_412	[p19l156t1234r728b1302],
2	.	.	O	.	_	0	SENT_412	[p19l156t1234r728b1302],

1	Caldas	FW	O	caldas	nn	4	SENT_413	[p19l156t1234r728b1302],
2	E.A	FW	O	e.a	nn	4	SENT_413	[p19l757t1237r871b1302],
3	new	JJ	O	new	amod	4	SENT_413	[p19l897t1253r1026b1302],
4	triad	NN	O	triad	_	0	SENT_413	[p19l1048t1234r1215b1302],
5	:	:	O	:	_	0	SENT_413	[p19l1048t1234r1215b1302],
6	sensitivity	NN	O	sensitivity	nn	8	SENT_413	[p19l1239t1236r1555b1322],
7	to	TO	O	to	dep	8	SENT_413	[p19l1576t1243r1637b1302],
8	aspirin	NN	O	aspirin	dep	4	SENT_413	[p19l1663t1236r1894b1322],
9	,	,	O	,	_	0	SENT_413	[p19l1663t1236r1894b1322],
10	allergic	JJ	O	allergic	amod	11	SENT_413	[p19l1919t1234r2148b1322],
11	rhinitis	NN	O	rhinitis	dep	4	SENT_413	[p19l154t1334r385b1413],
12	,	,	O	,	_	0	SENT_413	[p19l154t1334r385b1413],
13	and	CC	O	and	_	0	SENT_413	[p19l410t1334r523b1403],
14	severe	JJ	O	severe	amod	16	SENT_413	[p19l551t1353r752b1403],
15	allergic	JJ	O	allergic	amod	16	SENT_413	[p19l778t1334r1007b1423],
16	reaction	NN	O	reaction	dep	4	SENT_413	[p19l1034t1336r1287b1403],
17	to	TO	O	to	aux	18	SENT_413	[p19l1313t1343r1375b1403],
18	ingested	VBN	O	ingest	infmod	16	SENT_413	[p19l1404t1334r1669b1423],
19	aeroallergens	NNS	O	aeroallergen	dobj	18	SENT_413	[p19l1698t1334r2149b1423],
20	.	.	O	.	_	0	SENT_413	[p19l1698t1334r2149b1423],

1	Cutis	NNP	PERSON	Cutis	_	0	SENT_414	[p19l154t1438r328b1505],
2	.	.	O	.	_	0	SENT_414	[p19l154t1438r328b1505],

1	1997	CD	DATE	1997	_	0	SENT_415	[p19l360t1439r727b1515],
2	;	:	O	;	_	0	SENT_415	[p19l360t1439r727b1515],
3	59:31	CD	NUMBER	59:31	number	4	SENT_415	[p19l360t1439r727b1515],
4	1	CD	NUMBER	1	dep	1	SENT_415	[p19l750t1440r770b1504],
5	-4	CD	NUMBER	-4	dep	4	SENT_415	[p19l790t1439r872b1505],
6	.	.	O	.	_	0	SENT_415	[p19l790t1439r872b1505],

1	Sanchez	NNP	PERSON	Sanchez	_	0	SENT_416	[p19l153t1537r665b1626],
2	.	.	O	.	_	0	SENT_416	[p19l153t1537r665b1626],

1	—	NN	O	—	_	0	SENT_417	[p19l153t1537r665b1626],
2	.	.	O	.	_	0	SENT_417	[p19l153t1537r665b1626],

1	Borges	NNP	O	Borges	nn	2	SENT_418	[p19l153t1537r665b1626],
2	M	NNP	O	M	_	0	SENT_418	[p19l695t1542r769b1617],
3	,	,	O	,	_	0	SENT_418	[p19l695t1542r769b1617],
4	Capriles	NNP	PERSON	Capriles	appos	2	SENT_418	[p19l796t1538r1569b1626],
5	.	.	O	.	_	0	SENT_418	[p19l796t1538r1569b1626],

1	—	NN	O	—	_	0	SENT_419	[p19l796t1538r1569b1626],
2	.	.	O	.	_	0	SENT_419	[p19l796t1538r1569b1626],

1	HulettA	NN	O	huletta	_	0	SENT_420	[p19l796t1538r1569b1626],
2	.	.	O	.	_	0	SENT_420	[p19l796t1538r1569b1626],

1	Atopy	NN	O	atopy	nsubj	5	SENT_421	[p19l796t1538r1569b1626],
2	is	VBZ	O	be	cop	5	SENT_421	[p19l1595t1540r1637b1606],
3	a	DT	O	a	det	5	SENT_421	[p19l1663t1557r1693b1606],
4	risk	NN	O	risk	nn	5	SENT_421	[p19l1724t1538r1831b1606],
5	factor	NN	O	factor	_	0	SENT_421	[p19l1853t1537r2040b1606],
6	for	IN	O	for	_	0	SENT_421	[p19l2062t1537r2150b1606],
7	non-steroidal	JJ	O	non-steroidal	amod	10	SENT_421	[p19l155t1638r578b1707],
8	anti-inﬂammatory	JJ	O	anti-inﬂammatory	amod	10	SENT_421	[p19l617t1640r1197b1727],
9	drug	NN	O	drug	nn	10	SENT_421	[p19l1231t1638r1375b1727],
10	sensitivity	NN	O	sensitivity	prep_for	5	SENT_421	[p19l1410t1640r1740b1727],
11	.	.	O	.	_	0	SENT_421	[p19l1410t1640r1740b1727],

1	Ann	NNP	PERSON	Ann	nn	4	SENT_422	[p19l1767t1642r1894b1706],
2	Allergy	NNP	PERSON	Allergy	nn	4	SENT_422	[p19l1925t1638r2150b1727],
3	Asthma	NNP	PERSON	Asthma	nn	4	SENT_422	[p19l150t1739r393b1807],
4	Immunol	NNP	PERSON	Immunol	_	0	SENT_422	[p19l424t1739r725b1808],
5	.	.	O	.	_	0	SENT_422	[p19l424t1739r725b1808],

1	2000	CD	DATE	2000	_	0	SENT_423	[p19l754t1742r1269b1818],
2	;	:	O	;	_	0	SENT_423	[p19l754t1742r1269b1818],
3	84:101	CD	NUMBER	84:101	number	4	SENT_423	[p19l754t1742r1269b1818],
4	-6	CD	NUMBER	-6	dep	1	SENT_423	[p19l754t1742r1269b1818],
5	.	.	O	.	_	0	SENT_423	[p19l754t1742r1269b1818],

1	Acevedo	NNP	PERSON	Acevedo	nn	2	SENT_424	[p19l150t1841r424b1909],
2	N	NNP	O	N	nsubjpass	24	SENT_424	[p19l470t1845r529b1920],
3	,	,	O	,	_	0	SENT_424	[p19l470t1845r529b1920],
4	Vergara	NNP	PERSON	Vergara	nn	5	SENT_424	[p19l562t1845r807b1929],
5	C	NNP	O	C	appos	2	SENT_424	[p19l853t1844r909b1920],
6	,	,	O	,	_	0	SENT_424	[p19l853t1844r909b1920],
7	Mercado	NNP	ORGANIZATION	Mercado	nn	8	SENT_424	[p19l954t1841r1229b1909],
8	D	NNP	ORGANIZATION	D	appos	2	SENT_424	[p19l1275t1845r1330b1920],
9	,	,	O	,	_	0	SENT_424	[p19l1275t1845r1330b1920],
10	Jimenez	NNP	PERSON	Jimenez	nn	11	SENT_424	[p19l1359t1843r1623b1925],
11	S	NNP	O	S	appos	2	SENT_424	[p19l1665t1844r1713b1920],
12	,	,	O	,	_	0	SENT_424	[p19l1665t1844r1713b1920],
13	Caraballo	NNP	PERSON	Caraballo	nn	17	SENT_424	[p19l1755t1841r2058b1909],
14	L.	NNP	O	L.	nn	17	SENT_424	[p19l2104t1845r2149b1909],
15	The	NNP	O	The	nn	17	SENT_424	[p19l150t1941r260b2010],
16	A-444C	NN	O	a-444c	nn	17	SENT_424	[p19l290t1944r541b2010],
17	polymorphism	NN	O	polymorphism	appos	2	SENT_424	[p19l580t1941r1028b2030],
18	of	IN	O	of	_	0	SENT_424	[p19l1068t1941r1132b2010],
19	leukotriene	NN	O	leukotriene	nn	22	SENT_424	[p19l1165t1941r1521b2010],
20	C4	NN	O	c4	nn	22	SENT_424	[p19l1560t1944r1644b2010],
21	synthase	NN	O	synthase	nn	22	SENT_424	[p19l1679t1941r1957b2030],
22	gene	NN	O	gene	prep_of	17	SENT_424	[p19l1993t1960r2147b2030],
23	is	VBZ	O	be	auxpass	24	SENT_424	[p19l155t2044r196b2110],
24	associated	VBN	O	associate	_	0	SENT_424	[p19l259t2042r593b2110],
25	with	IN	O	with	_	0	SENT_424	[p19l656t2042r792b2110],
26	IgE	NN	O	ige	nn	27	SENT_424	[p19l857t2046r951b2131],
27	antibodies	NNS	O	antibody	prep_with	24	SENT_424	[p19l1016t2042r1349b2110],
28	to	TO	O	to	_	0	SENT_424	[p19l1409t2051r1471b2110],
29	Dermatophagoides	JJ	LOCATION	dermatophagoides	amod	30	SENT_424	[p19l1538t2042r2148b2131],
30	pteronyssinus	NN	O	pteronyssinus	prep_to	24	SENT_424	[p19l155t2146r592b2232],
31	in	IN	O	in	_	0	SENT_424	[p19l651t2146r700b2211],
32	a	DT	O	a	det	34	SENT_424	[p19l760t2163r790b2212],
33	Colombian	JJ	LOCATION	colombian	amod	34	SENT_424	[p19l852t2144r1195b2212],
34	population	NN	O	population	prep_in	30	SENT_424	[p19l1258t2144r1692b2232],
35	.	.	O	.	_	0	SENT_424	[p19l1258t2144r1692b2232],

1	j	NN	O	j	_	0	SENT_425	[p19l1258t2144r1692b2232],
2	Allergy	NNP	O	Allergy	nn	4	SENT_425	[p19l1747t2144r1972b2232],
3	Clin	NNP	O	Clin	nn	4	SENT_425	[p19l2028t2144r2145b2212],
4	Immunol	NNP	O	Immunol	dep	1	SENT_425	[p19l152t2244r453b2313],
5	.	.	O	.	_	0	SENT_425	[p19l152t2244r453b2313],

1	2007	CD	DATE	2007	_	0	SENT_426	[p19l482t2247r1041b2323],
2	;	:	O	;	_	0	SENT_426	[p19l482t2247r1041b2323],
3	119:505	CD	NUMBER	119:505	number	4	SENT_426	[p19l482t2247r1041b2323],
4	-7	CD	NUMBER	-7	dep	1	SENT_426	[p19l482t2247r1041b2323],
5	.	.	O	.	_	0	SENT_426	[p19l482t2247r1041b2323],

1	©	RB	O	©	dep	2	SENT_427	[p19l1368t2490r1420b2541],
2	2009	CD	DATE	2009	dep	4	SENT_427	[p19l1443t2490r1587b2542],
3	Esmon	NNP	O	Esmon	nn	4	SENT_427	[p19l1609t2491r1814b2541],
4	Publicidad	NNP	O	Publicidad	_	0	SENT_427	[p19l1834t2490r2151b2541],

1	The	DT	O	the	det	3	SENT_428	[p19l745t2617r803b2643],
2	A-444C	NN	O	a-444c	nn	3	SENT_428	[p19l811t2617r937b2643],
3	SNP	NN	O	snp	_	0	SENT_428	[p19l949t2617r1016b2643],
4	and	CC	O	and	_	0	SENT_428	[p19l1025t2617r1078b2643],
5	Aspirin-Induced	JJ	O	aspirin-induced	amod	6	SENT_428	[p19l1086t2617r1331b2651],
6	Urticaria	NN	O	urticarium	conj_and	3	SENT_428	[p19l1341t2617r1474b2643],
7	382	CD	NUMBER	382	dep	3	SENT_428	[p19l2041t2617r2100b2645],

1	Bae	NNP	ORGANIZATION	Bae	nn	2	SENT_429	[p19l157t2839r269b2904],
2	JS	NNP	O	JS	_	0	SENT_429	[p19l300t2839r387b2920],
3	,	,	O	,	_	0	SENT_429	[p19l300t2839r387b2920],
4	Kim	NNP	PERSON	Kim	nn	5	SENT_429	[p19l432t2838r543b2903],
5	SH	NNP	O	SH	appos	2	SENT_429	[p19l589t2839r690b2915],
6	,	,	O	,	_	0	SENT_429	[p19l589t2839r690b2915],
7	Ye	NNP	PERSON	Ye	nn	8	SENT_429	[p19l724t2839r795b2904],
8	YM	NNP	PERSON	YM	appos	5	SENT_429	[p19l831t2839r957b2915],
9	,	,	O	,	_	0	SENT_429	[p19l831t2839r957b2915],
10	Yoon	NNP	PERSON	Yoon	nn	12	SENT_429	[p19l991t2839r1148b2904],
11	H	NNP	O	H	nn	12	SENT_429	[p19l1196t2839r1279b2920],
12	]	NN	O	]	appos	5	SENT_429	[p19l1196t2839r1279b2920],
13	,	,	O	,	_	0	SENT_429	[p19l1196t2839r1279b2920],
14	Suh	NNP	PERSON	Suh	nn	15	SENT_429	[p19l1321t2836r1433b2904],
15	CH	NN	O	ch	appos	5	SENT_429	[p19l1479t2839r1589b2915],
16	,	,	O	,	_	0	SENT_429	[p19l1479t2839r1589b2915],
17	Nahm	NNP	ORGANIZATION	Nahm	nn	18	SENT_429	[p19l1634t2836r1816b2904],
18	DH	NNP	O	DH	appos	5	SENT_429	[p19l1865t2839r1974b2915],
19	,	,	O	,	_	0	SENT_429	[p19l1865t2839r1974b2915],
20	Park	NNP	O	Park	nn	21	SENT_429	[p19l2019t2836r2153b2904],
21	HS	NN	O	h	appos	5	SENT_429	[p19l157t2939r251b3005],
22	.	.	O	.	_	0	SENT_429	[p19l157t2939r251b3005],

1	Signiﬁcant	JJ	O	signiﬁcant	amod	2	SENT_430	[p19l312t2938r649b3025],
2	association	NN	O	association	_	0	SENT_430	[p19l709t2938r1065b3005],
3	of	IN	O	of	_	0	SENT_430	[p19l1130t2936r1193b3005],
4	FcepsilonRIalpha	NN	O	fcepsilonrialpha	nn	6	SENT_430	[p19l1253t2936r1792b3025],
5	promoter	NN	O	promoter	nn	6	SENT_430	[p19l1859t2945r2153b3025],
6	polymorphisms	NNS	O	polymorphism	prep_of	2	SENT_430	[p19l156t3037r628b3126],
7	with	IN	O	with	_	0	SENT_430	[p19l692t3037r826b3105],
8	aspirin-intolerant	JJ	O	aspirin-intolerant	amod	10	SENT_430	[p19l895t3037r1437b3126],
9	chronic	JJ	O	chronic	amod	10	SENT_430	[p19l1502t3037r1726b3105],
10	urticaria	NN	O	urticarium	prep_with	2	SENT_430	[p19l1794t3039r2066b3106],
11	.	.	O	.	_	0	SENT_430	[p19l1794t3039r2066b3106],

1	J	NNP	O	J	nn	4	SENT_431	[p19l2120t3041r2146b3121],
2	Allergy	NNP	O	Allergy	nn	4	SENT_431	[p19l150t3139r370b3227],
3	Clin	NNP	O	Clin	nn	4	SENT_431	[p19l397t3139r511b3207],
4	Immunol	NNP	O	Immunol	_	0	SENT_431	[p19l540t3139r835b3207],
5	.	.	O	.	_	0	SENT_431	[p19l540t3139r835b3207],

1	2007	CD	DATE	2007	_	0	SENT_432	[p19l862t3142r1452b3217],
2	;	:	O	;	_	0	SENT_432	[p19l862t3142r1452b3217],
3	119:449	CD	NUMBER	119:449	number	4	SENT_432	[p19l862t3142r1452b3217],
4	-56	CD	NUMBER	-56	dep	1	SENT_432	[p19l862t3142r1452b3217],
5	.	.	O	.	_	0	SENT_432	[p19l862t3142r1452b3217],

1	©	RB	O	©	dep	2	SENT_433	[p19l8t3248r59b3299],
2	2009	CD	DATE	2009	dep	4	SENT_433	[p19l82t3248r226b3300],
3	Esmon	NNP	O	Esmon	nn	4	SENT_433	[p19l248t3249r454b3299],
4	Publicidad	NNP	O	Publicidad	_	0	SENT_433	[p19l474t3248r791b3299],

1	I	PRP	O	I	nsubj	2	SENT_434	[p19l7t3340r37b3401],
2	Manuscr/pt	VBP	O	manuscr/pt	_	0	SENT_434	[p19l103t3343r527b3420],
3	rece/I/ea	NN	O	rece/i/ea	prep	2	SENT_434	[p19l571t3341r891b3402],
4	’	CD	NUMBER	’	dobj	2	SENT_434	[p19l571t3341r891b3402],
5	/	:	O	/	punct	7	SENT_434	[p19l913t3344r1232b3420],
6	anuary	JJ	O	anuary	amod	7	SENT_434	[p19l913t3344r1232b3420],
7	7	CD	NUMBER	7	dep	4	SENT_434	[p19l1282t3344r1335b3411],
8	,	,	O	,	_	0	SENT_434	[p19l1282t3344r1335b3411],
9	2009	CD	DATE	2009	appos	7	SENT_434	[p19l1395t3343r1599b3411],
10	,	,	O	,	_	0	SENT_434	[p19l1395t3343r1599b3411],
11	‘	CD	NUMBER	‘	appos	9	SENT_434	[p19l1395t3343r1599b3411],
12	accepted	VBN	O	accept	partmod	11	SENT_434	[p19l1651t3341r1991b3420],
13	for	IN	O	for	_	0	SENT_434	[p19l2040t3340r2153b3402],
14	pub	NN	O	pub	prep_for	12	SENT_434	[p19l6t3443r282b3522],
15	/	:	O	/	punct	7	SENT_434	[p19l6t3443r282b3522],
16	/	:	O	/	punct	19	SENT_434	[p19l6t3443r282b3522],
17	ca	MD	O	can	aux	19	SENT_434	[p19l6t3443r282b3522],
18	2	LS	NUMBER	2	dep	19	SENT_434	[p19l290t3444r754b3522],
19	‘	CD	NUMBER	‘	dep	4	SENT_434	[p19l290t3444r754b3522],
20	/	:	O	/	punct	19	SENT_434	[p19l290t3444r754b3522],
21	'	''	O	'	_	0	SENT_434	[p19l290t3444r754b3522],
22	0/7/3	CD	NUMBER	0/7/3	dep	2	SENT_434	[p19l290t3444r754b3522],
23	/	:	O	/	punct	25	SENT_434	[p19l290t3444r754b3522],
24	wary	JJ	O	wary	amod	25	SENT_434	[p19l290t3444r754b3522],
25	26	CD	NUMBER	26	dep	22	SENT_434	[p19l768t3445r872b3513],
26	,	,	O	,	_	0	SENT_434	[p19l768t3445r872b3513],
27	2009	CD	DATE	2009	appos	25	SENT_434	[p19l902t3445r1094b3504],
28	.	.	O	.	_	0	SENT_434	[p19l902t3445r1094b3504],

1	Luis	NNP	PERSON	Luis	nn	3	SENT_435	[p19l139t3689r301b3751],
2	Caraballo	NNP	PERSON	Caraballo	nn	3	SENT_435	[p19l330t3689r699b3752],
3	MD	NNP	O	MD	_	0	SENT_435	[p19l724t3690r889b3766],
4	,	,	O	,	_	0	SENT_435	[p19l724t3690r889b3766],
5	PhD	NN	O	phd	appos	3	SENT_435	[p19l914t3690r1076b3750],

1	Cra	NNP	ORGANIZATION	Cra	dep	7	SENT_436	[p20l140t100r264b161],
2	5	CD	NUMBER	5	num	1	SENT_436	[p20l289t99r324b161],
3	#	#	MONEY	#	dep	4	SENT_436	[p20l352t101r395b160],
4	7-77	CD	MONEY	7-77	dep	1	SENT_436	[p20l419t101r574b161],
5	Cartagena	NNP	LOCATION	Cartagena	dep	7	SENT_436	[p20l603t100r956b179],
6	Colombia	NNP	LOCATION	Colombia	nn	7	SENT_436	[p20l140t200r484b262],
7	E	NNP	O	E	dep	11	SENT_436	[p20l138t301r393b362],
8	—	CD	NUMBER	—	num	9	SENT_436	[p20l138t301r393b362],
9	mai1	NN	O	mai1	dep	7	SENT_436	[p20l138t301r393b362],
10	:	:	O	:	_	0	SENT_436	[p20l138t301r393b362],
11	luiscaraballo@te1ec0m.c0m.co	NN	O	luiscaraballo@te1ec0m.c0m.co	_	0	SENT_436	[p20l424t301r1505b362],

1	J	NNP	O	J	nn	5	SENT_437	[p20l384t530r421b580],
2	Investig	NNP	O	Investig	nn	5	SENT_437	[p20l435t530r668b593],
3	Allergol	NNP	O	Allergol	nn	5	SENT_437	[p20l683t528r927b593],
4	Clin	NNP	O	Clin	nn	5	SENT_437	[p20l949t528r1070b580],
5	Immunol	NNP	O	Immunol	_	0	SENT_437	[p20l1090t528r1354b579],
6	2009	CD	DATE	2009	num	5	SENT_437	[p20l1374t528r1536b589],
7	;	:	O	;	_	0	SENT_437	[p20l1374t528r1536b589],
8	Vol	NNP	O	Vol	dep	5	SENT_437	[p20l1558t528r1672b579],
9	.	.	O	.	_	0	SENT_437	[p20l1558t528r1672b579],

1	19	CD	NUMBER	19	num	2	SENT_438	[p20l1703t528r1870b591],
2	(	CD	NUMBER	(	_	0	SENT_438	[p20l1703t528r1870b591],
3	5	CD	NUMBER	5	num	4	SENT_438	[p20l1703t528r1870b591],
4	)	NN	O	)	dep	2	SENT_438	[p20l1703t528r1870b591],
5	:	:	O	:	_	0	SENT_438	[p20l1703t528r1870b591],
6	375-382	CD	NUMBER	375-382	dep	4	SENT_438	[p20l1898t528r2139b579],

